1	Leukemia	NN	O	leukemia	_	0	SENT_1	[p1l997t86r1096b109],
2	(	CD	NUMBER	(	num	3	SENT_1	[p1l1107t85r1179b112],
3	2007	CD	DATE	2007	dep	1	SENT_1	[p1l1107t85r1179b112],
4	)	CD	NUMBER	)	number	5	SENT_1	[p1l1107t85r1179b112],
5	21	CD	NUMBER	21	dep	3	SENT_1	[p1l1189t85r1223b114],
6	,	,	O	,	_	0	SENT_1	[p1l1189t85r1223b114],
7	2311-2315	CD	DATE	2311-2315	appos	1	SENT_1	[p1l1234t85r1362b109],
8	@	SYM	O	@	dep	10	SENT_1	[p1l2092t81r2154b142],
9	©	CD	NUMBER	©	number	10	SENT_1	[p1l996t124r1012b145],
10	2007	CD	DATE	2007	num	15	SENT_1	[p1l1022t121r1078b145],
11	Nature	NNP	O	Nature	nn	15	SENT_1	[p1l1090t121r1156b144],
12	Publishing	NNP	O	Publishing	nn	15	SENT_1	[p1l1167t121r1272b150],
13	Group	NNP	O	Group	nn	15	SENT_1	[p1l1281t121r1342b150],
14	All	NNP	O	All	nn	15	SENT_1	[p1l1350t121r1375b144],
15	rights	NNS	O	rights	nsubj	16	SENT_1	[p1l1387t121r1442b150],
16	reserved	VBD	O	reserve	rcmod	7	SENT_1	[p1l1452t121r1535b144],
17	0887-6924/07	CD	DURATION	0887-6924/07	dobj	16	SENT_1	[p1l1546t121r1705b147],
18	$	$	MONEY	$	tmod	16	SENT_1	[p1l1716t119r1794b147],
19	30.00	CD	MONEY	30.00	num	18	SENT_1	[p1l1716t119r1794b147],
20	www.nature.com/leu	NN	MONEY	www.nature.com/leu	dep	18	SENT_1	[p1l954t172r1205b196],

1	ORIGINAL	JJ	O	original	amod	2	SENT_2	[p1l6t246r264b285],
2	ARTICLE	NN	O	article	_	0	SENT_2	[p1l284t246r488b285],

1	UGT1	NN	O	ugt1	nn	4	SENT_3	[p1l6t339r136b379],
2	A1	NN	O	a1	nn	4	SENT_3	[p1l146t340r201b378],
3	promoter	NN	O	promoter	nn	4	SENT_3	[p1l228t342r445b392],
4	polymorphism	NN	O	polymorphism	_	0	SENT_3	[p1l463t336r796b392],
5	increases	VBZ	O	increase	dep	4	SENT_3	[p1l816t337r1027b379],
6	risk	NN	O	risk	dobj	5	SENT_3	[p1l1045t336r1125b379],
7	of	IN	O	of	_	0	SENT_3	[p1l1142t336r1189b379],
8	nilotinib-induced	JJ	O	nilotinib-induced	amod	9	SENT_3	[p1l1204t336r1603b379],
9	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	6	SENT_3	[p1l1622t336r2068b392],

1	JB	NN	O	jb	nn	2	SENT_4	[p1l6t448r38b479],
2	Singerl	NN	O	singerl	_	0	SENT_4	[p1l54t440r175b484],
3	,	,	O	,	_	0	SENT_4	[p1l54t440r175b484],
4	Y	NN	O	y	nn	5	SENT_4	[p1l192t448r213b474],
5	Shoug	NN	O	shoug	conj_and	2	SENT_4	[p1l228t440r330b480],
6	,	,	O	,	_	0	SENT_4	[p1l228t440r330b480],
7	F	NN	O	f	nn	8	SENT_4	[p1l348t448r363b474],
8	Giles3	NN	O	giles3	conj_and	2	SENT_4	[p1l378t440r482b480],
9	,	,	O	,	_	0	SENT_4	[p1l378t440r482b480],
10	HM	NNS	O	hm	nn	11	SENT_4	[p1l501t447r559b474],
11	Kantarjian3	NN	O	kantarjian3	conj_and	2	SENT_4	[p1l576t440r760b484],
12	,	,	O	,	_	0	SENT_4	[p1l576t440r760b484],
13	Y	NN	O	y	nn	14	SENT_4	[p1l776t448r797b474],
14	Hsuz	NN	O	hsuz	conj_and	2	SENT_4	[p1l814t440r898b480],
15	,	,	O	,	_	0	SENT_4	[p1l814t440r898b480],
16	AS	JJ	O	as	amod	17	SENT_4	[p1l914t447r956b474],
17	Robevaz	NNP	PERSON	Robevaz	conj_and	2	SENT_4	[p1l973t440r1113b480],
18	,	,	O	,	_	0	SENT_4	[p1l973t440r1113b480],
19	P	NN	O	p	nn	20	SENT_4	[p1l1131t448r1148b474],
20	Raez	NN	O	raez	conj_and	2	SENT_4	[p1l1165t440r1244b480],
21	,	,	O	,	_	0	SENT_4	[p1l1165t440r1244b480],
22	A	DT	O	a	det	23	SENT_4	[p1l1261t447r1284b474],
23	Weitzmanz	NNP	O	Weitzmanz	conj_and	2	SENT_4	[p1l1298t440r1486b480],
24	,	,	O	,	_	0	SENT_4	[p1l1298t440r1486b480],
25	JM	NN	PERSON	jm	nn	26	SENT_4	[p1l1501t447r1544b479],
26	Meyerl	NN	PERSON	meyerl	conj_and	2	SENT_4	[p1l1560t440r1682b484],
27	,	,	O	,	_	0	SENT_4	[p1l1560t440r1682b484],
28	M	NN	O	m	nn	29	SENT_4	[p1l1700t447r1730b474],
29	Duganz	NN	PERSON	duganz	conj_and	2	SENT_4	[p1l1747t440r1864b484],
30	and	CC	O	and	_	0	SENT_4	[p1l8t487r65b516],
31	oG	NN	O	og	nn	32	SENT_4	[p1l81t489r137b516],
32	Ottmann4	NN	O	ottmann4	conj_and	2	SENT_4	[p1l153t482r310b516],

1	’	NN	O	’	nn	3	SENT_5	[p1l10t564r152b600],
2	CIinicaI	NN	O	ciinicaus	nn	3	SENT_5	[p1l10t564r152b600],
3	Pharmacogenetics	NNS	O	pharmacogenetic	dep	20	SENT_5	[p1l163t570r471b610],
4	,	,	O	,	_	0	SENT_5	[p1l163t570r471b610],
5	Novartis	NNP	ORGANIZATION	Novartis	nn	6	SENT_5	[p1l488t572r625b600],
6	Institutes	NNPS	ORGANIZATION	Institutes	appos	3	SENT_5	[p1l637t572r781b600],
7	for	IN	ORGANIZATION	for	_	0	SENT_5	[p1l793t570r839b600],
8	Biomedical	NNP	ORGANIZATION	Biomedical	nn	9	SENT_5	[p1l849t570r1037b600],
9	Research	NNP	ORGANIZATION	Research	prep_for	3	SENT_5	[p1l1049t570r1204b606],
10	,	,	O	,	_	0	SENT_5	[p1l1049t570r1204b606],
11	Cambridge	NNP	LOCATION	Cambridge	appos	9	SENT_5	[p1l1220t570r1408b610],
12	,	,	O	,	_	0	SENT_5	[p1l1220t570r1408b610],
13	MA	NNP	O	MA	appos	9	SENT_5	[p1l1422t572r1489b606],
14	,	,	O	,	_	0	SENT_5	[p1l1422t572r1489b606],
15	USA	NNP	LOCATION	USA	appos	13	SENT_5	[p1l1506t572r1588b606],
16	;	:	O	;	_	0	SENT_5	[p1l1506t572r1588b606],
17	2	CD	NUMBER	2	num	18	SENT_5	[p1l1598t564r1614b582],
18	Oncology	NN	ORGANIZATION	oncology	dep	20	SENT_5	[p1l1617t570r1782b610],
19	Global	NNP	ORGANIZATION	Global	nn	20	SENT_5	[p1l1794t570r1906b600],
20	Development	NNP	ORGANIZATION	Development	dep	52	SENT_5	[p1l1917t570r2148b610],
21	,	,	O	,	_	0	SENT_5	[p1l1917t570r2148b610],
22	Novartis	NNP	ORGANIZATION	Novartis	nn	23	SENT_5	[p1l8t615r145b643],
23	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	appos	20	SENT_5	[p1l159t613r437b649],
24	,	,	O	,	_	0	SENT_5	[p1l159t613r437b649],
25	Florham	NNP	LOCATION	Florham	nn	26	SENT_5	[p1l454t613r589b643],
26	Park	NNP	LOCATION	Park	appos	20	SENT_5	[p1l603t613r681b649],
27	,	,	O	,	_	0	SENT_5	[p1l603t613r681b649],
28	NJ	NNP	O	NJ	appos	20	SENT_5	[p1l698t615r744b649],
29	,	,	O	,	_	0	SENT_5	[p1l698t615r744b649],
30	USA	NNP	LOCATION	USA	appos	20	SENT_5	[p1l763t615r844b649],
31	;	:	O	;	_	0	SENT_5	[p1l763t615r844b649],
32	3Leukemia	NNP	O	3Leukemia	nn	33	SENT_5	[p1l857t608r1032b643],
33	Department	NNP	O	Department	dep	30	SENT_5	[p1l1047t616r1250b653],
34	,	,	O	,	_	0	SENT_5	[p1l1047t616r1250b653],
35	MD	NNP	ORGANIZATION	MD	nn	38	SENT_5	[p1l1266t615r1330b643],
36	Anderson	NNP	ORGANIZATION	Anderson	nn	38	SENT_5	[p1l1341t613r1499b643],
37	Cancer	NNP	ORGANIZATION	Cancer	nn	38	SENT_5	[p1l1513t615r1631b643],
38	Center	NNP	ORGANIZATION	Center	dep	30	SENT_5	[p1l1643t615r1757b649],
39	,	,	O	,	_	0	SENT_5	[p1l1643t615r1757b649],
40	Houston	NNP	LOCATION	Houston	dep	30	SENT_5	[p1l1774t616r1921b649],
41	,	,	O	,	_	0	SENT_5	[p1l1774t616r1921b649],
42	TX	NNP	LOCATION	TX	dep	30	SENT_5	[p1l1940t616r1988b649],
43	,	,	O	,	_	0	SENT_5	[p1l1940t616r1988b649],
44	USA	NNP	LOCATION	USA	dep	30	SENT_5	[p1l2007t615r2076b643],
45	and	CC	O	and	_	0	SENT_5	[p1l2090t613r2154b643],
46	4Department	NN	O	4department	dep	30	SENT_5	[p1l6t651r222b696],
47	of	IN	O	of	_	0	SENT_5	[p1l234t656r270b686],
48	Hematology/Oncology	NN	O	hematology/oncology	prep_of	46	SENT_5	[p1l280t656r666b696],
49	,	,	O	,	_	0	SENT_5	[p1l280t656r666b696],
50	lohann	NN	O	lohann	appos	20	SENT_5	[p1l680t656r798b691],
51	Wolfgang	NNP	PERSON	Wolfgang	nn	52	SENT_5	[p1l816t656r975b696],
52	Goethe-Universitat	NNP	PERSON	Goethe-Universitat	_	0	SENT_5	[p1l990t656r1311b692],
53	,	,	O	,	_	0	SENT_5	[p1l990t656r1311b692],
54	Frankfurt	NNP	LOCATION	Frankfurt	appos	52	SENT_5	[p1l1330t656r1483b693],
55	,	,	O	,	_	0	SENT_5	[p1l1330t656r1483b693],
56	Germany	NNP	LOCATION	Germany	appos	52	SENT_5	[p1l1503t658r1657b696],

1	Nilotinib	NNP	MISC	Nilotinib	nsubj	6	SENT_6	[p1l10t858r291b912],
2	is	VBZ	O	be	cop	6	SENT_6	[p1l355t858r407b912],
3	a	DT	O	a	det	6	SENT_6	[p1l469t871r505b912],
4	novel	JJ	O	novel	amod	6	SENT_6	[p1l568t859r746b912],
5	BCR-ABL	NN	O	bcr-abl	nn	6	SENT_6	[p1l813t858r1130b912],
6	inhibitor	NN	O	inhibitor	_	0	SENT_6	[p1l1194t858r1476b912],
7	with	IN	O	with	_	0	SENT_6	[p1l1534t858r1673b911],
8	significantly	RB	O	significantly	advmod	9	SENT_6	[p1l1736t858r2150b926],
9	improved	VBN	O	improve	amod	10	SENT_6	[p1l10t938r323b1005],
10	potency	NN	O	potency	prep_with	6	SENT_6	[p1l355t941r623b1006],
11	and	CC	O	and	_	0	SENT_6	[p1l650t938r771b991],
12	selectivity	NN	O	selectivity	prep_with	6	SENT_6	[p1l801t938r1142b1006],
13	over	IN	O	over	_	0	SENT_6	[p1l1169t951r1317b991],
14	imatinib	NN	O	imatinib	prep_over	12	SENT_6	[p1l1345t938r1631b991],
15	.	.	O	.	_	0	SENT_6	[p1l1345t938r1631b991],

1	In	IN	O	in	_	0	SENT_7	[p1l1663t938r1718b991],
2	Phase	NN	O	phase	num	8	SENT_7	[p1l1752t938r1955b991],
3	I	CD	NUMBER	i	num	2	SENT_7	[p1l1984t938r1996b991],
4	and	CC	O	and	_	0	SENT_7	[p1l2026t938r2147b991],
5	Phase	NN	O	phase	num	8	SENT_7	[p1l11t1019r214b1072],
6	II	CD	NUMBER	ii	num	5	SENT_7	[p1l241t1019r272b1071],
7	clinical	JJ	O	clinical	amod	8	SENT_7	[p1l301t1019r537b1072],
8	studies	NNS	O	study	prep_in	29	SENT_7	[p1l565t1019r811b1072],
9	of	IN	O	of	_	0	SENT_7	[p1l837t1019r902b1072],
10	nilotinib	NN	O	nilotinib	prep_of	8	SENT_7	[p1l928t1019r1201b1072],
11	in	IN	O	in	_	0	SENT_7	[p1l1230t1019r1285b1071],
12	patients	NNS	O	patient	prep_in	10	SENT_7	[p1l1315t1019r1583b1086],
13	with	IN	O	with	_	0	SENT_7	[p1l1607t1019r1745b1072],
14	a	DT	O	a	det	15	SENT_7	[p1l1773t1032r1810b1072],
15	variety	NN	O	variety	prep_with	12	SENT_7	[p1l1834t1019r2062b1086],
16	of	IN	O	of	_	0	SENT_7	[p1l2086t1019r2150b1072],
17	leukemias	NNS	O	leukemia	prep_of	15	SENT_7	[p1l10t1099r365b1163],
18	,	,	O	,	_	0	SENT_7	[p1l10t1099r365b1163],
19	infrequent	JJ	O	infrequent	amod	20	SENT_7	[p1l397t1099r740b1166],
20	instances	NNS	O	instance	nsubjpass	29	SENT_7	[p1l769t1099r1091b1152],
21	of	IN	O	of	_	0	SENT_7	[p1l1118t1099r1182b1152],
22	reversible	JJ	O	reversible	amod	25	SENT_7	[p1l1210t1099r1558b1163],
23	,	,	O	,	_	0	SENT_7	[p1l1210t1099r1558b1163],
24	benign	JJ	O	benign	amod	25	SENT_7	[p1l1588t1099r1815b1167],
25	elevation	NN	O	elevation	prep_of	20	SENT_7	[p1l1844t1099r2147b1152],
26	of	IN	O	of	_	0	SENT_7	[p1l8t1178r73b1232],
27	bilirubin	NN	O	bilirubin	prep_of	25	SENT_7	[p1l103t1178r377b1232],
28	were	VBD	O	be	auxpass	29	SENT_7	[p1l408t1191r568b1232],
29	observed	VBN	O	observe	_	0	SENT_7	[p1l597t1179r928b1232],
30	.	.	O	.	_	0	SENT_7	[p1l597t1179r928b1232],

1	Uridine	NN	O	uridine	nn	4	SENT_8	[p1l962t1178r1201b1232],
2	diphosphate	NN	O	diphosphate	nn	4	SENT_8	[p1l1230t1178r1652b1246],
3	g	NN	O	g	nn	4	SENT_8	[p1l1681t1179r2149b1246, p1l6t1258r387b1311],
4	|	NN	O	|	dep	12	SENT_8	[p1l1681t1179r2149b1246, p1l6t1258r387b1311],
5	ucuronosy	NN	O	ucuronosy	nn	8	SENT_8	[p1l1681t1179r2149b1246, p1l6t1258r387b1311],
6	|	NN	O	|	nn	8	SENT_8	[p1l1681t1179r2149b1246, p1l6t1258r387b1311],
7	transferase	NN	O	transferase	nn	8	SENT_8	[p1l1681t1179r2149b1246, p1l6t1258r387b1311],
8	1A1	NN	O	1a1	dep	4	SENT_8	[p1l418t1259r532b1311],
9	(	CD	NUMBER	(	num	11	SENT_8	[p1l571t1257r896b1325],
10	UGT1A1	NN	O	ugt1a1	nn	11	SENT_8	[p1l571t1257r896b1325],
11	)	NN	O	)	nsubj	12	SENT_8	[p1l571t1257r896b1325],
12	glucuronidates	VBZ	O	glucuronidate	_	0	SENT_8	[p1l925t1258r1433b1326],
13	bilirubin	NN	O	bilirubin	dobj	12	SENT_8	[p1l1464t1258r1738b1311],
14	in	IN	O	in	_	0	SENT_8	[p1l1773t1258r1828b1311],
15	humans	NNS	O	human	prep_in	13	SENT_8	[p1l1862t1258r2147b1322],
16	,	,	O	,	_	0	SENT_8	[p1l1862t1258r2147b1322],
17	and	CC	O	and	_	0	SENT_8	[p1l8t1339r129b1392],
18	a	DT	O	a	det	19	SENT_8	[p1l153t1352r189b1392],
19	polymorphism	NN	O	polymorphism	nsubjpass	31	SENT_8	[p1l213t1339r696b1406],
20	in	IN	O	in	_	0	SENT_8	[p1l723t1339r777b1391],
21	the	DT	O	the	det	22	SENT_8	[p1l800t1339r906b1392],
22	promoter	NN	O	promoter	prep_in	19	SENT_8	[p1l929t1342r1238b1406],
23	of	IN	O	of	_	0	SENT_8	[p1l1258t1339r1323b1392],
24	the	DT	O	the	det	25	SENT_8	[p1l1342t1339r1448b1392],
25	gene	NN	O	gene	prep_of	22	SENT_8	[p1l1469t1352r1632b1407],
26	that	WDT	O	that	nsubj	27	SENT_8	[p1l1652t1339r1781b1392],
27	encodes	VBZ	O	encode	rcmod	25	SENT_8	[p1l1801t1339r2087b1392],
28	it	PRP	O	it	dobj	27	SENT_8	[p1l2112t1339r2150b1392],
29	has	VBZ	O	have	aux	31	SENT_8	[p1l10t1419r127b1472],
30	been	VBN	O	be	auxpass	31	SENT_8	[p1l159t1419r317b1472],
31	associated	VBN	O	associate	conj_and	12	SENT_8	[p1l349t1418r712b1472],
32	with	IN	O	with	_	0	SENT_8	[p1l743t1418r882b1471],
33	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_with	31	SENT_8	[p1l917t1418r1550b1486],
34	during	IN	O	during	_	0	SENT_8	[p1l1580t1418r1797b1486],
35	treatment	NN	O	treatment	prep_during	31	SENT_8	[p1l1827t1422r2150b1472],
36	with	IN	O	with	_	0	SENT_8	[p1l7t1498r145b1551],
37	a	DT	O	a	det	38	SENT_8	[p1l176t1511r212b1551],
38	number	NN	O	number	prep_with	31	SENT_8	[p1l243t1498r500b1551],
39	of	IN	O	of	_	0	SENT_8	[p1l526t1498r591b1551],
40	drugs	NNS	O	drug	prep_of	38	SENT_8	[p1l619t1498r831b1566],
41	.	.	O	.	_	0	SENT_8	[p1l619t1498r831b1566],

1	Pharmacogenetic	JJ	MISC	pharmacogenetic	amod	2	SENT_9	[p1l865t1498r1452b1566],
2	analysis	NN	O	analysis	nsubj	7	SENT_9	[p1l1480t1498r1758b1566],
3	of	IN	O	of	_	0	SENT_9	[p1l1787t1498r1851b1551],
4	that	DT	O	that	det	6	SENT_9	[p1l1877t1498r2006b1551],
5	TArepeat	NN	O	tarepeat	nn	6	SENT_9	[p1l2033t1498r2150b1551, p1l10t1582r218b1646],
6	polymorphism	NN	O	polymorphism	prep_of	2	SENT_9	[p1l249t1579r733b1646],
7	found	VBD	O	find	_	0	SENT_9	[p1l763t1579r958b1632],
8	an	DT	O	a	det	9	SENT_9	[p1l990t1592r1067b1632],
9	association	NN	O	association	dobj	7	SENT_9	[p1l1098t1579r1485b1632],
10	between	IN	O	between	_	0	SENT_9	[p1l1519t1579r1796b1632],
11	the	DT	O	the	quantmod	12	SENT_9	[p1l1826t1579r1932b1632],
12	(	CD	NUMBER	(	num	16	SENT_9	[p1l1961t1578r2154b1646],
13	TA	NNP	O	TA	nn	16	SENT_9	[p1l1961t1578r2154b1646],
14	)	CD	NUMBER	)	num	16	SENT_9	[p1l1961t1578r2154b1646],
15	7l	JJ	O	7l	amod	16	SENT_9	[p1l1961t1578r2154b1646],
16	(	NN	O	(	prep_between	9	SENT_9	[p1l8t1658r177b1726],
17	TA	NNP	O	TA	dep	16	SENT_9	[p1l8t1658r177b1726],
18	)	SYM	O	)	dep	9	SENT_9	[p1l8t1658r177b1726],
19	-	:	O	-	_	0	SENT_9	[p1l8t1658r177b1726],
20	,	,	O	,	_	0	SENT_9	[p1l8t1658r177b1726],
21	genotype	NN	O	genotype	dep	9	SENT_9	[p1l231t1662r545b1727],
22	and	CC	O	and	_	0	SENT_9	[p1l598t1659r719b1712],
23	risk	NN	O	risk	dobj	7	SENT_9	[p1l777t1659r900b1712],
24	of	IN	O	of	_	0	SENT_9	[p1l952t1659r1017b1712],
25	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	23	SENT_9	[p1l1072t1659r1705b1727],
26	in	IN	O	in	_	0	SENT_9	[p1l1761t1659r1816b1711],
27	Phase	NN	O	phase	nn	29	SENT_9	[p1l1876t1659r2080b1712],
28	I	CD	NUMBER	i	num	29	SENT_9	[p1l2135t1659r2146b1711],
29	patients	NNS	O	patient	prep_in	7	SENT_9	[p1l10t1738r278b1806],
30	with	IN	O	with	_	0	SENT_9	[p1l345t1738r484b1791],
31	imatinib-resistantlintolerant	JJ	O	imatinib-resistantlintolerant	amod	36	SENT_9	[p1l558t1738r1492b1792],
32	chronic	JJ	O	chronic	amod	36	SENT_9	[p1l1561t1738r1815b1792],
33	myeloid	JJ	O	myeloid	amod	36	SENT_9	[p1l1886t1738r2148b1806],
34	leukemia	NN	O	leukemia	nn	36	SENT_9	[p1l10t1818r309b1871],
35	(	NN	O	(	nn	36	SENT_9	[p1l337t1817r535b1885],
36	CML	NN	ORGANIZATION	cml	prep_with	7	SENT_9	[p1l337t1817r535b1885],
37	)	CD	NUMBER	)	dep	36	SENT_9	[p1l337t1817r535b1885],
38	or	CC	O	or	_	0	SENT_9	[p1l564t1831r632b1871],
39	relapsed/refractory	JJ	O	relapsed/refractory	amod	40	SENT_9	[p1l661t1817r1301b1886],
40	Ph	NN	O	ph	conj_or	36	SENT_9	[p1l1331t1818r1413b1871],
41	+	CC	O	+	_	0	SENT_9	[p1l1433t1828r1481b1876],
42	acute	JJ	O	acute	amod	44	SENT_9	[p1l1522t1821r1705b1871],
43	lymphoblastic	JJ	O	lymphoblastic	amod	44	SENT_9	[p1l1735t1818r2150b1886, p1l6t1899r88b1952],
44	leukemia	NN	O	leukemia	conj_or	36	SENT_9	[p1l124t1899r423b1952],
45	(	CD	NUMBER	(	num	47	SENT_9	[p1l457t1898r660b1966],
46	ALL	NN	O	all	nn	47	SENT_9	[p1l457t1898r660b1966],
47	)	NN	O	)	dep	44	SENT_9	[p1l457t1898r660b1966],
48	;	:	O	;	_	0	SENT_9	[p1l457t1898r660b1966],
49	this	DT	O	this	det	50	SENT_9	[p1l696t1899r821b1952],
50	result	NN	O	result	nsubjpass	52	SENT_9	[p1l857t1899r1046b1952],
51	was	VBD	O	be	auxpass	52	SENT_9	[p1l1079t1912r1211b1952],
52	replicated	VBN	O	replicate	parataxis	7	SENT_9	[p1l1248t1899r1577b1966],
53	in	IN	O	in	_	0	SENT_9	[p1l1615t1899r1670b1951],
54	two	CD	NUMBER	two	num	56	SENT_9	[p1l1705t1902r1826b1952],
55	separate	JJ	O	separate	amod	56	SENT_9	[p1l1861t1902r2150b1966],
56	analyses	NNS	O	analysis	prep_in	52	SENT_9	[p1l8t1979r304b2046],
57	of	IN	O	of	_	0	SENT_9	[p1l329t1978r394b2032],
58	the	DT	O	the	det	60	SENT_9	[p1l416t1979r522b2032],
59	chronic	JJ	O	chronic	amod	60	SENT_9	[p1l546t1978r801b2032],
60	phase	NN	O	phase	prep_of	56	SENT_9	[p1l827t1979r1028b2046],
61	(	CD	NUMBER	(	num	63	SENT_9	[p1l1052t1978r1195b2046],
62	CP	NN	MISC	cp	nn	63	SENT_9	[p1l1052t1978r1195b2046],
63	)	NN	O	)	dep	60	SENT_9	[p1l1052t1978r1195b2046],
64	and	CC	O	and	_	0	SENT_9	[p1l1219t1979r1341b2032],
65	accelerated	VBD	O	accelerate	parataxis	7	SENT_9	[p1l1368t1979r1753b2032],
66	phase	NN	O	phase	nn	68	SENT_9	[p1l1781t1979r1983b2046],
67	(	CD	NUMBER	(	num	68	SENT_9	[p1l2007t1978r2149b2046],
68	AP	NN	ORGANIZATION	ap	dobj	65	SENT_9	[p1l2007t1978r2149b2046],
69	)	CD	NUMBER	)	num	71	SENT_9	[p1l2007t1978r2149b2046],
70	CML	NN	ORGANIZATION	cml	nn	71	SENT_9	[p1l9t2057r159b2112],
71	arms	NNS	O	arm	dobj	52	SENT_9	[p1l188t2071r354b2111],
72	of	IN	O	of	_	0	SENT_9	[p1l384t2058r448b2111],
73	a	DT	O	a	det	76	SENT_9	[p1l477t2071r513b2111],
74	Phase	NN	O	phase	nn	76	SENT_9	[p1l545t2058r749b2111],
75	II	CD	NUMBER	ii	num	76	SENT_9	[p1l780t2058r811b2111],
76	study	NN	O	study	prep_of	71	SENT_9	[p1l843t2058r1048b2126],
77	.	.	O	.	_	0	SENT_9	[p1l843t2058r1048b2126],

1	As	IN	O	as	mark	5	SENT_10	[p1l1079t2059r1167b2111],
2	nilotinib	NN	O	nilotinib	nsubjpass	5	SENT_10	[p1l1199t2058r1472b2111],
3	is	VBZ	O	be	auxpass	5	SENT_10	[p1l1504t2058r1557b2111],
4	not	RB	O	not	neg	5	SENT_10	[p1l1589t2061r1695b2111],
5	known	VBN	O	know	advcl	30	SENT_10	[p1l1727t2059r1945b2111],
6	to	TO	O	to	aux	8	SENT_10	[p1l1975t2061r2040b2111],
7	be	VB	O	be	auxpass	8	SENT_10	[p1l2072t2059r2150b2111],
8	glucuronidated	VBN	O	glucuronidate	xcomp	5	SENT_10	[p1l9t2138r518b2206],
9	by	IN	O	by	_	0	SENT_10	[p1l552t2138r630b2206],
10	UGT1A1	NN	O	ugt1a1	agent	8	SENT_10	[p1l662t2137r953b2202],
11	,	,	O	,	_	0	SENT_10	[p1l662t2137r953b2202],
12	the	DT	O	the	det	14	SENT_10	[p1l984t2138r1089b2191],
13	combined	JJ	O	combined	amod	14	SENT_10	[p1l1118t2138r1449b2191],
14	impact	NN	O	impact	nsubj	30	SENT_10	[p1l1484t2138r1707b2205],
15	of	IN	O	of	_	0	SENT_10	[p1l1736t2138r1801b2191],
16	inhibition	NN	O	inhibition	prep_of	14	SENT_10	[p1l1833t2138r2147b2191],
17	of	IN	O	of	_	0	SENT_10	[p1l8t2219r73b2272],
18	UGT1	NN	O	ugt1	nn	20	SENT_10	[p1l95t2218r269b2273],
19	A1	NN	O	a1	nn	20	SENT_10	[p1l282t2219r359b2271],
20	activity	NN	O	activity	prep_of	16	SENT_10	[p1l390t2219r634b2287],
21	by	IN	O	by	_	0	SENT_10	[p1l655t2219r734b2287],
22	nilotinib	NN	O	nilotinib	nn	25	SENT_10	[p1l755t2219r1029b2272],
23	and	CC	O	and	_	0	SENT_10	[p1l1049t2219r1171b2272],
24	genetic	JJ	O	genetic	nn	25	SENT_10	[p1l1194t2219r1440b2287],
25	polymorphism	NN	O	polymorphism	prep_by	20	SENT_10	[p1l1463t2219r1947b2287],
26	is	VBZ	O	be	cop	30	SENT_10	[p1l1972t2219r2025b2272],
27	the	DT	O	the	det	30	SENT_10	[p1l2044t2219r2150b2272],
28	most	RBS	O	most	advmod	29	SENT_10	[p1l10t2302r175b2352],
29	likely	JJ	O	likely	amod	30	SENT_10	[p1l204t2298r378b2366],
30	cause	NN	O	cause	_	0	SENT_10	[p1l404t2311r602b2352],
31	of	IN	O	of	_	0	SENT_10	[p1l629t2298r694b2352],
32	the	DT	O	the	det	34	SENT_10	[p1l719t2299r824b2352],
33	increased	VBN	O	increase	amod	34	SENT_10	[p1l854t2298r1177b2352],
34	rate	NN	O	rate	prep_of	30	SENT_10	[p1l1209t2302r1334b2352],
35	of	IN	O	of	_	0	SENT_10	[p1l1361t2298r1426b2352],
36	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	34	SENT_10	[p1l1454t2298r2105b2366],
37	.	.	O	.	_	0	SENT_10	[p1l1454t2298r2105b2366],

1	Leukemia	NN	O	leukemia	_	0	SENT_11	[p1l11t2378r315b2432],
2	(	CD	NUMBER	(	num	3	SENT_11	[p1l342t2377r538b2445],
3	2007	CD	DATE	2007	dep	1	SENT_11	[p1l342t2377r538b2445],
4	)	CD	NUMBER	)	number	5	SENT_11	[p1l342t2377r538b2445],
5	21	CD	NUMBER	21	dep	3	SENT_11	[p1l568t2379r661b2442],
6	,	,	O	,	_	0	SENT_11	[p1l568t2379r661b2442],
7	231	CD	NUMBER	231	num	8	SENT_11	[p1l690t2379r793b2432],
8	1-2315	CD	NUMBER	1-2315	appos	3	SENT_11	[p1l814t2380r1057b2441],
9	;	:	O	;	_	0	SENT_11	[p1l814t2380r1057b2441],
10	doi	FW	O	doi	dep	3	SENT_11	[p1l1089t2377r1953b2445],
11	:10.1038	CD	NUMBER	:10.1038	dep	10	SENT_11	[p1l1089t2377r1953b2445],
12	/	:	O	/	punct	1	SENT_11	[p1l1089t2377r1953b2445],
13	sj	NN	O	sj	dep	1	SENT_11	[p1l1089t2377r1953b2445],
14	.	.	O	.	_	0	SENT_11	[p1l1089t2377r1953b2445],

1	leu	NN	O	leu	_	0	SENT_12	[p1l1089t2377r1953b2445],
2	.2404827	CD	NUMBER	.2404827	num	1	SENT_12	[p1l1089t2377r1953b2445],
3	;	:	O	;	_	0	SENT_12	[p1l1089t2377r1953b2445],
4	published	VBN	O	publish	dep	1	SENT_12	[p1l10t2459r306b2526],
5	online	NN	O	online	prep	4	SENT_12	[p1l335t2459r519b2512],
6	5	CD	DATE	5	dep	5	SENT_12	[p1l547t2461r582b2512],
7	July	NNP	DATE	July	dobj	4	SENT_12	[p1l609t2459r734b2526],
8	2007	CD	DATE	2007	num	9	SENT_12	[p1l760t2460r914b2512],
9	Keywords	NNPS	O	Keywords	dep	7	SENT_12	[p1l12t2539r364b2606],
10	:	:	O	:	_	0	SENT_12	[p1l12t2539r364b2606],
11	pharmacogenetics	NNS	O	pharmacogenetic	dep	7	SENT_12	[p1l409t2539r1000b2607],
12	;	:	O	;	_	0	SENT_12	[p1l409t2539r1000b2607],
13	UGT1A1	NN	O	ugt1a1	dep	11	SENT_12	[p1l1035t2538r1321b2601],
14	;	:	O	;	_	0	SENT_12	[p1l1035t2538r1321b2601],
15	hyperbilirubinemia	NN	O	hyperbilirubinemia	dep	7	SENT_12	[p1l1355t2539r1940b2606],
16	;	:	O	;	_	0	SENT_12	[p1l1355t2539r1940b2606],
17	nilotinib	NN	O	nilotinib	dep	15	SENT_12	[p1l10t2618r244b2672],

1	Introduction	NN	O	introduction	_	0	SENT_13	[p1l12t2834r443b2896],

1	Uridine	NN	O	uridine	nn	7	SENT_14	[p1l13t3023r257b3084],
2	diphosphate	NN	O	diphosphate	nn	7	SENT_14	[p1l284t3023r682b3104],
3	glucuronosyltransferase	NN	O	glucuronosyltransferase	nn	7	SENT_14	[p1l709t3023r1478b3104],
4	1A1	NN	O	1a1	nn	7	SENT_14	[p1l1509t3027r1622b3083],
5	(	CD	NUMBER	(	num	7	SENT_14	[p1l1666t3027r2019b3096],
6	UGTiAi	NN	O	ugtiaus	nn	7	SENT_14	[p1l1666t3027r2019b3096],
7	)	NN	O	)	nsubj	28	SENT_14	[p1l1666t3027r2019b3096],
8	,	,	O	,	_	0	SENT_14	[p1l1666t3027r2019b3096],
9	the	DT	O	the	det	11	SENT_14	[p1l2049t3023r2149b3084],
10	A1	NN	O	a1	nn	11	SENT_14	[p1l7t3120r84b3176],
11	isoform	NN	O	isoform	appos	7	SENT_14	[p1l135t3116r371b3177],
12	encoded	VBN	O	encode	partmod	11	SENT_14	[p1l406t3116r686b3177],
13	by	IN	O	by	_	0	SENT_14	[p1l722t3116r798b3196],
14	the	DT	O	the	det	21	SENT_14	[p1l828t3116r928b3177],
15	bilirubin	NN	O	bilirubin	nn	21	SENT_14	[p1l963t3116r1234b3177],
16	UDP	NN	O	udp	nn	21	SENT_14	[p1l1274t3121r1430b3177],
17	g	NN	O	g	nn	21	SENT_14	[p1l1462t3116r2148b3197],
18	|	NN	O	|	nn	21	SENT_14	[p1l1462t3116r2148b3197],
19	ucuronosyltransfer	NN	O	ucuronosyltransfer	nn	21	SENT_14	[p1l1462t3116r2148b3197],
20	—	CD	NUMBER	—	num	21	SENT_14	[p1l1462t3116r2148b3197],
21	ase	NN	O	ase	agent	12	SENT_14	[p1l9t3229r111b3269],
22	1	CD	NUMBER	1	num	23	SENT_14	[p1l175t3214r194b3268],
23	family	NN	O	family	tmod	12	SENT_14	[p1l267t3208r471b3289],
24	(	CD	NUMBER	(	num	26	SENT_14	[p1l532t3212r791b3282],
25	UGT1	NN	O	ugt1	nn	26	SENT_14	[p1l532t3212r791b3282],
26	)	NN	O	)	dep	23	SENT_14	[p1l532t3212r791b3282],
27	,	,	O	,	_	0	SENT_14	[p1l532t3212r791b3282],
28	catalyzes	VBZ	O	catalyze	_	0	SENT_14	[p1l855t3208r1153b3289],
29	glucuronidation	NN	O	glucuronidation	dobj	28	SENT_14	[p1l1212t3208r1728b3289],
30	of	IN	O	of	_	0	SENT_14	[p1l1791t3208r1855b3269],
31	hepatic	JJ	O	hepatic	amod	32	SENT_14	[p1l1914t3208r2149b3289],
32	bilirubin	NN	O	bilirubin	prep_of	29	SENT_14	[p1l10t3301r281b3362],
33	in	IN	O	in	_	0	SENT_14	[p1l316t3305r369b3361],
34	humans	NNS	O	human	prep_in	32	SENT_14	[p1l402t3301r672b3362],
35	.	.	O	.	_	0	SENT_14	[p1l402t3301r672b3362],

1	1	CD	NUMBER	1	dep	101	SENT_15	[p1l707t3290r721b3326],
2	An	DT	O	a	dep	101	SENT_15	[p1l758t3305r846b3361],
3	A	NN	O	a	dep	101	SENT_15	[p1l875t3305r1238b3374],
4	(	CD	NUMBER	(	dep	101	SENT_15	[p1l875t3305r1238b3374],
5	TA	NNP	O	TA	dep	101	SENT_15	[p1l875t3305r1238b3374],
6	)	CD	NUMBER	)	dep	101	SENT_15	[p1l875t3305r1238b3374],
7	7TAA	CD	NUMBER	7taa	dep	101	SENT_15	[p1l875t3305r1238b3374],
8	polymorphism	NN	O	polymorphism	dep	101	SENT_15	[p1l1266t3301r1734b3382],
9	in	IN	O	in	dep	101	SENT_15	[p1l1768t3305r1822b3361],
10	a	DT	O	a	dep	101	SENT_15	[p1l1852t3322r1886b3362],
11	TATAA	NN	O	tataa	dep	101	SENT_15	[p1l1913t3305r2150b3361],
12	element	NN	O	element	dep	101	SENT_15	[p1l8t3395r271b3456],
13	in	IN	O	in	dep	101	SENT_15	[p1l307t3399r361b3455],
14	the	DT	O	the	dep	101	SENT_15	[p1l397t3395r497b3456],
15	promoter	NN	O	promoter	dep	101	SENT_15	[p1l533t3406r831b3475],
16	region	NN	O	region	dep	101	SENT_15	[p1l867t3399r1085b3475],
17	,	,	O	,	_	0	SENT_15	[p1l867t3399r1085b3475],
18	in	IN	O	in	dep	101	SENT_15	[p1l1129t3399r1182b3455],
19	place	NN	O	place	dep	101	SENT_15	[p1l1221t3395r1394b3475],
20	of	IN	O	of	dep	101	SENT_15	[p1l1429t3395r1493b3456],
21	the	DT	O	the	dep	101	SENT_15	[p1l1522t3395r1622b3456],
22	more	JJR	O	more	dep	101	SENT_15	[p1l1660t3416r1823b3456],
23	common	JJ	O	common	dep	101	SENT_15	[p1l1859t3416r2146b3456],
24	A	NN	O	a	dep	101	SENT_15	[p1l7t3492r386b3561],
25	(	CD	NUMBER	(	dep	101	SENT_15	[p1l7t3492r386b3561],
26	TA	NNP	O	TA	dep	101	SENT_15	[p1l7t3492r386b3561],
27	)	CD	NUMBER	)	dep	101	SENT_15	[p1l7t3492r386b3561],
28	6TAA	NN	O	6taa	dep	101	SENT_15	[p1l7t3492r386b3561],
29	,	,	O	,	_	0	SENT_15	[p1l7t3492r386b3561],
30	reduces	VBZ	O	reduce	dep	101	SENT_15	[p1l426t3488r673b3548],
31	UGT1	NN	O	ugt1	dep	101	SENT_15	[p1l711t3492r893b3549],
32	Al	NNP	O	Al	dep	101	SENT_15	[p1l911t3492r987b3548],
33	expression	NN	O	expression	dep	101	SENT_15	[p1l1035t3492r1377b3568],
34	and	CC	O	and	dep	101	SENT_15	[p1l1412t3488r1530b3548],
35	contributes	VBZ	O	contribute	dep	101	SENT_15	[p1l1564t3488r1924b3548],
36	to	TO	O	to	dep	101	SENT_15	[p1l1957t3499r2017b3548],
37	the	DT	O	the	dep	101	SENT_15	[p1l2049t3488r2149b3548],
38	benign	JJ	O	benign	dep	101	SENT_15	[p1l10t3582r227b3663],
39	elevation	NN	O	elevation	dep	101	SENT_15	[p1l266t3582r562b3643],
40	of	IN	O	of	dep	101	SENT_15	[p1l601t3582r665b3643],
41	bilirubin	NN	O	bilirubin	dep	101	SENT_15	[p1l699t3582r970b3643],
42	termed	VBN	O	term	dep	101	SENT_15	[p1l1008t3582r1236b3643],
43	as	IN	O	as	dep	101	SENT_15	[p1l1273t3603r1337b3643],
44	’	CD	NUMBER	’	dep	101	SENT_15	[p1l1376t3582r1672b3643],
45	Gi	NN	O	gi	dep	101	SENT_15	[p1l1376t3582r1672b3643],
46	|	NN	O	|	dep	101	SENT_15	[p1l1376t3582r1672b3643],
47	bert	NN	O	bert	dep	101	SENT_15	[p1l1376t3582r1672b3643],
48	’s	POS	O	’s	dep	101	SENT_15	[p1l1376t3582r1672b3643],
49	syndrome	NN	O	syndrome	dep	101	SENT_15	[p1l1709t3570r2145b3662],
50	’	CD	NUMBER	’	dep	101	SENT_15	[p1l1709t3570r2145b3662],
51	.2	NN	NUMBER	.2	dep	101	SENT_15	[p1l1709t3570r2145b3662],
52	'	''	O	'	_	0	SENT_15	[p1l1709t3570r2145b3662],
53	3	CD	NUMBER	3	dep	101	SENT_15	[p1l1709t3570r2145b3662],
54	This	DT	O	this	dep	101	SENT_15	[p1l7t3675r140b3736],
55	allele	NN	O	allele	dep	101	SENT_15	[p1l165t3675r339b3736],
56	(	NN	O	(	dep	101	SENT_15	[p1l365t3675r730b3745],
57	henceforth	NN	O	henceforth	dep	101	SENT_15	[p1l365t3675r730b3745],
58	referred	VBD	O	refer	dep	101	SENT_15	[p1l761t3675r1006b3736],
59	to	TO	O	to	dep	101	SENT_15	[p1l1031t3687r1094b3736],
60	as	IN	O	as	dep	101	SENT_15	[p1l1118t3696r1182b3736],
61	’	NN	O	’	dep	101	SENT_15	[p1l1208t3679r1431b3748],
62	(	CD	NUMBER	(	dep	101	SENT_15	[p1l1208t3679r1431b3748],
63	TA	NNP	O	TA	dep	101	SENT_15	[p1l1208t3679r1431b3748],
64	)	CD	NUMBER	)	dep	101	SENT_15	[p1l1208t3679r1431b3748],
65	7	CD	NUMBER	7	dep	101	SENT_15	[p1l1208t3679r1431b3748],
66	’	NN	O	’	dep	101	SENT_15	[p1l1208t3679r1431b3748],
67	)	NN	O	)	dep	101	SENT_15	[p1l1208t3679r1431b3748],
68	occurs	VBZ	O	occur	dep	101	SENT_15	[p1l1458t3696r1671b3736],
69	at	IN	O	at	dep	101	SENT_15	[p1l1696t3686r1754b3736],
70	frequencies	NNS	O	frequency	dep	101	SENT_15	[p1l1774t3675r2149b3755],
71	up	IN	O	up	dep	101	SENT_15	[p2l11t34r90b94],
72	to	TO	O	to	dep	101	SENT_15	[p2l118t25r179b74],
73	42	CD	PERCENT	42	dep	101	SENT_15	[p2l209t18r359b76],
74	%	NN	PERCENT	%	dep	101	SENT_15	[p2l209t18r359b76],
75	in	IN	O	in	dep	101	SENT_15	[p2l394t17r447b73],
76	some	DT	O	some	dep	101	SENT_15	[p2l481t34r651b74],
77	African	JJ	MISC	african	dep	101	SENT_15	[p2l680t13r913b74],
78	and	CC	O	and	dep	101	SENT_15	[p2l947t13r1064b74],
79	South	JJ	LOCATION	south	dep	101	SENT_15	[p2l1097t13r1276b74],
80	Asian	JJ	LOCATION	asian	dep	101	SENT_15	[p2l1309t17r1485b74],
81	populations	NNS	O	population	dep	101	SENT_15	[p2l1520t13r1917b94],
82	,	,	O	,	_	0	SENT_15	[p2l1520t13r1917b94],
83	and	CC	O	and	dep	101	SENT_15	[p2l1953t13r2070b74],
84	is	VBZ	O	be	dep	101	SENT_15	[p2l2106t17r2149b74],
85	seen	VBN	O	see	dep	101	SENT_15	[p2l9t127r149b167],
86	in	IN	O	in	dep	101	SENT_15	[p2l187t110r240b166],
87	Asian	JJ	LOCATION	asian	dep	101	SENT_15	[p2l272t110r448b167],
88	and	CC	O	and	dep	101	SENT_15	[p2l482t106r599b167],
89	European	JJ	MISC	european	dep	101	SENT_15	[p2l634t111r933b187],
90	populations	NNS	O	population	dep	101	SENT_15	[p2l967t106r1348b187],
91	at	IN	O	at	dep	101	SENT_15	[p2l1378t118r1436b167],
92	lower	JJR	O	lower	dep	101	SENT_15	[p2l1468t106r1648b167],
93	rates	NNS	O	rate	dep	101	SENT_15	[p2l1680t118r1826b167],
94	(	VBP	O	(	dep	101	SENT_15	[p2l1857t111r2145b176],
95	1	CD	NUMBER	1	dep	101	SENT_15	[p2l1857t111r2145b176],
96	—	CD	NUMBER	—	dep	101	SENT_15	[p2l1857t111r2145b176],
97	15	CD	NUMBER	15	dep	101	SENT_15	[p2l1857t111r2145b176],
98	°	NN	O	°	dep	101	SENT_15	[p2l1857t111r2145b176],
99	/	:	O	/	dep	101	SENT_15	[p2l1857t111r2145b176],
100	o	NN	O	o	dep	101	SENT_15	[p2l1857t111r2145b176],
101	)	NN	O	)	_	0	SENT_15	[p2l1857t111r2145b176],
102	.	.	O	.	_	0	SENT_15	[p2l1857t111r2145b176],

1	Two	CD	NUMBER	two	num	3	SENT_16	[p2l7t204r150b259],
2	other	JJ	O	other	amod	3	SENT_16	[p2l186t199r353b259],
3	alleles	NNS	O	allele	nsubjpass	18	SENT_16	[p2l388t199r608b271],
4	,	,	O	,	_	0	SENT_16	[p2l388t199r608b271],
5	A	DT	O	a	quantmod	6	SENT_16	[p2l649t203r1011b271],
6	(	CD	NUMBER	(	num	9	SENT_16	[p2l649t203r1011b271],
7	TA	NNP	O	TA	nn	9	SENT_16	[p2l649t203r1011b271],
8	)	CD	NUMBER	)	num	9	SENT_16	[p2l649t203r1011b271],
9	5TAA	NN	O	5taa	appos	3	SENT_16	[p2l649t203r1011b271],
10	and	CC	O	and	_	0	SENT_16	[p2l1047t199r1165b259],
11	A	DT	O	a	quantmod	12	SENT_16	[p2l1201t203r1580b271],
12	(	CD	NUMBER	(	num	15	SENT_16	[p2l1201t203r1580b271],
13	TA	NNP	O	TA	nn	15	SENT_16	[p2l1201t203r1580b271],
14	)	CD	NUMBER	)	num	15	SENT_16	[p2l1201t203r1580b271],
15	3TAA	NN	O	3taa	appos	3	SENT_16	[p2l1201t203r1580b271],
16	,	,	O	,	_	0	SENT_16	[p2l1201t203r1580b271],
17	are	VBP	O	be	auxpass	18	SENT_16	[p2l1621t220r1719b259],
18	seen	VBN	O	see	_	0	SENT_16	[p2l1755t220r1897b259],
19	almost	RB	O	almost	advmod	20	SENT_16	[p2l1936t199r2152b259],
20	exclusively	RB	O	exclusively	advmod	18	SENT_16	[p2l8t290r371b370],
21	in	IN	O	in	_	0	SENT_16	[p2l404t295r457b350],
22	African	JJ	MISC	african	amod	24	SENT_16	[p2l488t290r720b350],
23	populations	NNS	O	population	nn	24	SENT_16	[p2l755t280r1233b370],
24	.4	NN	NUMBER	.4	prep_in	20	SENT_16	[p2l755t280r1233b370],
25	'	''	O	'	_	0	SENT_16	[p2l755t280r1233b370],
26	5	CD	NUMBER	5	tmod	20	SENT_16	[p2l755t280r1233b370],

1	This	DT	O	this	det	3	SENT_17	[p2l85t384r219b445],
2	heritable	JJ	O	heritable	amod	3	SENT_17	[p2l263t384r551b445],
3	variation	NN	O	variation	nsubjpass	10	SENT_17	[p2l591t388r879b445],
4	in	IN	O	in	_	0	SENT_17	[p2l927t388r980b444],
5	glucuronidation	NN	O	glucuronidation	nn	6	SENT_17	[p2l1022t384r1548b465],
6	activity	NN	O	activity	prep_in	3	SENT_17	[p2l1592t388r1832b464],
7	has	VBZ	O	have	aux	10	SENT_17	[p2l1874t384r1979b445],
8	also	RB	O	also	advmod	10	SENT_17	[p2l2019t384r2149b445],
9	been	VBN	O	be	auxpass	10	SENT_17	[p2l10t477r165b538],
10	investigated	VBN	O	investigate	_	0	SENT_17	[p2l228t477r618b558],
11	in	IN	O	in	_	0	SENT_17	[p2l680t481r733b537],
12	pharmacogenetic	JJ	O	pharmacogenetic	amod	13	SENT_17	[p2l794t477r1368b558],
13	contexts	NNS	O	context	prep_in	10	SENT_17	[p2l1425t489r1716b538],
14	.	.	O	.	_	0	SENT_17	[p2l1425t489r1716b538],

1	The	DT	O	the	det	3	SENT_18	[p2l1776t477r1898b538],
2	active	JJ	O	active	amod	3	SENT_18	[p2l1954t481r2149b538],
3	metabolite	NN	O	metabolite	dep	17	SENT_18	[p2l11t569r361b630],
4	of	IN	O	of	_	0	SENT_18	[p2l428t569r492b630],
5	the	DT	O	the	det	10	SENT_18	[p2l554t569r655b630],
6	anti	JJ	O	anti	amod	10	SENT_18	[p2l722t573r1070b630],
7	—	NN	O	—	nn	10	SENT_18	[p2l722t573r1070b630],
8	tumor	NN	O	tumor	nn	10	SENT_18	[p2l722t573r1070b630],
9	agent	NN	O	agent	nn	10	SENT_18	[p2l1137t581r1316b650],
10	irinotecan	NN	O	irinotecan	prep_of	3	SENT_18	[p2l1385t573r1732b643],
11	,	,	O	,	_	0	SENT_18	[p2l1385t573r1732b643],
12	SN	NN	O	sn	appos	10	SENT_18	[p2l1806t573r2030b642],
13	—	CD	NUMBER	—	number	14	SENT_18	[p2l1806t573r2030b642],
14	38	CD	NUMBER	38	dep	12	SENT_18	[p2l1806t573r2030b642],
15	,	,	O	,	_	0	SENT_18	[p2l1806t573r2030b642],
16	is	VBZ	O	be	auxpass	17	SENT_18	[p2l2106t573r2149b630],
17	glucuronidated	VBN	O	glucuronidate	_	0	SENT_18	[p2l8t662r510b743],
18	by	IN	O	by	_	0	SENT_18	[p2l543t662r620b743],
19	UGT1A1	NN	O	ugt1a1	agent	17	SENT_18	[p2l654t666r933b723],
20	to	TO	O	to	_	0	SENT_18	[p2l977t674r1039b723],
21	the	DT	O	the	det	24	SENT_18	[p2l1067t662r1169b723],
22	inactive	JJ	O	inactive	amod	24	SENT_18	[p2l1203t666r1460b723],
23	SN	NN	O	sn	nn	24	SENT_18	[p2l1491t666r1697b723],
24	—	NN	O	—	prep_to	17	SENT_18	[p2l1491t666r1697b723],
25	38	CD	NUMBER	38	num	26	SENT_18	[p2l1491t666r1697b723],
26	glucuronide	NN	O	glucuronide	nsubj	44	SENT_18	[p2l1728t662r2144b743],
27	,	,	O	,	_	0	SENT_18	[p2l1728t662r2144b743],
28	which	WDT	O	which	nsubjpass	30	SENT_18	[p2l7t754r209b815],
29	is	VBZ	O	be	auxpass	30	SENT_18	[p2l255t759r298b815],
30	excreted	VBN	O	excrete	rcmod	26	SENT_18	[p2l336t744r673b815],
31	.6	CD	NUMBER	.6	xcomp	30	SENT_18	[p2l336t744r673b815],
32	The	DT	O	the	det	33	SENT_18	[p2l710t754r832b815],
33	(	NN	O	(	dep	31	SENT_18	[p2l872t759r1037b827],
34	TA	NNP	O	TA	dep	31	SENT_18	[p2l872t759r1037b827],
35	)	CD	NUMBER	)	number	36	SENT_18	[p2l872t759r1037b827],
36	7	CD	NUMBER	7	num	37	SENT_18	[p2l872t759r1037b827],
37	allele	NN	O	allele	dep	34	SENT_18	[p2l1076t754r1271b827],
38	,	,	O	,	_	0	SENT_18	[p2l1076t754r1271b827],
39	whether	IN	O	whether	amod	26	SENT_18	[p2l1314t754r1585b815],
40	homozygous	JJ	O	homozygous	amod	26	SENT_18	[p2l1625t755r2045b834],
41	or	CC	O	or	_	0	SENT_18	[p2l2084t775r2150b815],
42	heterozygous	JJ	O	heterozygous	amod	26	SENT_18	[p2l11t848r467b928],
43	,	,	O	,	_	0	SENT_18	[p2l11t848r467b928],
44	confers	VBZ	O	confer	rcmod	24	SENT_18	[p2l533t847r771b908],
45	a	DT	O	a	det	47	SENT_18	[p2l832t869r866b908],
46	increased	VBN	O	increase	amod	47	SENT_18	[p2l931t848r1242b908],
47	risk	NN	O	risk	dobj	44	SENT_18	[p2l1307t848r1418b908],
48	of	IN	O	of	_	0	SENT_18	[p2l1478t847r1542b908],
49	leukopenia	NN	O	leukopenia	prep_of	47	SENT_18	[p2l1603t848r1967b928],
50	and	CC	O	and	_	0	SENT_18	[p2l2028t848r2147b908],
51	diarrhea	NN	O	diarrhea	prep_of	47	SENT_18	[p2l9t941r282b1002],
52	during	IN	O	during	_	0	SENT_18	[p2l354t941r566b1022],
53	irinotecan	NN	O	irinotecan	nn	55	SENT_18	[p2l642t945r969b1002],
54	treatment	NN	O	treatment	nn	55	SENT_18	[p2l1042t930r1460b1002],
55	.7	NN	NUMBER	.7	prep_during	17	SENT_18	[p2l1042t930r1460b1002],
56	'	''	O	'	_	0	SENT_18	[p2l1042t930r1460b1002],
57	8	CD	NUMBER	8	tmod	17	SENT_18	[p2l1042t930r1460b1002],
58	The	DT	O	the	det	59	SENT_18	[p2l1531t941r1653b1002],
59	homozygous	JJ	O	homozygous	nsubjpass	17	SENT_18	[p2l1728t941r2148b1022],

1	Correspondence	NN	O	correspondence	_	0	SENT_19	[p2l9t1132r522b1205],
2	:	:	O	:	_	0	SENT_19	[p2l9t1132r522b1205],
3	Dr	NN	O	dr	nn	4	SENT_19	[p2l566t1137r638b1187],
4	JB	NN	O	jb	dep	1	SENT_19	[p2l670t1137r731b1196],
5	Singer	NNP	O	Singer	dep	1	SENT_19	[p2l771t1136r973b1205],
6	,	,	O	,	_	0	SENT_19	[p2l771t1136r973b1205],
7	Clinical	JJ	O	clinical	amod	8	SENT_19	[p2l1014t1132r1244b1187],
8	Pharmacogenetics	NNS	O	pharmacogenetic	appos	1	SENT_19	[p2l1289t1132r1855b1205],
9	,	,	O	,	_	0	SENT_19	[p2l1289t1132r1855b1205],
10	Novartis	NNP	ORGANIZATION	Novartis	nn	11	SENT_19	[p2l1899t1136r2149b1187],
11	Institutes	NNPS	ORGANIZATION	Institutes	appos	1	SENT_19	[p2l12t1215r274b1267],
12	for	IN	ORGANIZATION	for	_	0	SENT_19	[p2l315t1212r397b1267],
13	Biomedical	NNP	ORGANIZATION	Biomedical	nn	14	SENT_19	[p2l442t1212r779b1267],
14	Research	NNP	ORGANIZATION	Research	prep_for	11	SENT_19	[p2l831t1212r1116b1278],
15	,	,	O	,	_	0	SENT_19	[p2l831t1212r1116b1278],
16	400	CD	NUMBER	400	num	18	SENT_19	[p2l1162t1217r1277b1267],
17	Technology	NNP	O	Technology	nn	18	SENT_19	[p2l1319t1212r1676b1285],
18	Square	NNP	O	Square	appos	1	SENT_19	[p2l1719t1215r1940b1285],
19	,	,	O	,	_	0	SENT_19	[p2l1719t1215r1940b1285],
20	Cambridge	NNP	LOCATION	Cambridge	appos	1	SENT_19	[p2l1987t1215r2149b1267, p2l10t1291r214b1364],
21	,	,	O	,	_	0	SENT_19	[p2l1987t1215r2149b1267, p2l10t1291r214b1364],
22	MA	NNP	O	MA	appos	1	SENT_19	[p2l247t1294r353b1345],
23	02139	CD	DATE	02139	num	22	SENT_19	[p2l381t1295r589b1357],
24	,	,	O	,	_	0	SENT_19	[p2l381t1295r589b1357],
25	USA	NNP	LOCATION	USA	appos	1	SENT_19	[p2l625t1294r773b1346],
26	.	.	O	.	_	0	SENT_19	[p2l625t1294r773b1346],

1	E	NN	O	e	nn	3	SENT_20	[p2l12t1370r215b1425],
2	—	CD	NUMBER	—	num	3	SENT_20	[p2l12t1370r215b1425],
3	mail	NN	O	mail	_	0	SENT_20	[p2l12t1370r215b1425],
4	:	:	O	:	_	0	SENT_20	[p2l12t1370r215b1425],
5	jonathan.singer@novartis.com	NNP	O	jonathan.singer@novartis.com	dep	3	SENT_20	[p2l244t1370r1164b1443],
6	Received	VBD	O	receive	rcmod	5	SENT_20	[p2l12t1450r285b1505],
7	15	CD	DATE	15	dobj	6	SENT_20	[p2l339t1455r406b1505],
8	May	NNP	DATE	May	tmod	6	SENT_20	[p2l448t1454r578b1523],
9	2007	CD	DATE	2007	num	8	SENT_20	[p2l613t1456r785b1517],
10	;	:	O	;	_	0	SENT_20	[p2l613t1456r785b1517],
11	accepted	VBN	O	accept	dep	5	SENT_20	[p2l825t1450r1097b1523],
12	28	CD	DATE	28	dobj	11	SENT_20	[p2l1134t1456r1209b1505],
13	May	NNP	DATE	May	tmod	11	SENT_20	[p2l1249t1454r1379b1523],
14	2007	CD	DATE	2007	num	13	SENT_20	[p2l1414t1456r1585b1516],
15	;	:	O	;	_	0	SENT_20	[p2l1414t1456r1585b1516],
16	published	VBN	O	publish	parataxis	11	SENT_20	[p2l1628t1450r1920b1523],
17	online	NN	O	online	prep	16	SENT_20	[p2l1959t1450r2150b1505],
18	5	CD	DATE	5	dep	17	SENT_20	[p2l10t1536r39b1586],
19	July	NNP	DATE	July	tmod	16	SENT_20	[p2l67t1531r183b1604],
20	2007	CD	DATE	2007	num	19	SENT_20	[p2l209t1536r363b1586],
21	(	CD	NUMBER	(	num	23	SENT_20	[p2l10t1623r369b1692],
22	TA	NNP	O	TA	nn	23	SENT_20	[p2l10t1623r369b1692],
23	)	NN	O	)	dep	5	SENT_20	[p2l10t1623r369b1692],
24	7	CD	NUMBER	7	dep	23	SENT_20	[p2l10t1623r369b1692],
25	/	:	O	/	punct	24	SENT_20	[p2l10t1623r369b1692],
26	(	CD	NUMBER	(	num	28	SENT_20	[p2l10t1623r369b1692],
27	TA	NNP	O	TA	nn	28	SENT_20	[p2l10t1623r369b1692],
28	)	NN	O	)	nsubjpass	43	SENT_20	[p2l10t1623r369b1692],
29	7	CD	NUMBER	7	num	32	SENT_20	[p2l10t1623r369b1692],
30	genotype	NN	O	genotype	nn	32	SENT_20	[p2l407t1631r711b1700],
31	(	NN	O	(	nn	32	SENT_20	[p2l752t1619r1125b1689],
32	henceforth	NN	O	henceforth	nsubj	33	SENT_20	[p2l752t1619r1125b1689],
33	referred	VBD	O	refer	rcmod	28	SENT_20	[p2l1169t1619r1421b1680],
34	to	TO	O	to	prep	33	SENT_20	[p2l1460t1631r1522b1680],
35	as	IN	O	as	_	0	SENT_20	[p2l1561t1640r1625b1680],
36	’	NN	O	’	prep_as	33	SENT_20	[p2l1667t1623r1831b1689],
37	7/7	CD	NUMBER	7/7	number	38	SENT_20	[p2l1667t1623r1831b1689],
38	’	CD	NUMBER	’	num	39	SENT_20	[p2l1667t1623r1831b1689],
39	)	NN	O	)	dep	33	SENT_20	[p2l1667t1623r1831b1689],
40	has	VBZ	O	have	aux	43	SENT_20	[p2l1875t1619r1980b1680],
41	also	RB	O	also	advmod	43	SENT_20	[p2l2020t1619r2149b1680],
42	been	VBN	O	be	auxpass	43	SENT_20	[p2l10t1712r164b1772],
43	associated	VBN	O	associate	dep	24	SENT_20	[p2l230t1712r570b1772],
44	with	IN	O	with	_	0	SENT_20	[p2l631t1712r773b1772],
45	increased	VBN	O	increase	amod	46	SENT_20	[p2l842t1712r1152b1772],
46	risk	NN	O	risk	prep_with	43	SENT_20	[p2l1218t1712r1329b1772],
47	of	IN	O	of	_	0	SENT_20	[p2l1389t1711r1453b1772],
48	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	46	SENT_20	[p2l1513t1712r2148b1792],
49	during	IN	O	during	_	0	SENT_20	[p2l8t1805r221b1885],
50	treatment	NN	O	treatment	prep_during	48	SENT_20	[p2l267t1816r583b1865],
51	with	IN	O	with	_	0	SENT_20	[p2l629t1805r770b1865],
52	the	DT	O	the	det	57	SENT_20	[p2l820t1805r922b1865],
53	anti	JJ	O	anti	amod	57	SENT_20	[p2l970t1809r1442b1865],
54	—	NN	O	—	nn	57	SENT_20	[p2l970t1809r1442b1865],
55	restenosis	NN	O	restenosis	nn	57	SENT_20	[p2l970t1809r1442b1865],
56	drug	NN	O	drug	nn	57	SENT_20	[p2l1492t1804r1639b1885],
57	tranilastg	NN	O	tranilastg	prep_with	50	SENT_20	[p2l1685t1793r1979b1865],
58	and	CC	O	and	_	0	SENT_20	[p2l2028t1805r2147b1865],
59	the	DT	O	the	det	60	SENT_20	[p2l7t1897r108b1957],
60	anti	JJ	O	anti	prep_with	50	SENT_20	[p2l139t1901r423b1957],
61	.	.	O	.	_	0	SENT_20	[p2l139t1901r423b1957],

1	—	NN	O	—	_	0	SENT_21	[p2l139t1901r423b1957],
2	.	.	O	.	_	0	SENT_21	[p2l139t1901r423b1957],

1	HIV	NN	O	hiv	nn	3	SENT_22	[p2l139t1901r423b1957],
2	treatment	NN	O	treatment	nn	3	SENT_22	[p2l451t1908r767b1957],
3	indinavir	NN	O	indinavir	_	0	SENT_22	[p2l800t1885r1178b1957],
4	.10	CD	NUMBER	.10	dep	3	SENT_22	[p2l800t1885r1178b1957],

1	Nilotinib	NNP	O	Nilotinib	nsubj	5	SENT_23	[p2l91t1989r382b2049],
2	is	VBZ	O	be	cop	5	SENT_23	[p2l414t1993r457b2049],
3	a	DT	O	a	det	5	SENT_23	[p2l487t2009r520b2049],
4	novel	JJ	O	novel	amod	5	SENT_23	[p2l551t1989r725b2049],
5	inhibitor	NN	O	inhibitor	_	0	SENT_23	[p2l763t1989r1042b2049],
6	of	IN	O	of	_	0	SENT_23	[p2l1069t1989r1133b2049],
7	the	DT	O	the	det	8	SENT_23	[p2l1156t1989r1257b2049],
8	BCR	NN	O	bcr	prep_of	5	SENT_23	[p2l1289t1993r1593b2049],
9	.	.	O	.	_	0	SENT_23	[p2l1289t1993r1593b2049],

1	—	NN	O	—	_	0	SENT_24	[p2l1289t1993r1593b2049],
2	.	.	O	.	_	0	SENT_24	[p2l1289t1993r1593b2049],

1	ABL	NN	ORGANIZATION	abl	nn	3	SENT_25	[p2l1289t1993r1593b2049],
2	chimeric	JJ	O	chimeric	amod	3	SENT_25	[p2l1623t1989r1912b2049],
3	kinase	NN	O	kinase	_	0	SENT_25	[p2l1944t1989r2149b2049],
4	that	WDT	O	that	nsubj	5	SENT_25	[p2l7t2082r132b2143],
5	causes	VBZ	O	cause	rcmod	3	SENT_25	[p2l193t2103r408b2143],
6	chronic	JJ	O	chronic	amod	11	SENT_25	[p2l471t2082r721b2143],
7	myeloid	JJ	O	myeloid	amod	11	SENT_25	[p2l787t2082r1052b2162],
8	leukemia	NN	O	leukemia	nn	11	SENT_25	[p2l1120t2082r1419b2143],
9	(	CD	NUMBER	(	num	11	SENT_25	[p2l1483t2086r1699b2152],
10	CML	NN	O	cml	nn	11	SENT_25	[p2l1483t2086r1699b2152],
11	)	NN	O	)	dobj	5	SENT_25	[p2l1483t2086r1699b2152],
12	.	.	O	.	_	0	SENT_25	[p2l1483t2086r1699b2152],

1	It	PRP	O	it	nsubj	2	SENT_26	[p2l1770t2087r1808b2143],
2	provides	VBZ	O	provide	_	0	SENT_26	[p2l1870t2082r2149b2163],
3	significantly	RB	O	significantly	advmod	4	SENT_26	[p2l9t2175r408b2256],
4	improved	VBN	O	improve	amod	5	SENT_26	[p2l457t2175r767b2256],
5	potency	NN	O	potency	dobj	2	SENT_26	[p2l816t2187r1079b2256],
6	and	CC	O	and	_	0	SENT_26	[p2l1123t2175r1242b2236],
7	selectivity	NN	O	selectivity	conj_and	5	SENT_26	[p2l1289t2175r1620b2256],
8	over	IN	O	over	_	0	SENT_26	[p2l1665t2196r1809b2236],
9	imatinib	NN	O	imatinib	prep_over	7	SENT_26	[p2l1857t2175r2144b2248],
10	,	,	O	,	_	0	SENT_26	[p2l1857t2175r2144b2248],
11	and	CC	O	and	_	0	SENT_26	[p2l8t2268r127b2328],
12	has	VBZ	O	have	aux	13	SENT_26	[p2l177t2268r282b2328],
13	demonstrated	VBN	O	demonstrate	conj_and	2	SENT_26	[p2l328t2267r776b2328],
14	clinical	JJ	O	clinical	amod	16	SENT_26	[p2l824t2268r1062b2328],
15	efficacy	NN	O	efficacy	nn	16	SENT_26	[p2l1113t2256r1423b2348],
16	“	NN	O	“	dobj	13	SENT_26	[p2l1113t2256r1423b2348],
17	in	IN	O	in	_	0	SENT_26	[p2l1483t2272r1536b2328],
18	the	DT	O	the	det	19	SENT_26	[p2l1583t2268r1685b2328],
19	treatment	NN	O	treatment	prep_in	16	SENT_26	[p2l1729t2279r2045b2328],
20	of	IN	O	of	_	0	SENT_26	[p2l2088t2267r2153b2328],
21	patients	NNS	O	patient	prep_of	19	SENT_26	[p2l10t2365r263b2441],
22	with	IN	O	with	_	0	SENT_26	[p2l319t2361r461b2422],
23	Ph	NN	O	ph	prep_with	21	SENT_26	[p2l524t2361r674b2427],
24	+	CC	O	+	_	0	SENT_26	[p2l524t2361r674b2427],
25	CML	NN	ORGANIZATION	cml	conj_+	16	SENT_26	[p2l745t2365r900b2422],
26	with	IN	O	with	_	0	SENT_26	[p2l956t2361r1097b2422],
27	resistance	NN	O	resistance	prep_with	25	SENT_26	[p2l1160t2365r1482b2422],
28	or	CC	O	or	_	0	SENT_26	[p2l1538t2382r1604b2422],
29	intolerance	NN	O	intolerance	conj_or	27	SENT_26	[p2l1663t2361r2032b2422],
30	to	TO	O	to	_	0	SENT_26	[p2l2087t2372r2149b2422],
31	imatinib	NN	O	imatinib	nn	32	SENT_26	[p2l12t2454r282b2515],
32	therapy	NN	O	therapy	prep_to	13	SENT_26	[p2l309t2442r734b2534],
33	.	.	O	.	_	0	SENT_26	[p2l309t2442r734b2534],

1	“	NN	O	“	nn	3	SENT_27	[p2l309t2442r734b2534],
2	'	''	O	'	_	0	SENT_27	[p2l309t2442r734b2534],
3	l3	NN	O	l3	nsubj	29	SENT_27	[p2l309t2442r734b2534],
4	While	IN	O	while	mark	8	SENT_27	[p2l764t2454r966b2515],
5	nilotinib	NN	O	nilotinib	nsubj	11	SENT_27	[p2l997t2454r1271b2515],
6	is	VBZ	O	be	cop	8	SENT_27	[p2l1303t2458r1347b2515],
7	generally	RB	O	generally	advmod	8	SENT_27	[p2l1375t2454r1680b2535],
8	safe	JJ	O	safe	advcl	22	SENT_27	[p2l1707t2454r1833b2515],
9	and	CC	O	and	_	0	SENT_27	[p2l1861t2454r1980b2515],
10	well	RB	O	well	advmod	8	SENT_27	[p2l2008t2454r2144b2515],
11	tolerated	VBD	O	tolerate	conj_and	8	SENT_27	[p2l7t2546r316b2620],
12	,	,	O	,	_	0	SENT_27	[p2l7t2546r316b2620],
13	findings	NNS	O	finding	nsubj	22	SENT_27	[p2l352t2546r612b2627],
14	that	WDT	O	that	nsubj	15	SENT_27	[p2l643t2546r768b2607],
15	appeared	VBD	O	appear	rcmod	13	SENT_27	[p2l798t2546r1103b2627],
16	in	IN	O	in	_	0	SENT_27	[p2l1141t2550r1194b2606],
17	preclinical	JJ	O	preclinical	amod	19	SENT_27	[p2l1230t2546r1576b2627],
18	safety	NN	O	safety	nn	19	SENT_27	[p2l1613t2546r1800b2627],
19	studies	NNS	O	study	prep_in	15	SENT_27	[p2l1832t2546r2056b2607],
20	in	IN	O	in	_	0	SENT_27	[p2l2093t2550r2146b2606],
21	animals	NNS	O	animal	prep_in	15	SENT_27	[p2l8t2640r263b2701],
22	included	VBD	O	include	rcmod	3	SENT_27	[p2l301t2640r585b2701],
23	hyperbilirubinemia	NN	O	hyperbilirubinemia	dobj	22	SENT_27	[p2l623t2640r1257b2721],
24	and	CC	O	and	_	0	SENT_27	[p2l1291t2640r1410b2701],
25	bilirubinuria	NN	O	bilirubinurium	dobj	22	SENT_27	[p2l1446t2640r1857b2701],
26	(	CD	NUMBER	(	num	28	SENT_27	[p2l1891t2640r2148b2721, p2l12t2733r201b2793],
27	unpublished	JJ	O	unpublished	amod	28	SENT_27	[p2l1891t2640r2148b2721, p2l12t2733r201b2793],
28	results	NNS	O	result	dep	23	SENT_27	[p2l251t2733r496b2802],
29	)	VBP	O	)	_	0	SENT_27	[p2l251t2733r496b2802],
30	.	.	O	.	_	0	SENT_27	[p2l251t2733r496b2802],

1	Because	IN	O	because	_	0	SENT_28	[p2l551t2738r819b2793],
2	of	IN	O	of	_	0	SENT_28	[p2l865t2732r929b2793],
3	the	DT	O	the	det	7	SENT_28	[p2l969t2733r1070b2793],
4	well	RB	O	well	advmod	5	SENT_28	[p2l1114t2733r1652b2793],
5	—	RB	O	—	amod	7	SENT_28	[p2l1114t2733r1652b2793],
6	established	VBN	O	establish	amod	7	SENT_28	[p2l1114t2733r1652b2793],
7	link	NN	O	link	prep_because_of	19	SENT_28	[p2l1704t2733r1823b2792],
8	between	IN	O	between	_	0	SENT_28	[p2l1868t2733r2146b2793],
9	UGT1A1	NN	O	ugt1a1	nn	10	SENT_28	[p2l12t2830r292b2887],
10	polymorphism	NN	O	polymorphism	prep_between	7	SENT_28	[p2l355t2826r831b2906],
11	and	CC	O	and	_	0	SENT_28	[p2l880t2826r999b2886],
12	hyperbilirubinemia	NN	O	hyperbilirubinemia	conj_and	10	SENT_28	[p2l1049t2826r1701b2906],
13	,	,	O	,	_	0	SENT_28	[p2l1049t2826r1701b2906],
14	an	DT	O	a	det	17	SENT_28	[p2l1752t2846r1827b2886],
15	optional	JJ	O	optional	amod	17	SENT_28	[p2l1876t2826r2144b2906],
16	pharmacogenetic	JJ	O	pharmacogenetic	amod	17	SENT_28	[p2l10t2919r584b3000],
17	study	NN	O	study	nsubjpass	19	SENT_28	[p2l614t2919r787b2999],
18	was	VBD	O	be	auxpass	19	SENT_28	[p2l813t2940r940b2980],
19	planned	VBN	O	plan	ccomp	47	SENT_28	[p2l969t2919r1235b2999],
20	in	IN	O	in	_	0	SENT_28	[p2l1268t2923r1321b2979],
21	the	DT	O	the	det	23	SENT_28	[p2l1351t2919r1452b2980],
22	Phase	NN	O	phase	nn	23	SENT_28	[p2l1484t2919r1670b2980],
23	I	NN	O	i	prep_in	19	SENT_28	[p2l1702t2924r1711b2979],
24	and	CC	O	and	_	0	SENT_28	[p2l1744t2919r1862b2980],
25	Phase	NN	O	phase	conj_and	19	SENT_28	[p2l1896t2919r2082b2980],
26	II	CD	NUMBER	ii	num	27	SENT_28	[p2l2114t2924r2144b2979],
27	portions	NNS	O	portion	dobj	25	SENT_28	[p2l10t3016r276b3092],
28	of	IN	O	of	_	0	SENT_28	[p2l333t3012r397b3073],
29	the	DT	O	the	det	33	SENT_28	[p2l449t3012r550b3073],
30	nilotinib	JJ	O	nilotinib	amod	33	SENT_28	[p2l610t3012r884b3073],
31	clinical	JJ	O	clinical	amod	33	SENT_28	[p2l942t3012r1180b3073],
32	trial	NN	O	trial	nn	33	SENT_28	[p2l1241t3012r1364b3073],
33	CAMN107A2101	NN	O	camn107a2101	prep_of	27	SENT_28	[p2l1426t3016r2026b3085],
34	,	,	O	,	_	0	SENT_28	[p2l1426t3016r2026b3085],
35	in	IN	O	in	conj_and	19	SENT_28	[p2l2093t3016r2146b3072],
36	patients	NNS	O	patient	pobj	35	SENT_28	[p2l10t3109r263b3186],
37	with	IN	O	with	_	0	SENT_28	[p2l314t3105r455b3166],
38	imatinib	NN	O	imatinib	npadvmod	40	SENT_28	[p2l513t3105r1428b3167],
39	—	CD	NUMBER	—	num	38	SENT_28	[p2l513t3105r1428b3167],
40	resistant/intolerant	JJ	O	resistant/intolerant	amod	41	SENT_28	[p2l513t3105r1428b3167],
41	CML	NN	ORGANIZATION	cml	prep_with	36	SENT_28	[p2l1478t3109r1632b3166],
42	who	WP	O	who	nsubj	43	SENT_28	[p2l1682t3105r1827b3166],
43	were	VBD	O	be	rcmod	41	SENT_28	[p2l1876t3126r2038b3166],
44	in	IN	O	in	_	0	SENT_28	[p2l2093t3109r2146b3165],
45	chronic	JJ	O	chronic	prep_in	43	SENT_28	[p2l8t3198r276b3271],
46	,	,	O	,	_	0	SENT_28	[p2l8t3198r276b3271],
47	accelerated	VBD	O	accelerate	_	0	SENT_28	[p2l311t3198r691b3259],
48	or	CC	O	or	_	0	SENT_28	[p2l723t3219r789b3259],
49	blast	NN	O	blast	nn	51	SENT_28	[p2l818t3198r971b3259],
50	crisis	NN	O	crisis	nn	51	SENT_28	[p2l998t3202r1162b3259],
51	phase	NN	O	phase	dobj	47	SENT_28	[p2l1194t3198r1399b3279],
52	,	,	O	,	_	0	SENT_28	[p2l1194t3198r1399b3279],
53	or	CC	O	or	_	0	SENT_28	[p2l1434t3219r1500b3259],
54	relapsed/refractory	JJ	O	relapsed/refractory	amod	55	SENT_28	[p2l1531t3198r2149b3279],
55	Ph	NN	O	ph	conj_or	51	SENT_28	[p2l12t3291r162b3357],
56	+	CC	O	+	_	0	SENT_28	[p2l12t3291r162b3357],
57	acute	JJ	O	acute	amod	58	SENT_28	[p2l207t3302r385b3351],
58	lymphoblastic	JJ	O	lymphoblastic	amod	59	SENT_28	[p2l420t3291r883b3371],
59	leukemia	NN	O	leukemia	conj_+	51	SENT_28	[p2l919t3291r1219b3351],
60	(	CD	NUMBER	(	num	62	SENT_28	[p2l1252t3295r1437b3360],
61	ALL	NN	O	all	nn	62	SENT_28	[p2l1252t3295r1437b3360],
62	)	NN	O	)	nsubj	47	SENT_28	[p2l1252t3295r1437b3360],
63	.	.	O	.	_	0	SENT_28	[p2l1252t3295r1437b3360],

1	Materials	NNPS	O	Materials	_	0	SENT_29	[p2l8t3533r329b3595],
2	and	CC	O	and	_	0	SENT_29	[p2l360t3533r484b3595],
3	methods	NNS	O	method	conj_and	1	SENT_29	[p2l518t3533r811b3595],

1	Patient	NN	O	patient	nn	2	SENT_30	[p2l13t3718r276b3782],
2	consent	NN	O	consent	_	0	SENT_30	[p2l306t3726r604b3782],

1	All	DT	O	all	det	2	SENT_31	[p3l7t23r94b83],
2	studies	NNS	O	study	nsubjpass	4	SENT_31	[p3l130t23r354b84],
3	were	VBD	O	be	auxpass	4	SENT_31	[p3l384t44r546b84],
4	performed	VBN	O	perform	_	0	SENT_31	[p3l577t23r916b104],
5	in	IN	O	in	_	0	SENT_31	[p3l952t27r1005b83],
6	accordance	NN	O	accordance	prep_in	4	SENT_31	[p3l1039t23r1424b84],
7	with	IN	O	with	_	0	SENT_31	[p3l1453t23r1594b84],
8	the	DT	O	the	det	9	SENT_31	[p3l1627t23r1728b84],
9	Declaration	NN	O	declaration	prep_with	4	SENT_31	[p3l1762t23r2146b84],
10	of	IN	O	of	_	0	SENT_31	[p3l8t115r72b176],
11	Helsinki	NNP	LOCATION	Helsinki	prep_of	9	SENT_31	[p3l136t116r423b176],
12	.	.	O	.	_	0	SENT_31	[p3l136t116r423b176],

1	Peripheral	JJ	O	peripheral	amod	2	SENT_32	[p3l495t116r823b196],
2	blood	NN	O	blood	nsubjpass	4	SENT_32	[p3l893t116r1080b176],
3	was	VBD	O	be	auxpass	4	SENT_32	[p3l1143t137r1269b176],
4	collected	VBN	O	collect	_	0	SENT_32	[p3l1333t116r1635b176],
5	for	IN	O	for	_	0	SENT_32	[p3l1699t115r1788b176],
6	UGT1A1	NN	O	ugt1a1	nn	7	SENT_32	[p3l1854t120r2134b177],
7	genotyping	NN	O	genotyping	prep_for	4	SENT_32	[p3l8t212r377b289],
8	in	IN	O	in	_	0	SENT_32	[p3l426t212r479b268],
9	patients	NNS	O	patient	prep_in	4	SENT_32	[p3l528t212r782b289],
10	who	WP	O	who	nsubj	11	SENT_32	[p3l826t208r970b269],
11	enrolled	VBD	O	enrol	rcmod	9	SENT_32	[p3l1015t208r1286b269],
12	into	IN	O	into	_	0	SENT_32	[p3l1337t212r1458b269],
13	the	DT	O	the	det	15	SENT_32	[p3l1501t208r1603b269],
14	Phase	NN	O	phase	nn	15	SENT_32	[p3l1652t208r1838b269],
15	I	NN	O	i	prep_into	11	SENT_32	[p3l1886t213r1895b268],
16	and	CC	O	and	_	0	SENT_32	[p3l1944t208r2063b269],
17	II	CD	NUMBER	ii	num	18	SENT_32	[p3l2114t213r2144b268],
18	components	NNS	O	component	prep_into	11	SENT_32	[p3l8t313r414b382],
19	of	IN	O	of	_	0	SENT_32	[p3l458t302r523b363],
20	the	DT	O	the	det	24	SENT_32	[p3l560t302r661b363],
21	nilotinib	JJ	O	nilotinib	amod	24	SENT_32	[p3l707t302r981b363],
22	trial	NN	O	trial	nn	24	SENT_32	[p3l1024t302r1147b363],
23	(	NN	O	(	nn	24	SENT_32	[p3l1197t306r1818b375],
24	CAMN107A2101	NN	O	camn107a2101	prep_of	18	SENT_32	[p3l1197t306r1818b375],
25	;	:	O	;	_	0	SENT_32	[p3l1197t306r1818b375],
26	ClinicalTrials	NNS	O	clinicaltrial	conj_and	15	SENT_32	[p3l1867t302r2148b363, p3l7t395r329b475],
27	.	.	O	.	_	0	SENT_32	[p3l1867t302r2148b363, p3l7t395r329b475],

1	gov	NN	O	gov	_	0	SENT_33	[p3l1867t302r2148b363, p3l7t395r329b475],
2	no.	NN	O	no.	dep	1	SENT_33	[p3l362t416r459b456],
3	.	.	O	.	_	0	SENT_33	[p3l362t416r459b456],

1	NCTOO109707	NN	O	nctoo109707	nn	2	SENT_34	[p3l497t399r1010b464],
2	)	NN	O	)	_	0	SENT_34	[p3l497t399r1010b464],
3	and	CC	O	and	_	0	SENT_34	[p3l1043t395r1161b456],
4	who	WP	O	who	nsubj	5	SENT_34	[p3l1191t395r1336b456],
5	agreed	VBD	O	agree	conj_and	2	SENT_34	[p3l1366t395r1585b475],
6	to	TO	O	to	aux	7	SENT_34	[p3l1614t406r1676b456],
7	participate	VB	O	participate	xcomp	5	SENT_34	[p3l1708t399r2059b475],
8	in	IN	O	in	_	0	SENT_34	[p3l2093t399r2146b455],
9	this	DT	O	this	det	11	SENT_34	[p3l7t488r120b549],
10	pharmacogenetic	JJ	O	pharmacogenetic	amod	11	SENT_34	[p3l146t488r720b569],
11	study	NN	O	study	prep_in	7	SENT_34	[p3l745t488r918b569],
12	upon	IN	O	upon	_	0	SENT_34	[p3l945t509r1106b569],
13	signing	VBG	O	sign	prepc_upon	7	SENT_34	[p3l1134t492r1368b569],
14	an	DT	O	a	det	17	SENT_34	[p3l1391t509r1465b549],
15	additional	JJ	O	additional	amod	17	SENT_34	[p3l1492t488r1821b549],
16	informed	JJ	O	informed	amod	17	SENT_34	[p3l1854t488r2147b549],
17	consent	NN	O	consent	dobj	13	SENT_34	[p3l8t569r281b617],
18	.	.	O	.	_	0	SENT_34	[p3l8t569r281b617],

1	Study	NNP	O	Study	nn	2	SENT_35	[p3l10t779r225b871],
2	design	NN	O	design	_	0	SENT_35	[p3l256t779r522b871],
3	:	:	O	:	_	0	SENT_35	[p3l256t779r522b871],
4	Phase	NN	O	phase	dep	2	SENT_35	[p3l560t779r778b848],
5	I	PRP	O	I	nsubjpass	23	SENT_35	[p3l813t784r834b847],
6	The	DT	O	the	det	7	SENT_35	[p3l7t880r129b941],
7	Phase	NN	O	phase	dep	5	SENT_35	[p3l157t880r343b941],
8	I	PRP	O	I	dep	5	SENT_35	[p3l371t885r379b940],
9	clinical	JJ	O	clinical	amod	10	SENT_35	[p3l408t880r647b941],
10	study	NN	O	study	dep	8	SENT_35	[p3l676t880r849b961],
11	was	VBD	O	be	auxpass	13	SENT_35	[p3l870t901r997b941],
12	primarily	RB	O	primarily	advmod	13	SENT_35	[p3l1023t880r1322b961],
13	designed	VBN	O	design	rcmod	4	SENT_35	[p3l1346t880r1638b961],
14	to	TO	O	to	aux	15	SENT_35	[p3l1662t892r1724b941],
15	evaluate	VB	O	evaluate	xcomp	13	SENT_35	[p3l1748t880r2026b941],
16	the	DT	O	the	det	17	SENT_35	[p3l2048t880r2149b941],
17	safety	NN	O	safety	dobj	15	SENT_35	[p3l9t974r195b1054],
18	and	CC	O	and	_	0	SENT_35	[p3l245t974r364b1035],
19	tolerability	NN	O	tolerability	conj_and	17	SENT_35	[p3l414t974r773b1054],
20	of	IN	O	of	_	0	SENT_35	[p3l822t974r886b1035],
21	nilotinib	NN	O	nilotinib	prep_of	17	SENT_35	[p3l935t974r1210b1035],
22	and	CC	O	and	_	0	SENT_35	[p3l1260t974r1379b1035],
23	studied	VBN	O	study	rcmod	4	SENT_35	[p3l1431t974r1667b1035],
24	119	CD	NUMBER	119	num	25	SENT_35	[p3l1723t979r1841b1035],
25	patients	NNS	O	patient	dobj	23	SENT_35	[p3l1894t978r2148b1054],
26	with	IN	O	with	_	0	SENT_35	[p3l7t1067r148b1128],
27	imatinib	NN	O	imatinib	nn	30	SENT_35	[p3l216t1067r1131b1128],
28	—	CD	NUMBER	—	num	30	SENT_35	[p3l216t1067r1131b1128],
29	resistant/intolerant	JJ	O	resistant/intolerant	amod	30	SENT_35	[p3l216t1067r1131b1128],
30	CML	NN	O	cml	prep_with	25	SENT_35	[p3l1189t1071r1344b1128],
31	or	CC	O	or	_	0	SENT_35	[p3l1404t1088r1470b1128],
32	relapsed/refractory	JJ	O	relapsed/refractory	amod	33	SENT_35	[p3l1531t1067r2149b1147],
33	Ph	NN	O	ph	conj_or	30	SENT_35	[p3l12t1160r162b1226],
34	+	CC	O	+	_	0	SENT_35	[p3l12t1160r162b1226],
35	ALL	NN	O	all	conj_+	25	SENT_35	[p3l212t1164r356b1233],
36	,	,	O	,	_	0	SENT_35	[p3l212t1164r356b1233],
37	of	IN	O	of	_	0	SENT_35	[p3l398t1160r462b1221],
38	at	IN	DURATION	at	quantmod	40	SENT_35	[p3l495t1172r553b1221],
39	least	JJS	DURATION	least	mwe	38	SENT_35	[p3l593t1160r738b1221],
40	18	CD	DURATION	18	num	41	SENT_35	[p3l777t1165r852b1221],
41	years	NNS	NUMBER	year	prep_of	35	SENT_35	[p3l890t1181r1059b1240],
42	of	IN	O	of	_	0	SENT_35	[p3l1097t1160r1161b1221],
43	age	NN	O	age	prep_of	41	SENT_35	[p3l1195t1181r1325b1241],
44	.	.	O	.	_	0	SENT_35	[p3l1195t1181r1325b1241],

1	A	DT	O	a	det	5	SENT_36	[p3l1365t1164r1414b1220],
2	modified	VBN	O	modify	amod	5	SENT_36	[p3l1453t1160r1743b1221],
3	continuous	JJ	O	continuous	amod	5	SENT_36	[p3l1782t1164r2149b1221],
4	reassessment	NN	O	reassessment	nn	5	SENT_36	[p3l11t1265r439b1313],
5	method	NN	O	method	nsubjpass	43	SENT_36	[p3l497t1253r744b1313],
6	(	CD	NUMBER	(	num	8	SENT_36	[p3l804t1257r1077b1322],
7	MCRM	NN	O	mcrm	nn	8	SENT_36	[p3l804t1257r1077b1322],
8	)	NN	O	)	nsubjpass	10	SENT_36	[p3l804t1257r1077b1322],
9	was	VBD	O	be	auxpass	10	SENT_36	[p3l1136t1274r1263b1313],
10	used	VBN	O	use	rcmod	5	SENT_36	[p3l1324t1253r1469b1313],
11	to	TO	O	to	aux	12	SENT_36	[p3l1526t1265r1589b1313],
12	escalate	VB	O	escalate	xcomp	10	SENT_36	[p3l1646t1253r1911b1313],
13	doses	NNS	O	dose	dobj	12	SENT_36	[p3l1969t1253r2149b1313],
14	through	IN	O	through	_	0	SENT_36	[p3l7t1345r260b1426],
15	50	CD	NUMBER	50	prep_through	12	SENT_36	[p3l303t1351r400b1419],
16	,	,	O	,	_	0	SENT_36	[p3l303t1351r400b1419],
17	100	CD	NUMBER	100	appos	15	SENT_36	[p3l448t1351r585b1419],
18	,	,	O	,	_	0	SENT_36	[p3l448t1351r585b1419],
19	200	CD	NUMBER	200	appos	15	SENT_36	[p3l627t1351r771b1418],
20	,	,	O	,	_	0	SENT_36	[p3l627t1351r771b1418],
21	400	CD	NUMBER	400	appos	15	SENT_36	[p3l812t1351r956b1419],
22	,	,	O	,	_	0	SENT_36	[p3l812t1351r956b1419],
23	600	CD	NUMBER	600	appos	15	SENT_36	[p3l1001t1351r1140b1419],
24	,	,	O	,	_	0	SENT_36	[p3l1001t1351r1140b1419],
25	800	CD	NUMBER	800	appos	15	SENT_36	[p3l1185t1351r1308b1406],
26	and	CC	O	and	_	0	SENT_36	[p3l1347t1345r1466b1406],
27	1200	CD	DATE	1200	num	28	SENT_36	[p3l1510t1351r1673b1406],
28	mg	NN	O	mg	npadvmod	29	SENT_36	[p3l1694t1366r1792b1426],
29	daily	JJ	SET	daily	appos	15	SENT_36	[p3l1830t1345r1990b1426],
30	and	CC	O	and	_	0	SENT_36	[p3l2029t1345r2147b1406],
31	400	CD	NUMBER	400	num	39	SENT_36	[p3l7t1445r132b1500],
32	and	CC	O	and	_	0	SENT_36	[p3l160t1439r278b1500],
33	600	CD	NUMBER	600	num	39	SENT_36	[p3l308t1445r430b1500],
34	mg	NN	O	mg	nn	39	SENT_36	[p3l451t1460r549b1519],
35	b.i.d.	NN	O	b.i.d.	nn	39	SENT_36	[p3l576t1439r739b1500],
36	(	CD	NUMBER	(	num	39	SENT_36	[p3l772t1443r971b1508],
37	twice	JJ	O	twice	amod	38	SENT_36	[p3l772t1443r971b1508],
38	daily	JJ	SET	daily	amod	39	SENT_36	[p3l997t1439r1177b1519],
39	)	NN	O	)	conj_and	15	SENT_36	[p3l997t1439r1177b1519],
40	The	DT	O	the	det	41	SENT_36	[p3l1204t1439r1326b1500],
41	study	NN	O	study	dep	39	SENT_36	[p3l1353t1439r1525b1519],
42	was	VBD	O	be	auxpass	43	SENT_36	[p3l1550t1460r1676b1500],
43	carried	VBN	O	carry	_	0	SENT_36	[p3l1703t1439r1931b1500],
44	out	RP	O	out	prt	43	SENT_36	[p3l1959t1450r2065b1500],
45	in	IN	O	in	_	0	SENT_36	[p3l2093t1443r2146b1499],
46	two	CD	NUMBER	two	num	47	SENT_36	[p3l7t1543r130b1593],
47	centers	NNS	O	center	prep_in	43	SENT_36	[p3l156t1543r389b1593],
48	in	IN	O	in	_	0	SENT_36	[p3l420t1536r474b1592],
49	the	DT	O	the	det	51	SENT_36	[p3l501t1532r603b1593],
50	United	NNP	LOCATION	United	nn	51	SENT_36	[p3l633t1532r853b1593],
51	States	NNPS	LOCATION	States	prep_in	47	SENT_36	[p3l881t1536r1067b1593],
52	and	CC	O	and	_	0	SENT_36	[p3l1094t1532r1213b1593],
53	two	CD	NUMBER	two	prep_in	43	SENT_36	[p3l1239t1543r1362b1593],
54	in	IN	O	in	_	0	SENT_36	[p3l1393t1536r1446b1592],
55	Germany	NNP	LOCATION	Germany	prep_in	53	SENT_36	[p3l1477t1536r1801b1612],
56	.	.	O	.	_	0	SENT_36	[p3l1477t1536r1801b1612],

1	Details	NNS	O	detail	nsubjpass	7	SENT_37	[p3l1836t1532r2062b1593],
2	of	IN	O	of	_	0	SENT_37	[p3l2088t1532r2153b1593],
3	the	DT	O	the	det	4	SENT_37	[p3l7t1626r108b1687],
4	study	NN	O	study	prep_of	1	SENT_37	[p3l155t1626r328b1706],
5	have	VBP	O	have	aux	7	SENT_37	[p3l377t1626r530b1687],
6	been	VBN	O	be	auxpass	7	SENT_37	[p3l577t1626r733b1687],
7	reported	VBN	O	report	_	0	SENT_37	[p3l785t1614r1136b1707],
8	.	.	O	.	_	0	SENT_37	[p3l785t1614r1136b1707],

1	“	NN	O	“	nn	3	SENT_38	[p3l785t1614r1136b1707],
2	Serum	NN	MISC	serum	nn	3	SENT_38	[p3l1193t1630r1397b1687],
3	chemistry	NN	O	chemistry	nsubjpass	12	SENT_38	[p3l1448t1626r1785b1706],
4	,	,	O	,	_	0	SENT_38	[p3l1448t1626r1785b1706],
5	including	VBG	O	include	_	0	SENT_38	[p3l1841t1626r2150b1707],
6	total	JJ	O	total	amod	7	SENT_38	[p3l7t1719r146b1780],
7	bilirubin	NN	O	bilirubin	prep_including	3	SENT_38	[p3l183t1719r481b1793],
8	,	,	O	,	_	0	SENT_38	[p3l183t1719r481b1793],
9	was	VBD	O	be	auxpass	10	SENT_38	[p3l515t1740r641b1780],
10	measured	VBN	O	measure	_	0	SENT_38	[p3l675t1719r991b1780],
11	and	CC	O	and	_	0	SENT_38	[p3l1023t1719r1142b1780],
12	monitored	VBN	O	monitor	conj_and	10	SENT_38	[p3l1176t1719r1514b1780],
13	weekly	JJ	SET	weekly	dobj	12	SENT_38	[p3l1546t1719r1782b1799],
14	in	IN	O	in	dep	13	SENT_38	[p3l1816t1723r1869b1779],
15	the	DT	O	the	det	19	SENT_38	[p3l1901t1719r2002b1780],
16	first	JJ	ORDINAL	first	amod	19	SENT_38	[p3l2031t1719r2151b1780],
17	two	CD	NUMBER	two	num	19	SENT_38	[p3l7t1823r130b1872],
18	monthly	JJ	SET	monthly	amod	19	SENT_38	[p3l163t1812r434b1892],
19	cycles	NNS	O	cycle	pobj	14	SENT_38	[p3l465t1812r668b1892],
20	and	CC	O	and	_	0	SENT_38	[p3l700t1812r818b1872],
21	biweekly	RB	SET	biweekly	dep	13	SENT_38	[p3l852t1812r1151b1892],
22	thereafter	RB	O	thereafter	advmod	12	SENT_38	[p3l1180t1811r1512b1872],
23	.	.	O	.	_	0	SENT_38	[p3l1180t1811r1512b1872],

1	Study	NNP	O	Study	nn	2	SENT_39	[p3l10t2054r225b2145],
2	design	NN	O	design	_	0	SENT_39	[p3l256t2054r522b2146],
3	:	:	O	:	_	0	SENT_39	[p3l256t2054r522b2146],
4	Phase	NN	O	phase	dep	2	SENT_39	[p3l560t2054r778b2123],
5	II	CD	NUMBER	ii	num	4	SENT_39	[p3l813t2059r874b2137],
6	,	,	O	,	_	0	SENT_39	[p3l813t2059r874b2137],
7	chronic	JJ	O	chronic	amod	8	SENT_39	[p3l917t2054r1207b2123],
8	phase	NN	O	phase	appos	4	SENT_39	[p3l1233t2054r1459b2145],
9	The	DT	O	the	det	15	SENT_39	[p3l7t2155r129b2215],
10	imatinib	NN	O	imatinib	nn	15	SENT_39	[p3l162t2155r733b2215],
11	—	NN	O	—	nn	15	SENT_39	[p3l162t2155r733b2215],
12	resistant	JJ	O	resistant	amod	15	SENT_39	[p3l162t2155r733b2215],
13	or	CC	O	or	_	0	SENT_39	[p3l760t2175r825b2215],
14	imatinib	JJ	O	imatinib	conj_or	12	SENT_39	[p3l857t2155r1477b2215],
15	—	NN	O	—	nsubjpass	29	SENT_39	[p3l857t2155r1477b2215],
16	intolerant	JJ	O	intolerant	amod	15	SENT_39	[p3l857t2155r1477b2215],
17	CP	NN	O	cp	nn	19	SENT_39	[p3l1504t2159r1594b2215],
18	CML	NN	ORGANIZATION	cml	nn	19	SENT_39	[p3l1622t2159r1777b2215],
19	arm	NN	O	arm	dep	16	SENT_39	[p3l1807t2175r1929b2215],
20	of	IN	O	of	_	0	SENT_39	[p3l1960t2155r2025b2215],
21	the	DT	O	the	det	25	SENT_39	[p3l2048t2155r2149b2215],
22	Phase	NN	O	phase	nn	25	SENT_39	[p3l12t2248r198b2309],
23	II	CD	NUMBER	ii	num	25	SENT_39	[p3l232t2253r263b2308],
24	clinical	JJ	O	clinical	amod	25	SENT_39	[p3l297t2248r536b2309],
25	study	NN	O	study	prep_of	19	SENT_39	[p3l571t2248r744b2328],
26	of	IN	O	of	_	0	SENT_39	[p3l773t2248r838b2309],
27	nilotinib	NN	O	nilotinib	prep_of	25	SENT_39	[p3l867t2248r1141b2309],
28	was	VBD	O	be	auxpass	29	SENT_39	[p3l1171t2269r1297b2309],
29	designed	VBN	O	design	rcmod	8	SENT_39	[p3l1327t2248r1619b2328],
30	to	TO	O	to	aux	31	SENT_39	[p3l1649t2259r1712b2309],
31	evaluate	VB	O	evaluate	xcomp	29	SENT_39	[p3l1742t2248r2020b2309],
32	the	DT	O	the	det	33	SENT_39	[p3l2048t2248r2149b2309],
33	efficacy	NN	O	efficacy	dobj	31	SENT_39	[p3l8t2341r264b2422],
34	of	IN	O	of	_	0	SENT_39	[p3l297t2341r361b2402],
35	nilotinib	JJ	O	nilotinib	amod	36	SENT_39	[p3l393t2341r668b2402],
36	treatment	NN	O	treatment	prep_of	33	SENT_39	[p3l700t2353r1017b2402],
37	for	IN	O	for	_	0	SENT_39	[p3l1046t2341r1135b2402],
38	that	DT	O	that	det	39	SENT_39	[p3l1166t2341r1291b2402],
39	indication	NN	O	indication	prep_for	31	SENT_39	[p3l1326t2341r1673b2414],
40	,	,	O	,	_	0	SENT_39	[p3l1326t2341r1673b2414],
41	so	RB	O	so	advmod	42	SENT_39	[p3l1711t2362r1780b2402],
42	far	RB	O	far	advmod	31	SENT_39	[p3l1811t2341r1896b2402],
43	having	VBG	O	have	dep	42	SENT_39	[p3l1931t2341r2150b2422],
44	mg	NN	O	mg	nn	46	SENT_39	[p3l10t2517r124b2629],
45	UGT1A1	NN	O	ugt1a1	nn	46	SENT_39	[p3l1142t2525r1317b2569],
46	pharmacogenetics	NNS	O	pharmacogenetic	nsubj	53	SENT_39	[p3l1342t2525r1723b2579],
47	and	CC	O	and	_	0	SENT_39	[p3l1742t2525r1817b2568],
48	nilotinib	JJ	O	nilotinib	amod	51	SENT_39	[p3l1839t2525r2008b2569],
49	safety	NN	O	safety	nn	51	SENT_39	[p3l2026t2525r2150b2579],
50	JB	NN	MISC	jb	nn	51	SENT_39	[p3l1865t2591r1912b2634],
51	Singer	NNP	MISC	Singer	conj_and	46	SENT_39	[p3l1931t2590r2048b2644],
52	et	FW	O	et	nn	53	SENT_39	[p3l2063t2593r2100b2634],
53	al	FW	O	al	xcomp	43	SENT_39	[p3l2115t2591r2150b2634],
54	reported	VBN	O	report	partmod	53	SENT_39	[p3l312t2771r546b2839],
55	efficacy	NN	O	efficacy	nn	56	SENT_39	[p3l576t2771r796b2839],
56	data	NNS	O	datum	dobj	54	SENT_39	[p3l825t2771r943b2823],
57	from	IN	O	from	_	0	SENT_39	[p3l971t2771r1100b2823],
58	132	CD	NUMBER	132	num	59	SENT_39	[p3l1134t2775r1233b2823],
59	patients	NNS	O	patient	prep_from	54	SENT_39	[p3l1267t2775r1485b2839],
60	with	IN	O	with	_	0	SENT_39	[p3l1513t2771r1634b2823],
61	CML	NN	ORGANIZATION	cml	prep_with	59	SENT_39	[p3l1666t2774r1904b2823],
62	.	.	O	.	_	0	SENT_39	[p3l1666t2774r1904b2823],

1	—	NN	O	—	_	0	SENT_40	[p3l1666t2774r1904b2823],
2	.	.	O	.	_	0	SENT_40	[p3l1666t2774r1904b2823],

1	CP	NN	O	cp	_	0	SENT_41	[p3l1666t2774r1904b2823],
2	without	IN	O	without	_	0	SENT_41	[p3l1931t2771r2150b2823],
3	prior	JJ	O	prior	amod	10	SENT_41	[p3l311t2854r445b2918],
4	tyrosine	NN	O	tyrosine	nn	10	SENT_41	[p3l471t2854r696b2918],
5	kinase	NN	O	kinase	nn	10	SENT_41	[p3l727t2850r903b2902],
6	inhibitor	NN	O	inhibitor	nn	10	SENT_41	[p3l936t2850r1175b2902],
7	(	NN	O	(	nn	10	SENT_41	[p3l1205t2854r1332b2909],
8	TKI	NN	O	tkus	nn	10	SENT_41	[p3l1205t2854r1332b2909],
9	)	NN	O	)	nn	10	SENT_41	[p3l1205t2854r1332b2909],
10	treatment	NN	O	treatment	prep_without	1	SENT_41	[p3l1362t2860r1646b2912],
11	,	,	O	,	_	0	SENT_41	[p3l1362t2860r1646b2912],
12	except	IN	O	except	_	0	SENT_41	[p3l1679t2860r1867b2918],
13	imatinib	NN	O	imatinib	prep_except	1	SENT_41	[p3l1898t2850r2145b2902],
14	.	.	O	.	_	0	SENT_41	[p3l1898t2850r2145b2902],

1	The	DT	O	the	det	5	SENT_42	[p3l309t2928r414b2980],
2	400	CD	NUMBER	400	num	5	SENT_42	[p3l435t2933r542b2980],
3	mg	NN	O	mg	nn	5	SENT_42	[p3l560t2946r644b2997],
4	b.i.d.	NN	O	b.i.d.	nn	5	SENT_42	[p3l667t2928r807b2980],
5	dose	NN	O	dose	nsubjpass	9	SENT_42	[p3l834t2928r963b2980],
6	of	IN	O	of	_	0	SENT_42	[p3l985t2928r1040b2980],
7	nilotinib	NN	O	nilotinib	prep_of	5	SENT_42	[p3l1062t2928r1297b2980],
8	was	VBD	O	be	auxpass	9	SENT_42	[p3l1319t2946r1428b2980],
9	used	VBN	O	use	_	0	SENT_42	[p3l1452t2928r1595b2980],
10	.	.	O	.	_	0	SENT_42	[p3l1452t2928r1595b2980],

1	Dose	NN	O	dose	nn	2	SENT_43	[p3l1624t2933r1766b2980],
2	escalation	NN	O	escalation	nsubjpass	8	SENT_43	[p3l1787t2928r2072b2980],
3	to	TO	O	to	_	0	SENT_43	[p3l2095t2938r2148b2980],
4	600	CD	NUMBER	600	num	6	SENT_43	[p3l311t3012r416b3059],
5	mg	NN	O	mg	nn	6	SENT_43	[p3l434t3025r518b3076],
6	b.i.d.	NN	O	b.i.d.	prep_to	2	SENT_43	[p3l546t3007r686b3059],
7	was	VBD	O	be	auxpass	8	SENT_43	[p3l715t3025r824b3059],
8	allowed	VBN	O	allow	_	0	SENT_43	[p3l851t3007r1077b3059],
9	for	IN	O	for	_	0	SENT_43	[p3l1103t3007r1180b3059],
10	patients	NNS	O	patient	prep_for	8	SENT_43	[p3l1207t3011r1425b3076],
11	who	WP	O	who	nsubj	12	SENT_43	[p3l1451t3007r1574b3059],
12	showed	VBD	O	show	rcmod	10	SENT_43	[p3l1601t3007r1818b3059],
13	either	CC	O	either	prep	12	SENT_43	[p3l1846t3007r2008b3059],
14	lack	NN	O	lack	dep	13	SENT_43	[p3l2037t3007r2150b3059],
15	of	IN	O	of	_	0	SENT_43	[p3l309t3088r365b3139],
16	response	NN	O	response	prep_of	14	SENT_43	[p3l408t3106r669b3156],
17	,	,	O	,	_	0	SENT_43	[p3l408t3106r669b3156],
18	loss	NN	O	loss	conj_or	14	SENT_43	[p3l721t3088r821b3139],
19	of	IN	O	of	_	0	SENT_43	[p3l865t3088r921b3139],
20	response	NN	O	response	prep_of	18	SENT_43	[p3l964t3106r1210b3156],
21	or	CC	O	or	_	0	SENT_43	[p3l1254t3106r1311b3139],
22	progressive	JJ	O	progressive	amod	23	SENT_43	[p3l1355t3091r1674b3156],
23	disease	NN	O	disease	conj_or	14	SENT_43	[p3l1719t3088r1923b3139],
24	during	IN	O	during	_	0	SENT_43	[p3l1967t3088r2149b3156],
25	therapy	NN	O	therapy	prep_during	23	SENT_43	[p3l308t3167r537b3235],
26	.	.	O	.	_	0	SENT_43	[p3l308t3167r537b3235],

1	The	DT	O	the	det	3	SENT_44	[p3l582t3167r687b3218],
2	132	CD	NUMBER	132	num	3	SENT_44	[p3l733t3171r831b3218],
3	patients	NNS	O	patient	nsubjpass	9	SENT_44	[p3l880t3170r1098b3235],
4	with	IN	O	with	_	0	SENT_44	[p3l1140t3166r1261b3218],
5	reported	VBN	O	report	amod	7	SENT_44	[p3l1309t3167r1543b3235],
6	efficacy	NN	O	efficacy	nn	7	SENT_44	[p3l1587t3166r1807b3235],
7	data	NNS	O	datum	prep_with	3	SENT_44	[p3l1849t3167r1968b3218],
8	were	VBD	O	be	auxpass	9	SENT_44	[p3l2009t3184r2149b3218],
9	enrolled	VBN	O	enrol	_	0	SENT_44	[p3l309t3246r543b3298],
10	in	IN	O	in	_	0	SENT_44	[p3l585t3250r630b3297],
11	centers	NNS	O	center	prep_in	9	SENT_44	[p3l670t3256r870b3298],
12	in	IN	O	in	_	0	SENT_44	[p3l911t3250r956b3297],
13	11	CD	NUMBER	11	num	14	SENT_44	[p3l1000t3251r1053b3297],
14	countries	NNS	O	country	prep_in	11	SENT_44	[p3l1103t3250r1362b3298],
15	(	CD	NUMBER	(	num	16	SENT_44	[p3l1401t3249r1698b3314],
16	Germany	NNP	LOCATION	Germany	dobj	9	SENT_44	[p3l1401t3249r1698b3314],
17	,	,	O	,	_	0	SENT_44	[p3l1401t3249r1698b3314],
18	United	NNP	LOCATION	United	nn	19	SENT_44	[p3l1743t3246r1931b3298],
19	States	NNPS	LOCATION	States	dobj	9	SENT_44	[p3l1970t3250r2145b3308],
20	,	,	O	,	_	0	SENT_44	[p3l1970t3250r2145b3308],
21	United	NNP	LOCATION	United	nn	37	SENT_44	[p3l313t3325r502b3377],
22	Kingdom	NNP	LOCATION	Kingdom	nn	37	SENT_44	[p3l545t3325r814b3394],
23	,	,	O	,	_	0	SENT_44	[p3l545t3325r814b3394],
24	France	NNP	LOCATION	France	appos	37	SENT_44	[p3l859t3329r1060b3387],
25	,	,	O	,	_	0	SENT_44	[p3l859t3329r1060b3387],
26	Netherlands	NNP	LOCATION	Netherlands	appos	37	SENT_44	[p3l1106t3325r1463b3387],
27	,	,	O	,	_	0	SENT_44	[p3l1106t3325r1463b3387],
28	Belgium	NNP	LOCATION	Belgium	appos	37	SENT_44	[p3l1508t3325r1755b3394],
29	,	,	O	,	_	0	SENT_44	[p3l1508t3325r1755b3394],
30	Spain	NNP	LOCATION	Spain	appos	37	SENT_44	[p3l1798t3328r1968b3393],
31	,	,	O	,	_	0	SENT_44	[p3l1798t3328r1968b3393],
32	Italy	NNP	LOCATION	Italy	appos	37	SENT_44	[p3l2014t3325r2145b3393],
33	,	,	O	,	_	0	SENT_44	[p3l2014t3325r2145b3393],
34	Switzerland	NNP	LOCATION	Switzerland	appos	37	SENT_44	[p3l310t3403r660b3466],
35	,	,	O	,	_	0	SENT_44	[p3l310t3403r660b3466],
36	South	NNP	LOCATION	South	appos	37	SENT_44	[p3l715t3403r871b3455],
37	Korea	NNP	LOCATION	Korea	conj_and	16	SENT_44	[p3l926t3408r1087b3455],
38	and	CC	O	and	_	0	SENT_44	[p3l1136t3403r1238b3455],
39	Australia	NNP	LOCATION	Australia	conj_and	16	SENT_44	[p3l1288t3403r1573b3463],
40	)	CD	NUMBER	)	num	39	SENT_44	[p3l1288t3403r1573b3463],
41	.	.	O	.	_	0	SENT_44	[p3l1288t3403r1573b3463],

1	Serum	NN	MISC	serum	nn	2	SENT_45	[p3l1627t3407r1802b3455],
2	chemistry	NN	O	chemistry	nsubjpass	11	SENT_45	[p3l1854t3403r2145b3472],
3	,	,	O	,	_	0	SENT_45	[p3l1854t3403r2145b3472],
4	including	VBG	O	include	_	0	SENT_45	[p3l313t3483r579b3552],
5	total	JJ	O	total	amod	6	SENT_45	[p3l606t3483r726b3535],
6	bilirubin	NN	O	bilirubin	prep_including	2	SENT_45	[p3l761t3483r1016b3546],
7	,	,	O	,	_	0	SENT_45	[p3l761t3483r1016b3546],
8	was	VBD	O	be	auxpass	9	SENT_45	[p3l1049t3501r1157b3535],
9	measured	VBN	O	measure	_	0	SENT_45	[p3l1189t3483r1460b3535],
10	and	CC	O	and	_	0	SENT_45	[p3l1491t3483r1593b3535],
11	monitored	VBN	O	monitor	conj_and	9	SENT_45	[p3l1626t3483r1916b3535],
12	weekly	JJ	SET	weekly	dobj	11	SENT_45	[p3l1946t3483r2149b3552],
13	in	IN	O	in	dep	12	SENT_45	[p3l313t3565r359b3613],
14	the	DT	O	the	det	18	SENT_45	[p3l387t3562r474b3613],
15	first	JJ	ORDINAL	first	amod	18	SENT_45	[p3l500t3561r602b3613],
16	two	CD	NUMBER	two	num	18	SENT_45	[p3l626t3571r731b3613],
17	monthly	JJ	SET	monthly	amod	18	SENT_45	[p3l760t3562r992b3630],
18	cycles	NNS	O	cycle	pobj	13	SENT_45	[p3l1019t3562r1194b3630],
19	and	CC	O	and	_	0	SENT_45	[p3l1221t3562r1323b3613],
20	biweekly	RB	SET	biweekly	dep	12	SENT_45	[p3l1352t3562r1608b3630],
21	thereafter	RB	O	thereafter	advmod	11	SENT_45	[p3l1633t3561r1919b3613],
22	.	.	O	.	_	0	SENT_45	[p3l1633t3561r1919b3613],

1	Study	NNP	O	Study	nn	2	SENT_46	[p4l311t76r496b155],
2	design	NN	O	design	nsubj	7	SENT_46	[p4l523t76r752b155],
3	:	:	O	:	_	0	SENT_46	[p4l523t76r752b155],
4	Phase	NN	O	phase	dep	2	SENT_46	[p4l784t76r971b135],
5	II	CD	NUMBER	ii	num	4	SENT_46	[p4l1001t81r1053b148],
6	,	,	O	,	_	0	SENT_46	[p4l1001t81r1053b148],
7	accelerated	VBD	O	accelerate	_	0	SENT_46	[p4l1089t76r1473b135],
8	phase	NN	O	phase	dobj	7	SENT_46	[p4l1491t76r1685b155],
9	The	DT	O	the	det	11	SENT_46	[p4l309t164r414b216],
10	imatinib	NN	O	imatinib	nn	11	SENT_46	[p4l441t164r932b216],
11	—	NN	O	—	npadvmod	12	SENT_46	[p4l441t164r932b216],
12	resistant	JJ	O	resistant	amod	8	SENT_46	[p4l441t164r932b216],
13	or	CC	O	or	_	0	SENT_46	[p4l955t182r1012b216],
14	imatinib-intolerant	JJ	O	imatinib-intolerant	amod	17	SENT_46	[p4l1039t164r1571b216],
15	AP	NN	ORGANIZATION	ap	nn	17	SENT_46	[p4l1593t168r1672b215],
16	CML	NN	ORGANIZATION	cml	nn	17	SENT_46	[p4l1697t168r1829b216],
17	arm	NN	O	arm	dobj	7	SENT_46	[p4l1855t182r1960b216],
18	of	IN	O	of	_	0	SENT_46	[p4l1987t164r2042b216],
19	the	DT	O	the	det	20	SENT_46	[p4l2062t164r2149b216],
20	Phase	NN	O	phase	prep_of	17	SENT_46	[p4l313t243r473b295],
21	II	CD	NUMBER	ii	num	23	SENT_46	[p4l504t247r530b294],
22	clinical	JJ	O	clinical	amod	23	SENT_46	[p4l562t243r767b295],
23	study	NN	O	study	nsubjpass	25	SENT_46	[p4l799t243r948b311],
24	was	VBD	O	be	auxpass	25	SENT_46	[p4l974t261r1082b295],
25	designed	VBN	O	design	rcmod	20	SENT_46	[p4l1111t243r1362b312],
26	to	TO	O	to	aux	27	SENT_46	[p4l1389t253r1442b295],
27	evaluate	VB	O	evaluate	xcomp	25	SENT_46	[p4l1470t243r1709b295],
28	the	DT	O	the	det	29	SENT_46	[p4l1735t243r1822b295],
29	efficacy	NN	O	efficacy	dobj	27	SENT_46	[p4l1849t243r2069b311],
30	of	IN	O	of	_	0	SENT_46	[p4l2096t243r2152b295],
31	nilotinib	JJ	O	nilotinib	amod	32	SENT_46	[p4l312t321r548b373],
32	treatment	NN	O	treatment	prep_of	29	SENT_46	[p4l583t331r855b373],
33	for	IN	O	for	_	0	SENT_46	[p4l888t321r965b373],
34	that	DT	O	that	det	35	SENT_46	[p4l999t321r1106b373],
35	indication	NN	O	indication	prep_for	27	SENT_46	[p4l1144t321r1442b383],
36	,	,	O	,	_	0	SENT_46	[p4l1144t321r1442b383],
37	so	RB	O	so	advmod	38	SENT_46	[p4l1483t339r1542b373],
38	far	RB	O	far	advmod	27	SENT_46	[p4l1576t321r1650b373],
39	having	VBG	O	have	aux	40	SENT_46	[p4l1687t321r1875b390],
40	reported	VBN	O	report	dep	38	SENT_46	[p4l1913t321r2147b390],
41	data	NNS	O	datum	dobj	40	SENT_46	[p4l310t401r429b452],
42	from	IN	O	from	_	0	SENT_46	[p4l453t401r582b452],
43	64	CD	NUMBER	64	num	44	SENT_46	[p4l611t406r679b453],
44	patients	NNS	O	patient	prep_from	40	SENT_46	[p4l706t404r924b469],
45	with	IN	O	with	_	0	SENT_46	[p4l949t401r1070b452],
46	CML	NN	ORGANIZATION	cml	prep_with	44	SENT_46	[p4l1098t404r1337b453],
47	.	.	O	.	_	0	SENT_46	[p4l1098t404r1337b453],

1	—	NN	O	—	_	0	SENT_47	[p4l1098t404r1337b453],
2	.	.	O	.	_	0	SENT_47	[p4l1098t404r1337b453],

1	AP	NN	O	ap	_	0	SENT_48	[p4l1098t404r1337b453],
2	without	IN	O	without	_	0	SENT_48	[p4l1360t401r1580b452],
3	prior	JJ	O	prior	amod	5	SENT_48	[p4l1604t404r1738b469],
4	TKI	NN	O	tkus	nn	5	SENT_48	[p4l1761t405r1851b452],
5	treatment	NN	O	treatment	prep_without	1	SENT_48	[p4l1878t410r2151b452],
6	other	JJ	O	other	advmod	1	SENT_48	[p4l309t480r456b531],
7	than	IN	O	than	_	0	SENT_48	[p4l490t480r611b531],
8	imatinib	NN	O	imatinib	prep_than	6	SENT_48	[p4l654t480r902b531],
9	.	.	O	.	_	0	SENT_48	[p4l654t480r902b531],

1	The	DT	O	the	det	5	SENT_49	[p4l941t480r1046b531],
2	400	CD	NUMBER	400	num	5	SENT_49	[p4l1082t485r1189b531],
3	mg	NN	O	mg	nn	5	SENT_49	[p4l1207t497r1291b548],
4	b.i.d.	NN	O	b.i.d.	nn	5	SENT_49	[p4l1329t480r1470b531],
5	dose	NN	O	dose	nsubjpass	9	SENT_49	[p4l1510t480r1640b531],
6	of	IN	O	of	_	0	SENT_49	[p4l1676t479r1732b531],
7	nilotinib	NN	O	nilotinib	prep_of	5	SENT_49	[p4l1768t480r2004b531],
8	was	VBD	O	be	auxpass	9	SENT_49	[p4l2040t497r2148b531],
9	used	VBN	O	use	_	0	SENT_49	[p4l312t559r455b611],
10	.	.	O	.	_	0	SENT_49	[p4l312t559r455b611],

1	Dose	NN	O	dose	nn	2	SENT_50	[p4l487t563r628b611],
2	escalation	NN	O	escalation	nsubjpass	8	SENT_50	[p4l653t559r937b611],
3	to	TO	O	to	_	0	SENT_50	[p4l963t569r1017b611],
4	600	CD	NUMBER	600	num	6	SENT_50	[p4l1043t564r1148b611],
5	mg	NN	O	mg	nn	6	SENT_50	[p4l1166t577r1250b628],
6	b.i.d.	NN	O	b.i.d.	prep_to	2	SENT_50	[p4l1276t559r1416b611],
7	was	VBD	O	be	auxpass	8	SENT_50	[p4l1444t577r1552b611],
8	allowed	VBN	O	allow	_	0	SENT_50	[p4l1578t559r1804b611],
9	for	IN	O	for	_	0	SENT_50	[p4l1828t559r1905b611],
10	patients	NNS	O	patient	prep_for	8	SENT_50	[p4l1930t563r2148b627],
11	who	WP	O	who	nsubj	12	SENT_50	[p4l309t638r433b690],
12	showed	VBD	O	show	rcmod	10	SENT_50	[p4l482t638r699b690],
13	either	CC	O	either	prep	12	SENT_50	[p4l750t638r911b690],
14	lack	NN	O	lack	dep	13	SENT_50	[p4l963t638r1076b690],
15	of	IN	O	of	_	0	SENT_50	[p4l1124t638r1179b690],
16	response	NN	O	response	prep_of	14	SENT_50	[p4l1228t656r1489b706],
17	,	,	O	,	_	0	SENT_50	[p4l1228t656r1489b706],
18	loss	NN	O	loss	conj_or	14	SENT_50	[p4l1545t638r1645b690],
19	of	IN	O	of	_	0	SENT_50	[p4l1694t638r1750b690],
20	response	NN	O	response	prep_of	18	SENT_50	[p4l1798t656r2044b706],
21	or	CC	O	or	_	0	SENT_50	[p4l2093t656r2149b690],
22	progressive	JJ	O	progressive	amod	23	SENT_50	[p4l311t720r630b785],
23	disease	NN	O	disease	conj_or	14	SENT_50	[p4l685t716r889b768],
24	during	IN	O	during	_	0	SENT_50	[p4l944t716r1126b785],
25	therapy	NN	O	therapy	prep_during	23	SENT_50	[p4l1180t716r1408b785],
26	.	.	O	.	_	0	SENT_50	[p4l1180t716r1408b785],

1	The	DT	O	the	det	3	SENT_51	[p4l1466t716r1571b768],
2	64	CD	NUMBER	64	num	3	SENT_51	[p4l1627t721r1694b768],
3	patients	NNS	O	patient	nsubjpass	9	SENT_51	[p4l1752t720r1970b785],
4	with	IN	O	with	_	0	SENT_51	[p4l2024t716r2146b768],
5	reported	VBN	O	report	amod	7	SENT_51	[p4l312t796r546b865],
6	efficacy	NN	O	efficacy	nn	7	SENT_51	[p4l570t796r790b865],
7	data	NNS	O	datum	prep_with	3	SENT_51	[p4l813t796r931b848],
8	were	VBD	O	be	auxpass	9	SENT_51	[p4l953t814r1092b848],
9	enrolled	VBN	O	enrol	_	0	SENT_51	[p4l1114t796r1347b848],
10	in	IN	O	in	_	0	SENT_51	[p4l1375t800r1420b847],
11	centers	NNS	O	center	prep_in	9	SENT_51	[p4l1446t806r1646b848],
12	in	IN	O	in	_	0	SENT_51	[p4l1672t800r1718b847],
13	nine	CD	NUMBER	nine	num	14	SENT_51	[p4l1746t800r1866b848],
14	countries	NNS	O	country	prep_in	11	SENT_51	[p4l1888t800r2148b848],
15	(	CD	NUMBER	(	num	17	SENT_51	[p4l311t875r521b934],
16	United	NNP	LOCATION	United	nn	17	SENT_51	[p4l311t875r521b934],
17	States	NNPS	LOCATION	States	dobj	9	SENT_51	[p4l581t878r755b937],
18	,	,	O	,	_	0	SENT_51	[p4l581t878r755b937],
19	Germany	NNP	LOCATION	Germany	dobj	9	SENT_51	[p4l819t878r1096b943],
20	,	,	O	,	_	0	SENT_51	[p4l819t878r1096b943],
21	Italy	NNP	LOCATION	Italy	dobj	9	SENT_51	[p4l1162t875r1293b943],
22	,	,	O	,	_	0	SENT_51	[p4l1162t875r1293b943],
23	United	NNP	LOCATION	United	nn	33	SENT_51	[p4l1359t875r1548b926],
24	Kingdom	NNP	LOCATION	Kingdom	nn	33	SENT_51	[p4l1610t875r1878b943],
25	,	,	O	,	_	0	SENT_51	[p4l1610t875r1878b943],
26	France	NNP	LOCATION	France	appos	33	SENT_51	[p4l1944t879r2145b937],
27	,	,	O	,	_	0	SENT_51	[p4l1944t879r2145b937],
28	Belgium	NNP	LOCATION	Belgium	appos	33	SENT_51	[p4l313t954r560b1022],
29	,	,	O	,	_	0	SENT_51	[p4l313t954r560b1022],
30	Spain	NNP	LOCATION	Spain	appos	33	SENT_51	[p4l591t957r762b1022],
31	,	,	O	,	_	0	SENT_51	[p4l591t957r762b1022],
32	South	NNP	LOCATION	South	appos	33	SENT_51	[p4l794t954r950b1005],
33	Korea	NNP	LOCATION	Korea	dobj	9	SENT_51	[p4l983t958r1143b1005],
34	and	CC	O	and	_	0	SENT_51	[p4l1171t954r1273b1005],
35	Singapore	NNP	LOCATION	Singapore	dobj	9	SENT_51	[p4l1302t957r1618b1022],
36	)	CD	NUMBER	)	num	35	SENT_51	[p4l1302t957r1618b1022],
37	.	.	O	.	_	0	SENT_51	[p4l1302t957r1618b1022],

1	Serum	NN	MISC	serum	nn	2	SENT_52	[p4l1649t957r1824b1005],
2	chemistry	NN	O	chemistry	nsubjpass	11	SENT_52	[p4l1854t954r2145b1022],
3	,	,	O	,	_	0	SENT_52	[p4l1854t954r2145b1022],
4	including	VBG	O	include	_	0	SENT_52	[p4l313t1033r579b1102],
5	total	JJ	O	total	amod	6	SENT_52	[p4l605t1033r726b1085],
6	bilirubin	NN	O	bilirubin	prep_including	2	SENT_52	[p4l761t1033r1016b1095],
7	,	,	O	,	_	0	SENT_52	[p4l761t1033r1016b1095],
8	was	VBD	O	be	auxpass	9	SENT_52	[p4l1049t1051r1157b1085],
9	measured	VBN	O	measure	_	0	SENT_52	[p4l1189t1033r1460b1085],
10	and	CC	O	and	_	0	SENT_52	[p4l1491t1033r1593b1085],
11	monitored	VBN	O	monitor	conj_and	9	SENT_52	[p4l1626t1033r1916b1085],
12	weekly	JJ	SET	weekly	dobj	11	SENT_52	[p4l1946t1033r2149b1101],
13	in	IN	O	in	dep	12	SENT_52	[p4l313t1116r359b1163],
14	the	DT	O	the	det	18	SENT_52	[p4l387t1112r474b1164],
15	first	JJ	ORDINAL	first	amod	18	SENT_52	[p4l500t1112r603b1164],
16	two	CD	NUMBER	two	num	18	SENT_52	[p4l626t1122r731b1164],
17	monthly	JJ	SET	monthly	amod	18	SENT_52	[p4l760t1112r992b1180],
18	cycles	NNS	O	cycle	pobj	13	SENT_52	[p4l1019t1112r1194b1180],
19	and	CC	O	and	_	0	SENT_52	[p4l1221t1112r1323b1164],
20	biweekly	RB	SET	biweekly	dep	12	SENT_52	[p4l1352t1112r1608b1180],
21	thereafter	RB	O	thereafter	advmod	11	SENT_52	[p4l1633t1112r1919b1164],
22	.	.	O	.	_	0	SENT_52	[p4l1633t1112r1919b1164],

1	UGT1A1	NN	O	ugt1a1	nn	5	SENT_53	[p4l318t1319r599b1375],
2	genotyping	NN	O	genotyping	nn	5	SENT_53	[p4l632t1319r1004b1394],
3	Baseline	NN	O	baseline	nn	5	SENT_53	[p4l313t1402r549b1454],
4	blood	NN	O	blood	nn	5	SENT_53	[p4l576t1402r736b1454],
5	samples	NNS	O	sample	nsubjpass	7	SENT_53	[p4l763t1402r989b1471],
6	were	VBD	O	be	auxpass	7	SENT_53	[p4l1014t1420r1153b1454],
7	obtained	VBN	O	obtain	dep	17	SENT_53	[p4l1179t1402r1427b1454],
8	and	CC	O	and	_	0	SENT_53	[p4l1454t1402r1556b1454],
9	DNA	NN	O	dna	nsubjpass	11	SENT_53	[p4l1586t1406r1729b1454],
10	was	VBD	O	be	auxpass	11	SENT_53	[p4l1753t1420r1862b1454],
11	extracted	VBN	O	extract	conj_and	7	SENT_53	[p4l1887t1402r2147b1454],
12	using	VBG	O	use	xcomp	11	SENT_53	[p4l312t1484r459b1549],
13	PUREGENE	NN	O	puregene	nn	16	SENT_53	[p4l488t1484r816b1532],
14	DNA	NN	O	dna	nn	16	SENT_53	[p4l847t1484r990b1532],
15	isolation	NN	O	isolation	nn	16	SENT_53	[p4l1019t1481r1255b1532],
16	kits	NNS	O	kit	dobj	12	SENT_53	[p4l1286t1481r1376b1532],
17	(	VBP	O	(	_	0	SENT_53	[p4l1405t1484r1616b1540],
18	Gentra	NNP	ORGANIZATION	Gentra	nn	19	SENT_53	[p4l1405t1484r1616b1540],
19	Systems	NNPS	ORGANIZATION	Systems	nsubj	17	SENT_53	[p4l1643t1484r1880b1549],
20	,	,	O	,	_	0	SENT_53	[p4l1643t1484r1880b1549],
21	Minneapolis	NNP	LOCATION	Minneapolis	appos	19	SENT_53	[p4l1911t1484r2148b1532, p4l311t1560r458b1628],
22	,	,	O	,	_	0	SENT_53	[p4l1911t1484r2148b1532, p4l311t1560r458b1628],
23	MN	NN	O	mn	appos	19	SENT_53	[p4l497t1563r619b1622],
24	,	,	O	,	_	0	SENT_53	[p4l497t1563r619b1622],
25	USA	NNP	LOCATION	USA	appos	19	SENT_53	[p4l660t1563r800b1619],
26	)	CD	NUMBER	)	num	25	SENT_53	[p4l660t1563r800b1619],
27	by	IN	O	by	_	0	SENT_53	[p4l836t1560r902b1628],
28	Quintiles	NNP	ORGANIZATION	Quintiles	nn	30	SENT_53	[p4l936t1560r1196b1624],
29	(	NNP	O	(	nn	30	SENT_53	[p4l1231t1560r1465b1622],
30	Atlanta	NNP	LOCATION	Atlanta	prep_by	25	SENT_53	[p4l1231t1560r1465b1622],
31	,	,	O	,	_	0	SENT_53	[p4l1231t1560r1465b1622],
32	GA	NNP	O	GA	appos	19	SENT_53	[p4l1504t1563r1611b1622],
33	,	,	O	,	_	0	SENT_53	[p4l1504t1563r1611b1622],
34	USA	NNP	LOCATION	USA	appos	32	SENT_53	[p4l1652t1563r1809b1619],
35	)	CD	NUMBER	)	num	34	SENT_53	[p4l1652t1563r1809b1619],
36	.	.	O	.	_	0	SENT_53	[p4l1652t1563r1809b1619],

1	Numerical	JJ	O	numerical	amod	2	SENT_54	[p4l1850t1560r2144b1611],
2	variations	NNS	O	variation	nsubjpass	18	SENT_54	[p4l309t1643r585b1691],
3	in	IN	O	in	_	0	SENT_54	[p4l617t1643r663b1690],
4	dinucleotide	NN	O	dinucleotide	nn	5	SENT_54	[p4l694t1639r1051b1691],
5	repeats	NNS	O	repeat	prep_in	2	SENT_54	[p4l1082t1649r1280b1707],
6	in	IN	O	in	_	0	SENT_54	[p4l1312t1642r1358b1690],
7	the	DT	O	the	det	10	SENT_54	[p4l1387t1639r1474b1691],
8	UGT1A1	NN	O	ugt1a1	nn	10	SENT_54	[p4l1505t1642r1746b1691],
9	(	NN	O	(	nn	10	SENT_54	[p4l1788t1642r2146b1698],
10	A	NN	O	a	prep_in	5	SENT_54	[p4l1788t1642r2146b1698],
11	(	CD	NUMBER	(	num	16	SENT_54	[p4l1788t1642r2146b1698],
12	TA	NNP	O	TA	nn	16	SENT_54	[p4l1788t1642r2146b1698],
13	)	CD	NUMBER	)	num	16	SENT_54	[p4l1788t1642r2146b1698],
14	nTAA	NN	O	ntaa	nn	16	SENT_54	[p4l1788t1642r2146b1698],
15	)	NN	O	)	nn	16	SENT_54	[p4l1788t1642r2146b1698],
16	region	NN	O	region	nsubjpass	18	SENT_54	[p4l312t1721r486b1786],
17	were	VBD	O	be	auxpass	18	SENT_54	[p4l520t1736r659b1769],
18	genotyped	VBN	O	genotype	_	0	SENT_54	[p4l692t1718r988b1786],
19	by	IN	O	by	_	0	SENT_54	[p4l1024t1718r1089b1786],
20	Epidauros	NNP	PERSON	Epidauros	agent	18	SENT_54	[p4l1126t1718r1400b1786],
21	(	CD	NUMBER	(	num	20	SENT_54	[p4l1435t1718r1709b1780],
22	Bernried	NNP	O	Bernried	dep	18	SENT_54	[p4l1435t1718r1709b1780],
23	,	,	O	,	_	0	SENT_54	[p4l1435t1718r1709b1780],
24	Germany	NNP	LOCATION	Germany	nn	25	SENT_54	[p4l1748t1721r2045b1786],
25	)	NNP	O	)	appos	22	SENT_54	[p4l1748t1721r2045b1786],
26	,	,	O	,	_	0	SENT_54	[p4l1748t1721r2045b1786],
27	by	IN	O	by	_	0	SENT_54	[p4l2083t1718r2149b1786],
28	sequencing	NN	O	sequencing	agent	18	SENT_54	[p4l310t1801r634b1866],
29	on	IN	O	on	_	0	SENT_54	[p4l655t1815r722b1849],
30	an	DT	O	a	det	32	SENT_54	[p4l748t1815r811b1849],
31	ABI	NNP	MISC	ABI	nn	32	SENT_54	[p4l834t1801r932b1848],
32	PRISM	NNP	O	PRISM	prep_on	28	SENT_54	[p4l962t1801r1143b1849],
33	3700	CD	NUMBER	3700	dep	40	SENT_54	[p4l1167t1802r1310b1849],
34	or	CC	O	or	_	0	SENT_54	[p4l1332t1815r1389b1849],
35	ABI	NNP	O	ABI	nn	36	SENT_54	[p4l1409t1801r1506b1848],
36	PRISM	NNP	O	PRISM	conj_or	33	SENT_54	[p4l1536t1800r1718b1849],
37	3100	CD	NUMBER	3100	dep	40	SENT_54	[p4l1741t1802r1884b1849],
38	(	NNP	O	(	nn	40	SENT_54	[p4l1908t1797r2147b1866],
39	Applied	NNP	O	Applied	nn	40	SENT_54	[p4l1908t1797r2147b1866],
40	Biosystems	NNP	O	Biosystems	dep	28	SENT_54	[p4l313t1880r637b1945],
41	,	,	O	,	_	0	SENT_54	[p4l313t1880r637b1945],
42	Foster	NNP	LOCATION	Foster	nn	43	SENT_54	[p4l680t1880r845b1928],
43	City	NNP	LOCATION	City	appos	40	SENT_54	[p4l879t1880r1005b1945],
44	,	,	O	,	_	0	SENT_54	[p4l879t1880r1005b1945],
45	CA	NNP	LOCATION	CA	appos	40	SENT_54	[p4l1045t1880r1145b1938],
46	,	,	O	,	_	0	SENT_54	[p4l1045t1880r1145b1938],
47	USA	NNP	LOCATION	USA	appos	40	SENT_54	[p4l1188t1880r1345b1936],
48	)	CD	NUMBER	)	num	47	SENT_54	[p4l1188t1880r1345b1936],
49	.	.	O	.	_	0	SENT_54	[p4l1188t1880r1345b1936],

1	Sequences	NNS	O	sequence	nsubjpass	3	SENT_55	[p4l1384t1880r1684b1945],
2	were	VBD	O	be	auxpass	3	SENT_55	[p4l1718t1894r1857b1928],
3	analyzed	VBN	O	analyze	_	0	SENT_55	[p4l1892t1876r2147b1945],
4	using	VBG	O	use	xcomp	3	SENT_55	[p4l312t1958r459b2023],
5	a	DT	O	a	det	8	SENT_55	[p4l496t1972r525b2006],
6	commercially	RB	O	commercially	advmod	7	SENT_55	[p4l562t1955r954b2023],
7	available	JJ	O	available	amod	8	SENT_55	[p4l991t1955r1249b2006],
8	software	NN	O	software	dobj	4	SENT_55	[p4l1286t1954r1524b2006],
9	suite	NN	O	suite	nn	11	SENT_55	[p4l1562t1958r1692b2006],
10	(	CD	NUMBER	(	num	11	SENT_55	[p4l1730t1955r1926b2017],
11	Phred	NNP	PERSON	Phred	dep	8	SENT_55	[p4l1730t1955r1926b2017],
12	,	,	O	,	_	0	SENT_55	[p4l1730t1955r1926b2017],
13	Phrap	NNP	O	Phrap	appos	11	SENT_55	[p4l1970t1955r2145b2023],
14	,	,	O	,	_	0	SENT_55	[p4l1970t1955r2145b2023],
15	Po	NNP	O	Po	nn	17	SENT_55	[p4l313t2034r598b2102],
16	|	NNP	O	|	nn	17	SENT_55	[p4l313t2034r598b2102],
17	yPhred	NNP	O	yPhred	appos	11	SENT_55	[p4l313t2034r598b2102],
18	and	CC	O	and	_	0	SENT_55	[p4l626t2034r728b2085],
19	Consed	NNP	O	Consed	appos	11	SENT_55	[p4l754t2034r980b2096],
20	,	,	O	,	_	0	SENT_55	[p4l754t2034r980b2096],
21	Seattle	NNP	LOCATION	Seattle	appos	11	SENT_55	[p4l1011t2034r1211b2096],
22	,	,	O	,	_	0	SENT_55	[p4l1011t2034r1211b2096],
23	University	NNP	ORGANIZATION	University	appos	11	SENT_55	[p4l1245t2037r1533b2102],
24	of	IN	ORGANIZATION	of	_	0	SENT_55	[p4l1558t2033r1613b2085],
25	Washington	NNP	ORGANIZATION	Washington	prep_of	23	SENT_55	[p4l1634t2034r1992b2102],
26	,	,	O	,	_	0	SENT_55	[p4l1634t2034r1992b2102],
27	WA	NNP	LOCATION	WA	nn	29	SENT_55	[p4l2020t2037r2145b2096],
28	,	,	O	,	_	0	SENT_55	[p4l2020t2037r2145b2096],
29	USA	NNP	LOCATION	USA	appos	11	SENT_55	[p4l313t2116r471b2172],
30	)	CD	NUMBER	)	num	29	SENT_55	[p4l313t2116r471b2172],
31	.	.	O	.	_	0	SENT_55	[p4l313t2116r471b2172],

1	Genotyping	VBG	O	genotype	_	0	SENT_56	[p4l521t2116r855b2182],
2	calls	NNS	O	call	dobj	1	SENT_56	[p4l900t2113r1026b2165],
3	were	VBD	O	be	auxpass	4	SENT_56	[p4l1071t2131r1210b2165],
4	compiled	VBN	O	compile	aux	1	SENT_56	[p4l1255t2113r1521b2181],
5	using	VBG	O	use	xcomp	4	SENT_56	[p4l1570t2117r1717b2182],
6	a	DT	O	a	det	9	SENT_56	[p4l1762t2131r1791b2165],
7	proprietary	JJ	O	proprietary	amod	9	SENT_56	[p4l1837t2117r2149b2181],
8	software	NN	O	software	nn	9	SENT_56	[p4l310t2192r549b2244],
9	tool	NN	O	tool	dobj	5	SENT_56	[p4l574t2192r679b2244],
10	(	CD	NUMBER	(	num	13	SENT_56	[p4l711t2195r848b2251],
11	SNP	NN	O	snp	nn	13	SENT_56	[p4l711t2195r848b2251],
12	Suite	NN	O	suite	nn	13	SENT_56	[p4l874t2195r1046b2251],
13	)	NN	O	)	nsubj	1	SENT_56	[p4l874t2195r1046b2251],
14	.	.	O	.	_	0	SENT_56	[p4l874t2195r1046b2251],

1	Statistical	JJ	O	statistical	amod	2	SENT_57	[p4l311t2390r625b2450],
2	analysis	NN	O	analysis	nsubjpass	7	SENT_57	[p4l651t2390r908b2469],
3	All	DT	O	all	det	5	SENT_57	[p4l309t2477r384b2528],
4	statistical	JJ	O	statistical	amod	5	SENT_57	[p4l421t2477r678b2528],
5	analysis	NN	O	analysis	dep	2	SENT_57	[p4l716t2477r938b2545],
6	was	VBD	O	be	auxpass	7	SENT_57	[p4l970t2494r1079b2528],
7	performed	VBN	O	perform	_	0	SENT_57	[p4l1113t2476r1404b2545],
8	in	IN	O	in	_	0	SENT_57	[p4l1442t2480r1488b2528],
9	SAS	NNP	ORGANIZATION	SAS	nn	10	SENT_57	[p4l1524t2480r1630b2528],
10	version	NN	O	version	prep_in	7	SENT_57	[p4l1662t2480r1865b2528],
11	8.2	CD	NUMBER	8.2	number	12	SENT_57	[p4l1902t2482r1984b2528],
12	(	CD	NUMBER	(	dep	10	SENT_57	[p4l2023t2480r2148b2536],
13	SAS	NNP	ORGANIZATION	SAS	nn	20	SENT_57	[p4l2023t2480r2148b2536],
14	Institute	NNP	ORGANIZATION	Institute	nn	20	SENT_57	[p4l313t2559r548b2618],
15	,	,	O	,	_	0	SENT_57	[p4l313t2559r548b2618],
16	Cary	NNP	PERSON	Cary	appos	20	SENT_57	[p4l605t2559r750b2624],
17	,	,	O	,	_	0	SENT_57	[p4l605t2559r750b2624],
18	NC	NNP	O	NC	appos	20	SENT_57	[p4l809t2559r914b2618],
19	,	,	O	,	_	0	SENT_57	[p4l809t2559r914b2618],
20	USA	NNP	LOCATION	USA	dep	12	SENT_57	[p4l974t2559r1131b2615],
21	)	CD	NUMBER	)	num	20	SENT_57	[p4l974t2559r1131b2615],
22	.	.	O	.	_	0	SENT_57	[p4l974t2559r1131b2615],

1	Relative	JJ	O	relative	amod	3	SENT_58	[p4l1190t2556r1415b2607],
2	risk	NN	O	risk	nn	3	SENT_58	[p4l1469t2556r1564b2607],
3	calculations	NNS	O	calculation	nsubjpass	5	SENT_58	[p4l1616t2556r1958b2607],
4	were	VBD	O	be	auxpass	5	SENT_58	[p4l2009t2573r2149b2607],
5	performed	VBN	O	perform	_	0	SENT_58	[p4l311t2635r602b2703],
6	in	IN	O	in	_	0	SENT_58	[p4l655t2639r701b2686],
7	PROC	NNP	O	PROC	nn	8	SENT_58	[p4l755t2639r927b2687],
8	FREQ	NNP	O	FREQ	prep_in	5	SENT_58	[p4l979t2638r1135b2700],
9	with	IN	O	with	_	0	SENT_58	[p4l1183t2635r1304b2687],
10	the	DT	O	the	det	12	SENT_58	[p4l1354t2635r1441b2687],
11	RELRISK	NN	O	relrisk	nn	12	SENT_58	[p4l1492t2638r1729b2687],
12	option	NN	O	option	prep_with	5	SENT_58	[p4l1776t2639r1973b2703],
13	,	,	O	,	_	0	SENT_58	[p4l1776t2639r1973b2703],
14	with	IN	O	with	_	0	SENT_58	[p4l2024t2635r2146b2687],
15	maximum	NN	O	maximum	nn	17	SENT_58	[p4l312t2717r594b2765],
16	total	JJ	O	total	amod	17	SENT_58	[p4l636t2714r756b2765],
17	bilirubin	NN	O	bilirubin	prep_with	5	SENT_58	[p4l802t2714r1040b2765],
18	expressed	VBN	O	express	partmod	17	SENT_58	[p4l1083t2714r1360b2782],
19	as	IN	O	as	_	0	SENT_58	[p4l1402t2732r1457b2765],
20	a	DT	O	a	det	22	SENT_58	[p4l1498t2732r1527b2765],
21	categorical	JJ	O	categorical	amod	22	SENT_58	[p4l1568t2714r1877b2782],
22	variable	JJ	O	variable	prep_as	18	SENT_58	[p4l1920t2714r2149b2765],
23	according	VBG	O	accord	_	0	SENT_58	[p4l310t2793r593b2862],
24	to	TO	O	to	prepc_according_to	18	SENT_58	[p4l622t2803r676b2845],
25	the	DT	O	the	det	26	SENT_58	[p4l705t2793r792b2845],
26	criteria	NNS	O	criterion	pobj	18	SENT_58	[p4l824t2797r1021b2845],
27	of	IN	O	of	_	0	SENT_58	[p4l1052t2793r1108b2845],
28	the	DT	O	the	det	31	SENT_58	[p4l1134t2793r1221b2845],
29	Common	JJ	O	common	amod	31	SENT_58	[p4l1252t2797r1513b2845],
30	Terminology	NN	O	terminology	nn	31	SENT_58	[p4l1546t2793r1908b2862],
31	Criteria	NNS	O	criterion	prep_of	26	SENT_58	[p4l1940t2797r2148b2845],
32	for	IN	O	for	mark	35	SENT_58	[p4l308t2873r385b2926],
33	Adverse	JJ	O	adverse	amod	34	SENT_58	[p4l416t2873r643b2926],
34	Events	NNS	O	event	nsubj	35	SENT_58	[p4l679t2878r854b2926],
35	(	VBP	O	(	advcl	18	SENT_58	[p4l888t2864r1199b2933],
36	CTCAE	NN	O	ctca	nn	37	SENT_58	[p4l888t2864r1199b2933],
37	)	NN	O	)	dobj	35	SENT_58	[p4l888t2864r1199b2933],
38	.	.	O	.	_	0	SENT_58	[p4l888t2864r1199b2933],

1	l4	NN	O	l4	nn	3	SENT_59	[p4l888t2864r1199b2933],
2	Significant	JJ	O	significant	amod	3	SENT_59	[p4l1233t2873r1532b2943],
3	increases	NNS	O	increase	nsubjpass	8	SENT_59	[p4l1566t2877r1823b2926],
4	in	IN	O	in	_	0	SENT_59	[p4l1859t2877r1905b2925],
5	relative	JJ	O	relative	amod	6	SENT_59	[p4l1942t2873r2149b2926],
6	risk	NN	O	risk	prep_in	3	SENT_59	[p4l312t2952r408b3003],
7	were	VBD	O	be	auxpass	8	SENT_59	[p4l455t2969r594b3003],
8	defined	VBN	O	define	_	0	SENT_59	[p4l644t2951r854b3003],
9	as	IN	O	as	_	0	SENT_59	[p4l906t2969r961b3003],
10	a	DT	O	a	det	17	SENT_59	[p4l1011t2969r1040b3003],
11	95	CD	PERCENT	95	number	12	SENT_59	[p4l1091t2955r1219b3005],
12	%	NN	PERCENT	%	amod	17	SENT_59	[p4l1091t2955r1219b3005],
13	confidence	NN	O	confidence	nn	17	SENT_59	[p4l1269t2951r1585b3003],
14	interval	NN	O	interval	nn	17	SENT_59	[p4l1638t2952r1843b3003],
15	(	CD	NUMBER	(	num	17	SENT_59	[p4l1899t2955r1992b3011],
16	CI	NN	O	ci	nn	17	SENT_59	[p4l1899t2955r1992b3011],
17	)	NN	O	)	prep_as	8	SENT_59	[p4l1899t2955r1992b3011],
18	that	WDT	O	that	nsubj	19	SENT_59	[p4l2043t2952r2150b3003],
19	excluded	VBD	O	exclude	rcmod	17	SENT_59	[p4l8t3037r310b3098],
20	1.0	CD	NUMBER	1.0	dobj	19	SENT_59	[p4l353t3042r470b3098],
21	.	.	O	.	_	0	SENT_59	[p4l353t3042r470b3098],

1	Only	RB	O	only	advmod	4	SENT_60	[p4l512t3037r677b3117],
2	the	DT	O	the	det	4	SENT_60	[p4l711t3037r813b3098],
3	(	CD	NUMBER	(	num	4	SENT_60	[p4l852t3041r1016b3110],
4	TA	NNP	O	TA	nsubjpass	14	SENT_60	[p4l852t3041r1016b3110],
5	)	CD	NUMBER	)	num	6	SENT_60	[p4l852t3041r1016b3110],
6	6	CD	NUMBER	6	dep	4	SENT_60	[p4l852t3041r1016b3110],
7	and	CC	O	and	_	0	SENT_60	[p4l1054t3037r1173b3098],
8	(	CD	NUMBER	(	num	12	SENT_60	[p4l1213t3041r1379b3110],
9	TA	NNP	O	TA	nn	12	SENT_60	[p4l1213t3041r1379b3110],
10	)	NN	O	)	nn	12	SENT_60	[p4l1213t3041r1379b3110],
11	7	CD	NUMBER	7	num	12	SENT_60	[p4l1213t3041r1379b3110],
12	alleles	NNS	O	allele	dep	4	SENT_60	[p4l1416t3037r1624b3098],
13	were	VBD	O	be	auxpass	14	SENT_60	[p4l1660t3058r1822b3098],
14	included	VBN	O	include	_	0	SENT_60	[p4l1863t3037r2148b3098],
15	in	IN	O	in	_	0	SENT_60	[p4l12t3134r66b3190],
16	the	DT	O	the	det	19	SENT_60	[p4l101t3130r202b3191],
17	relative	JJ	O	relative	amod	19	SENT_60	[p4l238t3130r479b3191],
18	risk	NN	O	risk	nn	19	SENT_60	[p4l516t3130r627b3191],
19	analyses	NNS	O	analysis	prep_in	14	SENT_60	[p4l659t3130r954b3210],
20	;	:	O	;	_	0	SENT_60	[p4l659t3130r954b3210],
21	patients	NNS	O	patient	nsubjpass	37	SENT_60	[p4l993t3134r1247b3210],
22	with	IN	O	with	_	0	SENT_60	[p4l1280t3130r1422b3191],
23	at	IN	O	at	quantmod	26	SENT_60	[p4l1459t3142r1517b3191],
24	least	JJS	O	least	mwe	23	SENT_60	[p4l1553t3130r1698b3191],
25	one	CD	NUMBER	one	number	26	SENT_60	[p4l1730t3151r1851b3191],
26	(	CD	NUMBER	(	prep_with	21	SENT_60	[p4l1886t3134r2048b3204],
27	TA	NNP	O	TA	dep	26	SENT_60	[p4l1886t3134r2048b3204],
28	)	CD	NUMBER	)	num	27	SENT_60	[p4l1886t3134r2048b3204],
29	5	CD	NUMBER	5	num	35	SENT_60	[p4l1886t3134r2048b3204],
30	or	CC	O	or	_	0	SENT_60	[p4l2084t3151r2150b3191],
31	(	CD	NUMBER	(	num	35	SENT_60	[p4l10t3226r175b3296],
32	TA	NNP	O	TA	nn	35	SENT_60	[p4l10t3226r175b3296],
33	)	CD	NUMBER	)	num	35	SENT_60	[p4l10t3226r175b3296],
34	8	CD	NUMBER	8	amod	35	SENT_60	[p4l10t3226r175b3296],
35	allele	NN	O	allele	dep	27	SENT_60	[p4l213t3222r391b3283],
36	were	VBD	O	be	auxpass	37	SENT_60	[p4l428t3243r590b3283],
37	excluded	VBN	O	exclude	parataxis	14	SENT_60	[p4l626t3222r947b3283],
38	.	.	O	.	_	0	SENT_60	[p4l626t3222r947b3283],

1	No	DT	O	no	det	2	SENT_61	[p4l993t3226r1089b3283],
2	correction	NN	O	correction	nsubjpass	7	SENT_61	[p4l1126t3226r1461b3283],
3	for	IN	O	for	_	0	SENT_61	[p4l1500t3222r1589b3283],
4	multiple	JJ	O	multiple	amod	5	SENT_61	[p4l1628t3222r1899b3303],
5	testing	NN	O	testing	prep_for	2	SENT_61	[p4l1935t3226r2150b3303],
6	was	VBD	O	be	auxpass	7	SENT_61	[p4l7t3336r133b3376],
7	performed	VBN	O	perform	_	0	SENT_61	[p4l164t3315r522b3396],
8	;	:	O	;	_	0	SENT_61	[p4l164t3315r522b3396],
9	the	DT	O	the	det	12	SENT_61	[p4l553t3315r654b3376],
10	Phase	NN	O	phase	nn	12	SENT_61	[p4l687t3315r873b3376],
11	I	NN	O	i	nn	12	SENT_61	[p4l905t3320r913b3375],
12	analysis	NN	O	analysis	nsubjpass	14	SENT_61	[p4l946t3315r1206b3396],
13	was	VBD	O	be	auxpass	14	SENT_61	[p4l1233t3336r1359b3376],
14	regarded	VBN	O	regard	parataxis	7	SENT_61	[p4l1390t3315r1676b3396],
15	as	IN	O	as	_	0	SENT_61	[p4l1706t3336r1770b3376],
16	hypothesis	NN	O	hypothesis	nn	17	SENT_61	[p4l1802t3315r2149b3396],
17	generating	NN	O	generating	prep_as	14	SENT_61	[p4l8t3413r356b3489],
18	and	CC	O	and	_	0	SENT_61	[p4l382t3409r500b3470],
19	each	DT	O	each	det	20	SENT_61	[p4l527t3409r680b3470],
20	test	NN	O	test	prep_as	14	SENT_61	[p4l707t3420r819b3470],
21	in	IN	O	in	_	0	SENT_61	[p4l847t3413r900b3469],
22	the	DT	O	the	det	23	SENT_61	[p4l927t3409r1028b3470],
23	Phase	NN	O	phase	prep_in	14	SENT_61	[p4l1058t3409r1243b3470],
24	II	CD	NUMBER	ii	num	25	SENT_61	[p4l1273t3414r1303b3469],
25	arms	NNS	O	arm	nsubjpass	27	SENT_61	[p4l1334t3430r1489b3470],
26	was	VBD	O	be	auxpass	27	SENT_61	[p4l1513t3430r1640b3470],
27	regarded	VBN	O	regard	rcmod	23	SENT_61	[p4l1669t3409r1954b3489],
28	as	IN	O	as	_	0	SENT_61	[p4l1982t3430r2046b3470],
29	an	DT	O	a	det	31	SENT_61	[p4l2072t3430r2146b3470],
30	independent	JJ	O	independent	amod	31	SENT_61	[p4l12t3502r426b3582],
31	hypothesis	NN	O	hypothesis	prep_as	27	SENT_61	[p4l458t3502r805b3582],
32	and	CC	O	and	_	0	SENT_61	[p4l837t3502r955b3562],
33	reported	VBD	O	report	rcmod	23	SENT_61	[p4l991t3502r1263b3582],
34	as	IN	O	as	_	0	SENT_61	[p4l1296t3522r1360b3562],
35	such	JJ	O	such	prep_such_as	33	SENT_61	[p4l1392t3502r1560b3562],
36	.	.	O	.	_	0	SENT_61	[p4l1392t3502r1560b3562],

1	Results	NNS	O	result	_	0	SENT_62	[p4l12t3744r249b3806],

1	Phase	NN	O	phase	nn	2	SENT_63	[p5l13t111r231b180],
2	I	NN	O	i	_	0	SENT_63	[p5l266t117r287b179],

1	Samples	NNS	O	sample	nsubj	12	SENT_64	[p5l9t213r281b293],
2	from	IN	O	from	_	0	SENT_64	[p5l332t213r482b274],
3	111	CD	NUMBER	111	number	5	SENT_64	[p5l540t218r646b273],
4	of	IN	O	of	quantmod	5	SENT_64	[p5l712t213r776b274],
5	119	CD	NUMBER	119	num	7	SENT_64	[p5l828t218r946b274],
6	total	JJ	O	total	amod	7	SENT_64	[p5l998t213r1139b274],
7	patients	NNS	O	patient	prep_from	1	SENT_64	[p5l1196t217r1450b293],
8	in	IN	O	in	_	0	SENT_64	[p5l1506t217r1559b273],
9	the	DT	O	the	det	10	SENT_64	[p5l1612t213r1713b274],
10	study	NN	O	study	prep_in	7	SENT_64	[p5l1765t213r1938b293],
11	were	VBD	O	be	cop	12	SENT_64	[p5l1987t234r2149b274],
12	available	JJ	O	available	_	0	SENT_64	[p5l9t306r309b367],
13	for	IN	O	for	_	0	SENT_64	[p5l345t306r434b367],
14	analysis	NN	O	analysis	prep_for	12	SENT_64	[p5l470t306r748b387],
15	.	.	O	.	_	0	SENT_64	[p5l470t306r748b387],

1	The	DT	O	the	det	3	SENT_65	[p5l789t306r911b367],
2	(	CD	NUMBER	(	num	3	SENT_65	[p5l950t310r1132b379],
3	TA	NNP	O	TA	nsubjpass	18	SENT_65	[p5l950t310r1132b379],
4	)	CD	NUMBER	)	number	5	SENT_65	[p5l950t310r1132b379],
5	5	CD	NUMBER	5	dep	3	SENT_65	[p5l950t310r1132b379],
6	,	,	O	,	_	0	SENT_65	[p5l950t310r1132b379],
7	(	CD	NUMBER	(	num	8	SENT_65	[p5l1176t310r1341b379],
8	TA	NNP	O	TA	conj_and	3	SENT_65	[p5l1176t310r1341b379],
9	)	CD	NUMBER	)	number	10	SENT_65	[p5l1176t310r1341b379],
10	6	CD	NUMBER	6	dep	8	SENT_65	[p5l1176t310r1341b379],
11	and	CC	O	and	_	0	SENT_65	[p5l1380t306r1498b367],
12	(	CD	NUMBER	(	num	14	SENT_65	[p5l1539t310r1704b379],
13	TA	NNP	O	TA	nn	14	SENT_65	[p5l1539t310r1704b379],
14	)	NN	O	)	conj_and	3	SENT_65	[p5l1539t310r1704b379],
15	7	CD	NUMBER	7	num	16	SENT_65	[p5l1539t310r1704b379],
16	alleles	NNS	O	allele	dep	14	SENT_65	[p5l1743t306r1950b367],
17	were	VBD	O	be	auxpass	18	SENT_65	[p5l1987t327r2149b367],
18	seen	VBN	O	see	_	0	SENT_65	[p5l9t420r152b460],
19	in	IN	O	in	_	0	SENT_65	[p5l183t403r237b459],
20	the	DT	O	the	det	22	SENT_65	[p5l262t399r364b460],
21	genotyped	JJ	O	genotyped	amod	22	SENT_65	[p5l387t399r732b480],
22	population	NN	O	population	prep_in	18	SENT_65	[p5l759t399r1135b480],
23	.	.	O	.	_	0	SENT_65	[p5l759t399r1135b480],

1	The	DT	O	the	det	2	SENT_66	[p5l1162t399r1284b460],
2	distribution	NN	O	distribution	nsubjpass	14	SENT_66	[p5l1308t399r1682b460],
3	of	IN	O	of	_	0	SENT_66	[p5l1709t399r1774b460],
4	genotypes	NNS	O	genotype	prep_of	2	SENT_66	[p5l1794t411r2145b480],
5	,	,	O	,	_	0	SENT_66	[p5l1794t411r2145b480],
6	and	CC	O	and	_	0	SENT_66	[p5l9t492r128b552],
7	their	PRP$	O	they	poss	8	SENT_66	[p5l153t492r303b552],
8	distribution	NN	O	distribution	conj_and	4	SENT_66	[p5l329t492r703b552],
9	by	IN	O	by	_	0	SENT_66	[p5l734t492r810b572],
10	race	NN	O	race	prep_by	8	SENT_66	[p5l838t512r974b552],
11	and	CC	O	and	_	0	SENT_66	[p5l1001t492r1119b552],
12	age	NN	O	age	conj_and	10	SENT_66	[p5l1147t512r1259b572],
13	is	VBZ	O	be	auxpass	14	SENT_66	[p5l1289t496r1332b552],
14	presented	VBN	O	present	ccomp	21	SENT_66	[p5l1360t492r1676b572],
15	in	IN	O	in	_	0	SENT_66	[p5l1708t496r1761b552],
16	Table	NNP	O	Table	prep_in	14	SENT_66	[p5l1789t492r1972b552],
17	1	CD	NUMBER	1	num	16	SENT_66	[p5l2003t497r2054b565],
18	,	,	O	,	_	0	SENT_66	[p5l2003t497r2054b565],
19	as	RB	O	as	advmod	21	SENT_66	[p5l2085t512r2149b552],
20	are	VBP	O	be	cop	21	SENT_66	[p5l9t606r108b645],
21	descriptive	JJ	O	descriptive	_	0	SENT_66	[p5l139t585r499b665],
22	statistics	NNS	O	statistics	nsubj	21	SENT_66	[p5l530t589r803b645],
23	for	IN	O	for	_	0	SENT_66	[p5l833t584r922b645],
24	baseline	NN	O	baseline	nn	25	SENT_66	[p5l953t585r1225b645],
25	bilirubin	NN	O	bilirubin	prep_for	22	SENT_66	[p5l1257t585r1534b645],
26	in	IN	O	in	_	0	SENT_66	[p5l1572t589r1625b645],
27	each	DT	O	each	det	29	SENT_66	[p5l1659t585r1812b645],
28	genotype	NN	O	genotype	nn	29	SENT_66	[p5l1846t596r2149b665],
29	class	NN	O	class	prep_in	25	SENT_66	[p5l9t678r182b739],
30	.	.	O	.	_	0	SENT_66	[p5l9t678r182b739],

1	As	IN	O	as	mark	2	SENT_67	[p5l218t682r297b739],
2	expected	VBN	O	expect	advcl	10	SENT_67	[p5l330t678r647b758],
3	,	,	O	,	_	0	SENT_67	[p5l330t678r647b758],
4	the	DT	O	the	det	6	SENT_67	[p5l683t678r785b739],
5	(	CD	NUMBER	(	num	6	SENT_67	[p5l820t682r985b751],
6	TA	NNP	O	TA	nsubj	10	SENT_67	[p5l820t682r985b751],
7	)	CD	NUMBER	)	num	9	SENT_67	[p5l820t682r985b751],
8	6	CD	NUMBER	6	num	9	SENT_67	[p5l820t682r985b751],
9	allele	NN	O	allele	dep	6	SENT_67	[p5l1019t678r1197b739],
10	predominated	VBD	O	predominate	_	0	SENT_67	[p5l1232t678r1692b758],
11	with	IN	O	with	_	0	SENT_67	[p5l1726t678r1868b739],
12	64	CD	PERCENT	64	num	13	SENT_67	[p5l1906t682r2055b741],
13	%	NN	PERCENT	%	prep_with	10	SENT_67	[p5l1906t682r2055b741],
14	of	IN	O	of	_	0	SENT_67	[p5l2088t678r2153b739],
15	the	DT	O	the	det	16	SENT_67	[p5l7t771r108b832],
16	alleles	NNS	O	allele	prep_of	13	SENT_67	[p5l152t771r379b844],
17	;	:	O	;	_	0	SENT_67	[p5l152t771r379b844],
18	only	RB	O	only	advmod	21	SENT_67	[p5l427t771r570b851],
19	a	DT	O	a	det	21	SENT_67	[p5l614t792r648b832],
20	single	JJ	O	single	amod	21	SENT_67	[p5l693t771r883b851],
21	patient	NN	O	patient	nsubjpass	27	SENT_67	[p5l929t775r1155b851],
22	with	IN	O	with	_	0	SENT_67	[p5l1196t771r1338b832],
23	the	DT	O	the	det	25	SENT_67	[p5l1383t771r1485b832],
24	5/6	CD	NUMBER	5/6	num	25	SENT_67	[p5l1530t775r1631b832],
25	genotype	NN	O	genotype	prep_with	21	SENT_67	[p5l1676t782r1979b851],
26	was	VBD	O	be	auxpass	27	SENT_67	[p5l2022t792r2149b832],
27	observed	VBN	O	observe	parataxis	10	SENT_67	[p5l8t863r325b923],
28	.	.	O	.	_	0	SENT_67	[p5l8t863r325b923],

1	The	DT	O	the	det	2	SENT_68	[p5l85t956r207b1017],
2	variation	NN	O	variation	nsubjpass	19	SENT_68	[p5l250t960r538b1017],
3	in	IN	O	in	_	0	SENT_68	[p5l589t960r642b1016],
4	baseline	NN	O	baseline	nn	5	SENT_68	[p5l691t956r962b1017],
5	bilirubin	NN	O	bilirubin	prep_in	2	SENT_68	[p5l1007t956r1284b1017],
6	across	IN	O	across	_	0	SENT_68	[p5l1331t977r1534b1017],
7	genotype	NN	O	genotype	nn	8	SENT_68	[p5l1577t968r1881b1037],
8	classes	NNS	O	class	prep_across	5	SENT_68	[p5l1925t956r2149b1017],
9	that	WDT	O	that	nsubjpass	13	SENT_68	[p5l7t1049r132b1109],
10	might	MD	O	might	aux	13	SENT_68	[p5l167t1049r354b1129],
11	have	VB	O	have	aux	13	SENT_68	[p5l390t1049r543b1109],
12	been	VBN	O	be	auxpass	13	SENT_68	[p5l580t1049r735b1109],
13	predicted	VBN	O	predict	rcmod	5	SENT_68	[p5l775t1049r1084b1129],
14	from	IN	O	from	_	0	SENT_68	[p5l1119t1048r1269b1109],
15	previous	JJ	O	previous	amod	16	SENT_68	[p5l1309t1053r1588b1129],
16	reports	NNS	O	report	prep_from	13	SENT_68	[p5l1627t1060r1848b1129],
17	was	VBD	O	be	auxpass	19	SENT_68	[p5l1883t1070r2010b1109],
18	not	RB	O	not	neg	19	SENT_68	[p5l2048t1060r2151b1109],
19	observed	VBN	O	observe	_	0	SENT_68	[p5l8t1142r305b1202],
20	in	IN	O	in	_	0	SENT_68	[p5l343t1146r396b1202],
21	this	DT	O	this	det	22	SENT_68	[p5l429t1142r543b1202],
22	set	NN	O	set	prep_in	19	SENT_68	[p5l575t1153r663b1202],
23	of	IN	O	of	_	0	SENT_68	[p5l693t1141r757b1202],
24	patients	NNS	O	patient	prep_of	22	SENT_68	[p5l786t1146r1058b1222],
25	.	.	O	.	_	0	SENT_68	[p5l786t1146r1058b1222],

1	The	DT	O	the	det	4	SENT_69	[p5l1093t1142r1215b1202],
2	mean	NN	O	mean	nn	4	SENT_69	[p5l1250t1163r1426b1202],
3	baseline	NN	O	baseline	nn	4	SENT_69	[p5l1462t1142r1733b1202],
4	level	NN	O	level	nsubj	10	SENT_69	[p5l1769t1142r1916b1202],
5	in	IN	O	in	_	0	SENT_69	[p5l1957t1146r2010b1202],
6	7/7	CD	NUMBER	7/7	num	7	SENT_69	[p5l2049t1145r2148b1203],
7	patients	NNS	O	patient	prep_in	4	SENT_69	[p5l10t1239r264b1315],
8	was	VBD	O	be	cop	10	SENT_69	[p5l292t1256r419b1296],
9	8.9	CD	NUMBER	8.9	num	10	SENT_69	[p5l450t1241r550b1296],
10	umol/l	NN	O	umol/l	dep	38	SENT_69	[p5l568t1235r800b1311],
11	,	,	O	,	_	0	SENT_69	[p5l568t1235r800b1311],
12	compared	VBN	O	compare	_	0	SENT_69	[p5l834t1235r1165b1315],
13	to	TO	O	to	prepc_compared_to	10	SENT_69	[p5l1195t1247r1256b1296],
14	9.2	CD	NUMBER	9.2	num	15	SENT_69	[p5l1287t1241r1384b1296],
15	umol/I	NN	O	umol/i	pobj	10	SENT_69	[p5l1406t1235r1615b1311],
16	in	IN	O	in	_	0	SENT_69	[p5l1653t1239r1706b1295],
17	6/7	CD	NUMBER	6/7	num	18	SENT_69	[p5l1741t1239r1841b1296],
18	patients	NNS	O	patient	prep_in	15	SENT_69	[p5l1873t1239r2144b1315],
19	,	,	O	,	_	0	SENT_69	[p5l1873t1239r2144b1315],
20	and	CC	O	and	_	0	SENT_69	[p5l9t1328r128b1389],
21	the	DT	O	the	det	22	SENT_69	[p5l170t1328r272b1389],
22	maximum	NN	O	maximum	nsubj	23	SENT_69	[p5l316t1332r645b1389],
23	observed	VBN	O	observe	conj_and	10	SENT_69	[p5l691t1328r987b1389],
24	baseline	NN	O	baseline	nn	25	SENT_69	[p5l1033t1328r1305b1389],
25	value	NN	O	value	npadvmod	23	SENT_69	[p5l1346t1328r1525b1389],
26	in	IN	O	in	_	0	SENT_69	[p5l1572t1332r1625b1388],
27	the	DT	O	the	det	29	SENT_69	[p5l1669t1328r1771b1389],
28	7/7	CD	NUMBER	7/7	num	29	SENT_69	[p5l1816t1331r1915b1389],
29	group	NN	O	group	prep_in	23	SENT_69	[p5l1959t1349r2149b1408],
30	(	CD	NUMBER	(	number	31	SENT_69	[p5l10t1424r162b1490],
31	17.1	CD	NUMBER	17.1	num	33	SENT_69	[p5l10t1424r162b1490],
32	umol/l	NN	O	umol/l	nn	33	SENT_69	[p5l194t1420r427b1495],
33	)	NN	O	)	dobj	23	SENT_69	[p5l194t1420r427b1495],
34	was	VBD	O	be	cop	38	SENT_69	[p5l494t1441r621b1480],
35	less	JJR	O	less	mwe	36	SENT_69	[p5l691t1420r803b1480],
36	than	IN	O	than	quantmod	38	SENT_69	[p5l867t1420r1008b1480],
37	the	DT	O	the	quantmod	38	SENT_69	[p5l1075t1420r1177b1480],
38	maximum	NN	O	maximum	_	0	SENT_69	[p5l1244t1424r1573b1480],
39	for	IN	O	for	_	0	SENT_69	[p5l1640t1420r1729b1480],
40	either	CC	O	either	preconj	42	SENT_69	[p5l1793t1420r1982b1480],
41	6/6	CD	NUMBER	6/6	number	42	SENT_69	[p5l2047t1424r2148b1481],
42	(	CD	NUMBER	(	prep_for	38	SENT_69	[p5l10t1516r176b1582],
43	25.7	CD	NUMBER	25.7	num	44	SENT_69	[p5l10t1516r176b1582],
44	umol/l	NN	O	umol/l	dep	42	SENT_69	[p5l194t1512r427b1587],
45	)	CD	NUMBER	)	dep	42	SENT_69	[p5l194t1512r427b1587],
46	or	CC	O	or	_	0	SENT_69	[p5l461t1533r526b1572],
47	6/7	CD	NUMBER	6/7	num	48	SENT_69	[p5l558t1516r658b1573],
48	(	NN	O	(	conj_or	42	SENT_69	[p5l692t1516r855b1582],
49	20.5	CD	NUMBER	20.5	num	51	SENT_69	[p5l692t1516r855b1582],
50	umol/l	NN	O	umol/l	nn	51	SENT_69	[p5l876t1512r1129b1587],
51	)	NN	O	)	nsubj	38	SENT_69	[p5l876t1512r1129b1587],
52	.	.	O	.	_	0	SENT_69	[p5l876t1512r1129b1587],

1	The	DT	O	the	det	2	SENT_70	[p5l86t1605r208b1665],
2	maximum	NN	O	maximum	nsubjpass	18	SENT_70	[p5l249t1609r577b1665],
3	within	IN	O	within	_	0	SENT_70	[p5l617t1605r1086b1685],
4	—	CD	NUMBER	—	num	5	SENT_70	[p5l617t1605r1086b1685],
5	patient	NN	O	patient	prep_within	18	SENT_70	[p5l617t1605r1086b1685],
6	total	JJ	O	total	amod	8	SENT_70	[p5l1121t1605r1261b1665],
7	bilirubin	NN	O	bilirubin	nn	8	SENT_70	[p5l1306t1605r1583b1665],
8	levels	NNS	O	level	nsubjpass	18	SENT_70	[p5l1630t1605r1812b1665],
9	observed	VBN	O	observe	partmod	8	SENT_70	[p5l1851t1605r2148b1665],
10	during	IN	O	during	_	0	SENT_70	[p5l9t1697r221b1778],
11	nilotinib	NN	O	nilotinib	nn	12	SENT_70	[p5l253t1697r527b1758],
12	therapy	NN	O	therapy	prep_during	9	SENT_70	[p5l556t1697r805b1778],
13	for	IN	O	for	_	0	SENT_70	[p5l833t1697r922b1758],
14	each	DT	O	each	det	16	SENT_70	[p5l950t1697r1103b1758],
15	genotype	NN	O	genotype	nn	16	SENT_70	[p5l1135t1709r1438b1778],
16	class	NN	O	class	prep_for	12	SENT_70	[p5l1468t1697r1623b1758],
17	are	VBP	O	be	auxpass	18	SENT_70	[p5l1653t1718r1753b1758],
18	reported	VBN	O	report	_	0	SENT_70	[p5l1786t1697r2058b1778],
19	in	IN	O	in	_	0	SENT_70	[p5l2093t1701r2146b1757],
20	Table	NNP	O	Table	prep_in	18	SENT_70	[p5l7t1790r190b1850],
21	2	CD	NUMBER	2	num	20	SENT_70	[p5l242t1796r300b1849],
22	.	.	O	.	_	0	SENT_70	[p5l242t1796r300b1849],

1	Relative	JJ	O	relative	amod	2	SENT_71	[p5l361t1790r623b1850],
2	risks	NNS	O	risk	nsubj	4	SENT_71	[p5l679t1790r819b1850],
3	were	VBD	O	be	aux	4	SENT_71	[p5l872t1810r1033b1850],
4	determined	VBN	O	determine	_	0	SENT_71	[p5l1087t1790r1462b1850],
5	for	IN	O	for	_	0	SENT_71	[p5l1516t1790r1605b1850],
6	three	CD	NUMBER	three	num	8	SENT_71	[p5l1656t1790r1822b1850],
7	different	JJ	O	different	amod	8	SENT_71	[p5l1876t1790r2151b1850],
8	models	NNS	O	model	prep_for	4	SENT_71	[p5l11t1883r246b1944],
9	of	IN	O	of	_	0	SENT_71	[p5l278t1883r343b1944],
10	genetic	JJ	O	genetic	amod	11	SENT_71	[p5l371t1887r609b1963],
11	effect	NN	O	effect	prep_of	8	SENT_71	[p5l642t1883r838b1956],
12	,	,	O	,	_	0	SENT_71	[p5l642t1883r838b1956],
13	presented	VBN	O	present	dep	4	SENT_71	[p5l877t1883r1194b1963],
14	in	IN	O	in	_	0	SENT_71	[p5l1231t1887r1284b1943],
15	Table	NNP	O	Table	prep_in	13	SENT_71	[p5l1318t1883r1502b1944],
16	3	CD	NUMBER	3	num	15	SENT_71	[p5l1534t1889r1589b1956],
17	,	,	O	,	_	0	SENT_71	[p5l1534t1889r1589b1956],
18	with	IN	O	with	_	0	SENT_71	[p5l1625t1883r1767b1944],
19	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_with	13	SENT_71	[p5l1804t1883r2148b1963, p5l11t1976r320b2037],
20	defined	VBN	O	define	partmod	19	SENT_71	[p5l377t1976r621b2037],
21	as	IN	O	as	_	0	SENT_71	[p5l679t1997r743b2037],
22	CTCAE	NN	O	ctca	nn	23	SENT_71	[p5l799t1980r1031b2037],
23	grade	NN	O	grade	prep_as	20	SENT_71	[p5l1089t1976r1271b2057],
24	3	CD	NUMBER	3	number	25	SENT_71	[p5l1327t1982r1359b2037],
25	elevation	NN	O	elevation	amod	23	SENT_71	[p5l1421t1976r1722b2037],
26	or	CC	O	or	_	0	SENT_71	[p5l1781t1997r1846b2037],
27	greater	JJR	O	greater	conj_or	25	SENT_71	[p5l1901t1988r2144b2057],
28	,	,	O	,	_	0	SENT_71	[p5l1901t1988r2144b2057],
29	observed	VBN	O	observe	dep	4	SENT_71	[p5l8t2069r305b2130],
30	at	IN	O	at	_	0	SENT_71	[p5l351t2081r409b2130],
31	any	DT	O	any	det	32	SENT_71	[p5l451t2090r568b2149],
32	post	NN	O	post	prep_at	29	SENT_71	[p5l612t2069r1048b2149],
33	—	RB	O	—	advmod	29	SENT_71	[p5l612t2069r1048b2149],
34	baseline	NN	O	baseline	nn	35	SENT_71	[p5l612t2069r1048b2149],
35	point	NN	O	point	dobj	4	SENT_71	[p5l1093t2073r1279b2150],
36	.	.	O	.	_	0	SENT_71	[p5l1093t2073r1279b2150],

1	In	IN	O	in	_	0	SENT_72	[p5l1330t2074r1384b2129],
2	a	DT	O	a	det	3	SENT_72	[p5l1431t2090r1464b2130],
3	comparison	NN	O	comparison	prep_in	25	SENT_72	[p5l1508t2073r1895b2150],
4	of	IN	O	of	_	0	SENT_72	[p5l1942t2069r2006b2130],
5	7/7	CD	NUMBER	7/7	num	6	SENT_72	[p5l2048t2073r2148b2131],
6	genotype	NN	O	genotype	prep_of	3	SENT_72	[p5l8t2173r312b2242],
7	versus	CC	O	versus	prep	6	SENT_72	[p5l343t2183r546b2222],
8	non	JJ	O	non	amod	11	SENT_72	[p5l582t2165r837b2223],
9	—	NN	O	—	nn	11	SENT_72	[p5l582t2165r837b2223],
10	7/7	CD	NUMBER	7/7	num	11	SENT_72	[p5l582t2165r837b2223],
11	genotype	NN	O	genotype	dep	7	SENT_72	[p5l870t2173r1191b2242],
12	,	,	O	,	_	0	SENT_72	[p5l870t2173r1191b2242],
13	the	DT	O	the	det	15	SENT_72	[p5l1226t2162r1327b2222],
14	relative	JJ	O	relative	amod	15	SENT_72	[p5l1362t2162r1603b2222],
15	risk	NN	O	risk	nsubj	25	SENT_72	[p5l1638t2162r1748b2222],
16	of	IN	O	of	_	0	SENT_72	[p5l1779t2161r1843b2222],
17	hyperbi	NN	O	hyperbus	nn	19	SENT_72	[p5l1875t2162r2148b2242],
18	—	NN	O	—	nn	19	SENT_72	[p5l1875t2162r2148b2242],
19	lirubinemia	NN	O	lirubinemia	prep_of	15	SENT_72	[p5l13t2254r390b2315],
20	for	IN	O	for	_	0	SENT_72	[p5l423t2254r512b2315],
21	the	DT	O	the	det	23	SENT_72	[p5l544t2254r645b2315],
22	7/7	CD	NUMBER	7/7	num	23	SENT_72	[p5l682t2258r781b2316],
23	genotype	NN	O	genotype	prep_for	19	SENT_72	[p5l816t2266r1120b2335],
24	is	VBZ	O	be	cop	25	SENT_72	[p5l1158t2258r1200b2315],
25	4.5	CD	NUMBER	4.5	_	0	SENT_72	[p5l1234t2261r1334b2315],
26	with	IN	O	with	_	0	SENT_72	[p5l1371t2254r1513b2315],
27	a	DT	O	a	det	30	SENT_72	[p5l1551t2275r1585b2315],
28	95	CD	PERCENT	95	number	29	SENT_72	[p5l1620t2259r1769b2317],
29	%	NN	PERCENT	%	amod	30	SENT_72	[p5l1620t2259r1769b2317],
30	CI	NN	O	ci	prep_with	25	SENT_72	[p5l1804t2258r1868b2315],
31	of	IN	O	of	_	0	SENT_72	[p5l1907t2254r1971b2315],
32	(	CD	NUMBER	(	number	33	SENT_72	[p5l2003t2259r2144b2327],
33	1.9	CD	NUMBER	1.9	prep_of	30	SENT_72	[p5l2003t2259r2144b2327],
34	,	,	O	,	_	0	SENT_72	[p5l2003t2259r2144b2327],
35	10.8	CD	NUMBER	10.8	num	36	SENT_72	[p5l13t2352r195b2418],
36	)	NN	O	)	appos	30	SENT_72	[p5l13t2352r195b2418],
37	.	.	O	.	_	0	SENT_72	[p5l13t2352r195b2418],

1	In	IN	O	in	_	0	SENT_73	[p5l230t2353r283b2408],
2	a	DT	O	a	det	3	SENT_73	[p5l314t2369r347b2409],
3	comparison	NN	O	comparison	prep_in	21	SENT_73	[p5l375t2352r761b2428],
4	of	IN	O	of	_	0	SENT_73	[p5l790t2348r855b2409],
5	7/7	CD	NUMBER	7/7	num	6	SENT_73	[p5l881t2352r980b2409],
6	genotype	NN	O	genotype	prep_of	3	SENT_73	[p5l1007t2359r1311b2428],
7	versus	CC	O	versus	prep	6	SENT_73	[p5l1337t2369r1540b2409],
8	6/7	CD	NUMBER	6/7	num	9	SENT_73	[p5l1569t2352r1670b2409],
9	genotype	NN	O	genotype	dep	7	SENT_73	[p5l1698t2359r2018b2428],
10	,	,	O	,	_	0	SENT_73	[p5l1698t2359r2018b2428],
11	the	DT	O	the	det	13	SENT_73	[p5l2048t2348r2149b2409],
12	relative	JJ	O	relative	amod	13	SENT_73	[p5l11t2441r253b2502],
13	risk	NN	O	risk	nsubj	21	SENT_73	[p5l299t2441r410b2502],
14	for	IN	O	for	_	0	SENT_73	[p5l450t2441r540b2502],
15	the	DT	O	the	det	17	SENT_73	[p5l581t2441r682b2502],
16	7/7	CD	NUMBER	7/7	num	17	SENT_73	[p5l729t2445r828b2502],
17	genotype	NN	O	genotype	prep_for	13	SENT_73	[p5l873t2453r1177b2522],
18	is	VBZ	O	be	cop	21	SENT_73	[p5l1224t2445r1267b2502],
19	3.6	CD	NUMBER	3.6	number	20	SENT_73	[p5l1312t2447r1413b2502],
20	(	CD	NUMBER	(	num	21	SENT_73	[p5l1460t2446r1601b2514],
21	1.4	CD	NUMBER	1.4	_	0	SENT_73	[p5l1460t2446r1601b2514],
22	,	,	O	,	_	0	SENT_73	[p5l1460t2446r1601b2514],
23	9.4	CD	NUMBER	9.4	num	24	SENT_73	[p5l1651t2445r1793b2511],
24	)	NN	O	)	appos	21	SENT_73	[p5l1651t2445r1793b2511],
25	.	.	O	.	_	0	SENT_73	[p5l1651t2445r1793b2511],

1	Both	DT	O	both	det	3	SENT_74	[p5l1846t2441r1990b2502],
2	risk	NN	O	risk	nn	3	SENT_74	[p5l2040t2441r2150b2502],
3	increases	NNS	O	increase	nsubj	8	SENT_74	[p5l12t2538r311b2595],
4	are	VBP	O	be	cop	8	SENT_74	[p5l343t2555r442b2595],
5	statistically	RB	O	statistically	advmod	6	SENT_74	[p5l473t2534r839b2614],
6	significant	JJ	O	significant	amod	8	SENT_74	[p5l870t2534r1211b2615],
7	(	NN	O	(	nn	8	SENT_74	[p5l1241t2538r1365b2604],
8	P	NN	O	p	_	0	SENT_74	[p5l1241t2538r1365b2604],
9	<	JJR	O	<	dep	8	SENT_74	[p5l1241t2538r1365b2604],
10	0.05	CD	NUMBER	0.05	num	11	SENT_74	[p5l1382t2538r1567b2604],
11	)	NN	O	)	dep	9	SENT_74	[p5l1382t2538r1567b2604],
12	.	.	O	.	_	0	SENT_74	[p5l1382t2538r1567b2604],

1	In	IN	O	in	_	0	SENT_75	[p5l1607t2539r1660b2594],
2	a	DT	O	a	det	3	SENT_75	[p5l1695t2555r1729b2595],
3	comparison	NN	O	comparison	prep_in	21	SENT_75	[p5l1760t2538r2146b2615],
4	of	IN	O	of	_	0	SENT_75	[p5l8t2626r73b2687],
5	6/7	CD	NUMBER	6/7	num	6	SENT_75	[p5l98t2630r199b2688],
6	genotype	NN	O	genotype	prep_of	3	SENT_75	[p5l226t2638r529b2707],
7	versus	CC	O	versus	prep	6	SENT_75	[p5l555t2648r759b2687],
8	6/6	CD	NUMBER	6/6	num	9	SENT_75	[p5l789t2630r889b2688],
9	genotype	NN	O	genotype	dep	7	SENT_75	[p5l917t2638r1238b2707],
10	,	,	O	,	_	0	SENT_75	[p5l917t2638r1238b2707],
11	the	DT	O	the	det	13	SENT_75	[p5l1268t2627r1369b2687],
12	relative	JJ	O	relative	amod	13	SENT_75	[p5l1399t2627r1640b2687],
13	risk	NN	O	risk	nsubj	21	SENT_75	[p5l1669t2627r1780b2687],
14	for	IN	O	for	_	0	SENT_75	[p5l1804t2626r1894b2687],
15	the	DT	O	the	det	17	SENT_75	[p5l1917t2627r2019b2687],
16	6/7	CD	NUMBER	6/7	num	17	SENT_75	[p5l2047t2630r2148b2688],
17	genotype	NN	O	genotype	prep_for	13	SENT_75	[p5l8t2731r312b2800],
18	is	VBZ	O	be	cop	21	SENT_75	[p5l356t2724r398b2780],
19	1.8	CD	NUMBER	1.8	number	20	SENT_75	[p5l443t2725r541b2780],
20	(	CD	NUMBER	(	num	21	SENT_75	[p5l584t2724r725b2793],
21	0.5	CD	NUMBER	0.5	_	0	SENT_75	[p5l584t2724r725b2793],
22	,	,	O	,	_	0	SENT_75	[p5l584t2724r725b2793],
23	6.8	CD	NUMBER	6.8	num	24	SENT_75	[p5l771t2724r912b2793],
24	)	NN	O	)	appos	21	SENT_75	[p5l771t2724r912b2793],
25	,	,	O	,	_	0	SENT_75	[p5l771t2724r912b2793],
26	but	CC	O	but	_	0	SENT_75	[p5l958t2720r1062b2780],
27	the	DT	O	the	det	28	SENT_75	[p5l1099t2720r1200b2780],
28	increase	NN	O	increase	nsubj	32	SENT_75	[p5l1243t2724r1513b2780],
29	is	VBZ	O	be	cop	32	SENT_75	[p5l1556t2724r1599b2780],
30	not	RB	O	not	neg	32	SENT_75	[p5l1643t2731r1746b2780],
31	statistically	RB	O	statistically	advmod	32	SENT_75	[p5l1784t2720r2150b2800],
32	significant	JJ	O	significant	conj_but	21	SENT_75	[p5l9t2813r364b2894],
33	.	.	O	.	_	0	SENT_75	[p5l9t2813r364b2894],

1	Analogous	JJ	O	analogous	amod	2	SENT_76	[p5l86t2906r437b2986],
2	tests	NNS	O	test	nsubjpass	4	SENT_76	[p5l493t2917r633b2967],
3	were	VBD	O	be	auxpass	4	SENT_76	[p5l690t2927r852b2967],
4	performed	VBN	O	perform	_	0	SENT_76	[p5l911t2906r1250b2986],
5	with	IN	O	with	_	0	SENT_76	[p5l1309t2906r1450b2967],
6	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_with	4	SENT_76	[p5l1514t2906r2149b2986],
7	defined	VBN	O	define	partmod	6	SENT_76	[p5l9t2999r253b3060],
8	as	IN	O	as	_	0	SENT_76	[p5l283t3020r347b3060],
9	grade	NN	O	grade	prep_as	7	SENT_76	[p5l375t2999r558b3080],
10	2	CD	NUMBER	2	number	11	SENT_76	[p5l585t3005r619b3059],
11	elevation	NN	O	elevation	amod	9	SENT_76	[p5l652t2999r953b3060],
12	or	CC	O	or	_	0	SENT_76	[p5l985t3020r1050b3060],
13	greater	JJR	O	greater	amod	9	SENT_76	[p5l1077t3011r1320b3080],
14	,	,	O	,	_	0	SENT_76	[p5l1077t3011r1320b3080],
15	and	CC	O	and	_	0	SENT_76	[p5l1354t2999r1472b3060],
16	similar	JJ	O	similar	amod	17	SENT_76	[p5l1503t2999r1726b3060],
17	results	NNS	O	result	nsubjpass	19	SENT_76	[p5l1755t2999r1959b3060],
18	were	VBD	O	be	auxpass	19	SENT_76	[p5l1987t3020r2149b3060],
19	obtained	VBN	O	obtain	conj_and	4	SENT_76	[p5l8t3091r316b3151],
20	.	.	O	.	_	0	SENT_76	[p5l8t3091r316b3151],

1	The	DT	O	the	det	3	SENT_77	[p5l344t3091r466b3151],
2	relative	JJ	O	relative	amod	3	SENT_77	[p5l493t3091r734b3151],
3	risks	NNS	O	risk	_	0	SENT_77	[p5l761t3091r900b3151],
4	for	IN	O	for	dep	3	SENT_77	[p5l923t3091r1013b3151],
5	7/7	CD	NUMBER	7/7	pobj	4	SENT_77	[p5l1038t3095r1138b3152],
6	versus	CC	O	versus	dep	3	SENT_77	[p5l1162t3112r1365b3151],
7	non	JJ	O	non	amod	8	SENT_77	[p5l1393t3095r1648b3152],
8	—	NN	O	—	dep	6	SENT_77	[p5l1393t3095r1648b3152],
9	7/7	CD	NUMBER	7/7	num	8	SENT_77	[p5l1393t3095r1648b3152],
10	and	CC	O	and	_	0	SENT_77	[p5l1674t3091r1792b3151],
11	7/7	CD	NUMBER	7/7	conj_and	8	SENT_77	[p5l1822t3095r1921b3152],
12	versus	CC	O	versus	cc	11	SENT_77	[p5l1945t3112r2149b3151],

1	6/7	CD	NUMBER	6/7	nsubj	3	SENT_78	[p5l10t3186r111b3243],
2	were	VBD	O	be	cop	3	SENT_78	[p5l155t3203r317b3243],
3	2.0	CD	NUMBER	2.0	_	0	SENT_78	[p5l359t3189r464b3243],
4	with	IN	O	with	_	0	SENT_78	[p5l506t3183r648b3243],
5	95	CD	PERCENT	95	number	6	SENT_78	[p5l696t3187r846b3244],
6	%	NN	PERCENT	%	amod	7	SENT_78	[p5l696t3187r846b3244],
7	Cls	NNS	O	cl	prep_with	3	SENT_78	[p5l890t3187r988b3243],
8	of	IN	O	of	_	0	SENT_78	[p5l1033t3182r1097b3243],
9	(	CD	NUMBER	(	number	10	SENT_78	[p5l1139t3187r1280b3255],
10	1.4	CD	NUMBER	1.4	prep_of	7	SENT_78	[p5l1139t3187r1280b3255],
11	,	,	O	,	_	0	SENT_78	[p5l1139t3187r1280b3255],
12	2.8	CD	NUMBER	2.8	num	13	SENT_78	[p5l1327t3187r1452b3252],
13	)	NN	O	)	conj_and	3	SENT_78	[p5l1327t3187r1452b3252],
14	and	CC	O	and	_	0	SENT_78	[p5l1498t3183r1617b3243],
15	1.6	CD	NUMBER	1.6	num	16	SENT_78	[p5l1667t3188r1765b3243],
16	(	NN	O	(	conj_and	3	SENT_78	[p5l1812t3187r1953b3255],
17	1.1	CD	NUMBER	1.1	dep	16	SENT_78	[p5l1812t3187r1953b3255],
18	,	,	O	,	_	0	SENT_78	[p5l1812t3187r1953b3255],
19	2.4	CD	NUMBER	2.4	num	20	SENT_78	[p5l2000t3187r2144b3255],
20	)	NN	O	)	appos	17	SENT_78	[p5l2000t3187r2144b3255],
21	,	,	O	,	_	0	SENT_78	[p5l2000t3187r2144b3255],
22	respectively	RB	O	respectively	advmod	3	SENT_78	[p5l11t3275r422b3356],
23	;	:	O	;	_	0	SENT_78	[p5l11t3275r422b3356],
24	both	CC	O	both	dep	3	SENT_78	[p5l462t3275r604b3336],
25	elevations	NNS	O	elevation	nsubj	27	SENT_78	[p5l642t3275r976b3336],
26	were	VBD	O	be	cop	27	SENT_78	[p5l1010t3296r1172b3336],
27	significant	JJ	O	significant	conj_and	3	SENT_78	[p5l1207t3275r1563b3356],
28	.	.	O	.	_	0	SENT_78	[p5l1207t3275r1563b3356],

1	The	DT	O	the	det	3	SENT_79	[p5l1601t3275r1723b3336],
2	relative	JJ	O	relative	amod	3	SENT_79	[p5l1761t3275r2002b3336],
3	risk	NN	O	risk	nsubj	11	SENT_79	[p5l2040t3275r2150b3336],
4	for	IN	O	for	_	0	SENT_79	[p5l7t3369r96b3430],
5	6/7	CD	NUMBER	6/7	prep_for	3	SENT_79	[p5l122t3373r223b3430],
6	versus	CC	O	versus	prep	5	SENT_79	[p5l248t3390r452b3430],
7	6/6	CD	NUMBER	6/6	dep	6	SENT_79	[p5l479t3372r579b3430],
8	was	VBD	O	be	cop	11	SENT_79	[p5l605t3390r732b3430],
9	1.5	CD	NUMBER	1.5	number	10	SENT_79	[p5l761t3374r856b3430],
10	(	CD	NUMBER	(	num	11	SENT_79	[p5l887t3373r1028b3442],
11	0.9	CD	NUMBER	0.9	_	0	SENT_79	[p5l887t3373r1028b3442],
12	,	,	O	,	_	0	SENT_79	[p5l887t3373r1028b3442],
13	2.6	CD	NUMBER	2.6	num	14	SENT_79	[p5l1057t3373r1201b3442],
14	)	NN	O	)	appos	11	SENT_79	[p5l1057t3373r1201b3442],
15	,	,	O	,	_	0	SENT_79	[p5l1057t3373r1201b3442],
16	not	RB	O	not	neg	20	SENT_79	[p5l1234t3380r1337b3430],
17	a	DT	O	a	det	20	SENT_79	[p5l1360t3390r1394b3430],
18	statistically	RB	O	statistically	advmod	19	SENT_79	[p5l1420t3369r1786b3449],
19	significant	JJ	O	significant	amod	20	SENT_79	[p5l1811t3369r2151b3449],
20	increase	NN	O	increase	appos	11	SENT_79	[p5l12t3465r282b3521],
21	in	IN	O	in	_	0	SENT_79	[p5l316t3465r369b3520],
22	risk	NN	O	risk	prep_in	11	SENT_79	[p5l407t3461r534b3521],
23	.	.	O	.	_	0	SENT_79	[p5l407t3461r534b3521],

1	These	DT	O	these	det	2	SENT_80	[p6l86t23r277b84],
2	results	NNS	O	result	nsubjpass	5	SENT_80	[p6l336t23r541b84],
3	were	VBD	O	be	auxpass	5	SENT_80	[p6l597t44r759b84],
4	not	RB	O	not	neg	5	SENT_80	[p6l819t35r922b84],
5	corrected	VBN	O	correct	_	0	SENT_80	[p6l976t23r1286b84],
6	for	IN	O	for	_	0	SENT_80	[p6l1343t23r1433b84],
7	testing	NN	O	testing	prep_for	5	SENT_80	[p6l1487t27r1702b104],
8	of	IN	O	of	_	0	SENT_80	[p6l1758t23r1822b84],
9	multiple	JJ	O	multiple	amod	10	SENT_80	[p6l1878t23r2150b104],
10	hypotheses	NNS	O	hypothesis	prep_of	7	SENT_80	[p6l11t116r376b197],
11	and	CC	O	and	_	0	SENT_80	[p6l412t116r530b177],
12	were	VBD	O	be	auxpass	13	SENT_80	[p6l567t137r728b177],
13	regarded	VBN	O	regard	conj_and	5	SENT_80	[p6l766t116r1052b197],
14	as	IN	O	as	_	0	SENT_80	[p6l1089t137r1153b177],
15	exploratory	NN	O	exploratory	prep_as	13	SENT_80	[p6l1188t116r1584b197],
16	.	.	O	.	_	0	SENT_80	[p6l1188t116r1584b197],

1	In	IN	O	in	_	0	SENT_81	[p6l1628t121r1681b176],
2	addition	NN	O	addition	prep_in	15	SENT_81	[p6l1720t116r2010b189],
3	,	,	O	,	_	0	SENT_81	[p6l1720t116r2010b189],
4	the	DT	O	the	det	5	SENT_81	[p6l2048t116r2149b177],
5	complexity	NN	O	complexity	nsubj	15	SENT_81	[p6l9t209r378b289],
6	of	IN	O	of	_	0	SENT_81	[p6l421t208r485b269],
7	the	DT	O	the	det	9	SENT_81	[p6l524t209r625b269],
8	MCRM	NNP	O	MCRM	nn	9	SENT_81	[p6l670t213r901b270],
9	design	NN	O	design	prep_of	5	SENT_81	[p6l947t209r1155b289],
10	of	IN	O	of	_	0	SENT_81	[p6l1202t208r1267b269],
11	the	DT	O	the	det	14	SENT_81	[p6l1305t209r1407b269],
12	study	NN	O	study	nn	14	SENT_81	[p6l1451t209r1623b289],
13	(	NN	O	(	nn	14	SENT_81	[p6l1668t213r1944b289],
14	patients	NNS	O	patient	prep_of	9	SENT_81	[p6l1668t213r1944b289],
15	were	VBD	O	be	_	0	SENT_81	[p6l1987t230r2149b269],

1	Table	NNP	O	Table	nsubj	3	SENT_82	[p6l87t364r165b390],
2	1	CD	NUMBER	1	num	1	SENT_82	[p6l178t367r189b390],
3	Phase	NN	O	phase	_	0	SENT_82	[p6l264t364r343b390],
4	I	PRP	O	I	dobj	3	SENT_82	[p6l358t366r370b396],
5	,	,	O	,	_	0	SENT_82	[p6l358t366r370b396],
6	distribution	NN	O	distribution	dobj	3	SENT_82	[p6l386t364r544b390],
7	of	IN	O	of	_	0	SENT_82	[p6l558t364r586b390],
8	baseline	NN	O	baseline	nn	11	SENT_82	[p6l598t364r713b390],
9	total	JJ	O	total	amod	11	SENT_82	[p6l725t364r785b390],
10	bilirubin	NN	O	bilirubin	nn	11	SENT_82	[p6l800t364r918b390],
11	(	NN	O	(	prep_of	6	SENT_82	[p6l933t364r1048b397],
12	,	,	O	,	_	0	SENT_82	[p6l933t364r1048b397],
13	umol/I	NN	O	umol/i	nn	14	SENT_82	[p6l933t364r1048b397],
14	)	NN	O	)	dobj	3	SENT_82	[p6l933t364r1048b397],
15	,	,	O	,	_	0	SENT_82	[p6l933t364r1048b397],
16	age	NN	O	age	conj_and	4	SENT_82	[p6l1063t373r1111b399],
17	and	CC	O	and	_	0	SENT_82	[p6l1124t364r1174b390],
18	reported	VBD	O	report	dep	25	SENT_82	[p6l1189t364r1305b399],
19	race	NN	O	race	dep	18	SENT_82	[p6l1320t373r1385b396],
20	,	,	O	,	_	0	SENT_82	[p6l1320t373r1385b396],
21	by	IN	O	by	dep	19	SENT_82	[p6l1400t364r1432b399],
22	UGT1	NN	O	ugt1	pobj	21	SENT_82	[p6l1447t366r1566b390],
23	/	:	O	/	punct	19	SENT_82	[p6l1447t366r1566b390],
24	-	:	O	-	_	0	SENT_82	[p6l1447t366r1566b390],
25	\	NN	O	\	dobj	3	SENT_82	[p6l1447t366r1566b390],
26	1	CD	NUMBER	1	num	27	SENT_82	[p6l1447t366r1566b390],
27	genotype	NN	O	genotype	dep	25	SENT_82	[p6l1585t369r1714b399],

1	(	NN	O	(	_	0	SENT_83	[p6l791t460r937b491],
2	TA	NNP	O	TA	nsubj	35	SENT_83	[p6l791t460r937b491],
3	)	CD	NUMBER	)	num	4	SENT_83	[p6l791t460r937b491],
4	s	NNS	O	s	dep	2	SENT_83	[p6l791t460r937b491],
5	/	:	O	/	punct	7	SENT_83	[p6l791t460r937b491],
6	(	CD	NUMBER	(	num	7	SENT_83	[p6l791t460r937b491],
7	T	NN	O	t	dep	2	SENT_83	[p6l791t460r937b491],
8	‘	CD	NUMBER	‘	number	9	SENT_83	[p6l791t460r937b491],
9	\	CD	NUMBER	\	num	11	SENT_83	[p6l791t460r937b491],
10	)	NN	O	)	nn	11	SENT_83	[p6l791t460r937b491],
11	s	NNS	O	s	nsubj	12	SENT_83	[p6l791t460r937b491],
12	(	VBP	O	(	rcmod	7	SENT_83	[p6l1183t460r1328b491],
13	TA	NNP	O	TA	dobj	12	SENT_83	[p6l1183t460r1328b491],
14	)	CD	NUMBER	)	num	15	SENT_83	[p6l1183t460r1328b491],
15	s	NNS	O	s	dep	13	SENT_83	[p6l1183t460r1328b491],
16	/	:	O	/	punct	17	SENT_83	[p6l1183t460r1328b491],
17	(	CD	NUMBER	(	dep	13	SENT_83	[p6l1183t460r1328b491],
18	We	PRP	O	we	nsubj	19	SENT_83	[p6l1183t460r1328b491],
19	(	VBP	O	(	rcmod	17	SENT_83	[p6l1583t460r1729b491],
20	TA	NNP	O	TA	nn	22	SENT_83	[p6l1583t460r1729b491],
21	)	CD	NUMBER	)	num	22	SENT_83	[p6l1583t460r1729b491],
22	s	NNS	O	s	dobj	19	SENT_83	[p6l1583t460r1729b491],
23	/	:	O	/	punct	17	SENT_83	[p6l1583t460r1729b491],
24	(	CD	NUMBER	(	num	26	SENT_83	[p6l1583t460r1729b491],
25	TA	NNP	O	TA	nn	26	SENT_83	[p6l1583t460r1729b491],
26	)	NN	O	)	dep	13	SENT_83	[p6l1583t460r1729b491],
27	7	CD	NUMBER	7	number	28	SENT_83	[p6l1583t460r1729b491],
28	(	CD	NUMBER	(	dep	26	SENT_83	[p6l1983t460r2129b491],
29	TA	NNP	O	TA	nn	30	SENT_83	[p6l1983t460r2129b491],
30	)	NN	O	)	dep	28	SENT_83	[p6l1983t460r2129b491],
31	7	CD	NUMBER	7	num	30	SENT_83	[p6l1983t460r2129b491],
32	/	:	O	/	punct	7	SENT_83	[p6l1983t460r2129b491],
33	(	CD	NUMBER	(	dep	2	SENT_83	[p6l1983t460r2129b491],
34	TA	NNP	O	TA	dep	35	SENT_83	[p6l1983t460r2129b491],
35	)	NN	O	)	rcmod	1	SENT_83	[p6l1983t460r2129b491],
36	7	CD	NUMBER	7	num	35	SENT_83	[p6l1983t460r2129b491],

1	Number	NN	O	number	_	0	SENT_84	[p6l89t540r203b565],
2	1	CD	NUMBER	1	num	3	SENT_84	[p6l857t540r866b565],
3	46	CD	NUMBER	46	dep	1	SENT_84	[p6l1237t540r1272b565],
4	50	CD	NUMBER	50	number	5	SENT_84	[p6l1638t540r1673b565],
5	14	CD	NUMBER	14	num	9	SENT_84	[p6l2040t540r2073b565],
6	Baseline	NN	O	baseline	nn	9	SENT_84	[p6l89t582r206b607],
7	bilirubin	NN	O	bilirubin	nn	9	SENT_84	[p6l219t582r325b607],
8	(	NN	O	(	nn	9	SENT_84	[p6l339t582r518b613],
9	meanis	NN	O	meani	dep	3	SENT_84	[p6l339t582r518b613],
10	.	.	O	.	_	0	SENT_84	[p6l339t582r518b613],

1	d.	NN	O	d.	nsubj	10	SENT_85	[p6l339t582r518b613],
2	)	CD	NUMBER	)	num	1	SENT_85	[p6l339t582r518b613],
3	8.6	CD	NUMBER	8.6	num	4	SENT_85	[p6l842t582r886b607],
4	7.5343	CD	NUMBER	7.5343	dep	1	SENT_85	[p6l1194t582r1316b611],
5	9234.7	CD	NUMBER	9234.7	number	6	SENT_85	[p6l1594t582r1716b611],
6	8.9329	CD	NUMBER	8.9329	num	10	SENT_85	[p6l1994t582r2117b611],
7	Baseline	NN	O	baseline	nn	10	SENT_85	[p6l89t623r206b648],
8	bilirubin	NN	O	bilirubin	nn	10	SENT_85	[p6l219t623r325b648],
9	(	CD	NUMBER	(	num	10	SENT_85	[p6l339t623r404b654],
10	min	NN	DURATION	min	_	0	SENT_85	[p6l339t623r404b654],
11	,	,	O	,	_	0	SENT_85	[p6l339t623r404b654],
12	med	VBN	O	med	partmod	10	SENT_85	[p6l419t623r488b652],
13	,	,	O	,	_	0	SENT_85	[p6l419t623r488b652],
14	max	FW	O	max	nn	15	SENT_85	[p6l504t623r569b654],
15	)	FW	O	)	nn	38	SENT_85	[p6l504t623r569b654],
16	8.6	CD	NUMBER	8.6	dep	15	SENT_85	[p6l775t624r827b652],
17	,	,	O	,	_	0	SENT_85	[p6l775t624r827b652],
18	8.6	CD	NUMBER	8.6	appos	16	SENT_85	[p6l841t624r893b652],
19	,	,	O	,	_	0	SENT_85	[p6l841t624r893b652],
20	8.6	CD	NUMBER	8.6	num	21	SENT_85	[p6l908t624r952b648],
21	3.4	CD	NUMBER	3.4	appos	16	SENT_85	[p6l1157t624r1209b652],
22	,	,	O	,	_	0	SENT_85	[p6l1157t624r1209b652],
23	6.8	CD	NUMBER	6.8	appos	16	SENT_85	[p6l1224t624r1275b652],
24	,	,	O	,	_	0	SENT_85	[p6l1224t624r1275b652],
25	25.7	CD	NUMBER	25.7	num	26	SENT_85	[p6l1290t624r1352b648],
26	3.4	CD	NUMBER	3.4	appos	16	SENT_85	[p6l1558t624r1609b652],
27	,	,	O	,	_	0	SENT_85	[p6l1558t624r1609b652],
28	8.6	CD	NUMBER	8.6	appos	16	SENT_85	[p6l1624t624r1675b652],
29	,	,	O	,	_	0	SENT_85	[p6l1624t624r1675b652],
30	20.5	CD	NUMBER	20.5	num	31	SENT_85	[p6l1690t624r1752b648],
31	5.1	CD	NUMBER	5.1	appos	16	SENT_85	[p6l1958t624r2009b652],
32	,	,	O	,	_	0	SENT_85	[p6l1958t624r2009b652],
33	8.6	CD	NUMBER	8.6	appos	16	SENT_85	[p6l2024t624r2075b652],
34	,	,	O	,	_	0	SENT_85	[p6l2024t624r2075b652],
35	17.1	CD	NUMBER	17.1	num	36	SENT_85	[p6l2093t624r2147b648],
36	Age	NNP	O	Age	appos	16	SENT_85	[p6l86t665r142b696],
37	(	CD	NUMBER	(	num	36	SENT_85	[p6l155t664r334b696],
38	meanis	NN	O	meani	dobj	10	SENT_85	[p6l155t664r334b696],
39	.	.	O	.	_	0	SENT_85	[p6l155t664r334b696],

1	d.	NN	O	d.	_	0	SENT_86	[p6l155t664r334b696],
2	)	CD	NUMBER	)	num	1	SENT_86	[p6l155t664r334b696],
3	18.0	CD	NUMBER	18.0	number	4	SENT_86	[p6l834t665r895b690],
4	59.5	CD	NUMBER	59.5	dep	1	SENT_86	[p6l1175t665r1265b693],
5	:	:	O	:	_	0	SENT_86	[p6l1175t665r1265b693],
6	13.6	CD	NUMBER	13.6	dep	1	SENT_86	[p6l1274t665r1334b690],
7	55.1	CD	NUMBER	55.1	number	8	SENT_86	[p6l1576t665r1632b690],
8	:15.7	CD	NUMBER	:15.7	rcmod	6	SENT_86	[p6l1644t665r1734b693],
9	53.4:13.4	CD	TIME	53.4:13.4	num	11	SENT_86	[p6l1976t665r2135b693],
10	Caucasian	JJ	MISC	caucasian	amod	11	SENT_86	[p6l87t706r235b731],
11	O	NN	O	o	dep	8	SENT_86	[p6l855t707r872b731],
12	37	CD	NUMBER	37	number	13	SENT_86	[p6l1237t707r1272b731],
13	45	CD	NUMBER	45	num	15	SENT_86	[p6l1638t707r1672b731],
14	1	CD	NUMBER	1	number	15	SENT_86	[p6l2040t707r2049b731],
15	1	CD	NUMBER	1	npadvmod	16	SENT_86	[p6l2058t707r2067b731],
16	Hispanic	JJ	O	hispanic	amod	17	SENT_86	[p6l89t748r209b778],
17	o	NN	O	o	dep	8	SENT_86	[p6l855t748r872b772],
18	—	SYM	O	—	dep	8	SENT_86	[p6l1246t764r1263b766],
19	-	:	O	-	_	0	SENT_86	[p6l1246t764r1263b766],
20	4	CD	NUMBER	4	num	21	SENT_86	[p6l1647t748r1663b772],
21	o	NN	O	o	dep	1	SENT_86	[p6l2047t748r2064b772],
22	Black	JJ	O	black	amod	31	SENT_86	[p6l89t789r166b814],
23	1	CD	NUMBER	1	number	24	SENT_86	[p6l857t790r866b814],
24	3	CD	NUMBER	3	dep	27	SENT_86	[p6l1246t789r1263b814],
25	o	NN	O	o	npadvmod	27	SENT_86	[p6l1647t789r1664b814],
26	3	CD	NUMBER	3	num	25	SENT_86	[p6l2047t789r2063b814],
27	Oriental	JJ	O	oriental	amod	31	SENT_86	[p6l87t830r194b855],
28	o	NN	O	o	nn	31	SENT_86	[p6l855t831r872b855],
29	‘	NN	O	‘	nn	31	SENT_86	[p6l1249t831r1257b837],
30	1	CD	NUMBER	1	num	31	SENT_86	[p6l1649t831r1658b855],
31	o	NN	O	o	dep	21	SENT_86	[p6l2047t831r2064b855],
32	Missing	VBG	O	miss	partmod	1	SENT_86	[p6l88t872r193b903],
33	o	NN	O	o	nn	35	SENT_86	[p6l855t872r872b897],
34	O	NN	O	o	nn	35	SENT_86	[p6l1647t872r1664b897],
35	O	NN	O	o	dobj	32	SENT_86	[p6l2047t872r2064b897],

1	Leukemia	NN	O	leukemia	_	0	SENT_87	[p6l6t991r138b1014],

1	UGT1A1	NN	O	ugt1a1	nn	2	SENT_88	[p6l998t1066r1093b1090],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_88	[p6l1106t1067r1312b1096],
3	and	CC	O	and	_	0	SENT_88	[p6l1322t1067r1363b1090],
4	nilotinib	JJ	O	nilotinib	amod	5	SENT_88	[p6l1375t1067r1466b1090],
5	safety	NN	O	safety	conj_and	2	SENT_88	[p6l1476t1066r1543b1096],
6	@	IN	O	@	_	0	SENT_88	[p6l2092t1062r2154b1123],
7	JB	NNP	O	JB	nn	8	SENT_88	[p6l996t1102r1021b1126],
8	Singer	NNP	O	Singer	prep_@	5	SENT_88	[p6l1031t1102r1095b1131],
9	et	FW	O	et	nn	10	SENT_88	[p6l1103t1103r1123b1126],
10	al	FW	O	al	dep	2	SENT_88	[p6l1131t1102r1150b1125],

1	Table	NNP	O	Table	nn	3	SENT_89	[p6l6t1177r84b1203],
2	2	CD	NUMBER	2	num	3	SENT_89	[p6l97t1180r112b1203],
3	Phase	NN	O	phase	_	0	SENT_89	[p6l183t1177r262b1203],
4	I	PRP	O	I	dep	3	SENT_89	[p6l276t1179r289b1209],
5	,	,	O	,	_	0	SENT_89	[p6l276t1179r289b1209],
6	descriptive	JJ	O	descriptive	amod	18	SENT_89	[p6l305t1177r458b1212],
7	statistics	NNS	O	statistics	dep	6	SENT_89	[p6l470t1179r586b1203],
8	of	IN	O	of	_	0	SENT_89	[p6l599t1177r626b1203],
9	the	DT	O	the	det	13	SENT_89	[p6l637t1177r680b1203],
10	post	NN	O	post	nn	13	SENT_89	[p6l694t1182r896b1212],
11	—	NN	O	—	nn	13	SENT_89	[p6l694t1182r896b1212],
12	treatment	NN	O	treatment	nn	13	SENT_89	[p6l694t1182r896b1212],
13	maximum	NN	O	maximum	prep_of	7	SENT_89	[p6l909t1179r1049b1203],
14	within	IN	O	within	_	0	SENT_89	[p6l1063t1177r1261b1212],
15	—	CD	NUMBER	—	num	16	SENT_89	[p6l1063t1177r1261b1212],
16	patient	NN	O	patient	prep_within	13	SENT_89	[p6l1063t1177r1261b1212],
17	total	JJ	O	total	amod	18	SENT_89	[p6l1273t1177r1332b1203],
18	bilirubin	NN	O	bilirubin	appos	4	SENT_89	[p6l1348t1177r1465b1203],
19	by	IN	O	by	_	0	SENT_89	[p6l1480t1177r1513b1212],
20	UGTlA1	NN	O	ugtla1	nn	21	SENT_89	[p6l1527t1179r1646b1203],
21	genotype	NN	O	genotype	prep_by	18	SENT_89	[p6l1665t1182r1794b1212],

1	Genotype	NN	O	genotype	nsubj	4	SENT_90	[p6l7t1273r144b1304],
2	Number	NNP	O	Number	nn	3	SENT_90	[p6l238t1273r355b1298],
3	Mean	NN	O	mean	dep	1	SENT_90	[p6l442t1273r521b1298],
4	is	VBZ	O	be	_	0	SENT_90	[p6l528t1276r575b1302],
5	.	.	O	.	_	0	SENT_90	[p6l528t1276r575b1302],

1	d.	NNP	O	d.	dep	11	SENT_91	[p6l580t1273r603b1298],
2	Median	JJ	O	median	amod	6	SENT_91	[p6l696t1273r800b1298],
3	Minimum	NNP	O	Minimum	nn	6	SENT_91	[p6l890t1273r1021b1298],
4	Maximum	NNP	O	Maximum	nn	6	SENT_91	[p6l1110t1273r1249b1298],
5	Grade	NNP	O	Grade	nn	6	SENT_91	[p6l1339t1273r1426b1298],
6	o	NN	O	o	dep	1	SENT_91	[p6l1438t1274r1456b1298],
7	Grade	NNP	O	Grade	dep	11	SENT_91	[p6l1545t1273r1632b1298],
8	7	CD	NUMBER	7	num	11	SENT_91	[p6l1648t1274r1657b1298],
9	Grade	NNP	O	Grade	nn	11	SENT_91	[p6l1751t1273r1837b1298],
10	2	CD	NUMBER	2	num	11	SENT_91	[p6l1849t1274r1867b1298],
11	Grade	NNP	O	Grade	dep	16	SENT_91	[p6l1956t1273r2043b1298],
12	8	CD	NUMBER	8	number	13	SENT_91	[p6l2055t1274r2072b1298],
13	(	CD	NUMBER	(	dep	11	SENT_91	[p6l7t1352r149b1383],
14	TA	NNP	O	TA	dep	13	SENT_91	[p6l7t1352r149b1383],
15	)	CD	NUMBER	)	num	16	SENT_91	[p6l7t1352r149b1383],
16	5	CD	NUMBER	5	_	0	SENT_91	[p6l7t1352r149b1383],
17	/	:	O	/	punct	16	SENT_91	[p6l7t1352r149b1383],
18	(	CD	NUMBER	(	num	19	SENT_91	[p6l7t1352r149b1383],
19	TA	NNP	O	TA	dep	29	SENT_91	[p6l7t1352r149b1383],
20	)	CD	NUMBER	)	num	19	SENT_91	[p6l7t1352r149b1383],
21	5	CD	NUMBER	5	num	22	SENT_91	[p6l7t1352r149b1383],
22	1	CD	NUMBER	1	dep	19	SENT_91	[p6l299t1353r307b1377],
23	56.4	CD	NUMBER	56.4	number	24	SENT_91	[p6l494t1353r556b1377],
24	56.4	CD	NUMBER	56.4	num	26	SENT_91	[p6l718t1353r781b1377],
25	56.4	CD	NUMBER	56.4	number	26	SENT_91	[p6l925t1353r988b1377],
26	56.4	CD	NUMBER	56.4	dep	22	SENT_91	[p6l1158t1353r1221b1377],
27	o	NN	O	o	dep	29	SENT_91	[p6l1398t1353r1415b1377],
28	o	NN	O	o	nn	29	SENT_91	[p6l1604t1353r1620b1377],
29	o	NN	O	o	dep	72	SENT_91	[p6l1810t1353r1826b1377],
30	1	CD	NUMBER	1	number	31	SENT_91	[p6l2008t1353r2017b1377],
31	(	CD	NUMBER	(	num	69	SENT_91	[p6l7t1389r149b1420],
32	TA	NNP	O	TA	nn	69	SENT_91	[p6l7t1389r149b1420],
33	)	CD	NUMBER	)	number	34	SENT_91	[p6l7t1389r149b1420],
34	6	CD	NUMBER	6	amod	69	SENT_91	[p6l7t1389r149b1420],
35	/	:	O	/	punct	53	SENT_91	[p6l7t1389r149b1420],
36	(	CD	NUMBER	(	num	51	SENT_91	[p6l7t1389r149b1420],
37	TA	NNP	O	TA	nn	51	SENT_91	[p6l7t1389r149b1420],
38	)	CD	NUMBER	)	num	51	SENT_91	[p6l7t1389r149b1420],
39	6	CD	NUMBER	6	num	51	SENT_91	[p6l7t1389r149b1420],
40	45	CD	NUMBER	45	num	51	SENT_91	[p6l278t1390r313b1414],
41	24.2:13.5	CD	TIME	24.2:13.5	num	51	SENT_91	[p6l446t1390r604b1418],
42	22.2	CD	NUMBER	22.2	num	51	SENT_91	[p6l718t1390r780b1414],
43	5.1	CD	NUMBER	5.1	num	51	SENT_91	[p6l943t1390r982b1414],
44	61.6	CD	DATE	61.6	num	51	SENT_91	[p6l1158t1390r1221b1414],
45	19	CD	DATE	19	num	51	SENT_91	[p6l1382t1390r1415b1414],
46	12	CD	DATE	12	num	51	SENT_91	[p6l1588t1390r1620b1414],
47	11	CD	DATE	11	num	51	SENT_91	[p6l1793t1390r1820b1414],
48	3	CD	DATE	3	num	51	SENT_91	[p6l2006t1390r2022b1414],
49	(	NN	O	(	nn	51	SENT_91	[p6l7t1426r149b1457],
50	l'	NN	O	l'	nn	51	SENT_91	[p6l7t1426r149b1457],
51	A	NN	O	a	dep	53	SENT_91	[p6l7t1426r149b1457],
52	)	CD	NUMBER	)	number	53	SENT_91	[p6l7t1426r149b1457],
53	5	CD	NUMBER	5	dep	34	SENT_91	[p6l7t1426r149b1457],
54	/	:	O	/	punct	60	SENT_91	[p6l7t1426r149b1457],
55	(	CD	NUMBER	(	num	57	SENT_91	[p6l7t1426r149b1457],
56	TA	NNP	O	TA	nn	57	SENT_91	[p6l7t1426r149b1457],
57	)	NN	O	)	dep	60	SENT_91	[p6l7t1426r149b1457],
58	7	CD	NUMBER	7	number	59	SENT_91	[p6l7t1426r149b1457],
59	50	CD	NUMBER	50	num	60	SENT_91	[p6l278t1427r313b1451],
60	31	CD	NUMBER	31	dep	53	SENT_91	[p6l445t1427r475b1451],
61	9322.9	CD	NUMBER	9322.9	number	62	SENT_91	[p6l484t1427r605b1455],
62	27.4	CD	NUMBER	27.4	num	60	SENT_91	[p6l718t1427r781b1451],
63	3.4	CD	NUMBER	3.4	number	64	SENT_91	[p6l943t1427r987b1451],
64	123.1	CD	NUMBER	123.1	num	60	SENT_91	[p6l1142t1427r1215b1451],
65	12	CD	NUMBER	12	number	66	SENT_91	[p6l1382t1427r1414b1451],
66	14	CD	NUMBER	14	amod	60	SENT_91	[p6l1588t1427r1620b1451],
67	18	CD	NUMBER	18	number	68	SENT_91	[p6l1793t1427r1826b1451],
68	6	CD	NUMBER	6	amod	53	SENT_91	[p6l2006t1427r2023b1451],
69	(	NN	O	(	dep	29	SENT_91	[p6l7t1463r149b1494],
70	TA	NNP	O	TA	dep	69	SENT_91	[p6l7t1463r149b1494],
71	)	CD	NUMBER	)	num	72	SENT_91	[p6l7t1463r149b1494],
72	7	CD	NUMBER	7	dep	16	SENT_91	[p6l7t1463r149b1494],
73	/	:	O	/	punct	72	SENT_91	[p6l7t1463r149b1494],
74	(	CD	NUMBER	(	num	76	SENT_91	[p6l7t1463r149b1494],
75	TA	NNP	O	TA	nn	76	SENT_91	[p6l7t1463r149b1494],
76	)	NN	O	)	dep	72	SENT_91	[p6l7t1463r149b1494],
77	7	CD	NUMBER	7	number	78	SENT_91	[p6l7t1463r149b1494],
78	14	CD	NUMBER	14	num	80	SENT_91	[p6l280t1464r313b1488],
79	51.5:32.9	CD	TIME	51.5:32.9	number	80	SENT_91	[p6l446t1464r605b1492],
80	53.9	CD	NUMBER	53.9	dep	76	SENT_91	[p6l718t1464r781b1488],
81	12.0	CD	NUMBER	12.0	dep	76	SENT_91	[p6l927t1464r988b1488],
82	143.6	CD	NUMBER	143.6	number	83	SENT_91	[p6l1142t1464r1221b1488],
83	2	CD	NUMBER	2	num	85	SENT_91	[p6l1398t1464r1414b1488],
84	1	CD	NUMBER	1	number	85	SENT_91	[p6l1606t1464r1614b1488],
85	5	CD	NUMBER	5	npadvmod	89	SENT_91	[p6l1810t1464r1826b1488],
86	6	CD	NUMBER	6	num	87	SENT_91	[p6l2006t1464r2023b1488],
87	Results	NNS	O	result	dep	88	SENT_91	[p6l8t1527r110b1552],
88	(	RB	O	(	amod	85	SENT_91	[p6l124t1527r153b1558],
89	in	IN	O	in	dep	76	SENT_91	[p6l124t1527r153b1558],
90	pmol/I	NN	O	pmol/i	nn	91	SENT_91	[p6l167t1527r261b1558],
91	)	NN	O	)	pobj	89	SENT_91	[p6l167t1527r261b1558],
92	and	CC	O	and	_	0	SENT_91	[p6l275t1527r327b1552],
93	CTCAE	NN	O	ctca	nn	94	SENT_91	[p6l342t1527r446b1552],
94	grades	NNS	O	grade	pobj	89	SENT_91	[p6l459t1527r563b1558],
95	.	.	O	.	_	0	SENT_91	[p6l459t1527r563b1558],

1	For	IN	O	for	_	0	SENT_92	[p6l580t1527r625b1552],
2	each	DT	O	each	det	3	SENT_92	[p6l637t1527r704b1552],
3	patient	NN	O	patient	prep_for	19	SENT_92	[p6l719t1527r821b1558],
4	,	,	O	,	_	0	SENT_92	[p6l719t1527r821b1558],
5	the	DT	O	the	det	8	SENT_92	[p6l836t1527r880b1552],
6	maximal	JJ	O	maximal	amod	8	SENT_92	[p6l895t1527r1009b1552],
7	total	JJ	O	total	amod	8	SENT_92	[p6l1023t1527r1082b1552],
8	bilirubin	NN	O	bilirubin	nsubjpass	19	SENT_92	[p6l1098t1527r1203b1552],
9	and	CC	O	and	_	0	SENT_92	[p6l1218t1527r1270b1552],
10	CTCAE	NN	O	ctca	nn	11	SENT_92	[p6l1284t1527r1388b1552],
11	grade	NN	O	grade	nsubjpass	19	SENT_92	[p6l1402t1527r1482b1558],
12	after	IN	O	after	_	0	SENT_92	[p6l1496t1527r1559b1552],
13	the	DT	O	the	det	15	SENT_92	[p6l1570t1527r1614b1552],
14	first	JJ	ORDINAL	first	amod	15	SENT_92	[p6l1627t1527r1677b1552],
15	dose	NN	O	dose	prep_after	8	SENT_92	[p6l1691t1527r1760b1552],
16	of	IN	O	of	_	0	SENT_92	[p6l1773t1527r1800b1552],
17	treatment	NN	O	treatment	prep_of	15	SENT_92	[p6l1811t1529r1947b1552],
18	is	VBZ	O	be	auxpass	19	SENT_92	[p6l1961t1527r1981b1552],
19	used	VBN	O	use	_	0	SENT_92	[p6l1995t1527r2070b1552],
20	.	.	O	.	_	0	SENT_92	[p6l1995t1527r2070b1552],

1	A	DT	O	a	det	4	SENT_93	[p6l7t1571r52b1622],
2	single	JJ	O	single	amod	4	SENT_93	[p6l76t1571r247b1637],
3	6/6	CD	NUMBER	6/6	num	4	SENT_93	[p6l275t1570r372b1623],
4	patient	NN	O	patient	nsubj	7	SENT_93	[p6l401t1571r602b1636],
5	did	VBD	O	do	aux	7	SENT_93	[p6l630t1571r718b1623],
6	not	RB	O	not	neg	7	SENT_93	[p6l748t1574r841b1623],
7	have	VB	O	have	_	0	SENT_93	[p6l870t1571r1008b1623],
8	post	NN	O	post	dobj	7	SENT_93	[p6l1037t1571r1442b1636],
9	—	RB	O	—	advmod	12	SENT_93	[p6l1037t1571r1442b1636],
10	baseline	NN	O	baseline	nn	12	SENT_93	[p6l1037t1571r1442b1636],
11	bilirubin	NN	O	bilirubin	nn	12	SENT_93	[p6l1470t1571r1695b1623],
12	data	NNS	O	datum	dep	8	SENT_93	[p6l1725t1571r1856b1623],
13	available	JJ	O	available	amod	12	SENT_93	[p6l1882t1571r2153b1623],
14	.	.	O	.	_	0	SENT_93	[p6l1882t1571r2153b1623],

1	Table	NNP	O	Table	nn	3	SENT_94	[p6l8t1797r174b1852],
2	3	CD	NUMBER	3	num	3	SENT_94	[p6l227t1803r259b1852],
3	Phase	NN	O	phase	_	0	SENT_94	[p6l410t1798r578b1852],
4	I	PRP	O	I	dep	3	SENT_94	[p6l634t1802r662b1863],
5	,	,	O	,	_	0	SENT_94	[p6l634t1802r662b1863],
6	relative	JJ	O	relative	amod	8	SENT_94	[p6l722t1798r940b1852],
7	risk	NN	O	risk	nn	8	SENT_94	[p6l995t1797r1095b1852],
8	calculations	NNS	O	calculation	appos	4	SENT_94	[p6l1147t1797r1506b1852],
9	for	IN	O	for	_	0	SENT_94	[p6l1558t1797r1639b1852],
10	prevalence	NN	O	prevalence	prep_for	8	SENT_94	[p6l1692t1798r2019b1869],
11	of	IN	O	of	_	0	SENT_94	[p6l2072t1797r2130b1852],
12	maximum	NN	O	maximum	nn	14	SENT_94	[p6l12t1880r308b1930],
13	total	JJ	O	total	amod	14	SENT_94	[p6l337t1876r464b1930],
14	bilirubin	NN	O	bilirubin	prep_of	10	SENT_94	[p6l497t1876r748b1930],
15	>	JJR	O	>	amod	16	SENT_94	[p6l787t1876r1012b1948],
16	grade	NN	O	grade	dep	14	SENT_94	[p6l787t1876r1012b1948],
17	3	CD	NUMBER	3	dep	3	SENT_94	[p6l1039t1881r1068b1930],

1	Max	NNP	O	Max	nn	2	SENT_95	[p6l578t2076r709b2128],
2	grade	NN	O	grade	_	0	SENT_95	[p6l729t2076r904b2141],
3	<	JJR	O	<	dep	2	SENT_95	[p6l941t2076r1035b2134],
4	2	CD	NUMBER	2	number	5	SENT_95	[p6l941t2076r1035b2134],
5	Max	NN	O	max	num	6	SENT_95	[p6l1282t2076r1414b2128],
6	grade	NN	O	grade	npadvmod	7	SENT_95	[p6l1433t2076r1608b2141],
7	>	JJR	O	>	dep	3	SENT_95	[p6l1645t2076r1739b2134],
8	3	CD	NUMBER	3	dep	7	SENT_95	[p6l1645t2076r1739b2134],
9	Total	JJ	O	total	amod	7	SENT_95	[p6l1991t2076r2131b2128],

1	Non	JJ	O	non	amod	2	SENT_96	[p6l82t2399r330b2452],
2	—	NN	O	—	_	0	SENT_96	[p6l82t2399r330b2452],
3	7/7	CD	NUMBER	7/7	number	4	SENT_96	[p6l82t2399r330b2452],
4	86	CD	NUMBER	86	dep	2	SENT_96	[p6l771t2401r844b2452],
5	9	CD	NUMBER	9	num	6	SENT_96	[p6l1495t2401r1529b2452],
6	95	CD	NUMBER	95	dep	4	SENT_96	[p6l2040t2401r2114b2452],

1	Total	JJ	O	total	_	0	SENT_97	[p6l77t2576r215b2628],
2	94	CD	NUMBER	94	number	3	SENT_97	[p6l770t2577r844b2628],
3	15	CD	NUMBER	15	dep	1	SENT_97	[p6l1479t2577r1548b2628],
4	109	CD	NUMBER	109	dep	3	SENT_97	[p6l2006t2577r2114b2628],

1	Relative	JJ	O	relative	amod	2	SENT_98	[p6l7t2735r240b2787],
2	ris	NN	O	ri	_	0	SENT_98	[p6l265t2735r552b2796],
3	/	:	O	/	punct	4	SENT_98	[p6l265t2735r552b2796],
4	<	JJR	O	<	dep	2	SENT_98	[p6l265t2735r552b2796],
5	=	JJ	O	=	amod	4	SENT_98	[p6l265t2735r552b2796],
6	4.5	CD	NUMBER	4.5	tmod	5	SENT_98	[p6l265t2735r552b2796],
7	,	,	O	,	_	0	SENT_98	[p6l265t2735r552b2796],
8	95	CD	PERCENT	95	number	9	SENT_98	[p6l586t2735r719b2788],
9	%	NN	PERCENT	%	amod	10	SENT_98	[p6l586t2735r719b2788],
10	CI	NN	O	ci	appos	4	SENT_98	[p6l748t2734r812b2787],
11	of	IN	O	of	_	0	SENT_98	[p6l836t2735r899b2787],
12	(	CD	NUMBER	(	number	13	SENT_98	[p6l919t2734r1042b2800],
13	1.9	CD	NUMBER	1.9	prep_of	10	SENT_98	[p6l919t2734r1042b2800],
14	,	,	O	,	_	0	SENT_98	[p6l919t2734r1042b2800],
15	70.8	CD	NUMBER	70.8	appos	4	SENT_98	[p6l1085t2734r1227b2800],
16	)	NN	O	)	dep	15	SENT_98	[p6l1085t2734r1227b2800],

1	Total	JJ	O	total	_	0	SENT_99	[p6l77t3165r215b3217],
2	52	CD	NUMBER	52	number	3	SENT_99	[p6l771t3166r843b3217],
3	12	CD	NUMBER	12	dep	1	SENT_99	[p6l1479t3166r1547b3216],
4	64	CD	NUMBER	64	dep	3	SENT_99	[p6l2041t3166r2114b3217],

1	Relative	JJ	O	relative	amod	2	SENT_100	[p6l7t3324r240b3376],
2	ris	NN	O	ri	_	0	SENT_100	[p6l265t3324r493b3376],
3	/	:	O	/	punct	2	SENT_100	[p6l265t3324r493b3376],
4	(	NN	O	(	dep	2	SENT_100	[p6l265t3324r493b3376],
5	=	JJ	O	=	dep	4	SENT_100	[p6l265t3324r493b3376],
6	3	CD	NUMBER	3	dep	5	SENT_100	[p6l265t3324r493b3376],
7	.	.	O	.	_	0	SENT_100	[p6l265t3324r493b3376],

1	6	CD	NUMBER	6	_	0	SENT_101	[p6l506t3325r552b3385],
2	,	,	O	,	_	0	SENT_101	[p6l506t3325r552b3385],
3	95	CD	PERCENT	95	number	4	SENT_101	[p6l586t3324r719b3377],
4	%	NN	PERCENT	%	amod	5	SENT_101	[p6l586t3324r719b3377],
5	CI	NN	O	ci	dep	1	SENT_101	[p6l748t3323r812b3376],
6	of	IN	O	of	_	0	SENT_101	[p6l836t3324r899b3376],
7	(	CD	NUMBER	(	number	8	SENT_101	[p6l919t3323r1042b3389],
8	1.4	CD	NUMBER	1.4	prep_of	5	SENT_101	[p6l919t3323r1042b3389],
9	,	,	O	,	_	0	SENT_101	[p6l919t3323r1042b3389],
10	9.4	CD	NUMBER	9.4	num	11	SENT_101	[p6l1076t3323r1188b3389],
11	)	NN	O	)	dep	1	SENT_101	[p6l1076t3323r1188b3389],

1	Total	JJ	O	total	_	0	SENT_102	[p6l77t3755r215b3807],
2	86	CD	NUMBER	86	number	3	SENT_102	[p6l770t3756r844b3807],
3	9	CD	NUMBER	9	dep	1	SENT_102	[p6l1495t3756r1529b3807],
4	95	CD	NUMBER	95	dep	3	SENT_102	[p6l2040t3756r2114b3807],

1	/	:	O	/	punct	2	SENT_103	[p7l7t31r240b83],
2	-	:	O	-	_	0	SENT_103	[p7l7t31r240b83],
3	?	.	O	?	_	0	SENT_103	[p7l7t31r240b83],

1	e/at/ve	JJ	O	e/at/ve	amod	2	SENT_104	[p7l7t31r240b83],
2	risk	NN	O	risk	_	0	SENT_104	[p7l265t30r430b82],
3	:	:	O	:	_	0	SENT_104	[p7l265t30r430b82],
4	7.8	CD	NUMBER	7.8	dep	2	SENT_104	[p7l454t31r552b91],
5	,	,	O	,	_	0	SENT_104	[p7l454t31r552b91],
6	95	CD	PERCENT	95	number	7	SENT_104	[p7l586t30r719b84],
7	%	NN	PERCENT	%	amod	8	SENT_104	[p7l586t30r719b84],
8	CI	NN	O	ci	appos	4	SENT_104	[p7l748t30r812b82],
9	of	IN	O	of	_	0	SENT_104	[p7l836t31r899b82],
10	(	CD	NUMBER	(	number	11	SENT_104	[p7l919t30r1042b95],
11	0.5	CD	NUMBER	0.5	prep_of	8	SENT_104	[p7l919t30r1042b95],
12	,	,	O	,	_	0	SENT_104	[p7l919t30r1042b95],
13	6.8	CD	NUMBER	6.8	num	14	SENT_104	[p7l1078t30r1187b95],
14	)	NN	O	)	appos	4	SENT_104	[p7l1078t30r1187b95],

1	Abbreviation	NN	O	abbreviation	_	0	SENT_105	[p7l7t203r396b255],
2	:	:	O	:	_	0	SENT_105	[p7l7t203r396b255],
3	CI	NN	O	ci	dep	1	SENT_105	[p7l429t202r505b263],
4	,	,	O	,	_	0	SENT_105	[p7l429t202r505b263],
5	confidence	NN	O	confidence	nn	6	SENT_105	[p7l537t203r868b255],
6	interval	NN	O	interval	appos	3	SENT_105	[p7l897t203r1119b255],
7	.	.	O	.	_	0	SENT_105	[p7l897t203r1119b255],

1	successively	RB	O	successively	advmod	2	SENT_106	[p7l10t423r413b503],
2	assigned	VBN	O	assign	_	0	SENT_106	[p7l450t423r726b503],
3	to	TO	O	to	_	0	SENT_106	[p7l764t435r825b483],
4	one	CD	TIME	one	prep_to	2	SENT_106	[p7l862t444r982b483],
5	of	IN	TIME	of	_	0	SENT_106	[p7l1019t423r1082b483],
6	nine	CD	TIME	nine	prep_of	4	SENT_106	[p7l1119t427r1257b483],
7	different	JJ	O	different	amod	6	SENT_106	[p7l1294t423r1567b483],
8	once	RB	DATE	once	advmod	7	SENT_106	[p7l1602t444r1785b483],
9	—	CD	NUMBER	—	tmod	7	SENT_106	[p7l1602t444r1785b483],
10	or	CC	O	or	_	0	SENT_106	[p7l1823t444r1888b483],
11	twicedaily	RB	O	twicedaily	advmod	14	SENT_106	[p7l1923t427r2126b483, p7l10t516r169b595],
12	initial	JJ	O	initial	amod	14	SENT_106	[p7l201t516r378b576],
13	dose	NN	O	dose	nn	14	SENT_106	[p7l412t516r561b576],
14	cohorts	NNS	O	cohort	conj_or	2	SENT_106	[p7l591t516r846b588],
15	,	,	O	,	_	0	SENT_106	[p7l591t516r846b588],
16	and	CC	O	and	_	0	SENT_106	[p7l881t516r998b576],
17	doses	NNS	O	dose	nsubjpass	19	SENT_106	[p7l1029t516r1207b576],
18	were	VBD	O	be	auxpass	19	SENT_106	[p7l1236t536r1396b576],
19	escalated	VBN	O	escalate	conj_and	2	SENT_106	[p7l1425t516r1728b576],
20	for	IN	O	for	mark	26	SENT_106	[p7l1758t516r1846b576],
21	patients	NNS	O	patient	nsubj	26	SENT_106	[p7l1875t520r2126b595],
22	with	IN	O	with	_	0	SENT_106	[p7l8t608r149b668],
23	inadequate	JJ	O	inadequate	amod	25	SENT_106	[p7l183t608r543b687],
24	response	NN	O	response	nn	25	SENT_106	[p7l573t612r875b687],
25	)	NN	O	)	prep_with	21	SENT_106	[p7l573t612r875b687],
26	made	VBD	O	make	advcl	19	SENT_106	[p7l908t608r1085b668],
27	it	PRP	O	it	nsubj	28	SENT_106	[p7l1117t612r1153b667],
28	difficult	JJ	O	difficult	xcomp	26	SENT_106	[p7l1179t607r1430b668],
29	to	TO	O	to	_	0	SENT_106	[p7l1453t619r1514b668],
30	separate	JJ	O	separate	amod	31	SENT_106	[p7l1542t619r1812b687],
31	potential	JJ	O	potential	prep_to	28	SENT_106	[p7l1841t608r2121b687],
32	confounding	JJ	O	confounding	amod	31	SENT_106	[p7l10t700r426b780],
33	by	IN	O	by	_	0	SENT_106	[p7l454t700r530b779],
34	dose	NN	O	dose	prep_by	32	SENT_106	[p7l558t700r707b760],
35	from	IN	O	from	_	0	SENT_106	[p7l733t700r882b760],
36	the	DT	O	the	det	37	SENT_106	[p7l912t700r1012b760],
37	effect	NN	O	effect	prep_from	26	SENT_106	[p7l1040t700r1219b760],
38	of	IN	O	of	_	0	SENT_106	[p7l1245t700r1309b760],
39	UGT1A1	NN	O	ugt1a1	nn	40	SENT_106	[p7l1338t704r1614b760],
40	genotype	NN	O	genotype	prep_of	37	SENT_106	[p7l1657t711r1975b780],
41	.	.	O	.	_	0	SENT_106	[p7l1657t711r1975b780],

1	The	DT	O	the	det	3	SENT_107	[p7l2006t700r2127b760],
2	further	JJ	O	further	amod	3	SENT_107	[p7l8t792r225b852],
3	development	NN	O	development	nsubj	11	SENT_107	[p7l267t792r697b871],
4	of	IN	O	of	_	0	SENT_107	[p7l739t792r802b852],
5	nilotinib	NN	O	nilotinib	prep_of	3	SENT_107	[p7l844t792r1116b852],
6	in	IN	O	in	_	0	SENT_107	[p7l1163t796r1216b851],
7	a	DT	O	a	det	10	SENT_107	[p7l1262t813r1296b852],
8	Phase	NN	O	phase	nn	10	SENT_107	[p7l1343t792r1527b852],
9	II	CD	NUMBER	ii	num	10	SENT_107	[p7l1573t797r1604b851],
10	study	NN	O	study	prep_in	5	SENT_107	[p7l1652t792r1822b871],
11	made	VBD	O	make	_	0	SENT_107	[p7l1867t792r2045b852],
12	it	PRP	O	it	nsubj	13	SENT_107	[p7l2092t796r2129b852],
13	possible	JJ	O	possible	xcomp	11	SENT_107	[p7l11t883r275b963],
14	to	TO	O	to	aux	15	SENT_107	[p7l310t895r371b943],
15	validate	VB	O	validate	xcomp	13	SENT_107	[p7l407t883r666b943],
16	these	DT	O	these	det	17	SENT_107	[p7l701t883r870b943],
17	findings	NNS	O	finding	dobj	15	SENT_107	[p7l906t883r1163b963],
18	in	IN	O	in	_	0	SENT_107	[p7l1203t887r1256b943],
19	two	CD	NUMBER	two	num	22	SENT_107	[p7l1294t895r1416b943],
20	new	JJ	O	new	amod	22	SENT_107	[p7l1456t904r1591b943],
21	patient	NN	O	patient	nn	22	SENT_107	[p7l1629t887r1853b963],
22	cohorts	NNS	O	cohort	prep_in	15	SENT_107	[p7l1888t883r2126b943],
23	with	IN	O	with	_	0	SENT_107	[p7l8t975r149b1035],
24	simple	JJ	O	simple	amod	26	SENT_107	[p7l182t975r396b1055],
25	dosing	NN	O	dosing	nn	26	SENT_107	[p7l427t975r641b1055],
26	structures	NNS	O	structure	prep_with	22	SENT_107	[p7l672t987r1001b1035],
27	.	.	O	.	_	0	SENT_107	[p7l672t987r1001b1035],

1	Phase	NN	O	phase	_	0	SENT_108	[p7l14t1215r230b1283],
2	II	CD	NUMBER	ii	num	3	SENT_108	[p7l265t1221r310b1282],
3	Samples	NNS	O	sample	dep	1	SENT_108	[p7l10t1315r279b1394],
4	from	IN	O	from	_	0	SENT_108	[p7l303t1315r451b1375],
5	62	CD	NUMBER	62	num	6	SENT_108	[p7l480t1321r553b1375],
6	patients	NNS	O	patient	prep_from	3	SENT_108	[p7l584t1319r836b1394],
7	in	IN	O	in	_	0	SENT_108	[p7l864t1319r917b1374],
8	ClvlL	NN	O	clvll	prep_in	6	SENT_108	[p7l945t1319r1219b1375],
9	.	.	O	.	_	0	SENT_108	[p7l945t1319r1219b1375],

1	—	NN	O	—	_	0	SENT_109	[p7l945t1319r1219b1375],
2	.	.	O	.	_	0	SENT_109	[p7l945t1319r1219b1375],

1	CP	NN	O	cp	nn	4	SENT_110	[p7l945t1319r1219b1375],
2	and	CC	O	and	_	0	SENT_110	[p7l1243t1315r1361b1375],
3	39	CD	NUMBER	39	nn	4	SENT_110	[p7l1387t1321r1465b1375],
4	patients	NNS	O	patient	_	0	SENT_110	[p7l1493t1319r1744b1394],
5	in	IN	O	in	_	0	SENT_110	[p7l1773t1319r1825b1374],
6	CML	NN	ORGANIZATION	cml	prep_in	4	SENT_110	[p7l1853t1319r2127b1375],
7	.	.	O	.	_	0	SENT_110	[p7l1853t1319r2127b1375],

1	—	NN	O	—	_	0	SENT_111	[p7l1853t1319r2127b1375],
2	.	.	O	.	_	0	SENT_111	[p7l1853t1319r2127b1375],

1	AP	NN	O	ap	nsubj	3	SENT_112	[p7l1853t1319r2127b1375],
2	were	VBD	O	be	cop	3	SENT_112	[p7l8t1427r169b1466],
3	available	JJ	O	available	_	0	SENT_112	[p7l204t1406r500b1466],
4	for	IN	O	for	_	0	SENT_112	[p7l535t1406r623b1466],
5	analysis	NN	O	analysis	prep_for	3	SENT_112	[p7l658t1406r914b1486],
6	in	IN	O	in	_	0	SENT_112	[p7l955t1410r1007b1466],
7	the	DT	O	the	det	11	SENT_112	[p7l1044t1406r1145b1466],
8	ongoing	JJ	O	ongoing	amod	11	SENT_112	[p7l1180t1410r1446b1486],
9	Phase	NN	O	phase	nn	11	SENT_112	[p7l1485t1406r1669b1466],
10	II	CD	NUMBER	ii	num	11	SENT_112	[p7l1708t1411r1738b1466],
11	study	NN	O	study	prep_in	3	SENT_112	[p7l1779t1406r1967b1486],
12	.	.	O	.	_	0	SENT_112	[p7l1779t1406r1967b1486],

1	The	DT	O	the	det	3	SENT_113	[p7l2006t1406r2127b1466],
2	(	CD	NUMBER	(	num	3	SENT_113	[p7l11t1503r191b1571],
3	TA	NNP	O	TA	nsubjpass	23	SENT_113	[p7l11t1503r191b1571],
4	)	CD	NUMBER	)	number	5	SENT_113	[p7l11t1503r191b1571],
5	5	CD	NUMBER	5	dep	3	SENT_113	[p7l11t1503r191b1571],
6	,	,	O	,	_	0	SENT_113	[p7l11t1503r191b1571],
7	(	CD	NUMBER	(	num	8	SENT_113	[p7l249t1503r430b1571],
8	TA	NNP	O	TA	conj_and	3	SENT_113	[p7l249t1503r430b1571],
9	)	CD	NUMBER	)	number	10	SENT_113	[p7l249t1503r430b1571],
10	6	CD	NUMBER	6	dep	8	SENT_113	[p7l249t1503r430b1571],
11	,	,	O	,	_	0	SENT_113	[p7l249t1503r430b1571],
12	(	CD	NUMBER	(	num	14	SENT_113	[p7l488t1503r651b1571],
13	TA	NNP	O	TA	nn	14	SENT_113	[p7l488t1503r651b1571],
14	)	NN	O	)	conj_and	3	SENT_113	[p7l488t1503r651b1571],
15	7	CD	NUMBER	7	dep	14	SENT_113	[p7l488t1503r651b1571],
16	and	CC	O	and	_	0	SENT_113	[p7l703t1499r820b1559],
17	(	CD	NUMBER	(	num	21	SENT_113	[p7l875t1503r1038b1571],
18	TA	NNP	O	TA	nn	21	SENT_113	[p7l875t1503r1038b1571],
19	)	CD	NUMBER	)	num	21	SENT_113	[p7l875t1503r1038b1571],
20	8	CD	NUMBER	8	num	21	SENT_113	[p7l875t1503r1038b1571],
21	alleles	NNS	O	allele	conj_and	3	SENT_113	[p7l1090t1499r1296b1559],
22	were	VBD	O	be	auxpass	23	SENT_113	[p7l1346t1519r1507b1559],
23	seen	VBN	O	see	_	0	SENT_113	[p7l1558t1519r1700b1559],
24	among	IN	O	among	_	0	SENT_113	[p7l1755t1519r1978b1578],
25	the	DT	O	the	det	27	SENT_113	[p7l2027t1499r2127b1559],
26	genotyped	JJ	O	genotyped	amod	27	SENT_113	[p7l9t1591r350b1670],
27	patients	NNS	O	patient	prep_among	23	SENT_113	[p7l389t1595r658b1670],
28	.	.	O	.	_	0	SENT_113	[p7l389t1595r658b1670],

1	Again	RB	O	again	advmod	38	SENT_114	[p7l697t1595r903b1670],
2	,	,	O	,	_	0	SENT_114	[p7l697t1595r903b1670],
3	the	DT	O	the	det	5	SENT_114	[p7l942t1591r1042b1651],
4	(	CD	NUMBER	(	num	5	SENT_114	[p7l1079t1595r1243b1664],
5	TA	NNP	O	TA	nsubjpass	38	SENT_114	[p7l1079t1595r1243b1664],
6	)	CD	NUMBER	)	number	7	SENT_114	[p7l1079t1595r1243b1664],
7	6	CD	NUMBER	6	num	8	SENT_114	[p7l1079t1595r1243b1664],
8	allele	NN	O	allele	nsubj	9	SENT_114	[p7l1279t1591r1455b1651],
9	predominated	VBD	O	predominate	rcmod	5	SENT_114	[p7l1492t1591r1947b1670],
10	with	IN	O	with	_	0	SENT_114	[p7l1984t1591r2124b1651],
11	66	CD	PERCENT	66	num	12	SENT_114	[p7l11t1687r158b1744],
12	%	NN	PERCENT	%	prep_with	9	SENT_114	[p7l11t1687r158b1744],
13	of	IN	O	of	_	0	SENT_114	[p7l190t1683r254b1743],
14	the	DT	O	the	det	15	SENT_114	[p7l281t1683r381b1743],
15	alleles	NNS	O	allele	prep_of	12	SENT_114	[p7l414t1683r619b1743],
16	in	IN	O	in	_	0	SENT_114	[p7l655t1687r708b1742],
17	the	DT	O	the	det	19	SENT_114	[p7l742t1683r842b1743],
18	CP	NNP	O	CP	nn	19	SENT_114	[p7l874t1687r964b1743],
19	arm	NN	O	arm	prep_in	15	SENT_114	[p7l996t1704r1117b1742],
20	and	CC	O	and	_	0	SENT_114	[p7l1153t1683r1270b1743],
21	60	CD	PERCENT	60	num	22	SENT_114	[p7l1305t1687r1452b1744],
22	%	NN	PERCENT	%	prep_of	12	SENT_114	[p7l1305t1687r1452b1744],
23	in	IN	O	in	_	0	SENT_114	[p7l1489t1687r1542b1742],
24	the	DT	O	the	det	26	SENT_114	[p7l1575t1683r1675b1743],
25	AP	NN	O	ap	nn	26	SENT_114	[p7l1707t1687r1798b1742],
26	arm	NN	O	arm	prep_in	22	SENT_114	[p7l1829t1704r1971b1755],
27	;	:	O	;	_	0	SENT_114	[p7l1829t1704r1971b1755],
28	one	CD	NUMBER	one	num	29	SENT_114	[p7l2007t1704r2127b1743],
29	patient	NN	O	patient	dep	22	SENT_114	[p7l11t1778r235b1853],
30	each	DT	O	each	dep	29	SENT_114	[p7l269t1774r420b1834],
31	with	IN	O	with	_	0	SENT_114	[p7l459t1774r599b1834],
32	the	DT	O	the	det	36	SENT_114	[p7l637t1774r737b1834],
33	5/5	CD	NUMBER	5/5	nn	36	SENT_114	[p7l775t1778r872b1834],
34	and	CC	O	and	_	0	SENT_114	[p7l913t1774r1030b1834],
35	6/8	CD	NUMBER	6/8	nn	36	SENT_114	[p7l1071t1778r1170b1834],
36	genotypes	NNS	O	genotype	prep_with	9	SENT_114	[p7l1208t1785r1537b1854],
37	was	VBD	O	be	auxpass	38	SENT_114	[p7l1573t1795r1698b1834],
38	observed	VBN	O	observe	_	0	SENT_114	[p7l1735t1774r2029b1834],
39	in	IN	O	in	_	0	SENT_114	[p7l2071t1778r2123b1833],
40	CML-CP	NN	O	cml-cp	prep_in	38	SENT_114	[p7l10t1869r300b1938],
41	,	,	O	,	_	0	SENT_114	[p7l10t1869r300b1938],
42	and	CC	O	and	_	0	SENT_114	[p7l336t1865r454b1925],
43	one	CD	NUMBER	one	num	44	SENT_114	[p7l487t1886r607b1925],
44	patient	NN	O	patient	nsubjpass	53	SENT_114	[p7l639t1869r863b1945],
45	each	DT	O	each	dep	44	SENT_114	[p7l892t1865r1042b1925],
46	with	IN	O	with	_	0	SENT_114	[p7l1075t1865r1216b1925],
47	the	DT	O	the	det	51	SENT_114	[p7l1248t1865r1348b1925],
48	6/8	CD	NUMBER	6/8	nn	51	SENT_114	[p7l1381t1869r1480b1926],
49	and	CC	O	and	_	0	SENT_114	[p7l1513t1865r1630b1925],
50	7/8	CD	NUMBER	7/8	conj_and	48	SENT_114	[p7l1667t1869r1764b1926],
51	genotypes	NNS	O	genotype	prep_with	44	SENT_114	[p7l1796t1877r2126b1945],
52	was	VBD	O	be	auxpass	53	SENT_114	[p7l8t1978r133b2017],
53	observed	VBN	O	observe	conj_and	38	SENT_114	[p7l171t1957r464b2017],
54	in	IN	O	in	_	0	SENT_114	[p7l506t1961r559b2017],
55	ClvlL	NN	O	clvll	prep_in	53	SENT_114	[p7l599t1961r891b2018],
56	.	.	O	.	_	0	SENT_114	[p7l599t1961r891b2018],

1	—	NN	O	—	_	0	SENT_115	[p7l599t1961r891b2018],
2	.	.	O	.	_	0	SENT_115	[p7l599t1961r891b2018],

1	AP	NN	O	ap	_	0	SENT_116	[p7l599t1961r891b2018],
2	.	.	O	.	_	0	SENT_116	[p7l599t1961r891b2018],

1	Consistent	JJ	O	consistent	nsubjpass	48	SENT_117	[p7l933t1961r1273b2017],
2	with	IN	O	with	_	0	SENT_117	[p7l1306t1957r1446b2017],
3	previous	JJ	O	previous	amod	5	SENT_117	[p7l1488t1961r1764b2037],
4	reports	NNS	O	report	nn	5	SENT_117	[p7l1805t1946r2123b2037],
5	,2	NN	O	,2	prep_with	1	SENT_117	[p7l1805t1946r2123b2037],
6	'	''	O	'	_	0	SENT_117	[p7l1805t1946r2123b2037],
7	3	CD	NUMBER	3	num	8	SENT_117	[p7l1805t1946r2123b2037],
8	baseline	NN	O	baseline	nsubj	13	SENT_117	[p7l11t2050r280b2110],
9	total	JJ	O	total	amod	11	SENT_117	[p7l304t2050r442b2110],
10	bilirubin	NN	O	bilirubin	nn	11	SENT_117	[p7l475t2050r749b2110],
11	levels	NNS	O	level	dep	8	SENT_117	[p7l783t2050r963b2110],
12	were	VBD	O	be	cop	13	SENT_117	[p7l988t2070r1148b2110],
13	higher	JJR	O	higher	rcmod	5	SENT_117	[p7l1177t2050r1381b2129],
14	in	IN	O	in	prep	13	SENT_117	[p7l1410t2054r1463b2109],
15	7/7	CD	NUMBER	7/7	num	16	SENT_117	[p7l1495t2054r1593b2110],
16	patients	NNS	O	patient	npadvmod	17	SENT_117	[p7l1622t2054r1873b2129],
17	than	IN	O	than	pcomp	14	SENT_117	[p7l1898t2050r2038b2110],
18	in	IN	O	in	_	0	SENT_117	[p7l2071t2054r2123b2109],
19	6/6	CD	NUMBER	6/6	num	22	SENT_117	[p7l11t2145r111b2202],
20	and	CC	O	and	_	0	SENT_117	[p7l143t2142r261b2202],
21	6/7	CD	NUMBER	6/7	num	22	SENT_117	[p7l295t2145r394b2202],
22	patients	NNS	O	patient	prep_in	13	SENT_117	[p7l428t2146r679b2221],
23	(	RB	O	(	dep	24	SENT_117	[p7l712t2142r912b2211],
24	Table	NNP	O	Table	dep	22	SENT_117	[p7l712t2142r912b2211],
25	4	CD	NUMBER	4	number	26	SENT_117	[p7l942t2146r1020b2214],
26	)	CD	NUMBER	)	num	24	SENT_117	[p7l942t2146r1020b2214],
27	,	,	O	,	_	0	SENT_117	[p7l942t2146r1020b2214],
28	in	IN	O	in	_	0	SENT_117	[p7l1060t2146r1112b2201],
29	contrast	NN	O	contrast	prep_in	13	SENT_117	[p7l1146t2153r1406b2202],
30	to	TO	O	to	_	0	SENT_117	[p7l1433t2153r1494b2202],
31	the	DT	O	the	det	32	SENT_117	[p7l1523t2142r1624b2202],
32	results	NNS	O	result	prep_to	29	SENT_117	[p7l1658t2142r1859b2202],
33	seen	VBN	O	see	partmod	32	SENT_117	[p7l1891t2162r2033b2202],
34	in	IN	O	in	_	0	SENT_117	[p7l2071t2146r2123b2201],
35	Phase	NN	O	phase	nn	36	SENT_117	[p7l14t2234r198b2294],
36	I.	NN	O	i.	prep_in	33	SENT_117	[p7l228t2239r259b2294],
37	The	DT	O	the	det	38	SENT_117	[p7l289t2234r410b2294],
38	highest	JJS	O	highest	dobj	33	SENT_117	[p7l440t2234r671b2314],
39	observed	VBN	O	observe	partmod	38	SENT_117	[p7l696t2234r989b2294],
40	baseline	NN	O	baseline	nn	42	SENT_117	[p7l1020t2234r1288b2294],
41	bilirubin	NN	O	bilirubin	nn	42	SENT_117	[p7l1317t2234r1591b2294],
42	value	NN	O	value	dobj	39	SENT_117	[p7l1621t2234r1797b2294],
43	in	IN	O	in	_	0	SENT_117	[p7l1828t2238r1881b2293],
44	the	DT	O	the	det	46	SENT_117	[p7l1910t2234r2010b2294],
45	AP	NN	ORGANIZATION	ap	nn	46	SENT_117	[p7l2036t2238r2128b2293],
46	arm	NN	O	arm	prep_in	42	SENT_117	[p7l10t2347r131b2386],
47	was	VBD	O	be	auxpass	48	SENT_117	[p7l156t2347r281b2386],
48	seen	VBN	O	see	_	0	SENT_117	[p7l305t2347r447b2386],
49	in	IN	O	in	_	0	SENT_117	[p7l478t2330r530b2385],
50	the	DT	O	the	det	53	SENT_117	[p7l555t2326r656b2386],
51	sole	JJ	O	sole	amod	53	SENT_117	[p7l680t2326r808b2386],
52	7/8	CD	NUMBER	7/8	num	53	SENT_117	[p7l834t2330r932b2386],
53	patient	NN	O	patient	prep_in	48	SENT_117	[p7l959t2330r1197b2405],
54	,	,	O	,	_	0	SENT_117	[p7l959t2330r1197b2405],
55	and	CC	O	and	_	0	SENT_117	[p7l1226t2326r1343b2386],
56	the	DT	O	the	det	58	SENT_117	[p7l1367t2326r1467b2386],
57	highest	JJS	O	highest	amod	58	SENT_117	[p7l1494t2326r1724b2406],
58	value	NN	O	value	nsubjpass	64	SENT_117	[p7l1745t2326r1921b2386],
59	in	IN	O	in	_	0	SENT_117	[p7l1949t2330r2002b2385],
60	the	DT	O	the	det	62	SENT_117	[p7l2027t2326r2127b2386],
61	CP	NNP	MISC	CP	nn	62	SENT_117	[p7l10t2421r100b2478],
62	arm	NN	O	arm	prep_in	58	SENT_117	[p7l129t2438r251b2477],
63	was	VBD	O	be	auxpass	64	SENT_117	[p7l283t2438r408b2477],
64	seen	VBN	O	see	conj_and	48	SENT_117	[p7l439t2438r581b2477],
65	in	IN	O	in	_	0	SENT_117	[p7l618t2421r671b2477],
66	a	DT	O	a	det	68	SENT_117	[p7l705t2438r739b2477],
67	7/7	CD	NUMBER	7/7	num	68	SENT_117	[p7l773t2421r871b2478],
68	patient	NN	O	patient	prep_in	64	SENT_117	[p7l904t2421r1143b2497],
69	.	.	O	.	_	0	SENT_117	[p7l904t2421r1143b2497],

1	The	DT	O	the	det	2	SENT_118	[p7l85t2509r206b2569],
2	maximum	NN	O	maximum	nsubjpass	18	SENT_118	[p7l247t2513r572b2569],
3	within	IN	O	within	_	0	SENT_118	[p7l612t2509r1075b2589],
4	—	CD	NUMBER	—	num	5	SENT_118	[p7l612t2509r1075b2589],
5	patient	NN	O	patient	prep_within	2	SENT_118	[p7l612t2509r1075b2589],
6	total	JJ	O	total	amod	8	SENT_118	[p7l1110t2509r1248b2569],
7	bilirubin	NN	O	bilirubin	nn	8	SENT_118	[p7l1293t2509r1567b2569],
8	levels	NNS	O	level	nsubj	12	SENT_118	[p7l1613t2509r1793b2569],
9	observed	VBN	O	observe	partmod	8	SENT_118	[p7l1831t2509r2125b2569],
10	during	IN	O	during	_	0	SENT_118	[p7l10t2602r220b2681],
11	therapy	NN	O	therapy	prep_during	9	SENT_118	[p7l242t2602r488b2681],
12	reported	VBD	O	report	rcmod	5	SENT_118	[p7l515t2602r785b2681],
13	for	IN	O	for	_	0	SENT_118	[p7l810t2602r898b2662],
14	each	DT	O	each	det	16	SENT_118	[p7l921t2602r1072b2662],
15	genotype	NN	O	genotype	nn	16	SENT_118	[p7l1100t2613r1400b2681],
16	class	NN	O	class	prep_for	12	SENT_118	[p7l1424t2602r1577b2662],
17	are	VBP	O	be	auxpass	18	SENT_118	[p7l1603t2622r1701b2662],
18	presented	VBN	O	present	_	0	SENT_118	[p7l1727t2602r2041b2681],
19	in	IN	O	in	_	0	SENT_118	[p7l2071t2606r2123b2661],
20	Table	NNP	O	Table	prep_in	18	SENT_118	[p7l8t2694r189b2754],
21	5	CD	NUMBER	5	num	20	SENT_118	[p7l226t2700r280b2754],
22	.	.	O	.	_	0	SENT_118	[p7l226t2700r280b2754],

1	The	DT	O	the	det	4	SENT_119	[p7l319t2694r440b2754],
2	relative	JJ	O	relative	amod	4	SENT_119	[p7l479t2694r716b2754],
3	risk	NN	O	risk	nn	4	SENT_119	[p7l755t2694r864b2754],
4	findings	NNS	O	finding	nsubj	9	SENT_119	[p7l898t2693r1155b2773],
5	from	IN	O	from	_	0	SENT_119	[p7l1189t2693r1338b2754],
6	Phase	NN	O	phase	nn	7	SENT_119	[p7l1381t2694r1565b2754],
7	I	NN	O	i	prep_from	4	SENT_119	[p7l1604t2699r1613b2753],
8	were	VBD	O	be	cop	9	SENT_119	[p7l1652t2714r1812b2754],
9	re	JJ	O	re	_	0	SENT_119	[p7l1850t2694r2124b2754],
10	—	NN	O	—	tmod	9	SENT_119	[p7l1850t2694r2124b2754],
11	tested	VBN	O	test	partmod	10	SENT_119	[p7l1850t2694r2124b2754],
12	separately	RB	O	separately	advmod	11	SENT_119	[p7l10t2786r340b2865],
13	in	IN	O	in	_	0	SENT_119	[p7l374t2790r426b2845],
14	CML	NN	ORGANIZATION	cml	nn	15	SENT_119	[p7l460t2790r613b2846],
15	CP	NN	O	cp	prep_in	11	SENT_119	[p7l644t2790r734b2846],
16	and	CC	O	and	_	0	SENT_119	[p7l764t2786r882b2846],
17	CML	NN	ORGANIZATION	cml	nn	19	SENT_119	[p7l913t2790r1066b2846],
18	AP	NN	ORGANIZATION	ap	nn	19	SENT_119	[p7l1096t2790r1188b2845],
19	patients	NNS	O	patient	prep_in	11	SENT_119	[p7l1219t2790r1487b2865],
20	,	,	O	,	_	0	SENT_119	[p7l1219t2790r1487b2865],
21	at	IN	O	at	_	0	SENT_119	[p7l1522t2797r1580b2846],
22	the	DT	O	the	det	24	SENT_119	[p7l1606t2786r1707b2846],
23	significance	NN	O	significance	nn	24	SENT_119	[p7l1737t2786r2127b2866],
24	level	NN	O	level	prep_at	11	SENT_119	[p7l12t2873r139b2925],
25	of	IN	O	of	_	0	SENT_119	[p7l175t2873r231b2925],
26	0.05	CD	NUMBER	0.05	num	27	SENT_119	[p7l260t2878r382b2925],
27	(	CD	NUMBER	(	prep_of	24	SENT_119	[p7l419t2873r593b2932],
28	Table	NNP	O	Table	nn	30	SENT_119	[p7l419t2873r593b2932],
29	6	CD	NUMBER	6	num	30	SENT_119	[p7l627t2877r692b2932],
30	)	NN	O	)	dep	10	SENT_119	[p7l627t2877r692b2932],
31	.	.	O	.	_	0	SENT_119	[p7l627t2877r692b2932],

1	All	DT	O	all	det	3	SENT_120	[p7l727t2873r802b2924],
2	significant	JJ	O	significant	amod	3	SENT_120	[p7l839t2873r1131b2942],
3	results	NNS	O	result	nsubj	15	SENT_120	[p7l1164t2873r1340b2925],
4	from	IN	O	from	_	0	SENT_120	[p7l1371t2873r1500b2925],
5	Phase	NN	O	phase	nn	6	SENT_120	[p7l1538t2873r1698b2925],
6	I	NN	O	i	prep_from	3	SENT_120	[p7l1734t2877r1741b2924],
7	for	IN	O	for	_	0	SENT_120	[p7l1776t2873r1852b2925],
8	which	WDT	O	which	rel	14	SENT_120	[p7l8t2953r181b3005],
9	relative	JJ	O	relative	amod	11	SENT_120	[p7l238t2953r446b3005],
10	risk	NN	O	risk	nn	11	SENT_120	[p7l500t2953r595b3005],
11	statistics	NNS	O	statistics	nsubjpass	14	SENT_120	[p7l646t2957r881b3005],
12	could	MD	O	could	aux	14	SENT_120	[p7l933t2953r1091b3005],
13	be	VB	O	be	auxpass	14	SENT_120	[p7l1146t2953r1211b3005],
14	calculated	VBN	O	calculate	rcmod	6	SENT_120	[p7l1263t2953r1556b3005],
15	met	VBD	O	meet	_	0	SENT_120	[p7l1612t2963r1716b3005],
16	the	DT	O	the	det	17	SENT_120	[p7l1764t2953r1851b3005],
17	threshold	NN	O	threshold	dobj	15	SENT_120	[p7l8t3031r272b3083],
18	for	IN	O	for	_	0	SENT_120	[p7l311t3031r388b3083],
19	significance	NN	O	significance	prep_for	15	SENT_120	[p7l425t3031r765b3100],
20	in	IN	O	in	_	0	SENT_120	[p7l807t3035r852b3082],
21	both	CC	O	both	preconj	22	SENT_120	[p7l895t3031r1017b3083],
22	CP	NN	O	cp	prep_in	15	SENT_120	[p7l1059t3035r1137b3083],
23	and	CC	O	and	_	0	SENT_120	[p7l1176t3031r1278b3083],
24	AP	NN	ORGANIZATION	ap	nn	25	SENT_120	[p7l1317t3035r1397b3082],
25	patients	NNS	O	patient	prep_in	15	SENT_120	[p7l1436t3035r1670b3100],
26	.	.	O	.	_	0	SENT_120	[p7l1436t3035r1670b3100],

1	With	IN	O	with	_	0	SENT_121	[p7l1712t3031r1848b3083],
2	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_with	34	SENT_121	[p7l11t3111r558b3180],
3	again	RB	O	again	advmod	4	SENT_121	[p7l611t3115r760b3180],
4	defined	VBN	O	define	partmod	2	SENT_121	[p7l816t3111r1026b3163],
5	as	IN	O	as	_	0	SENT_121	[p7l1080t3129r1135b3163],
6	grade	NN	O	grade	prep_as	4	SENT_121	[p7l1187t3111r1344b3180],
7	3	CD	NUMBER	3	number	8	SENT_121	[p7l1397t3116r1425b3163],
8	elevation	NN	O	elevation	amod	6	SENT_121	[p7l1482t3111r1741b3163],
9	or	CC	O	or	_	0	SENT_121	[p7l1796t3129r1852b3163],
10	greater	JJR	O	greater	amod	6	SENT_121	[p7l9t3200r218b3260],
11	,	,	O	,	_	0	SENT_121	[p7l9t3200r218b3260],
12	the	DT	O	the	det	14	SENT_121	[p7l263t3191r350b3243],
13	relative	JJ	O	relative	amod	14	SENT_121	[p7l394t3191r602b3243],
14	risk	NN	O	risk	nsubj	34	SENT_121	[p7l646t3191r741b3243],
15	in	IN	O	in	_	0	SENT_121	[p7l786t3194r832b3242],
16	CP	NN	O	cp	nn	19	SENT_121	[p7l877t3194r955b3243],
17	and	CC	O	and	_	0	SENT_121	[p7l997t3191r1099b3243],
18	AP	NN	ORGANIZATION	ap	nn	19	SENT_121	[p7l1142t3194r1221b3242],
19	patients	NNS	O	patient	prep_in	14	SENT_121	[p7l1264t3194r1482b3260],
20	with	IN	O	with	_	0	SENT_121	[p7l1524t3191r1645b3243],
21	a	DT	O	a	det	24	SENT_121	[p7l1691t3209r1720b3243],
22	7/7	CD	NUMBER	7/7	num	24	SENT_121	[p7l1765t3194r1850b3243],
23	genotype	NN	O	genotype	nn	24	SENT_121	[p7l9t3280r270b3340],
24	(	NN	O	(	prep_with	19	SENT_121	[p7l307t3271r534b3331],
25	relative	JJ	O	relative	advmod	19	SENT_121	[p7l307t3271r534b3331],
26	to	TO	O	to	_	0	SENT_121	[p7l568t3280r621b3323],
27	all	DT	O	all	det	29	SENT_121	[p7l656t3271r719b3323],
28	non	JJ	O	non	amod	29	SENT_121	[p7l761t3274r981b3323],
29	—	NN	O	—	prep_to	25	SENT_121	[p7l761t3274r981b3323],
30	7/7	CD	NUMBER	7/7	num	31	SENT_121	[p7l761t3274r981b3323],
31	genotypes	NNS	O	genotype	dep	19	SENT_121	[p7l1017t3274r1321b3340],
32	)	NN	O	)	dep	31	SENT_121	[p7l1017t3274r1321b3340],
33	was	VBD	O	be	cop	34	SENT_121	[p7l1357t3289r1466b3323],
34	18.0	CD	NUMBER	18.0	_	0	SENT_121	[p7l1505t3275r1627b3323],
35	with	IN	O	with	_	0	SENT_121	[p7l1662t3271r1784b3323],
36	a	DT	O	a	det	39	SENT_121	[p7l1822t3289r1851b3323],
37	95	CD	PERCENT	95	number	38	SENT_121	[p7l10t3355r138b3405],
38	%	NN	PERCENT	%	amod	39	SENT_121	[p7l10t3355r138b3405],
39	CI	NN	O	ci	prep_with	34	SENT_121	[p7l176t3355r231b3403],
40	of	IN	O	of	_	0	SENT_121	[p7l272t3351r327b3403],
41	(	CD	NUMBER	(	number	42	SENT_121	[p7l362t3355r483b3414],
42	4.1	CD	NUMBER	4.1	prep_of	39	SENT_121	[p7l362t3355r483b3414],
43	,	,	O	,	_	0	SENT_121	[p7l362t3355r483b3414],
44	78.5	CD	NUMBER	78.5	num	45	SENT_121	[p7l527t3355r667b3411],
45	)	NN	O	)	conj_and	34	SENT_121	[p7l527t3355r667b3411],
46	and	CC	O	and	_	0	SENT_121	[p7l706t3351r809b3403],
47	7.3	CD	NUMBER	7.3	number	48	SENT_121	[p7l849t3356r931b3403],
48	(	CD	NUMBER	(	num	49	SENT_121	[p7l974t3355r1095b3414],
49	1.5	CD	NUMBER	1.5	conj_and	34	SENT_121	[p7l974t3355r1095b3414],
50	,	,	O	,	_	0	SENT_121	[p7l974t3355r1095b3414],
51	34.4	CD	NUMBER	34.4	num	52	SENT_121	[p7l1137t3355r1296b3414],
52	)	NN	O	)	appos	49	SENT_121	[p7l1137t3355r1296b3414],
53	,	,	O	,	_	0	SENT_121	[p7l1137t3355r1296b3414],
54	respectively	RB	O	respectively	advmod	34	SENT_121	[p7l1339t3351r1692b3420],
55	.	.	O	.	_	0	SENT_121	[p7l1339t3351r1692b3420],

1	In	IN	O	in	_	0	SENT_122	[p7l1737t3355r1782b3403],
2	a	DT	O	a	det	3	SENT_122	[p7l1822t3369r1851b3403],
3	comparison	NN	O	comparison	prep_in	21	SENT_122	[p7l9t3435r341b3500],
4	of	IN	O	of	_	0	SENT_122	[p7l374t3431r430b3483],
5	7/7	CD	NUMBER	7/7	prep_of	3	SENT_122	[p7l459t3434r544b3484],
6	and	CC	O	and	_	0	SENT_122	[p7l576t3431r678b3483],
7	6/7	CD	NUMBER	6/7	num	8	SENT_122	[p7l710t3434r797b3484],
8	patients	NNS	O	patient	prep_in	21	SENT_122	[p7l829t3435r1063b3500],
9	,	,	O	,	_	0	SENT_122	[p7l829t3435r1063b3500],
10	a	DT	O	a	det	12	SENT_122	[p7l1097t3449r1126b3483],
11	relative	JJ	O	relative	amod	12	SENT_122	[p7l1159t3431r1366b3483],
12	risk	NN	O	risk	appos	8	SENT_122	[p7l1399t3431r1494b3483],
13	of	IN	O	of	_	0	SENT_122	[p7l1523t3431r1578b3483],
14	9.3	CD	NUMBER	9.3	number	15	SENT_122	[p7l1606t3436r1689b3483],
15	(	CD	NUMBER	(	num	16	SENT_122	[p7l1726t3435r1847b3494],
16	2.2	CD	NUMBER	2.2	prep_of	12	SENT_122	[p7l1726t3435r1847b3494],
17	,	,	O	,	_	0	SENT_122	[p7l1726t3435r1847b3494],
18	39.8	CD	NUMBER	39.8	num	19	SENT_122	[p7l9t3514r152b3570],
19	)	NN	O	)	nsubjpass	21	SENT_122	[p7l9t3514r152b3570],
20	was	VBD	O	be	auxpass	21	SENT_122	[p7l189t3528r298b3562],
21	seen	VBN	O	see	_	0	SENT_122	[p7l334t3528r457b3562],
22	in	IN	O	in	_	0	SENT_122	[p7l500t3514r545b3562],
23	the	DT	O	the	det	25	SENT_122	[p7l582t3510r669b3562],
24	CP	NNP	MISC	CP	nn	25	SENT_122	[p7l705t3514r783b3563],
25	arm	NN	O	arm	prep_in	21	SENT_122	[p7l819t3528r941b3573],
26	,	,	O	,	_	0	SENT_122	[p7l819t3528r941b3573],
27	while	IN	O	while	mark	44	SENT_122	[p7l980t3510r1139b3562],
28	the	DT	O	the	det	29	SENT_122	[p7l1173t3510r1260b3562],
29	absence	NN	O	absence	nsubj	44	SENT_122	[p7l1296t3510r1526b3562],
30	of	IN	O	of	_	0	SENT_122	[p7l1562t3510r1617b3562],
31	CTCAE	NNP	O	CTCAE	nn	32	SENT_122	[p7l1650t3514r1850b3563],
32	grade	NN	O	grade	prep_of	29	SENT_122	[p7l9t3590r165b3659],
33	3	CD	NUMBER	3	num	32	SENT_122	[p7l188t3595r216b3642],
34	or	CC	O	or	_	0	SENT_122	[p7l242t3608r299b3642],
35	4	CD	NUMBER	4	num	36	SENT_122	[p7l318t3596r351b3641],
36	events	NNS	O	event	prep_of	29	SENT_122	[p7l374t3600r552b3642],
37	in	IN	O	in	_	0	SENT_122	[p7l578t3594r624b3641],
38	6/7	CD	NUMBER	6/7	num	39	SENT_122	[p7l650t3593r736b3642],
39	patients	NNS	O	patient	prep_in	36	SENT_122	[p7l760t3594r979b3659],
40	in	IN	O	in	_	0	SENT_122	[p7l1005t3594r1050b3641],
41	the	DT	O	the	det	43	SENT_122	[p7l1074t3590r1161b3642],
42	AP	NN	O	ap	nn	43	SENT_122	[p7l1181t3594r1261b3641],
43	arm	NN	O	arm	prep_in	39	SENT_122	[p7l1283t3608r1388b3642],
44	made	VBD	O	make	advcl	21	SENT_122	[p7l1414t3590r1568b3642],
45	a	DT	O	a	det	48	SENT_122	[p7l1590t3608r1619b3642],
46	relative	JJ	O	relative	amod	48	SENT_122	[p7l1644t3590r1852b3642],
47	risk	NN	O	risk	nn	48	SENT_122	[p7l11t3670r107b3722],
48	calculation	NN	O	calculation	nsubj	49	SENT_122	[p7l133t3670r447b3722],
49	impossible	JJ	O	impossible	xcomp	44	SENT_122	[p7l480t3670r798b3739],
50	.	.	O	.	_	0	SENT_122	[p7l480t3670r798b3739],

1	Again	RB	O	again	dep	7	SENT_123	[p7l75t3752r255b3818],
2	,	,	O	,	_	0	SENT_123	[p7l75t3752r255b3818],
3	when	WRB	O	when	advmod	7	SENT_123	[p7l283t3749r437b3801],
4	analogous	JJ	O	analogous	amod	5	SENT_123	[p7l465t3749r755b3818],
5	tests	NNS	O	test	nsubjpass	7	SENT_123	[p7l778t3759r898b3801],
6	were	VBD	O	be	auxpass	7	SENT_123	[p7l922t3767r1061b3801],
7	performed	VBN	O	perform	_	0	SENT_123	[p7l1087t3749r1379b3817],
8	with	IN	O	with	_	0	SENT_123	[p7l1403t3749r1525b3801],
9	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_with	7	SENT_123	[p7l1555t3749r1850b3817, p8l11t12r277b64],

1	defined	VBN	O	define	partmod	12	SENT_124	[p8l302t12r512b64],
2	as	IN	O	as	_	0	SENT_124	[p8l538t30r593b64],
3	grade	NN	O	grade	prep_as	1	SENT_124	[p8l617t12r774b81],
4	2	CD	NUMBER	2	number	5	SENT_124	[p8l796t17r826b63],
5	elevation	NN	O	elevation	amod	3	SENT_124	[p8l855t12r1114b64],
6	or	CC	O	or	_	0	SENT_124	[p8l1140t30r1197b64],
7	greater	JJR	O	greater	amod	3	SENT_124	[p8l1220t22r1429b81],
8	,	,	O	,	_	0	SENT_124	[p8l1220t22r1429b81],
9	similar	JJ	O	similar	amod	10	SENT_124	[p8l1458t12r1649b64],
10	results	NNS	O	result	nsubjpass	12	SENT_124	[p8l1675t12r1851b64],
11	were	VBD	O	be	auxpass	12	SENT_124	[p8l8t108r147b142],
12	obtained	VBN	O	obtain	_	0	SENT_124	[p8l175t90r441b142],
13	.	.	O	.	_	0	SENT_124	[p8l175t90r441b142],

1	There	EX	O	there	expl	2	SENT_125	[p8l471t90r633b142],
2	were	VBD	O	be	conj_and	2	SENT_125	[p8l659t108r799b142],
3	significant	JJ	O	significant	amod	4	SENT_125	[p8l828t90r1120b159],
4	increases	NNS	O	increase	nsubj	2	SENT_125	[p8l1150t94r1407b142],
5	in	IN	O	in	_	0	SENT_125	[p8l1439t94r1485b141],
6	relative	JJ	O	relative	amod	7	SENT_125	[p8l1519t90r1726b142],
7	risk	NN	O	risk	prep_in	4	SENT_125	[p8l1757t90r1852b142],
8	in	IN	O	in	_	0	SENT_125	[p8l12t173r58b220],
9	comparison	NN	O	comparison	prep_in	7	SENT_125	[p8l100t173r433b238],
10	of	IN	O	of	_	0	SENT_125	[p8l475t169r530b221],
11	7/7	CD	NUMBER	7/7	prep_of	9	SENT_125	[p8l569t173r654b222],
12	to	TO	O	to	_	0	SENT_125	[p8l693t179r747b221],
13	non	JJ	O	non	amod	14	SENT_125	[p8l789t173r1008b222],
14	—	NN	O	—	prep_to	2	SENT_125	[p8l789t173r1008b222],
15	7/7	CD	NUMBER	7/7	num	16	SENT_125	[p8l789t173r1008b222],
16	patients	NNS	O	patient	dep	14	SENT_125	[p8l1049t173r1268b238],
17	and	CC	O	and	_	0	SENT_125	[p8l1308t169r1410b221],
18	of	IN	O	of	_	0	SENT_125	[p8l1451t169r1506b221],
19	7/7	CD	NUMBER	7/7	number	21	SENT_125	[p8l1545t173r1631b222],
20	to	TO	O	to	dep	21	SENT_125	[p8l1669t179r1722b221],
21	6/7	CD	NUMBER	6/7	num	22	SENT_125	[p8l1764t173r1850b222],
22	patients	NNS	O	patient	prep_of	2	SENT_125	[p8l10t253r244b319],
23	,	,	O	,	_	0	SENT_125	[p8l10t253r244b319],
24	and	CC	O	and	_	0	SENT_125	[p8l272t250r374b302],
25	non	JJ	O	non	amod	28	SENT_125	[p8l401t250r826b319],
26	—	NN	O	—	nn	28	SENT_125	[p8l401t250r826b319],
27	significant	JJ	O	significant	amod	28	SENT_125	[p8l401t250r826b319],
28	changes	NNS	O	change	prep_of	2	SENT_125	[p8l848t250r1078b319],
29	in	IN	O	in	_	0	SENT_125	[p8l1105t253r1151b301],
30	comparison	NN	O	comparison	prep_in	28	SENT_125	[p8l1177t253r1509b319],
31	of	IN	O	of	_	0	SENT_125	[p8l1536t250r1591b302],
32	6/7	CD	NUMBER	6/7	number	34	SENT_125	[p8l1613t253r1699b303],
33	to	TO	O	to	dep	34	SENT_125	[p8l1723t260r1776b302],
34	6	CD	NUMBER	6	prep_of	30	SENT_125	[p8l1801t253r1854b303],
35	/	:	O	/	punct	37	SENT_125	[p8l1801t253r1854b303],
36	6	CD	NUMBER	6	num	37	SENT_125	[p8l10t335r41b382],
37	patients	NNS	O	patient	dep	34	SENT_125	[p8l70t334r304b399],
38	.	.	O	.	_	0	SENT_125	[p8l70t334r304b399],

1	Discussion	NN	O	discussion	_	0	SENT_126	[p8l12t538r326b592],

1	The	DT	O	the	det	2	SENT_127	[p8l8t701r113b753],
2	results	NNS	O	result	nsubj	12	SENT_127	[p8l139t701r315b753],
3	of	IN	O	of	_	0	SENT_127	[p8l339t701r395b753],
4	the	DT	O	the	det	6	SENT_127	[p8l414t701r501b753],
5	pharmacogenetic	JJ	O	pharmacogenetic	amod	6	SENT_127	[p8l526t701r1020b770],
6	analysis	NN	O	analysis	prep_of	2	SENT_127	[p8l1045t701r1268b770],
7	in	IN	O	in	_	0	SENT_127	[p8l1296t704r1342b752],
8	the	DT	O	the	det	10	SENT_127	[p8l1367t701r1454b753],
9	three	CD	NUMBER	three	num	10	SENT_127	[p8l1476t701r1619b753],
10	cohorts	NNS	O	cohort	prep_in	6	SENT_127	[p8l1643t701r1851b753],
11	were	VBD	O	be	cop	12	SENT_127	[p8l8t799r147b833],
12	consistent	JJ	O	consistent	dep	26	SENT_127	[p8l194t784r492b833],
13	:	:	O	:	_	0	SENT_127	[p8l194t784r492b833],
14	the	DT	O	the	det	16	SENT_127	[p8l541t781r629b833],
15	7/7	CD	NUMBER	7/7	num	16	SENT_127	[p8l678t784r763b833],
16	genotype	NN	O	genotype	nsubjpass	18	SENT_127	[p8l810t790r1072b850],
17	was	VBD	O	be	auxpass	18	SENT_127	[p8l1118t799r1226b833],
18	associated	VBN	O	associate	parataxis	12	SENT_127	[p8l1273t781r1566b833],
19	with	IN	O	with	_	0	SENT_127	[p8l1613t781r1735b833],
20	an	DT	O	a	det	22	SENT_127	[p8l1785t799r1848b833],
21	elevated	JJ	O	elevated	amod	22	SENT_127	[p8l9t861r246b913],
22	risk	NN	O	risk	prep_with	18	SENT_127	[p8l275t861r371b913],
23	of	IN	O	of	_	0	SENT_127	[p8l394t861r449b913],
24	nilotinib	JJ	O	nilotinib	amod	25	SENT_127	[p8l473t861r965b913],
25	—	NN	O	—	prep_of	22	SENT_127	[p8l473t861r965b913],
26	induced	VBD	O	induce	_	0	SENT_127	[p8l473t861r965b913],
27	hyperbilirubinemia	NN	O	hyperbilirubinemia	dobj	26	SENT_127	[p8l994t861r1540b930],
28	relative	JJ	O	relative	advmod	26	SENT_127	[p8l1567t861r1775b913],
29	to	TO	O	to	_	0	SENT_127	[p8l1798t871r1851b913],
30	the	DT	O	the	det	32	SENT_127	[p8l8t940r94b992],
31	other	JJ	O	other	amod	32	SENT_127	[p8l121t940r267b992],
32	two	CD	NUMBER	two	prep_to	28	SENT_127	[p8l291t950r397b992],
33	common	JJ	O	common	amod	35	SENT_127	[p8l423t958r673b992],
34	genotype	NN	O	genotype	nn	35	SENT_127	[p8l702t950r964b1009],
35	classes	NNS	O	class	nsubj	26	SENT_127	[p8l990t940r1199b992],
36	.	.	O	.	_	0	SENT_127	[p8l990t940r1199b992],

1	The	DT	O	the	det	4	SENT_128	[p8l1227t940r1332b992],
2	observed	VBN	O	observe	amod	4	SENT_128	[p8l1358t940r1614b992],
3	relative	JJ	O	relative	amod	4	SENT_128	[p8l1644t940r1851b992],
4	risks	NNS	O	risk	nsubj	5	SENT_128	[p8l11t1018r131b1070],
5	varied	VBD	O	vary	_	0	SENT_128	[p8l157t1018r332b1070],
6	between	IN	O	between	quantmod	7	SENT_128	[p8l361t1018r599b1070],
7	4.5	CD	NUMBER	4.5	dobj	5	SENT_128	[p8l628t1023r714b1070],
8	and	CC	NUMBER	and	_	0	SENT_128	[p8l744t1018r846b1070],
9	18.0	CD	NUMBER	18.0	dobj	5	SENT_128	[p8l878t1023r1015b1070],
10	.	.	O	.	_	0	SENT_128	[p8l878t1023r1015b1070],

1	Owing	VBG	O	owe	partmod	15	SENT_129	[p8l1046t1022r1240b1087],
2	to	TO	O	to	_	0	SENT_129	[p8l1265t1028r1318b1070],
3	the	DT	O	the	det	5	SENT_129	[p8l1343t1018r1430b1070],
4	small	JJ	O	small	amod	5	SENT_129	[p8l1456t1018r1601b1070],
5	number	NN	O	number	prep_to	1	SENT_129	[p8l1634t1018r1852b1070],
6	of	IN	O	of	_	0	SENT_129	[p8l9t1097r64b1149],
7	7/7	CD	NUMBER	7/7	num	8	SENT_129	[p8l86t1101r171b1150],
8	patients	NNS	O	patient	prep_of	5	SENT_129	[p8l196t1101r429b1166],
9	,	,	O	,	_	0	SENT_129	[p8l196t1101r429b1166],
10	the	DT	O	the	det	11	SENT_129	[p8l454t1097r542b1149],
11	estimations	NNS	O	estimation	nsubj	15	SENT_129	[p8l564t1101r885b1149],
12	of	IN	O	of	_	0	SENT_129	[p8l907t1097r962b1149],
13	relative	JJ	O	relative	amod	14	SENT_129	[p8l984t1097r1191b1149],
14	risk	NN	O	risk	prep_of	11	SENT_129	[p8l1216t1097r1311b1149],
15	varied	VBD	O	vary	_	0	SENT_129	[p8l1332t1097r1506b1149],
16	widely	RB	O	widely	advmod	15	SENT_129	[p8l1529t1097r1735b1166],
17	,	,	O	,	_	0	SENT_129	[p8l1529t1097r1735b1166],
18	but	CC	O	but	_	0	SENT_129	[p8l1763t1097r1853b1149],
19	all	DT	O	all	nsubj	22	SENT_129	[p8l9t1178r72b1230],
20	were	VBD	O	be	cop	22	SENT_129	[p8l105t1196r245b1230],
21	statistically	RB	O	statistically	advmod	22	SENT_129	[p8l275t1178r589b1247],
22	significant	JJ	O	significant	conj_but	15	SENT_129	[p8l620t1178r912b1247],
23	at	IN	O	at	_	0	SENT_129	[p8l941t1188r991b1230],
24	the	DT	O	the	det	26	SENT_129	[p8l1018t1178r1105b1230],
25	0.05	CD	NUMBER	0.05	num	26	SENT_129	[p8l1135t1183r1257b1230],
26	level	NN	O	level	prep_at	22	SENT_129	[p8l1295t1178r1441b1230],
27	.	.	O	.	_	0	SENT_129	[p8l1295t1178r1441b1230],

1	The	DT	O	the	det	3	SENT_130	[p8l1473t1178r1578b1230],
2	resulting	VBG	O	result	amod	3	SENT_130	[p8l1611t1178r1852b1247],
3	hyperbilirubinemia	NN	O	hyperbilirubinemia	nsubj	10	SENT_130	[p8l11t1258r557b1327],
4	was	VBD	O	be	cop	8	SENT_130	[p8l591t1276r715b1321],
5	,	,	O	,	_	0	SENT_130	[p8l591t1276r715b1321],
6	however	RB	O	however	advmod	8	SENT_130	[p8l755t1258r1014b1321],
7	,	,	O	,	_	0	SENT_130	[p8l755t1258r1014b1321],
8	benign	JJ	O	benign	_	0	SENT_130	[p8l1053t1258r1243b1327],
9	and	CC	O	and	_	0	SENT_130	[p8l1280t1258r1382b1310],
10	reversible	JJ	O	reversible	conj_and	8	SENT_130	[p8l1420t1258r1694b1310],
11	with	IN	O	with	_	0	SENT_130	[p8l1726t1258r1848b1310],
12	continuation	NN	O	continuation	prep_with	8	SENT_130	[p8l9t1341r368b1389],
13	of	IN	O	of	_	0	SENT_130	[p8l393t1337r449b1389],
14	therapy	NN	O	therapy	prep_of	12	SENT_130	[p8l467t1337r696b1405],
15	.	.	O	.	_	0	SENT_130	[p8l467t1337r696b1405],

1	(	NN	O	(	nn	3	SENT_131	[p8l724t1340r942b1396],
2	CTCAE	NN	O	ctca	nn	3	SENT_131	[p8l724t1340r942b1396],
3	grade	NN	O	grade	nsubj	5	SENT_131	[p8l965t1337r1122b1406],
4	3	CD	NUMBER	3	dep	3	SENT_131	[p8l1146t1342r1174b1389],
5	includes	VBZ	O	include	_	0	SENT_131	[p8l1204t1337r1439b1389],
6	total	JJ	O	total	amod	8	SENT_131	[p8l1461t1337r1581b1389],
7	bilirubin	NN	O	bilirubin	nn	8	SENT_131	[p8l1610t1337r1848b1389],
8	levels	NNS	O	level	dobj	5	SENT_131	[p8l12t1417r169b1469],
9	between	IN	O	between	_	0	SENT_131	[p8l214t1417r453b1469],
10	3	CD	NUMBER	3	number	13	SENT_131	[p8l500t1422r527b1469],
11	and	CC	NUMBER	and	_	0	SENT_131	[p8l576t1417r678b1469],
12	10	CD	NUMBER	10	num	16	SENT_131	[p8l726t1422r792b1469],
13	times	NNS	O	time	num	16	SENT_131	[p8l835t1421r985b1469],
14	the	DT	O	the	det	16	SENT_131	[p8l1027t1417r1114b1469],
15	upper	JJ	O	upper	amod	16	SENT_131	[p8l1160t1435r1322b1486],
16	limit	NN	O	limit	prep_between	8	SENT_131	[p8l1368t1417r1494b1469],
17	of	IN	O	of	_	0	SENT_131	[p8l1536t1417r1591b1469],
18	normal	JJ	O	normal	prep_of	16	SENT_131	[p8l1633t1417r1847b1480],
19	;	:	O	;	_	0	SENT_131	[p8l1633t1417r1847b1480],
20	Gilbert	NNP	PERSON	Gilbert	poss	22	SENT_131	[p8l10t1495r252b1547],
21	's	POS	O	's	_	0	SENT_131	[p8l10t1495r252b1547],
22	syndrome	NN	O	syndrome	nsubjpass	25	SENT_131	[p8l273t1495r552b1564],
23	is	VBZ	O	be	auxpass	25	SENT_131	[p8l575t1499r612b1547],
24	typically	RB	O	typically	advmod	25	SENT_131	[p8l631t1495r876b1564],
25	defined	VBN	O	define	parataxis	5	SENT_131	[p8l895t1495r1106b1547],
26	as	IN	O	as	_	0	SENT_131	[p8l1128t1513r1182b1547],
27	total	JJ	O	total	amod	28	SENT_131	[p8l1201t1495r1322b1547],
28	bilirubin	NN	O	bilirubin	prep_as	25	SENT_131	[p8l1347t1495r1585b1547],
29	between	IN	O	between	_	0	SENT_131	[p8l1610t1495r1848b1547],
30	one	CD	NUMBER	one	prep_between	28	SENT_131	[p8l9t1592r113b1626],
31	and	CC	NUMBER	and	_	0	SENT_131	[p8l139t1574r242b1626],
32	four	CD	NUMBER	four	num	33	SENT_131	[p8l268t1574r382b1626],
33	times	NNS	O	time	prep_as	25	SENT_131	[p8l407t1578r557b1626],
34	the	DT	O	the	det	36	SENT_131	[p8l583t1574r670b1626],
35	upper	JJ	O	upper	amod	36	SENT_131	[p8l699t1592r860b1643],
36	limit	NN	O	limit	dep	33	SENT_131	[p8l890t1574r1015b1626],
37	of	IN	O	of	prep	36	SENT_131	[p8l1040t1574r1095b1626],
38	normal	JJ	O	normal	dep	37	SENT_131	[p8l1121t1574r1356b1634],
39	.	.	O	.	_	0	SENT_131	[p8l1121t1574r1356b1634],
40	)	SYM	O	)	dep	36	SENT_131	[p8l1121t1574r1356b1634],

1	Together	RB	O	together	_	0	SENT_132	[p8l75t1655r327b1724],
2	with	IN	O	with	_	0	SENT_132	[p8l350t1655r472b1707],
3	thiopurine	JJ	O	thiopurine	amod	4	SENT_132	[p8l498t1655r794b1724],
4	methyltransferase	NN	O	methyltransferase	prep_together_with	11	SENT_132	[p8l821t1655r1320b1724],
5	(	CD	NUMBER	(	num	7	SENT_132	[p8l1346t1658r1564b1718],
6	TPMT	NN	O	tpmt	nn	7	SENT_132	[p8l1346t1658r1564b1718],
7	)	NN	O	)	dep	11	SENT_132	[p8l1346t1658r1564b1718],
8	,	,	O	,	_	0	SENT_132	[p8l1346t1658r1564b1718],
9	UGT1A1	NN	O	ugt1a1	nsubj	11	SENT_132	[p8l1598t1658r1838b1707],
10	is	VBZ	O	be	cop	11	SENT_132	[p8l12t1737r49b1785],
11	one	CD	NUMBER	one	_	0	SENT_132	[p8l80t1751r185b1785],
12	of	IN	O	of	_	0	SENT_132	[p8l215t1733r270b1785],
13	the	DT	O	the	det	15	SENT_132	[p8l296t1734r383b1785],
14	best	JJS	O	best	amod	15	SENT_132	[p8l415t1734r808b1802],
15	—	NN	O	—	prep_of	11	SENT_132	[p8l415t1734r808b1802],
16	accepted	VBD	O	accept	rcmod	15	SENT_132	[p8l415t1734r808b1802],
17	cases	NNS	O	case	dobj	16	SENT_132	[p8l840t1751r988b1785],
18	of	IN	O	of	_	0	SENT_132	[p8l1019t1733r1075b1785],
19	a	DT	O	a	det	20	SENT_132	[p8l1103t1751r1132b1785],
20	gene	NN	O	gene	prep_of	17	SENT_132	[p8l1162t1751r1297b1802],
21	with	IN	O	with	_	0	SENT_132	[p8l1326t1734r1448b1785],
22	a	DT	O	a	det	24	SENT_132	[p8l1482t1751r1511b1785],
23	pharmacogenetic	JJ	O	pharmacogenetic	amod	24	SENT_132	[p8l1543t1734r1850b1802, p8l9t1818r214b1884],
24	effect	NN	O	effect	prep_with	20	SENT_132	[p8l257t1814r413b1866],
25	from	IN	O	from	_	0	SENT_132	[p8l451t1814r581b1866],
26	its	PRP$	O	its	poss	27	SENT_132	[p8l629t1818r685b1866],
27	variation	NN	O	variation	prep_from	16	SENT_132	[p8l727t1805r1050b1877],
28	,	,	O	,	_	0	SENT_132	[p8l727t1805r1050b1877],
29	”	CD	NUMBER	”	appos	27	SENT_132	[p8l727t1805r1050b1877],
30	both	CC	O	both	prep	29	SENT_132	[p8l1096t1814r1218b1866],
31	having	VBG	O	have	aux	32	SENT_132	[p8l1266t1814r1454b1884],
32	reached	VBN	O	reach	dep	30	SENT_132	[p8l1499t1814r1722b1866],
33	the	DT	O	the	det	34	SENT_132	[p8l1764t1814r1851b1866],
34	standard	NN	O	standard	dobj	32	SENT_132	[p8l9t1894r249b1946],
35	for	IN	O	for	_	0	SENT_132	[p8l278t1894r355b1946],
36	inclusion	NN	O	inclusion	prep_for	34	SENT_132	[p8l386t1894r641b1946],
37	in	IN	O	in	_	0	SENT_132	[p8l675t1898r721b1946],
38	label	NN	O	label	nn	39	SENT_132	[p8l756t1894r886b1946],
39	text	NN	O	text	prep_in	32	SENT_132	[p8l918t1904r1022b1946],
40	by	IN	O	by	_	0	SENT_132	[p8l1050t1894r1116b1963],
41	the	DT	O	the	det	42	SENT_132	[p8l1143t1894r1230b1946],
42	FDA	NNP	ORGANIZATION	FDA	prep_by	32	SENT_132	[p8l1261t1898r1400b1946],
43	.	.	O	.	_	0	SENT_132	[p8l1261t1898r1400b1946],

1	Of	IN	O	of	_	0	SENT_133	[p8l1433t1894r1507b1946],
2	the	DT	O	the	det	4	SENT_133	[p8l1531t1894r1618b1946],
3	various	JJ	O	various	amod	4	SENT_133	[p8l1646t1898r1851b1946],
4	compounds	NNS	O	compound	prep_of	5	SENT_133	[p8l9t1972r343b2041],
5	reported	VBD	O	report	_	0	SENT_133	[p8l372t1972r607b2041],
6	to	TO	O	to	aux	8	SENT_133	[p8l632t1982r685b2024],
7	be	VB	O	be	cop	8	SENT_133	[p8l713t1972r778b2024],
8	subject	JJ	O	subject	xcomp	5	SENT_133	[p8l804t1972r1007b2041],
9	to	TO	O	to	_	0	SENT_133	[p8l1030t1982r1083b2024],
10	UGT1A1	NN	O	ugt1a1	nn	11	SENT_133	[p8l1112t1972r1585b2024],
11	—	NN	O	—	prep_to	8	SENT_133	[p8l1112t1972r1585b2024],
12	related	JJ	O	related	amod	14	SENT_133	[p8l1112t1972r1585b2024],
13	pharmacogenetic	JJ	O	pharmacogenetic	amod	14	SENT_133	[p8l1614t1972r1850b2041, p8l9t2056r284b2122],
14	interactions	NNS	O	interaction	nsubj	5	SENT_133	[p8l315t2056r658b2116],
15	,	,	O	,	_	0	SENT_133	[p8l315t2056r658b2116],
16	the	DT	O	the	det	17	SENT_133	[p8l687t2053r774b2105],
17	effects	NNS	O	effect	appos	14	SENT_133	[p8l800t2053r979b2105],
18	with	IN	O	with	_	0	SENT_133	[p8l1005t2053r1126b2105],
19	nilotinib	NN	O	nilotinib	prep_with	17	SENT_133	[p8l1158t2053r1393b2105],
20	appear	VBP	O	appear	rcmod	19	SENT_133	[p8l1420t2071r1614b2122],
21	to	TO	O	to	_	0	SENT_133	[p8l1638t2063r1692b2105],
22	most	JJS	O	most	prep_to	20	SENT_133	[p8l1719t2063r1853b2105],
23	resemble	VBP	O	resemble	cop	24	SENT_133	[p8l11t2133r266b2185],
24	those	DT	O	those	rcmod	22	SENT_133	[p8l290t2133r440b2185],
25	for	IN	O	for	_	0	SENT_133	[p8l463t2133r540b2185],
26	tranilast	NN	O	tranilast	prep_for	24	SENT_133	[p8l562t2133r802b2196],
27	,	,	O	,	_	0	SENT_133	[p8l562t2133r802b2196],
28	in	IN	O	in	_	0	SENT_133	[p8l834t2136r880b2184],
29	that	DT	O	that	prep_in	24	SENT_133	[p8l906t2133r1014b2185],
30	neither	CC	O	neither	dep	29	SENT_133	[p8l1039t2133r1236b2185],
31	compound	NN	O	compound	conj	29	SENT_133	[p8l1259t2133r1566b2202],
32	is	VBZ	O	be	auxpass	33	SENT_133	[p8l1596t2136r1633b2185],
33	known	VBN	O	know	rcmod	31	SENT_133	[p8l1660t2133r1848b2185],
34	to	TO	O	to	aux	36	SENT_133	[p8l8t2222r61b2264],
35	be	VB	O	be	cop	36	SENT_133	[p8l110t2212r175b2264],
36	subject	JJ	O	subject	xcomp	33	SENT_133	[p8l222t2212r425b2281],
37	to	TO	O	to	_	0	SENT_133	[p8l469t2222r522b2264],
38	glucuronidation	NN	O	glucuronidation	prep_to	36	SENT_133	[p8l569t2212r1022b2281],
39	by	IN	O	by	_	0	SENT_133	[p8l1073t2212r1139b2281],
40	UGT1A1	NN	O	ugt1a1	prep_by	36	SENT_133	[p8l1190t2216r1458b2264],
41	.	.	O	.	_	0	SENT_133	[p8l1190t2216r1458b2264],

1	In	IN	O	in	_	0	SENT_134	[p8l1513t2217r1559b2263],
2	contrast	NN	O	contrast	prep_in	23	SENT_134	[p8l1609t2222r1847b2274],
3	,	,	O	,	_	0	SENT_134	[p8l1609t2222r1847b2274],
4	indinavir	NN	O	indinavir	nsubjpass	23	SENT_134	[p8l12t2292r264b2344],
5	is	VBZ	O	be	auxpass	6	SENT_134	[p8l296t2296r333b2344],
6	thought	VBN	O	think	rcmod	4	SENT_134	[p8l362t2292r582b2362],
7	to	TO	O	to	aux	9	SENT_134	[p8l608t2302r661b2344],
8	be	VB	O	be	auxpass	9	SENT_134	[p8l692t2292r758b2344],
9	metabolized	VBN	O	metabolize	xcomp	6	SENT_134	[p8l790t2292r1141b2344],
10	by	IN	O	by	_	0	SENT_134	[p8l1174t2292r1240b2361],
11	UGT1A1	NN	O	ugt1a1	agent	9	SENT_134	[p8l1273t2283r1602b2355],
12	,	,	O	,	_	0	SENT_134	[p8l1273t2283r1602b2355],
13	lO	NN	O	lo	conj_and	4	SENT_134	[p8l1273t2283r1602b2355],
14	and	CC	O	and	_	0	SENT_134	[p8l1632t2292r1734b2344],
15	the	DT	O	the	det	17	SENT_134	[p8l1764t2292r1851b2344],
16	adverse	JJ	O	adverse	amod	17	SENT_134	[p8l9t2370r225b2422],
17	events	NNS	O	event	conj_and	4	SENT_134	[p8l270t2380r449b2422],
18	associated	VBN	O	associate	partmod	17	SENT_134	[p8l495t2370r788b2422],
19	with	IN	O	with	_	0	SENT_134	[p8l834t2370r956b2422],
20	irinotecan	NN	O	irinotecan	prep_with	18	SENT_134	[p8l1008t2374r1289b2422],
21	are	VBP	O	be	auxpass	23	SENT_134	[p8l1338t2388r1423b2422],
22	explicitly	RB	O	explicitly	advmod	23	SENT_134	[p8l1468t2370r1731b2439],
23	restricted	VBN	O	restrict	_	0	SENT_134	[p8l1779t2388r1851b2422, p8l9t2451r213b2503],
24	by	IN	O	by	_	0	SENT_134	[p8l242t2451r308b2520],
25	glucuronidation	NN	O	glucuronidation	agent	23	SENT_134	[p8l334t2451r787b2520],
26	to	TO	O	to	_	0	SENT_134	[p8l815t2460r868b2503],
27	a	DT	O	a	det	29	SENT_134	[p8l895t2469r924b2503],
28	non	JJ	O	non	amod	29	SENT_134	[p8l953t2454r1222b2503],
29	—	NN	O	—	prep_to	23	SENT_134	[p8l953t2454r1222b2503],
30	toxic	JJ	O	toxic	amod	32	SENT_134	[p8l953t2454r1222b2503],
31	derivative	JJ	O	derivative	amod	32	SENT_134	[p8l1250t2441r1576b2503],
32	.8	NN	NUMBER	.8	dep	29	SENT_134	[p8l1250t2441r1576b2503],

1	The	DT	O	the	det	2	SENT_135	[p8l75t2531r180b2583],
2	mechanism	NN	O	mechanism	nsubj	18	SENT_135	[p8l217t2531r540b2583],
3	by	IN	O	by	_	0	SENT_135	[p8l578t2531r644b2600],
4	which	WDT	O	which	rel	9	SENT_135	[p8l677t2531r850b2583],
5	nilotinib	NN	O	nilotinib	nn	8	SENT_135	[p8l890t2531r1126b2583],
6	and	CC	O	and	_	0	SENT_135	[p8l1161t2531r1263b2583],
7	UGT1A1	NN	O	ugt1a1	nn	8	SENT_135	[p8l1302t2534r1543b2583],
8	genotype	NN	O	genotype	nsubj	9	SENT_135	[p8l1590t2541r1852b2600],
9	interact	VBP	O	interact	rcmod	2	SENT_135	[p8l12t2614r224b2663],
10	to	TO	O	to	aux	11	SENT_135	[p8l253t2621r306b2663],
11	produce	VB	O	produce	xcomp	9	SENT_135	[p8l339t2611r573b2680],
12	an	DT	O	a	det	14	SENT_135	[p8l605t2629r669b2663],
13	increased	VBN	O	increase	amod	14	SENT_135	[p8l707t2611r975b2663],
14	rate	NN	O	rate	dobj	11	SENT_135	[p8l1011t2621r1113b2663],
15	of	IN	O	of	_	0	SENT_135	[p8l1145t2611r1200b2663],
16	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	14	SENT_135	[p8l1232t2611r1778b2680],
17	is	VBZ	O	be	cop	18	SENT_135	[p8l1814t2614r1850b2663],
18	unclear	JJ	O	unclear	_	0	SENT_135	[p8l11t2690r237b2742],
19	.	.	O	.	_	0	SENT_135	[p8l11t2690r237b2742],

1	While	IN	O	while	mark	6	SENT_136	[p8l280t2690r454b2742],
2	preclinical	JJ	O	preclinical	amod	3	SENT_136	[p8l495t2690r793b2759],
3	evaluations	NNS	O	evaluation	nsubj	6	SENT_136	[p8l838t2690r1162b2742],
4	of	IN	O	of	_	0	SENT_136	[p8l1203t2690r1259b2742],
5	nilotinib	JJ	O	nilotinib	prep_of	3	SENT_136	[p8l1299t2690r1535b2742],
6	found	VBN	O	find	advcl	21	SENT_136	[p8l1575t2690r1738b2742],
7	no	DT	O	no	det	8	SENT_136	[p8l1783t2708r1851b2742],
8	indication	NN	O	indication	dobj	6	SENT_136	[p8l12t2769r293b2821],
9	of	IN	O	of	_	0	SENT_136	[p8l323t2769r379b2821],
10	glucuronidation	NN	O	glucuronidation	prep_of	8	SENT_136	[p8l402t2769r855b2838],
11	by	IN	O	by	_	0	SENT_136	[p8l885t2769r951b2837],
12	UGTTAT	NNP	O	UGTTAT	prep_by	6	SENT_136	[p8l981t2772r1250b2831],
13	,	,	O	,	_	0	SENT_136	[p8l981t2772r1250b2831],
14	subsequent	JJ	O	subsequent	amod	15	SENT_136	[p8l1281t2769r1603b2837],
15	analysis	NN	O	analysis	nsubj	21	SENT_136	[p8l1627t2769r1850b2837],
16	(	CD	NUMBER	(	num	18	SENT_136	[p8l10t2847r380b2916],
17	unpublished	JJ	O	unpublished	amod	18	SENT_136	[p8l10t2847r380b2916],
18	results	NNS	O	result	nsubj	19	SENT_136	[p8l413t2847r606b2907],
19	)	VBP	O	)	rcmod	15	SENT_136	[p8l413t2847r606b2907],
20	has	VBZ	O	have	aux	21	SENT_136	[p8l640t2847r730b2899],
21	found	VBN	O	find	_	0	SENT_136	[p8l758t2847r922b2899],
22	that	IN	O	that	complm	24	SENT_136	[p8l951t2847r1059b2899],
23	nilotinib	NN	O	nilotinib	nsubj	24	SENT_136	[p8l1089t2847r1325b2899],
24	inhibits	VBZ	O	inhibit	ccomp	21	SENT_136	[p8l1359t2847r1564b2899],
25	UGT1A1	NN	O	ugt1a1	nn	26	SENT_136	[p8l1598t2851r1838b2899],
26	activity	NN	O	activity	dobj	24	SENT_136	[p8l9t2930r230b2995],
27	,	,	O	,	_	0	SENT_136	[p8l9t2930r230b2995],
28	including	VBG	O	include	_	0	SENT_136	[p8l265t2926r532b2995],
29	glucuronidation	NN	O	glucuronidation	prep_including	26	SENT_136	[p8l559t2926r1011b2995],
30	of	IN	O	of	_	0	SENT_136	[p8l1042t2926r1098b2978],
31	bilirubin	NN	O	bilirubin	prep_of	29	SENT_136	[p8l1124t2926r1381b2978],
32	.	.	O	.	_	0	SENT_136	[p8l1124t2926r1381b2978],

1	One	CD	NUMBER	one	num	2	SENT_137	[p8l1413t2930r1536b2978],
2	possibility	NN	O	possibility	nsubj	3	SENT_137	[p8l1565t2926r1852b2995],
3	is	VBZ	O	be	_	0	SENT_137	[p8l12t3010r49b3059],
4	that	IN	O	that	complm	7	SENT_137	[p8l86t3007r194b3059],
5	this	DT	O	this	det	6	SENT_137	[p8l229t3007r327b3059],
6	inhibition	NN	O	inhibition	nsubj	7	SENT_137	[p8l368t3007r638b3059],
7	pushes	VBZ	O	push	ccomp	3	SENT_137	[p8l680t3007r872b3076],
8	already	RB	O	already	advmod	7	SENT_137	[p8l910t3007r1424b3076],
9	—	RB	O	—	advmod	10	SENT_137	[p8l910t3007r1424b3076],
10	sensitized	VBN	O	sensitize	dep	7	SENT_137	[p8l910t3007r1424b3076],
11	7/7	CD	NUMBER	7/7	num	13	SENT_137	[p8l1466t3010r1551b3059],
12	genotype	NN	O	genotype	nn	13	SENT_137	[p8l1590t3017r1852b3076],
13	patients	NNS	O	patient	dobj	10	SENT_137	[p8l10t3090r229b3156],
14	into	IN	O	into	_	0	SENT_137	[p8l257t3090r362b3139],
15	a	DT	O	a	det	18	SENT_137	[p8l387t3105r416b3139],
16	mild	JJ	O	mild	amod	18	SENT_137	[p8l442t3087r566b3139],
17	hyperbilirubinemic	JJ	O	hyperbilirubinemic	amod	18	SENT_137	[p8l594t3087r1139b3156],
18	state	NN	O	state	prep_into	10	SENT_137	[p8l1165t3096r1292b3139],
19	similar	JJ	O	similar	amod	18	SENT_137	[p8l1317t3087r1508b3139],
20	to	TO	O	to	_	0	SENT_137	[p8l1530t3096r1583b3139],
21	Gilbert	NNP	PERSON	Gilbert	poss	23	SENT_137	[p8l1610t3087r1851b3139],
22	's	POS	O	's	_	0	SENT_137	[p8l1610t3087r1851b3139],
23	syndrome	NN	O	syndrome	prep_to	19	SENT_137	[p8l9t3168r303b3237],
24	.	.	O	.	_	0	SENT_137	[p8l9t3168r303b3237],

1	UGT1A1	NN	O	ugt1a1	nn	2	SENT_138	[p8l618t3483r713b3507],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_138	[p8l726t3484r932b3513],
3	and	CC	O	and	_	0	SENT_138	[p8l942t3484r983b3507],
4	nilotinib	JJ	O	nilotinib	amod	7	SENT_138	[p8l995t3484r1086b3507],
5	safety	NN	O	safety	nn	7	SENT_138	[p8l1096t3483r1163b3513],
6	JB	NN	MISC	jb	nn	7	SENT_138	[p8l1009t3519r1034b3543],
7	Singer	NNP	MISC	Singer	conj_and	2	SENT_138	[p8l1044t3519r1108b3548],
8	et	FW	MISC	et	nn	9	SENT_138	[p8l1116t3520r1136b3542],
9	al	FW	MISC	al	dep	2	SENT_138	[p8l1144t3519r1163b3542],

1	Table	NNP	O	Table	_	0	SENT_139	[p8l168t3614r246b3640],
2	4	CD	NUMBER	4	dep	1	SENT_139	[p8l259t3617r275b3640],

1	Leukemia	NN	O	leukemia	_	0	SENT_140	[p8l1904t3362r2149b3404],

1	Phase	NN	O	phase	nsubj	2	SENT_141	[p8l346t3614r425b3640],
2	II	CD	NUMBER	ii	_	0	SENT_141	[p8l439t3616r461b3646],
3	,	,	O	,	_	0	SENT_141	[p8l439t3616r461b3646],
4	distribution	NN	O	distribution	dobj	2	SENT_141	[p8l477t3614r635b3640],
5	of	IN	O	of	_	0	SENT_141	[p8l649t3614r677b3640],
6	baseline	NN	O	baseline	nn	8	SENT_141	[p8l689t3614r804b3640],
7	total	JJ	O	total	amod	8	SENT_141	[p8l816t3614r876b3640],
8	bilirubin	NN	O	bilirubin	prep_of	4	SENT_141	[p8l891t3614r1009b3640],
9	(	CD	NUMBER	(	num	11	SENT_141	[p8l1024t3614r1139b3647],
10	umol/I	NN	O	umol/i	nn	11	SENT_141	[p8l1024t3614r1139b3647],
11	)	NN	O	)	dep	8	SENT_141	[p8l1024t3614r1139b3647],
12	,	,	O	,	_	0	SENT_141	[p8l1024t3614r1139b3647],
13	age	NN	O	age	appos	8	SENT_141	[p8l1154t3623r1202b3649],
14	and	CC	O	and	_	0	SENT_141	[p8l1215t3614r1266b3640],
15	reported	VBD	O	report	conj_and	2	SENT_141	[p8l1280t3614r1396b3649],
16	race	NN	O	race	dobj	15	SENT_141	[p8l1411t3623r1476b3646],
17	,	,	O	,	_	0	SENT_141	[p8l1411t3623r1476b3646],
18	by	IN	O	by	_	0	SENT_141	[p8l1491t3614r1524b3649],
19	study	NN	O	study	nn	20	SENT_141	[p8l1537t3614r1610b3649],
20	arm	NN	O	arm	prep_by	15	SENT_141	[p8l1623t3623r1675b3640],
21	and	CC	O	and	_	0	SENT_141	[p8l1689t3614r1740b3640],
22	UGTTAT	NN	O	ugttat	nn	23	SENT_141	[p8l1755t3616r1874b3640],
23	genotype	NN	O	genotype	prep_by	15	SENT_141	[p8l1893t3619r2022b3649],

1	(	NN	O	(	dep	16	SENT_142	[p8l646t3709r791b3740],
2	TA	NNP	O	TA	dep	1	SENT_142	[p8l646t3709r791b3740],
3	)	CD	NUMBER	)	num	4	SENT_142	[p8l646t3709r791b3740],
4	s	NNS	O	s	dep	2	SENT_142	[p8l646t3709r791b3740],
5	/	:	O	/	punct	7	SENT_142	[p8l646t3709r791b3740],
6	(	CD	NUMBER	(	num	7	SENT_142	[p8l646t3709r791b3740],
7	W5	NN	O	w5	dep	4	SENT_142	[p8l646t3709r791b3740],
8	(	CD	NUMBER	(	num	11	SENT_142	[p8l886t3709r1031b3740],
9	TA	NNP	O	TA	nn	11	SENT_142	[p8l886t3709r1031b3740],
10	)	CD	NUMBER	)	num	11	SENT_142	[p8l886t3709r1031b3740],
11	s	NNS	O	s	dep	7	SENT_142	[p8l886t3709r1031b3740],
12	/	:	O	/	punct	7	SENT_142	[p8l886t3709r1031b3740],
13	(	CD	NUMBER	(	dep	16	SENT_142	[p8l886t3709r1031b3740],
14	TA	NNP	O	TA	nn	16	SENT_142	[p8l886t3709r1031b3740],
15	)	CD	NUMBER	)	num	16	SENT_142	[p8l886t3709r1031b3740],
16	s	NNS	O	s	dep	29	SENT_142	[p8l886t3709r1031b3740],
17	(	CD	NUMBER	(	dep	16	SENT_142	[p8l1163t3709r1308b3740],
18	We	PRP	O	we	dep	17	SENT_142	[p8l1163t3709r1308b3740],
19	/	:	O	/	punct	21	SENT_142	[p8l1163t3709r1308b3740],
20	(	CD	NUMBER	(	num	21	SENT_142	[p8l1163t3709r1308b3740],
21	TA	NNP	O	TA	dep	18	SENT_142	[p8l1163t3709r1308b3740],
22	)	CD	NUMBER	)	num	21	SENT_142	[p8l1163t3709r1308b3740],
23	7	CD	NUMBER	7	num	24	SENT_142	[p8l1163t3709r1308b3740],
24	(	NN	O	(	dep	21	SENT_142	[p8l1430t3709r1575b3740],
25	73	CD	PERCENT	73	num	26	SENT_142	[p8l1430t3709r1575b3740],
26	%	NN	PERCENT	%	dep	24	SENT_142	[p8l1430t3709r1575b3740],
27	/	:	O	/	punct	21	SENT_142	[p8l1430t3709r1575b3740],
28	(	CD	NUMBER	(	num	29	SENT_142	[p8l1430t3709r1575b3740],
29	T	NN	O	t	_	0	SENT_142	[p8l1430t3709r1575b3740],
30	‘	CD	NUMBER	‘	number	31	SENT_142	[p8l1430t3709r1575b3740],
31	\	CD	NUMBER	\	num	33	SENT_142	[p8l1430t3709r1575b3740],
32	)	NN	O	)	nn	33	SENT_142	[p8l1430t3709r1575b3740],
33	s	NNS	O	s	nsubj	34	SENT_142	[p8l1430t3709r1575b3740],
34	(	VBP	O	(	rcmod	29	SENT_142	[p8l1698t3709r1844b3740],
35	TA	NNP	O	TA	nsubj	42	SENT_142	[p8l1698t3709r1844b3740],
36	)	CD	NUMBER	)	num	35	SENT_142	[p8l1698t3709r1844b3740],
37	/	:	O	/	punct	38	SENT_142	[p8l1698t3709r1844b3740],
38	(	CD	NUMBER	(	dep	35	SENT_142	[p8l1698t3709r1844b3740],
39	7	CD	NUMBER	7	dep	35	SENT_142	[p8l1698t3709r1844b3740],
40	'	''	O	'	_	0	SENT_142	[p8l1698t3709r1844b3740],
41	A	DT	O	a	det	42	SENT_142	[p8l1698t3709r1844b3740],
42	)	NN	O	)	xcomp	34	SENT_142	[p8l1698t3709r1844b3740],
43	7	CD	NUMBER	7	dep	42	SENT_142	[p8l1698t3709r1844b3740],

1	(	NN	O	(	nn	2	SENT_143	[p8l1965t3709r2110b3740],
2	T	NN	O	t	_	0	SENT_143	[p8l1965t3709r2110b3740],
3	/	:	O	/	punct	5	SENT_143	[p8l1965t3709r2110b3740],
4	\	CD	NUMBER	\	num	5	SENT_143	[p8l1965t3709r2110b3740],
5	)	NN	O	)	dep	2	SENT_143	[p8l1965t3709r2110b3740],
6	7	CD	NUMBER	7	dep	5	SENT_143	[p8l1965t3709r2110b3740],
7	/	:	O	/	punct	5	SENT_143	[p8l1965t3709r2110b3740],
8	(	CD	NUMBER	(	num	11	SENT_143	[p8l1965t3709r2110b3740],
9	TA	NNP	O	TA	nn	11	SENT_143	[p8l1965t3709r2110b3740],
10	)	CD	NUMBER	)	num	11	SENT_143	[p8l1965t3709r2110b3740],
11	s	NNS	O	s	dep	2	SENT_143	[p8l1965t3709r2110b3740],

1	C/l/IL	NN	O	c/l/il	_	0	SENT_144	[p9l7t28r151b82],
2	—	CD	NUMBER	—	num	4	SENT_144	[p9l177t58r214b64],
3	chronic	JJ	O	chronic	amod	4	SENT_144	[p9l239t29r464b82],
4	phase	NN	O	phase	dep	1	SENT_144	[p9l486t29r676b95],

1	Number	NN	O	number	_	0	SENT_145	[p9l81t109r326b162],
2	1	CD	NUMBER	1	number	3	SENT_145	[p9l1353t110r1371b161],
3	26	CD	NUMBER	26	dep	1	SENT_145	[p9l1847t109r1922b162],
4	Baseline	NN	O	baseline	nn	7	SENT_145	[p9l81t189r334b242],
5	bilirubin	NN	O	bilirubin	nn	7	SENT_145	[p9l363t189r590b242],
6	(	NN	O	(	nn	7	SENT_145	[p9l621t188r1007b255],
7	meanis	NN	O	meani	dep	3	SENT_145	[p9l621t188r1007b255],
8	.	.	O	.	_	0	SENT_145	[p9l621t188r1007b255],

1	d.	NN	O	d.	nsubj	4	SENT_146	[p9l621t188r1007b255],
2	)	CD	NUMBER	)	num	1	SENT_146	[p9l621t188r1007b255],
3	5.8	CD	NUMBER	5.8	number	4	SENT_146	[p9l1319t190r1414b242],
4	6.4	CD	NUMBER	6.4	_	0	SENT_146	[p9l1753t190r2016b250],
5	i2	NN	O	i2	nn	8	SENT_146	[p9l1753t190r2016b250],
6	.0	CD	NUMBER	.0	num	8	SENT_146	[p9l1753t190r2016b250],
7	Baseline	NN	O	baseline	nn	8	SENT_146	[p9l81t269r334b322],
8	bilirubin	NN	O	bilirubin	dep	4	SENT_146	[p9l363t269r590b322],
9	(	CD	NUMBER	(	num	10	SENT_146	[p9l621t268r760b334],
10	min	NN	DURATION	min	dep	4	SENT_146	[p9l621t268r760b334],
11	,	,	O	,	_	0	SENT_146	[p9l621t268r760b334],
12	med	VBN	O	med	partmod	4	SENT_146	[p9l794t269r941b330],
13	,	,	O	,	_	0	SENT_146	[p9l794t269r941b330],
14	max	NN	O	max	dobj	4	SENT_146	[p9l976t268r1117b334],
15	)	CD	NUMBER	)	num	16	SENT_146	[p9l976t268r1117b334],
16	5.8	CD	NUMBER	5.8	dep	14	SENT_146	[p9l1176t270r1286b330],
17	,	,	O	,	_	0	SENT_146	[p9l1176t270r1286b330],
18	5.8	CD	NUMBER	5.8	appos	16	SENT_146	[p9l1319t270r1430b331],
19	,	,	O	,	_	0	SENT_146	[p9l1319t270r1430b331],
20	5.8	CD	NUMBER	5.8	num	21	SENT_146	[p9l1462t270r1557b322],
21	3.0	CD	NUMBER	3.0	appos	16	SENT_146	[p9l1674t270r1785b330],
22	,	,	O	,	_	0	SENT_146	[p9l1674t270r1785b330],
23	6.7	CD	NUMBER	6.7	appos	16	SENT_146	[p9l1817t270r1927b330],
24	,	,	O	,	_	0	SENT_146	[p9l1817t270r1927b330],
25	10.3	CD	NUMBER	10.3	num	28	SENT_146	[p9l1964t270r2094b322],
26	Age	NN	O	age	nn	28	SENT_146	[p9l76t349r196b415],
27	mean1	NN	O	mean1	nn	28	SENT_146	[p9l225t349r572b410],
28	_	NN	O	_	appos	16	SENT_146	[p9l225t349r572b410],
29	.	.	O	.	_	0	SENT_146	[p9l225t349r572b410],

1	—	NN	O	—	_	0	SENT_147	[p9l225t349r572b410],
2	.	.	O	.	_	0	SENT_147	[p9l225t349r572b410],

1	s.d.	NN	O	s.d.	nn	3	SENT_148	[p9l225t349r572b410],
2	(	CD	NUMBER	(	num	3	SENT_148	[p9l606t348r861b414],
3	median	NN	O	median	dep	18	SENT_148	[p9l606t348r861b414],
4	)	CD	NUMBER	)	number	5	SENT_148	[p9l606t348r861b414],
5	39.0	CD	NUMBER	39.0	dep	3	SENT_148	[p9l1201t349r1336b402],
6	(	NN	O	(	dep	5	SENT_148	[p9l1365t348r1531b414],
7	39.0	CD	NUMBER	39.0	num	6	SENT_148	[p9l1365t348r1531b414],
8	)	CD	NUMBER	)	number	9	SENT_148	[p9l1365t348r1531b414],
9	60.7	CD	NUMBER	60.7	num	10	SENT_148	[p9l1615t349r1957b410],
10	i13	NN	O	i13	dep	5	SENT_148	[p9l1615t349r1957b410],
11	.5	CD	NUMBER	.5	number	12	SENT_148	[p9l1615t349r1957b410],
12	(	CD	NUMBER	(	num	14	SENT_148	[p9l1987t348r2153b414],
13	61.5	CD	NUMBER	61.5	number	14	SENT_148	[p9l1987t348r2153b414],
14	)	CD	NUMBER	)	dep	10	SENT_148	[p9l1987t348r2153b414],
15	Caucasian	JJ	ORGANIZATION	caucasian	amod	16	SENT_148	[p9l78t428r397b482],
16	o	NN	O	o	dep	18	SENT_148	[p9l1349t429r1384b482],
17	24	CD	NUMBER	24	num	18	SENT_148	[p9l1847t429r1922b481],
18	Black	NNP	O	Black	dep	23	SENT_148	[p9l81t509r248b562],
19	1	CD	NUMBER	1	num	18	SENT_148	[p9l1353t510r1371b561],
20	1	CD	NUMBER	1	num	22	SENT_148	[p9l1871t510r1889b561],
21	Other	JJ	O	other	amod	22	SENT_148	[p9l78t588r249b642],
22	o	NN	O	o	dep	18	SENT_148	[p9l1349t590r1384b642],
23	1	CD	NUMBER	1	_	0	SENT_148	[p9l1871t590r1889b641],

1	CML	NN	O	cml	nsubj	3	SENT_149	[p9l7t748r151b802],
2	—	CD	NUMBER	—	num	1	SENT_149	[p9l177t779r214b784],
3	accelerated	VBD	O	accelerate	_	0	SENT_149	[p9l238t749r598b802],
4	phase	NN	O	phase	dobj	3	SENT_149	[p9l617t749r807b815],

1	Number	NN	O	number	nn	2	SENT_150	[p9l81t829r326b882],
2	o	NN	O	o	_	0	SENT_150	[p9l1349t830r1384b882],
3	15	CD	NUMBER	15	num	4	SENT_150	[p9l1852t830r1921b882],
4	Baseline	NN	O	baseline	dep	2	SENT_150	[p9l81t909r334b962],
5	bilirubin	NN	O	bilirubin	nn	7	SENT_150	[p9l363t909r590b962],
6	(	NN	O	(	nn	7	SENT_150	[p9l621t908r1007b975],
7	meanis	NN	O	meani	dep	4	SENT_150	[p9l621t908r1007b975],
8	.	.	O	.	_	0	SENT_150	[p9l621t908r1007b975],

1	d.	NN	O	d.	nsubj	4	SENT_151	[p9l621t908r1007b975],
2	)	CD	NUMBER	)	num	1	SENT_151	[p9l621t908r1007b975],
3	—	CD	NUMBER	—	number	4	SENT_151	[p9l1330t941r1403b944],
4	9.2	CD	NUMBER	9.2	_	0	SENT_151	[p9l1752t910r2016b970],
5	J_r3	NN	O	j_r3	nn	8	SENT_151	[p9l1752t910r2016b970],
6	.9	CD	NUMBER	.9	num	8	SENT_151	[p9l1752t910r2016b970],
7	Baseline	NN	O	baseline	nn	8	SENT_151	[p9l81t989r334b1042],
8	bilirubin	NN	O	bilirubin	dep	4	SENT_151	[p9l363t989r590b1042],
9	(	CD	NUMBER	(	num	10	SENT_151	[p9l621t988r760b1054],
10	min	NN	DURATION	min	dep	4	SENT_151	[p9l621t988r760b1054],
11	,	,	O	,	_	0	SENT_151	[p9l621t988r760b1054],
12	med	VBN	O	med	partmod	4	SENT_151	[p9l794t989r941b1050],
13	,	,	O	,	_	0	SENT_151	[p9l794t989r941b1050],
14	max	NN	O	max	dobj	4	SENT_151	[p9l976t988r1117b1054],
15	)	CD	NUMBER	)	num	14	SENT_151	[p9l976t988r1117b1054],
16	—	NN	O	—	dep	14	SENT_151	[p9l1330t1021r1403b1024],
17	5.1	CD	NUMBER	5.1	num	16	SENT_151	[p9l1674t990r1785b1050],
18	,	,	O	,	_	0	SENT_151	[p9l1674t990r1785b1050],
19	7.9	CD	NUMBER	7.9	appos	16	SENT_151	[p9l1818t989r1927b1050],
20	,	,	O	,	_	0	SENT_151	[p9l1818t989r1927b1050],
21	19.8	CD	NUMBER	19.8	num	23	SENT_151	[p9l1964t989r2095b1042],
22	Age	NN	O	age	nn	23	SENT_151	[p9l76t1069r196b1136],
23	meanis	NN	O	meani	appos	16	SENT_151	[p9l225t1069r572b1130],
24	.	.	O	.	_	0	SENT_151	[p9l225t1069r572b1130],

1	d.	NN	O	d.	dep	11	SENT_152	[p9l225t1069r572b1130],
2	(	CD	NUMBER	(	num	1	SENT_152	[p9l606t1068r861b1135],
3	median	NN	O	median	dep	1	SENT_152	[p9l606t1068r861b1135],
4	)	CD	NUMBER	)	num	3	SENT_152	[p9l606t1068r861b1135],
5	—	CD	NUMBER	—	number	6	SENT_152	[p9l1330t1101r1403b1104],
6	60.7	CD	NUMBER	60.7	num	7	SENT_152	[p9l1615t1070r1957b1130],
7	i15	NN	O	i15	dep	3	SENT_152	[p9l1615t1070r1957b1130],
8	.3	NN	NUMBER	.3	dep	11	SENT_152	[p9l1615t1070r1957b1130],
9	(	CD	NUMBER	(	num	8	SENT_152	[p9l1987t1068r2153b1135],
10	64.0	CD	NUMBER	64.0	num	11	SENT_152	[p9l1987t1068r2153b1135],
11	)	CD	NUMBER	)	dep	16	SENT_152	[p9l1987t1068r2153b1135],
12	Caucasian	JJ	ORGANIZATION	caucasian	amod	13	SENT_152	[p9l78t1148r397b1202],
13	o	NN	O	o	dep	11	SENT_152	[p9l1349t1150r1384b1202],
14	11	CD	NUMBER	11	num	16	SENT_152	[p9l1852t1150r1909b1201],
15	Black	JJ	O	black	amod	16	SENT_152	[p9l81t1229r248b1282],
16	o	NN	O	o	dep	24	SENT_152	[p9l1349t1229r1384b1282],
17	2	CD	NUMBER	2	num	19	SENT_152	[p9l1867t1229r1900b1281],
18	Asian	JJ	MISC	asian	amod	19	SENT_152	[p9l76t1309r240b1362],
19	o	NN	O	o	dep	16	SENT_152	[p9l1349t1310r1384b1362],
20	2	CD	NUMBER	2	number	21	SENT_152	[p9l1867t1310r1900b1361],
21	28	CD	NUMBER	28	num	23	SENT_152	[p9l228t1397r299b1446],
22	1	CD	NUMBER	1	number	23	SENT_152	[p9l801t1398r818b1446],
23	6	CD	NUMBER	6	dep	19	SENT_152	[p9l1347t1397r1381b1446],
24	o	NN	O	o	dep	26	SENT_152	[p9l1897t1397r1931b1447],
25	8.4	CD	NUMBER	8.4	num	24	SENT_152	[p9l138t1483r389b1540],
26	i3	NN	O	i3	dep	33	SENT_152	[p9l138t1483r389b1540],
27	.0	CD	NUMBER	.0	num	26	SENT_152	[p9l138t1483r389b1540],
28	10.3	CD	NUMBER	10.3	number	29	SENT_152	[p9l753t1483r877b1532],
29	17.7	CD	NUMBER	17.7	dep	26	SENT_152	[p9l1205t1483r1527b1540],
30	i10	NN	O	i10	nn	31	SENT_152	[p9l1205t1483r1527b1540],
31	.3	NN	NUMBER	.3	dep	29	SENT_152	[p9l1205t1483r1527b1540],
32	—	CD	NUMBER	—	num	33	SENT_152	[p9l1879t1513r1949b1515],
33	3.4	CD	NUMBER	3.4	dep	50	SENT_152	[p9l63t1559r168b1616],
34	,	,	O	,	_	0	SENT_152	[p9l63t1559r168b1616],
35	8.6	CD	NUMBER	8.6	appos	33	SENT_152	[p9l199t1559r304b1617],
36	,	,	O	,	_	0	SENT_152	[p9l199t1559r304b1617],
37	18.8	CD	NUMBER	18.8	num	38	SENT_152	[p9l340t1559r464b1609],
38	10.3	CD	NUMBER	10.3	appos	33	SENT_152	[p9l580t1559r718b1616],
39	,	,	O	,	_	0	SENT_152	[p9l580t1559r718b1616],
40	10.3	CD	NUMBER	10.3	appos	33	SENT_152	[p9l753t1559r892b1617],
41	,	,	O	,	_	0	SENT_152	[p9l753t1559r892b1617],
42	10.3	CD	NUMBER	10.3	num	43	SENT_152	[p9l927t1559r1051b1609],
43	6.8	CD	NUMBER	6.8	appos	33	SENT_152	[p9l1145t1559r1249b1617],
44	,	,	O	,	_	0	SENT_152	[p9l1145t1559r1249b1617],
45	14.8	CD	NUMBER	14.8	appos	33	SENT_152	[p9l1285t1559r1424b1617],
46	,	,	O	,	_	0	SENT_152	[p9l1285t1559r1424b1617],
47	36.0	CD	NUMBER	36.0	num	48	SENT_152	[p9l1455t1559r1583b1609],
48	—	CD	NUMBER	—	appos	33	SENT_152	[p9l1879t1589r1949b1592],
49	55.9	CD	NUMBER	55.9	num	50	SENT_152	[p9l7t1635r334b1693],
50	i12	NN	O	i12	dep	54	SENT_152	[p9l7t1635r334b1693],
51	.0	CD	NUMBER	.0	num	52	SENT_152	[p9l7t1635r334b1693],
52	(	CD	NUMBER	(	dep	50	SENT_152	[p9l361t1634r519b1697],
53	57.0	CD	NUMBER	57.0	num	54	SENT_152	[p9l361t1634r519b1697],
54	)	NN	O	)	dep	60	SENT_152	[p9l361t1634r519b1697],
55	45.0	CD	NUMBER	45.0	number	56	SENT_152	[p9l655t1635r784b1685],
56	(	CD	NUMBER	(	dep	54	SENT_152	[p9l812t1634r971b1697],
57	45.0	CD	NUMBER	45.0	num	58	SENT_152	[p9l812t1634r971b1697],
58	)	NN	O	)	dep	56	SENT_152	[p9l812t1634r971b1697],
59	56.3	CD	NUMBER	56.3	num	60	SENT_152	[p9l1107t1635r1422b1693],
60	i16	NN	O	i16	dep	67	SENT_152	[p9l1107t1635r1422b1693],
61	.1	CD	NUMBER	.1	number	62	SENT_152	[p9l1107t1635r1422b1693],
62	(	CD	NUMBER	(	dep	60	SENT_152	[p9l1461t1634r1620b1697],
63	59.0	CD	NUMBER	59.0	num	64	SENT_152	[p9l1461t1634r1620b1697],
64	)	NN	O	)	dep	62	SENT_152	[p9l1461t1634r1620b1697],
65	—	CD	NUMBER	—	num	67	SENT_152	[p9l1879t1666r1949b1668],
66	25	CD	NUMBER	25	num	67	SENT_152	[p9l228t1721r298b1771],
67	o	NN	O	o	dep	77	SENT_152	[p9l797t1721r831b1771],
68	6	CD	NUMBER	6	num	69	SENT_152	[p9l1347t1721r1381b1770],
69	o	NN	O	o	dep	67	SENT_152	[p9l1897t1721r1931b1771],
70	3	CD	NUMBER	3	number	71	SENT_152	[p9l246t1807r280b1856],
71	1	CD	NUMBER	1	num	73	SENT_152	[p9l801t1807r818b1855],
72	o	NN	O	o	nn	73	SENT_152	[p9l1347t1807r1381b1856],
73	o	NN	O	o	dep	69	SENT_152	[p9l1897t1807r1931b1856],
74	o	NN	O	o	nn	77	SENT_152	[p9l246t1892r281b1941],
75	o	NN	O	o	nn	77	SENT_152	[p9l797t1892r831b1941],
76	o	NN	O	o	nn	77	SENT_152	[p9l1347t1892r1381b1941],
77	o	NN	O	o	_	0	SENT_152	[p9l1897t1892r1931b1941],

1	7.2	CD	NUMBER	7.2	num	2	SENT_153	[p9l139t2173r388b2229],
2	i2	NN	O	i2	_	0	SENT_153	[p9l139t2173r388b2229],
3	.7	CD	NUMBER	.7	number	4	SENT_153	[p9l139t2173r388b2229],
4	10.3	CD	NUMBER	10.3	dep	2	SENT_153	[p9l753t2173r877b2222],
5	144153	CD	NUMBER	144153	num	6	SENT_153	[p9l1223t2173r1508b2229],
6	23.9	CD	NUMBER	23.9	dep	4	SENT_153	[p9l1850t2173r1978b2222],

1	3.4	CD	NUMBER	3.4	dep	26	SENT_154	[p9l63t2249r168b2306],
2	,	,	O	,	_	0	SENT_154	[p9l63t2249r168b2306],
3	7.7	CD	NUMBER	7.7	appos	1	SENT_154	[p9l200t2250r305b2306],
4	,	,	O	,	_	0	SENT_154	[p9l200t2250r305b2306],
5	12.0	CD	NUMBER	12.0	num	6	SENT_154	[p9l340t2249r464b2298],
6	10.3	CD	NUMBER	10.3	appos	1	SENT_154	[p9l580t2249r718b2306],
7	,	,	O	,	_	0	SENT_154	[p9l580t2249r718b2306],
8	10.3	CD	NUMBER	10.3	appos	1	SENT_154	[p9l753t2249r892b2306],
9	,	,	O	,	_	0	SENT_154	[p9l753t2249r892b2306],
10	10.3	CD	NUMBER	10.3	num	11	SENT_154	[p9l927t2249r1051b2298],
11	7.9	CD	NUMBER	7.9	appos	1	SENT_154	[p9l1145t2249r1249b2306],
12	,	,	O	,	_	0	SENT_154	[p9l1145t2249r1249b2306],
13	15.4	CD	NUMBER	15.4	appos	1	SENT_154	[p9l1285t2249r1424b2306],
14	,	,	O	,	_	0	SENT_154	[p9l1285t2249r1424b2306],
15	20.5	CD	NUMBER	20.5	num	16	SENT_154	[p9l1455t2249r1582b2298],
16	23.9	CD	NUMBER	23.9	appos	1	SENT_154	[p9l1676t2249r1819b2306],
17	,	,	O	,	_	0	SENT_154	[p9l1676t2249r1819b2306],
18	23.9	CD	NUMBER	23.9	appos	1	SENT_154	[p9l1850t2249r1993b2306],
19	,	,	O	,	_	0	SENT_154	[p9l1850t2249r1993b2306],
20	23.9	CD	NUMBER	23.9	num	21	SENT_154	[p9l2024t2249r2152b2298],
21	62.6	CD	NUMBER	62.6	appos	1	SENT_154	[p9l25t2325r314b2382],
22	i8	NN	O	i8	dep	26	SENT_154	[p9l25t2325r314b2382],
23	.9	CD	NUMBER	.9	num	22	SENT_154	[p9l25t2325r314b2382],
24	(	CD	NUMBER	(	num	26	SENT_154	[p9l342t2323r501b2387],
25	63.5	CD	NUMBER	63.5	num	26	SENT_154	[p9l342t2323r501b2387],
26	)	NN	O	)	dep	32	SENT_154	[p9l342t2323r501b2387],
27	54.0	CD	NUMBER	54.0	number	28	SENT_154	[p9l656t2325r784b2375],
28	(	CD	NUMBER	(	dep	26	SENT_154	[p9l812t2323r971b2387],
29	54.0	CD	NUMBER	54.0	num	30	SENT_154	[p9l812t2323r971b2387],
30	)	NN	O	)	dep	28	SENT_154	[p9l812t2323r971b2387],
31	60.5	CD	NUMBER	60.5	num	32	SENT_154	[p9l1126t2325r1414b2382],
32	i9	NN	O	i9	dep	34	SENT_154	[p9l1126t2325r1414b2382],
33	.7	CD	NUMBER	.7	num	34	SENT_154	[p9l1126t2325r1414b2382],
34	(	CD	NUMBER	(	dep	40	SENT_154	[p9l1442t2323r1601b2387],
35	60.0	CD	NUMBER	60.0	num	36	SENT_154	[p9l1442t2323r1601b2387],
36	)	NN	O	)	dep	34	SENT_154	[p9l1442t2323r1601b2387],
37	28.0	CD	NUMBER	28.0	number	38	SENT_154	[p9l1756t2325r1885b2375],
38	(	CD	NUMBER	(	dep	36	SENT_154	[p9l1912t2323r2071b2387],
39	28.0	CD	NUMBER	28.0	num	40	SENT_154	[p9l1912t2323r2071b2387],
40	)	NN	O	)	_	0	SENT_154	[p9l1912t2323r2071b2387],

1	1	CD	NUMBER	1	number	2	SENT_155	[p9l232t2410r250b2458],
2	5	CD	NUMBER	5	num	3	SENT_155	[p9l266t2411r298b2459],
3	O	NN	O	o	_	0	SENT_155	[p9l797t2410r831b2459],
4	5	CD	NUMBER	5	num	5	SENT_155	[p9l1347t2411r1380b2459],
5	o	NN	O	o	dep	3	SENT_155	[p9l1897t2410r1931b2459],
6	1	CD	NUMBER	1	num	7	SENT_155	[p9l251t2487r268b2535],
7	1	CD	NUMBER	1	dep	3	SENT_155	[p9l801t2487r818b2535],
8	1	CD	NUMBER	1	number	9	SENT_155	[p9l1351t2487r1369b2535],
9	1	CD	NUMBER	1	num	13	SENT_155	[p9l1901t2487r1919b2535],
10	o	NN	O	o	nn	13	SENT_155	[p9l246t2552r281b2601],
11	o	NN	O	o	nn	13	SENT_155	[p9l797t2552r831b2601],
12	o	NN	O	o	nn	13	SENT_155	[p9l1347t2552r1381b2601],
13	o	NN	O	o	dep	7	SENT_155	[p9l1897t2552r1931b2601],

1	Table	NNP	O	Table	_	0	SENT_156	[p9l46t2696r124b2722],
2	5	CD	NUMBER	5	num	1	SENT_156	[p9l137t2699r152b2722],
3	Phase	NN	O	phase	dep	1	SENT_156	[p9l223t2696r303b2722],
4	II	CD	NUMBER	ii	num	3	SENT_156	[p9l317t2698r340b2727],
5	,	,	O	,	_	0	SENT_156	[p9l317t2698r340b2727],
6	descriptive	JJ	O	descriptive	amod	14	SENT_156	[p9l355t2696r508b2730],
7	statistics	NNS	O	statistics	dep	6	SENT_156	[p9l520t2698r636b2722],
8	of	IN	O	of	_	0	SENT_156	[p9l649t2696r676b2722],
9	the	DT	O	the	det	11	SENT_156	[p9l687t2696r730b2722],
10	post-treatment	JJ	O	post-treatment	amod	11	SENT_156	[p9l744t2701r946b2730],
11	maximum	NN	O	maximum	prep_of	7	SENT_156	[p9l959t2698r1099b2722],
12	within-patient	JJ	O	within-patient	amod	14	SENT_156	[p9l1112t2696r1311b2730],
13	total	JJ	O	total	amod	14	SENT_156	[p9l1322t2696r1382b2722],
14	bilirubin	NN	O	bilirubin	appos	3	SENT_156	[p9l1397t2696r1515b2722],
15	by	IN	O	by	_	0	SENT_156	[p9l1530t2696r1563b2730],
16	UGT1A1	NN	O	ugt1a1	nn	17	SENT_156	[p9l1577t2698r1696b2722],
17	genotype	NN	O	genotype	prep_by	14	SENT_156	[p9l1715t2701r1851b2730],
18	,	,	O	,	_	0	SENT_156	[p9l1715t2701r1851b2730],
19	by	IN	O	by	_	0	SENT_156	[p9l1866t2696r1899b2730],
20	study	NN	O	study	nn	21	SENT_156	[p9l1912t2696r1985b2730],
21	arm	NN	O	arm	prep_by	3	SENT_156	[p9l1998t2705r2050b2722],

1	Genotype	NN	O	genotype	nn	3	SENT_157	[p9l9t2845r312b2914],
2	Number	NNP	O	Number	nn	3	SENT_157	[p9l543t2846r802b2901],
3	Mean	NN	O	mean	_	0	SENT_157	[p9l942t2846r1116b2901],
4	i	FW	O	i	nn	7	SENT_157	[p9l1133t2853r1180b2909],
5	s.	FW	O	s.	nn	7	SENT_157	[p9l1191t2860r1236b2901],
6	o	NN	O	o	nn	7	SENT_157	[p9l1248t2846r1299b2901],
7	’	NN	O	’	dep	3	SENT_157	[p9l1248t2846r1299b2901],
8	.	.	O	.	_	0	SENT_157	[p9l1248t2846r1299b2901],

1	Median	JJ	O	median	amod	2	SENT_158	[p9l1453t2846r1684b2901],
2	Minimum	NNP	O	Minimum	_	0	SENT_158	[p9l1831t2846r2119b2901],

1	CML	NN	O	cml	_	0	SENT_159	[p9l9t3000r157b3054],
2	—	CD	NUMBER	—	num	4	SENT_159	[p9l184t3031r221b3035],
3	chronic	JJ	O	chronic	amod	4	SENT_159	[p9l247t3001r477b3055],
4	phase	NN	O	phase	dep	1	SENT_159	[p9l500t3001r695b3067],

1	(	NN	O	(	nn	3	SENT_160	[p9l83t3091r396b3160],
2	l'	NN	O	l'	nn	3	SENT_160	[p9l83t3091r396b3160],
3	A	NN	O	a	_	0	SENT_160	[p9l83t3091r396b3160],
4	)	CD	NUMBER	)	number	5	SENT_160	[p9l83t3091r396b3160],
5	5	CD	NUMBER	5	dep	3	SENT_160	[p9l83t3091r396b3160],
6	/	:	O	/	punct	20	SENT_160	[p9l83t3091r396b3160],
7	(	CD	NUMBER	(	num	8	SENT_160	[p9l83t3091r396b3160],
8	TA	NNP	O	TA	dep	16	SENT_160	[p9l83t3091r396b3160],
9	)	CD	NUMBER	)	num	8	SENT_160	[p9l83t3091r396b3160],
10	5	CD	NUMBER	5	dep	8	SENT_160	[p9l83t3091r396b3160],
11	1	CD	NUMBER	1	number	12	SENT_160	[p9l677t3093r696b3146],
12	13.7	CD	NUMBER	13.7	num	14	SENT_160	[p9l1061t3093r1193b3147],
13	13.7	CD	NUMBER	13.7	number	14	SENT_160	[p9l1507t3093r1639b3147],
14	13.7	CD	NUMBER	13.7	dep	10	SENT_160	[p9l1913t3093r2045b3147],
15	(	CD	NUMBER	(	dep	16	SENT_160	[p9l83t3181r397b3248],
16	|	NN	O	|	dep	20	SENT_160	[p9l83t3181r397b3248],
17	'	''	O	'	_	0	SENT_160	[p9l83t3181r397b3248],
18	A	DT	O	a	det	19	SENT_160	[p9l83t3181r397b3248],
19	)	NN	O	)	dep	16	SENT_160	[p9l83t3181r397b3248],
20	6	CD	NUMBER	6	dep	5	SENT_160	[p9l83t3181r397b3248],
21	/	:	O	/	punct	20	SENT_160	[p9l83t3181r397b3248],
22	(	CD	NUMBER	(	num	23	SENT_160	[p9l83t3181r397b3248],
23	TA	NNP	O	TA	dep	28	SENT_160	[p9l83t3181r397b3248],
24	)	CD	NUMBER	)	num	23	SENT_160	[p9l83t3181r397b3248],
25	5	CD	NUMBER	5	dep	23	SENT_160	[p9l83t3181r397b3248],
26	26	CD	NUMBER	26	dep	28	SENT_160	[p9l632t3183r709b3236],
27	18.8	CD	NUMBER	18.8	num	28	SENT_160	[p9l975t3183r1281b3244],
28	i5	NN	O	i5	dep	35	SENT_160	[p9l975t3183r1281b3244],
29	.9	CD	NUMBER	.9	number	30	SENT_160	[p9l975t3183r1281b3244],
30	17.6	CD	NUMBER	17.6	num	32	SENT_160	[p9l1507t3183r1640b3236],
31	10	CD	NUMBER	10	number	32	SENT_160	[p9l1913t3183r1985b3236],
32	(	CD	NUMBER	(	dep	28	SENT_160	[p9l83t3271r396b3338],
33	TA	NNP	O	TA	dep	32	SENT_160	[p9l83t3271r396b3338],
34	)	CD	NUMBER	)	num	35	SENT_160	[p9l83t3271r396b3338],
35	5	CD	NUMBER	5	dep	20	SENT_160	[p9l83t3271r396b3338],
36	/	:	O	/	punct	35	SENT_160	[p9l83t3271r396b3338],
37	(	CD	NUMBER	(	num	39	SENT_160	[p9l83t3271r396b3338],
38	TA	NNP	O	TA	nn	39	SENT_160	[p9l83t3271r396b3338],
39	)	NN	O	)	dep	44	SENT_160	[p9l83t3271r396b3338],
40	7	CD	NUMBER	7	num	41	SENT_160	[p9l83t3271r396b3338],
41	28	CD	NUMBER	28	dep	39	SENT_160	[p9l632t3272r709b3326],
42	29.3	CD	NUMBER	29.3	num	43	SENT_160	[p9l951t3272r1300b3334],
43	i21	NN	O	i21	dep	44	SENT_160	[p9l951t3272r1300b3334],
44	.7	CD	NUMBER	.7	dep	50	SENT_160	[p9l951t3272r1300b3334],
45	22.8	CD	NUMBER	22.8	number	46	SENT_160	[p9l1502t3272r1640b3325],
46	6.8	CD	NUMBER	6.8	dep	44	SENT_160	[p9l1950t3272r2046b3325],
47	(	CD	NUMBER	(	num	49	SENT_160	[p9l83t3362r397b3431],
48	FA	NN	O	fa	nn	49	SENT_160	[p9l83t3362r397b3431],
49	)	NN	O	)	dep	46	SENT_160	[p9l83t3362r397b3431],
50	6	CD	NUMBER	6	dep	35	SENT_160	[p9l83t3362r397b3431],
51	/	:	O	/	punct	50	SENT_160	[p9l83t3362r397b3431],
52	(	CD	NUMBER	(	dep	55	SENT_160	[p9l83t3362r397b3431],
53	TA	NNP	O	TA	dep	52	SENT_160	[p9l83t3362r397b3431],
54	)	CD	NUMBER	)	dep	55	SENT_160	[p9l83t3362r397b3431],
55	8	CD	NUMBER	8	dep	63	SENT_160	[p9l83t3362r397b3431],
56	1	CD	NUMBER	1	number	57	SENT_160	[p9l677t3364r696b3417],
57	29.1	CD	NUMBER	29.1	num	59	SENT_160	[p9l1057t3364r1182b3418],
58	29.1	CD	NUMBER	29.1	number	59	SENT_160	[p9l1502t3364r1627b3418],
59	29.1	CD	NUMBER	29.1	dep	55	SENT_160	[p9l1909t3364r2034b3418],
60	(	CD	NUMBER	(	num	62	SENT_160	[p9l83t3452r396b3519],
61	FA	NN	O	fa	nn	62	SENT_160	[p9l83t3452r396b3519],
62	)	NN	O	)	dep	59	SENT_160	[p9l83t3452r396b3519],
63	7	CD	NUMBER	7	dep	50	SENT_160	[p9l83t3452r396b3519],
64	/	:	O	/	punct	3	SENT_160	[p9l83t3452r396b3519],
65	(	CD	NUMBER	(	num	67	SENT_160	[p9l83t3452r396b3519],
66	TA	NNP	O	TA	nn	67	SENT_160	[p9l83t3452r396b3519],
67	)	NN	O	)	dep	3	SENT_160	[p9l83t3452r396b3519],
68	7	CD	NUMBER	7	num	71	SENT_160	[p9l83t3452r396b3519],
69	3	CD	NUMBER	3	number	70	SENT_160	[p9l672t3454r709b3507],
70	59.3	CD	NUMBER	59.3	amod	71	SENT_160	[p9l951t3454r1302b3515],
71	i23	NN	O	i23	dep	67	SENT_160	[p9l951t3454r1302b3515],
72	.	.	O	.	_	0	SENT_160	[p9l951t3454r1302b3515],

1	o	NN	O	o	nsubj	12	SENT_161	[p9l951t3454r1302b3515],
2	57.4	CD	NUMBER	57.4	number	3	SENT_161	[p9l1502t3454r1640b3507],
3	22.2	CD	NUMBER	22.2	num	5	SENT_161	[p9l1909t3454r2045b3506],
4	(	NN	O	(	nn	5	SENT_161	[p9l83t3529r397b3596],
5	W7	NN	O	w7	dep	1	SENT_161	[p9l83t3529r397b3596],
6	/	:	O	/	punct	9	SENT_161	[p9l83t3529r397b3596],
7	(	CD	NUMBER	(	num	9	SENT_161	[p9l83t3529r397b3596],
8	FA	NN	O	fa	nn	9	SENT_161	[p9l83t3529r397b3596],
9	)	NN	O	)	dep	1	SENT_161	[p9l83t3529r397b3596],
10	s	VBZ	O	s	cop	12	SENT_161	[p9l83t3529r397b3596],
11	—	CD	NUMBER	—	num	12	SENT_161	[p9l632t3562r708b3565],
12	—	NN	O	—	_	0	SENT_161	[p9l1089t3562r1163b3565],

1	CML	NN	O	cml	nsubj	3	SENT_162	[p10l9t55r157b111],
2	—	CD	NUMBER	—	num	1	SENT_162	[p10l184t87r221b92],
3	accelerated	VBD	O	accelerate	_	0	SENT_162	[p10l246t56r615b111],
4	phase	NN	O	phase	dobj	3	SENT_162	[p10l634t56r829b124],

1	Cl	NN	O	cl	nn	2	SENT_163	[p10l83t134r139b201],
2	A	NN	O	a	dep	89	SENT_163	[p10l133t134r253b201],
3	)	CD	NUMBER	)	number	4	SENT_163	[p10l133t134r253b201],
4	5	CD	NUMBER	5	dep	2	SENT_163	[p10l133t134r253b201],
5	/	:	O	/	punct	17	SENT_163	[p10l133t134r253b201],
6	(	CD	NUMBER	(	num	7	SENT_163	[p10l255t134r311b201],
7	T	NN	O	t	dep	15	SENT_163	[p10l255t134r311b201],
8	A	DT	O	a	det	11	SENT_163	[p10l304t134r396b201],
9	)	NN	O	)	nn	11	SENT_163	[p10l304t134r396b201],
10	5	CD	NUMBER	5	num	11	SENT_163	[p10l304t134r396b201],
11	~	NN	O	~	dep	7	SENT_163	[p10l1089t168r1163b170],
12	~	NN	O	~	dep	15	SENT_163	[p10l1534t168r1608b170],
13	—	CD	NUMBER	—	num	12	SENT_163	[p10l1940t168r2015b170],
14	(	CD	NUMBER	(	num	15	SENT_163	[p10l83t215r397b282],
15	FA	NN	O	fa	dep	17	SENT_163	[p10l83t215r397b282],
16	)	NN	O	)	dep	15	SENT_163	[p10l83t215r397b282],
17	6	CD	NUMBER	6	dep	4	SENT_163	[p10l83t215r397b282],
18	/	:	O	/	punct	17	SENT_163	[p10l83t215r397b282],
19	(	CD	NUMBER	(	num	20	SENT_163	[p10l83t215r397b282],
20	TA	NNP	O	TA	dep	25	SENT_163	[p10l83t215r397b282],
21	)	CD	NUMBER	)	num	20	SENT_163	[p10l83t215r397b282],
22	6	CD	NUMBER	6	num	23	SENT_163	[p10l83t215r397b282],
23	15	CD	NUMBER	15	dep	20	SENT_163	[p10l637t217r708b269],
24	33.4	CD	NUMBER	33.4	dep	25	SENT_163	[p10l951t216r1088b269],
25	i	FW	O	i	dep	33	SENT_163	[p10l1102t222r1149b278],
26	29.7	CD	NUMBER	29.7	number	27	SENT_163	[p10l1164t216r1300b269],
27	21	CD	NUMBER	21	num	29	SENT_163	[p10l1502t216r1566b269],
28	1	CD	NUMBER	1	number	29	SENT_163	[p10l1913t217r1932b269],
29	1	CD	NUMBER	1	dep	25	SENT_163	[p10l1953t217r1972b269],
30	(	NN	O	(	nn	31	SENT_163	[p10l83t310r396b379],
31	iA	NN	O	ia	dep	29	SENT_163	[p10l83t310r396b379],
32	)	CD	NUMBER	)	num	33	SENT_163	[p10l83t310r396b379],
33	5	CD	NUMBER	5	dep	17	SENT_163	[p10l83t310r396b379],
34	/	:	O	/	punct	33	SENT_163	[p10l83t310r396b379],
35	(	CD	NUMBER	(	num	37	SENT_163	[p10l83t310r396b379],
36	TA	NNP	O	TA	nn	37	SENT_163	[p10l83t310r396b379],
37	)	NN	O	)	dep	44	SENT_163	[p10l83t310r396b379],
38	7	CD	NUMBER	7	number	39	SENT_163	[p10l83t310r396b379],
39	14	CD	NUMBER	14	dep	37	SENT_163	[p10l637t312r709b365],
40	22.4	CD	NUMBER	22.4	dep	39	SENT_163	[p10l970t312r1268b374],
41	i9	NN	O	i9	dep	44	SENT_163	[p10l970t312r1268b374],
42	.1	CD	NUMBER	.1	num	41	SENT_163	[p10l970t312r1268b374],
43	20.5	CD	NUMBER	20.5	num	44	SENT_163	[p10l1502t312r1639b366],
44	13.7	CD	NUMBER	13.7	dep	48	SENT_163	[p10l1913t312r2045b366],
45	(	CD	NUMBER	(	num	47	SENT_163	[p10l83t403r397b470],
46	FA	NN	O	fa	nn	47	SENT_163	[p10l83t403r397b470],
47	)	NN	O	)	dep	44	SENT_163	[p10l83t403r397b470],
48	5	CD	NUMBER	5	dep	33	SENT_163	[p10l83t403r397b470],
49	/	:	O	/	punct	48	SENT_163	[p10l83t403r397b470],
50	(	CD	NUMBER	(	num	51	SENT_163	[p10l83t403r397b470],
51	TA	NNP	O	TA	dep	59	SENT_163	[p10l83t403r397b470],
52	)	CD	NUMBER	)	num	51	SENT_163	[p10l83t403r397b470],
53	8	CD	NUMBER	8	number	54	SENT_163	[p10l83t403r397b470],
54	1	CD	NUMBER	1	dep	51	SENT_163	[p10l677t405r696b457],
55	18.8	CD	NUMBER	18.8	num	56	SENT_163	[p10l1061t405r1195b458],
56	18.8	CD	NUMBER	18.8	dep	54	SENT_163	[p10l1507t405r1640b458],
57	18.8	CD	NUMBER	18.8	dep	59	SENT_163	[p10l1913t405r2046b458],
58	(	CD	NUMBER	(	num	59	SENT_163	[p10l83t498r396b567],
59	FA	NN	O	fa	dep	61	SENT_163	[p10l83t498r396b567],
60	)	NN	O	)	dep	59	SENT_163	[p10l83t498r396b567],
61	7	CD	NUMBER	7	dep	48	SENT_163	[p10l83t498r396b567],
62	/	:	O	/	punct	61	SENT_163	[p10l83t498r396b567],
63	(	CD	NUMBER	(	num	65	SENT_163	[p10l83t498r396b567],
64	iA	NN	O	ia	nn	65	SENT_163	[p10l83t498r396b567],
65	)	NN	O	)	dep	69	SENT_163	[p10l83t498r396b567],
66	7	CD	NUMBER	7	num	67	SENT_163	[p10l83t498r396b567],
67	6	CD	NUMBER	6	dep	65	SENT_163	[p10l672t500r709b554],
68	66.9	CD	NUMBER	66.9	dep	69	SENT_163	[p10l951t500r1088b554],
69	i	FW	O	i	dep	75	SENT_163	[p10l1102t506r1149b562],
70	41.6	CD	NUMBER	41.6	number	71	SENT_163	[p10l1164t500r1302b554],
71	60.5	CD	NUMBER	60.5	dep	69	SENT_163	[p10l1503t500r1639b554],
72	23.9	CD	NUMBER	23.9	num	74	SENT_163	[p10l1909t500r2046b554],
73	(	CD	NUMBER	(	num	74	SENT_163	[p10l83t591r397b658],
74	FA	NN	O	fa	dep	71	SENT_163	[p10l83t591r397b658],
75	)	NN	O	)	dep	78	SENT_163	[p10l83t591r397b658],
76	7	CD	NUMBER	7	num	75	SENT_163	[p10l83t591r397b658],
77	/	:	O	/	punct	78	SENT_163	[p10l83t591r397b658],
78	(	CD	NUMBER	(	dep	61	SENT_163	[p10l83t591r397b658],
79	TA	NNP	O	TA	nn	87	SENT_163	[p10l83t591r397b658],
80	)	CD	NUMBER	)	num	87	SENT_163	[p10l83t591r397b658],
81	8	CD	NUMBER	8	num	87	SENT_163	[p10l83t591r397b658],
82	1	CD	NUMBER	1	num	87	SENT_163	[p10l677t593r696b645],
83	25.7	CD	NUMBER	25.7	num	87	SENT_163	[p10l1057t592r1193b645],
84	25.7	CD	NUMBER	25.7	num	87	SENT_163	[p10l1502t592r1639b645],
85	25.7	CD	NUMBER	25.7	num	87	SENT_163	[p10l1909t592r2045b645],
86	Maximum	NNP	O	Maximum	nn	87	SENT_163	[p10l108t690r379b738],
87	Grade	NNP	O	Grade	dep	4	SENT_163	[p10l512t689r681b738],
88	o	NN	O	o	dep	89	SENT_163	[p10l706t691r739b738],
89	Grade	NNP	O	Grade	dep	93	SENT_163	[p10l870t689r1039b738],
90	7	CD	NUMBER	7	num	89	SENT_163	[p10l1070t691r1089b737],
91	Grade	NNP	O	Grade	dep	89	SENT_163	[p10l1227t689r1396b738],
92	2	CD	NUMBER	2	num	91	SENT_163	[p10l1418t691r1454b737],
93	Grade	NNP	O	Grade	_	0	SENT_163	[p10l1584t689r1754b738],
94	3	CD	NUMBER	3	num	93	SENT_163	[p10l1777t691r1811b738],
95	Missing	VBG	O	miss	rcmod	93	SENT_163	[p10l1940t690r2152b751],

1	13.7	CD	NUMBER	13.7	num	3	SENT_164	[p10l207t904r323b951],
2	1	CD	NUMBER	1	num	3	SENT_164	[p10l631t904r648b950],
3	o	NN	O	o	dep	16	SENT_164	[p10l966t904r999b951],
4	O	NN	O	o	nn	6	SENT_164	[p10l1324t904r1356b951],
5	O	NN	O	o	nn	6	SENT_164	[p10l1681t904r1714b951],
6	O	NN	O	o	dep	3	SENT_164	[p10l2030t904r2062b951],
7	32.5	CD	NUMBER	32.5	number	8	SENT_164	[p10l203t977r324b1024],
8	17	CD	NUMBER	17	num	10	SENT_164	[p10l595t977r658b1023],
9	5	CD	NUMBER	5	number	10	SENT_164	[p10l967t977r998b1024],
10	4	CD	NUMBER	4	dep	6	SENT_164	[p10l1323t977r1356b1023],
11	O	NN	O	o	nn	12	SENT_164	[p10l1681t977r1714b1024],
12	O	NN	O	o	dep	16	SENT_164	[p10l2030t977r2062b1024],
13	106	CD	NUMBER	106	number	14	SENT_164	[p10l171t1057r271b1105],
14	10	CD	NUMBER	10	num	16	SENT_164	[p10l595t1057r659b1105],
15	9	CD	NUMBER	9	number	16	SENT_164	[p10l966t1057r998b1105],
16	7	CD	NUMBER	7	dep	18	SENT_164	[p10l1325t1058r1355b1104],
17	2	CD	NUMBER	2	dep	16	SENT_164	[p10l1681t1057r1712b1104],
18	O	NN	O	o	dep	20	SENT_164	[p10l2030t1057r2062b1105],
19	29.1	CD	NUMBER	29.1	num	18	SENT_164	[p10l203t1139r313b1186],
20	o	NN	O	o	dep	24	SENT_164	[p10l627t1139r659b1186],
21	1	CD	NUMBER	1	num	20	SENT_164	[p10l970t1139r987b1185],
22	O	NN	ORGANIZATION	o	nn	24	SENT_164	[p10l1324t1139r1356b1186],
23	O	NN	ORGANIZATION	o	nn	24	SENT_164	[p10l1681t1139r1714b1186],
24	O	NN	ORGANIZATION	o	dep	27	SENT_164	[p10l2030t1139r2062b1186],
25	91	CD	NUMBER	91	num	26	SENT_164	[p10l203t1220r260b1267],
26	1	CD	NUMBER	1	dep	24	SENT_164	[p10l631t1220r648b1266],
27	o	NN	O	o	dep	30	SENT_164	[p10l966t1220r999b1267],
28	1	CD	NUMBER	1	num	27	SENT_164	[p10l1328t1220r1344b1266],
29	4	CD	NUMBER	4	num	30	SENT_164	[p10l1681t1220r1713b1266],
30	o	NN	O	o	_	0	SENT_164	[p10l2030t1220r2062b1267],

1	107.7	CD	NUMBER	107.7	number	2	SENT_165	[p10l171t1515r323b1563],
2	6	CD	NUMBER	6	num	4	SENT_165	[p10l627t1515r659b1563],
3	5	CD	NUMBER	5	number	4	SENT_165	[p10l967t1516r998b1563],
4	2	CD	NUMBER	2	dep	11	SENT_165	[p10l1324t1515r1354b1562],
5	2	CD	NUMBER	2	dep	4	SENT_165	[p10l1682t1515r1712b1562],
6	O	NN	O	o	dep	11	SENT_165	[p10l2030t1515r2062b1563],
7	41	CD	NUMBER	41	num	6	SENT_165	[p10l202t1597r260b1643],
8	7	CD	NUMBER	7	num	11	SENT_165	[p10l628t1598r658b1643],
9	4	CD	NUMBER	4	number	10	SENT_165	[p10l966t1597r998b1643],
10	3	CD	NUMBER	3	amod	11	SENT_165	[p10l1324t1597r1355b1644],
11	o	NN	O	o	dep	14	SENT_165	[p10l1681t1597r1714b1644],
12	2	CD	NUMBER	2	dep	11	SENT_165	[p10l2030t1597r2061b1643],
13	18.8	CD	NUMBER	18.8	num	14	SENT_165	[p10l206t1678r325b1725],
14	o	NN	O	o	dep	20	SENT_165	[p10l627t1678r659b1725],
15	1	CD	NUMBER	1	num	18	SENT_165	[p10l970t1678r987b1724],
16	O	NN	ORGANIZATION	o	nn	18	SENT_165	[p10l1324t1678r1356b1725],
17	O	NN	ORGANIZATION	o	nn	18	SENT_165	[p10l1681t1678r1714b1725],
18	o	NN	O	o	dep	14	SENT_165	[p10l2030t1678r2062b1725],
19	136.8	CD	NUMBER	136.8	num	20	SENT_165	[p10l171t1759r324b1806],
20	o	NN	O	o	dep	26	SENT_165	[p10l627t1759r659b1806],
21	1	CD	NUMBER	1	number	22	SENT_165	[p10l970t1759r987b1805],
22	2	CD	NUMBER	2	dep	20	SENT_165	[p10l1324t1759r1354b1805],
23	3	CD	NUMBER	3	num	24	SENT_165	[p10l1681t1759r1713b1806],
24	O	NN	O	o	dep	22	SENT_165	[p10l2030t1759r2062b1806],
25	25.7	CD	NUMBER	25.7	num	26	SENT_165	[p10l203t1839r323b1887],
26	o	NN	O	o	_	0	SENT_165	[p10l627t1839r659b1887],
27	1	CD	NUMBER	1	num	30	SENT_165	[p10l970t1840r987b1886],
28	O	NN	O	o	nn	30	SENT_165	[p10l1324t1839r1356b1887],
29	O	NN	O	o	nn	30	SENT_165	[p10l1681t1839r1714b1887],
30	o	NN	O	o	dep	26	SENT_165	[p10l2030t1839r2062b1887],

1	Results	NNS	O	result	_	0	SENT_166	[p10l48t1925r150b1950],
2	(	CD	NUMBER	(	dep	1	SENT_166	[p10l161t1925r190b1956],
3	in	IN	O	in	_	0	SENT_166	[p10l161t1925r190b1956],
4	umol/l	JJ	O	umol/l	amod	5	SENT_166	[p10l202t1925r296b1956],
5	)	NN	O	)	prep_in	2	SENT_166	[p10l202t1925r296b1956],
6	and	CC	O	and	_	0	SENT_166	[p10l307t1925r359b1950],
7	CTCAE	NN	O	ctca	nn	8	SENT_166	[p10l370t1925r475b1950],
8	grades	NNS	O	grade	prep_in	2	SENT_166	[p10l485t1925r588b1956],
9	.	.	O	.	_	0	SENT_166	[p10l485t1925r588b1956],

1	For	IN	O	for	_	0	SENT_167	[p10l603t1925r647b1950],
2	each	DT	O	each	det	3	SENT_167	[p10l657t1925r724b1950],
3	patient	NN	O	patient	prep_for	19	SENT_167	[p10l736t1925r838b1956],
4	,	,	O	,	_	0	SENT_167	[p10l736t1925r838b1956],
5	the	DT	O	the	det	8	SENT_167	[p10l850t1925r894b1950],
6	maximal	JJ	O	maximal	amod	8	SENT_167	[p10l906t1925r1020b1950],
7	total	JJ	O	total	amod	8	SENT_167	[p10l1031t1925r1091b1950],
8	bilirubin	NN	O	bilirubin	nsubjpass	19	SENT_167	[p10l1103t1925r1209b1950],
9	and	CC	O	and	_	0	SENT_167	[p10l1221t1925r1272b1950],
10	CTCAE	NN	O	ctca	nn	11	SENT_167	[p10l1284t1925r1388b1950],
11	grade	NN	O	grade	nsubjpass	19	SENT_167	[p10l1399t1925r1480b1956],
12	after	IN	O	after	_	0	SENT_167	[p10l1490t1925r1553b1950],
13	the	DT	O	the	det	15	SENT_167	[p10l1561t1925r1606b1950],
14	first	JJ	ORDINAL	first	amod	15	SENT_167	[p10l1615t1925r1666b1950],
15	dose	NN	O	dose	prep_after	8	SENT_167	[p10l1676t1925r1745b1950],
16	of	IN	O	of	_	0	SENT_167	[p10l1756t1925r1783b1950],
17	treatment	NN	O	treatment	prep_of	15	SENT_167	[p10l1791t1927r1927b1950],
18	is	VBZ	O	be	auxpass	19	SENT_167	[p10l1938t1925r1958b1950],
19	used	VBN	O	use	_	0	SENT_167	[p10l1969t1925r2044b1950],
20	.	.	O	.	_	0	SENT_167	[p10l1969t1925r2044b1950],

1	Two	CD	NUMBER	two	num	3	SENT_168	[p10l2056t1925r2113b1950],
2	6/7	CD	NUMBER	6/7	num	3	SENT_168	[p10l47t1971r92b1996],
3	patients	NNS	O	patient	nsubj	10	SENT_168	[p10l106t1971r217b2002],
4	in	IN	O	in	_	0	SENT_168	[p10l230t1971r251b1996],
5	the	DT	O	the	det	7	SENT_168	[p10l264t1971r308b1996],
6	AP	NN	O	ap	nn	7	SENT_168	[p10l320t1971r361b1996],
7	arm	NN	O	arm	prep_in	3	SENT_168	[p10l373t1977r426b1996],
8	did	VBD	O	do	aux	10	SENT_168	[p10l439t1971r481b1996],
9	not	RB	O	not	neg	10	SENT_168	[p10l495t1973r539b1996],
10	have	VB	O	have	_	0	SENT_168	[p10l552t1971r618b1996],
11	post	NN	O	post	dobj	10	SENT_168	[p10l631t1971r821b2002],
12	—	RB	O	—	advmod	15	SENT_168	[p10l631t1971r821b2002],
13	baseline	NN	O	baseline	nn	15	SENT_168	[p10l631t1971r821b2002],
14	bilirubin	NN	O	bilirubin	nn	15	SENT_168	[p10l834t1971r940b1996],
15	data	NNS	O	datum	dep	11	SENT_168	[p10l954t1971r1016b1996],
16	available	JJ	O	available	amod	15	SENT_168	[p10l1028t1971r1155b1996],
17	.	.	O	.	_	0	SENT_168	[p10l1028t1971r1155b1996],

1	Table	NNP	O	Table	_	0	SENT_169	[p10l46t2015r124b2041],
2	6	CD	NUMBER	6	num	1	SENT_169	[p10l138t2018r154b2041],
3	Phase	NN	O	phase	dep	1	SENT_169	[p10l223t2015r303b2041],
4	II	CD	NUMBER	ii	num	3	SENT_169	[p10l317t2017r339b2047],
5	,	,	O	,	_	0	SENT_169	[p10l317t2017r339b2047],
6	relative	JJ	O	relative	amod	8	SENT_169	[p10l356t2015r458b2041],
7	risk	NN	O	risk	nn	8	SENT_169	[p10l472t2015r519b2041],
8	calculations	NNS	O	calculation	appos	3	SENT_169	[p10l531t2015r700b2041],
9	for	IN	O	for	_	0	SENT_169	[p10l713t2015r751b2041],
10	prevalence	NN	O	prevalence	prep_for	8	SENT_169	[p10l764t2015r918b2050],
11	of	IN	O	of	_	0	SENT_169	[p10l931t2015r958b2041],
12	maximum	NN	O	maximum	nn	14	SENT_169	[p10l970t2017r1110b2041],
13	total	JJ	O	total	amod	14	SENT_169	[p10l1123t2015r1183b2041],
14	bilirubin	NN	O	bilirubin	prep_of	10	SENT_169	[p10l1198t2015r1316b2041],
15	>	JJR	O	>	amod	14	SENT_169	[p10l1335t2015r1450b2044],
16	Grade	NNP	O	Grade	dep	1	SENT_169	[p10l1335t2015r1450b2044],
17	3	CD	NUMBER	3	num	16	SENT_169	[p10l1462t2018r1476b2041],

1	CML	NN	O	cml	_	0	SENT_170	[p10l986t2163r1131b2216],
2	—	CD	NUMBER	—	num	4	SENT_170	[p10l1157t2193r1194b2198],
3	chronic	JJ	O	chronic	amod	4	SENT_170	[p10l1219t2164r1445b2216],
4	phase	NN	O	phase	dep	1	SENT_170	[p10l1467t2164r1658b2229],

1	Max	NNP	O	Max	nn	2	SENT_171	[p10l525t2315r659b2367],
2	grade	NN	O	grade	_	0	SENT_171	[p10l678t2315r856b2381],
3	<	JJR	O	<	dep	2	SENT_171	[p10l894t2315r990b2374],
4	2	CD	NUMBER	2	number	5	SENT_171	[p10l894t2315r990b2374],
5	Max	NN	O	max	num	6	SENT_171	[p10l1249t2315r1383b2368],
6	grade	NN	O	grade	npadvmod	7	SENT_171	[p10l1403t2315r1581b2381],
7	>	JJR	O	>	dep	3	SENT_171	[p10l1619t2315r1715b2374],
8	3	CD	NUMBER	3	dep	7	SENT_171	[p10l1619t2315r1715b2374],
9	Total	JJ	O	total	amod	7	SENT_171	[p10l1979t2315r2121b2368],

1	Non	JJ	O	non	amod	2	SENT_172	[p10l12t2625r265b2678],
2	—	NN	O	—	_	0	SENT_172	[p10l12t2625r265b2678],
3	7/7	CD	NUMBER	7/7	number	4	SENT_172	[p10l12t2625r265b2678],
4	52	CD	NUMBER	52	dep	2	SENT_172	[p10l721t2626r795b2678],
5	2	CD	NUMBER	2	num	6	SENT_172	[p10l1465t2626r1499b2677],
6	54	CD	NUMBER	54	dep	4	SENT_172	[p10l2009t2627r2084b2678],

1	Total	JJ	O	total	_	0	SENT_173	[p10l7t2785r148b2838],
2	54	CD	NUMBER	54	number	3	SENT_173	[p10l721t2786r796b2838],
3	6	CD	NUMBER	6	dep	1	SENT_173	[p10l1465t2786r1501b2838],
4	60	CD	NUMBER	60	dep	3	SENT_173	[p10l2009t2786r2084b2838],

1	Relative	JJ	O	relative	amod	2	SENT_174	[p10l463t2946r700b2999],
2	risk	NN	O	risk	_	0	SENT_174	[p10l724t2946r893b2999],
3	:	:	O	:	_	0	SENT_174	[p10l724t2946r893b2999],
4	18.0	CD	NUMBER	18.0	dep	2	SENT_174	[p10l917t2947r1057b3008],
5	,	,	O	,	_	0	SENT_174	[p10l917t2947r1057b3008],
6	95	CD	PERCENT	95	number	7	SENT_174	[p10l1091t2946r1226b3000],
7	%	NN	PERCENT	%	amod	8	SENT_174	[p10l1091t2946r1226b3000],
8	Cl	NN	O	cl	appos	4	SENT_174	[p10l1256t2945r1321b2999],
9	(	CD	NUMBER	(	number	10	SENT_174	[p10l1348t2945r1413b3012],
10	4	CD	NUMBER	4	num	8	SENT_174	[p10l1348t2945r1413b3012],
11	.	.	O	.	_	0	SENT_174	[p10l1348t2945r1413b3012],

1	7	CD	NUMBER	7	_	0	SENT_175	[p10l1433t2947r1473b3008],
2	,	,	O	,	_	0	SENT_175	[p10l1433t2947r1473b3008],
3	78.5	CD	NUMBER	78.5	num	4	SENT_175	[p10l1514t2945r1661b3012],
4	)	NN	O	)	appos	1	SENT_175	[p10l1514t2945r1661b3012],

1	Total	JJ	O	total	_	0	SENT_176	[p10l7t3387r148b3440],
2	28	CD	NUMBER	28	number	3	SENT_176	[p10l721t3388r796b3440],
3	6	CD	NUMBER	6	dep	1	SENT_176	[p10l1465t3388r1501b3440],
4	34	CD	NUMBER	34	dep	3	SENT_176	[p10l2009t3388r2084b3440],

1	Relative	JJ	O	relative	amod	2	SENT_177	[p10l482t3549r720b3602],
2	risi	NN	O	risus	_	0	SENT_177	[p10l745t3549r977b3602],
3	<	JJR	O	<	dep	2	SENT_177	[p10l745t3549r977b3602],
4	=	JJ	O	=	dep	2	SENT_177	[p10l745t3549r977b3602],
5	9	CD	NUMBER	9	dep	4	SENT_177	[p10l745t3549r977b3602],
6	.	.	O	.	_	0	SENT_177	[p10l745t3549r977b3602],

1	3	CD	NUMBER	3	_	0	SENT_178	[p10l988t3549r1037b3610],
2	,	,	O	,	_	0	SENT_178	[p10l988t3549r1037b3610],
3	95	CD	PERCENT	95	number	4	SENT_178	[p10l1072t3548r1206b3603],
4	%	NN	PERCENT	%	amod	5	SENT_178	[p10l1072t3548r1206b3603],
5	CI	NN	O	ci	appos	1	SENT_178	[p10l1236t3548r1302b3602],
6	(	CD	NUMBER	(	num	7	SENT_178	[p10l1328t3548r1453b3614],
7	2.2	CD	NUMBER	2.2	dep	1	SENT_178	[p10l1328t3548r1453b3614],
8	,	,	O	,	_	0	SENT_178	[p10l1328t3548r1453b3614],
9	39.8	CD	NUMBER	39.8	num	10	SENT_178	[p10l1487t3548r1641b3614],
10	)	NN	O	)	appos	7	SENT_178	[p10l1487t3548r1641b3614],

1	Total	JJ	O	total	_	0	SENT_179	[p11l7t207r148b260],
2	52	CD	NUMBER	52	number	3	SENT_179	[p11l721t208r795b260],
3	2	CD	NUMBER	2	dep	1	SENT_179	[p11l1465t208r1499b259],
4	54	CD	NUMBER	54	dep	3	SENT_179	[p11l2009t208r2084b260],

1	CML	NN	O	cml	nsubj	3	SENT_180	[p11l1049t471r1183b520],
2	—	CD	NUMBER	—	num	1	SENT_180	[p11l1207t499r1241b503],
3	accelerated	VBD	O	accelerate	_	0	SENT_180	[p11l1262t472r1595b520],
4	phase	NN	O	phase	dobj	3	SENT_180	[p11l1612t472r1787b532],

1	Max	NNP	O	Max	nn	2	SENT_181	[p11l686t614r810b663],
2	grade	NN	O	grade	_	0	SENT_181	[p11l828t614r991b675],
3	<	JJR	O	<	dep	2	SENT_181	[p11l1026t614r1114b669],
4	2	CD	NUMBER	2	number	5	SENT_181	[p11l1026t614r1114b669],
5	Max	NN	O	max	num	6	SENT_181	[p11l1352t614r1475b662],
6	grade	NN	O	grade	npadvmod	7	SENT_181	[p11l1493t614r1656b675],
7	>	JJR	O	>	dep	3	SENT_181	[p11l1691t614r1779b669],
8	3	CD	NUMBER	3	dep	7	SENT_181	[p11l1691t614r1779b669],
9	Total	JJ	O	total	amod	7	SENT_181	[p11l2022t614r2152b663],

1	Non	JJ	O	non	amod	2	SENT_182	[p11l216t929r448b978],
2	—	NN	O	—	_	0	SENT_182	[p11l216t929r448b978],
3	7/7	CD	NUMBER	7/7	number	4	SENT_182	[p11l216t929r448b978],
4	27	CD	NUMBER	27	dep	2	SENT_182	[p11l867t930r935b977],
5	2	CD	NUMBER	2	num	6	SENT_182	[p11l1550t930r1581b977],
6	29	CD	NUMBER	29	dep	4	SENT_182	[p11l2049t930r2118b978],

1	Total	JJ	O	total	_	0	SENT_183	[p11l264t1077r393b1126],
2	30	CD	NUMBER	30	number	3	SENT_183	[p11l866t1078r936b1126],
3	5	CD	NUMBER	5	dep	1	SENT_183	[p11l1550t1078r1582b1126],
4	35	CD	NUMBER	35	dep	3	SENT_183	[p11l2049t1078r2118b1126],

1	Relative	JJ	O	relative	amod	2	SENT_184	[p11l648t1225r866b1274],
2	risk	NN	O	risk	_	0	SENT_184	[p11l888t1225r1043b1274],
3	:	:	O	:	_	0	SENT_184	[p11l888t1225r1043b1274],
4	7.3	CD	NUMBER	7.3	dep	2	SENT_184	[p11l1063t1226r1157b1282],
5	,	,	O	,	_	0	SENT_184	[p11l1063t1226r1157b1282],
6	95	CD	PERCENT	95	number	7	SENT_184	[p11l1189t1225r1312b1275],
7	%	NN	PERCENT	%	amod	8	SENT_184	[p11l1189t1225r1312b1275],
8	CI	NN	O	ci	appos	4	SENT_184	[p11l1340t1224r1400b1274],
9	(	CD	NUMBER	(	number	10	SENT_184	[p11l1424t1224r1539b1286],
10	1.5	CD	NUMBER	1.5	num	8	SENT_184	[p11l1424t1224r1539b1286],
11	,	,	O	,	_	0	SENT_184	[p11l1424t1224r1539b1286],
12	34.4	CD	NUMBER	34.4	num	13	SENT_184	[p11l1571t1224r1711b1286],
13	)	NN	O	)	appos	8	SENT_184	[p11l1571t1224r1711b1286],

1	Total	JJ	O	total	_	0	SENT_185	[p11l264t2156r393b2205],
2	27	CD	NUMBER	27	number	3	SENT_185	[p11l867t2157r935b2204],
3	2	CD	NUMBER	2	dep	1	SENT_185	[p11l1550t2157r1581b2204],
4	29	CD	NUMBER	29	dep	3	SENT_185	[p11l2049t2157r2118b2205],

1	Abbreviation	NN	O	abbreviation	_	0	SENT_186	[p11l168t2301r351b2326],
2	:	:	O	:	_	0	SENT_186	[p11l168t2301r351b2326],
3	CI	NN	O	ci	dep	1	SENT_186	[p11l366t2301r402b2330],
4	,	,	O	,	_	0	SENT_186	[p11l366t2301r402b2330],
5	confidence	NN	O	confidence	nn	6	SENT_186	[p11l417t2301r573b2326],
6	interval	NN	O	interval	appos	3	SENT_186	[p11l586t2301r690b2326],
7	.	.	O	.	_	0	SENT_186	[p11l586t2301r690b2326],

1	‘	NN	O	‘	_	0	SENT_187	[p11l171t2340r222b2356],
2	.	.	O	.	_	0	SENT_187	[p11l171t2340r222b2356],

1	—	NN	O	—	_	0	SENT_188	[p11l171t2340r222b2356],
2	.	.	O	.	_	0	SENT_188	[p11l171t2340r222b2356],

1	‘	NN	O	‘	nsubj	2	SENT_189	[p11l171t2340r222b2356],
2	indicates	VBZ	O	indicate	_	0	SENT_189	[p11l238t2340r362b2364],
3	a	DT	O	a	det	5	SENT_189	[p11l375t2346r391b2364],
4	relative	JJ	O	relative	amod	5	SENT_189	[p11l404t2340r501b2364],
5	risk	NN	O	risk	dobj	2	SENT_189	[p11l514t2340r561b2364],
6	that	WDT	O	that	nsubjpass	10	SENT_189	[p11l572t2340r626b2364],
7	could	MD	O	could	aux	10	SENT_189	[p11l639t2340r715b2364],
8	not	RB	O	not	neg	10	SENT_189	[p11l729t2341r773b2364],
9	be	VB	O	be	auxpass	10	SENT_189	[p11l786t2340r820b2364],
10	calculated	VBN	O	calculate	rcmod	5	SENT_189	[p11l833t2340r975b2364],
11	owing	VBG	O	owe	xcomp	10	SENT_189	[p11l989t2340r1072b2370],
12	to	TO	O	to	_	0	SENT_189	[p11l1084t2341r1111b2364],
13	absence	NN	O	absence	prep_to	11	SENT_189	[p11l1124t2340r1244b2364],
14	of	IN	O	of	_	0	SENT_189	[p11l1257t2340r1283b2364],
15	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	13	SENT_189	[p11l1295t2340r1551b2370],
16	in	IN	O	in	_	0	SENT_189	[p11l1564t2340r1584b2364],
17	a	DT	O	a	det	20	SENT_189	[p11l1598t2346r1614b2364],
18	given	VBN	O	give	amod	20	SENT_189	[p11l1626t2340r1699b2370],
19	genetic	JJ	O	genetic	amod	20	SENT_189	[p11l1712t2340r1814b2370],
20	cohort	NN	O	cohort	prep_in	11	SENT_189	[p11l1827t2340r1924b2364],
21	.	.	O	.	_	0	SENT_189	[p11l1827t2340r1924b2364],

1	Leukemia	NN	O	leukemia	_	0	SENT_190	[p11l6t2414r138b2437],

1	Only	RB	O	only	advmod	14	SENT_191	[p11l86t2599r250b2679],
2	the	DT	O	the	det	4	SENT_191	[p11l282t2599r383b2660],
3	(	CD	NUMBER	(	num	4	SENT_191	[p11l418t2603r582b2672],
4	TA	NNP	O	TA	nsubjpass	14	SENT_191	[p11l418t2603r582b2672],
5	)	CD	NUMBER	)	number	6	SENT_191	[p11l418t2603r582b2672],
6	6	CD	NUMBER	6	dep	4	SENT_191	[p11l418t2603r582b2672],
7	and	CC	O	and	_	0	SENT_191	[p11l617t2599r735b2660],
8	(	CD	NUMBER	(	num	10	SENT_191	[p11l772t2603r937b2671],
9	TA	NNP	O	TA	nn	10	SENT_191	[p11l772t2603r937b2671],
10	)	NN	O	)	nsubjpass	14	SENT_191	[p11l772t2603r937b2671],
11	;	:	O	;	_	0	SENT_191	[p11l772t2603r937b2671],
12	alleles	NNS	O	allele	dep	10	SENT_191	[p11l971t2599r1179b2660],
13	were	VBD	O	be	auxpass	14	SENT_191	[p11l1212t2620r1373b2660],
14	used	VBN	O	use	_	0	SENT_191	[p11l1410t2599r1556b2660],
15	for	IN	O	for	_	0	SENT_191	[p11l1589t2599r1678b2660],
16	pharmacoge	NN	O	pharmacoge	nn	19	SENT_191	[p11l1711t2599r2147b2680],
17	—	NN	O	—	nn	19	SENT_191	[p11l1711t2599r2147b2680],
18	netic	JJ	O	netic	amod	19	SENT_191	[p11l10t2696r167b2753],
19	analysis	NN	O	analysis	prep_for	14	SENT_191	[p11l208t2692r485b2772],
20	,	,	O	,	_	0	SENT_191	[p11l208t2692r485b2772],
21	as	IN	O	as	mark	33	SENT_191	[p11l530t2713r593b2753],
22	patients	NNS	O	patient	nsubjpass	33	SENT_191	[p11l635t2696r889b2772],
23	with	IN	O	with	_	0	SENT_191	[p11l929t2692r1070b2753],
24	at	IN	O	at	quantmod	26	SENT_191	[p11l1113t2704r1171b2753],
25	least	JJS	O	least	mwe	24	SENT_191	[p11l1213t2692r1359b2753],
26	one	CD	NUMBER	one	num	27	SENT_191	[p11l1397t2713r1518b2753],
27	copy	NN	O	copy	prep_with	22	SENT_191	[p11l1557t2713r1717b2772],
28	of	IN	O	of	_	0	SENT_191	[p11l1757t2692r1821b2753],
29	the	DT	O	the	det	31	SENT_191	[p11l1856t2692r1957b2753],
30	rarer	JJR	O	rarer	amod	31	SENT_191	[p11l2000t2713r2149b2753],
31	alleles	NNS	O	allele	prep_of	27	SENT_191	[p11l8t2783r216b2843],
32	were	VBD	O	be	auxpass	33	SENT_191	[p11l255t2804r416b2843],
33	excluded	VBN	O	exclude	advcl	14	SENT_191	[p11l456t2783r758b2843],
34	from	IN	O	from	_	0	SENT_191	[p11l798t2783r948b2843],
35	the	DT	O	the	det	38	SENT_191	[p11l989t2783r1090b2843],
36	relative	JJ	O	relative	amod	38	SENT_191	[p11l1133t2783r1374b2843],
37	risk	NN	O	risk	nn	38	SENT_191	[p11l1416t2783r1527b2843],
38	calculations	NNS	O	calculation	prep_from	33	SENT_191	[p11l1566t2783r1983b2843],
39	.	.	O	.	_	0	SENT_191	[p11l1566t2783r1983b2843],

1	The	DT	O	the	det	2	SENT_192	[p11l2026t2783r2148b2843],
2	number	NN	O	number	nsubj	8	SENT_192	[p11l10t2875r264b2935],
3	of	IN	O	of	_	0	SENT_192	[p11l290t2875r354b2935],
4	such	JJ	O	such	amod	5	SENT_192	[p11l377t2875r525b2935],
5	cases	NNS	O	case	prep_of	2	SENT_192	[p11l556t2896r728b2935],
6	was	VBD	O	be	cop	8	SENT_192	[p11l755t2896r881b2935],
7	too	RB	O	too	advmod	8	SENT_192	[p11l907t2887r1012b2935],
8	small	JJ	O	small	_	0	SENT_192	[p11l1039t2875r1208b2935],
9	to	TO	O	to	aux	10	SENT_192	[p11l1239t2887r1300b2935],
10	allow	VB	O	allow	xcomp	8	SENT_192	[p11l1328t2875r1511b2935],
11	them	PRP	O	they	nsubjpass	14	SENT_192	[p11l1536t2875r1699b2935],
12	to	TO	O	to	aux	14	SENT_192	[p11l1728t2887r1790b2935],
13	be	VB	O	be	auxpass	14	SENT_192	[p11l1819t2875r1895b2935],
14	treated	VBN	O	treat	xcomp	10	SENT_192	[p11l1920t2875r2146b2935],
15	as	IN	O	as	_	0	SENT_192	[p11l8t2990r72b3030],
16	independent	JJ	O	independent	amod	18	SENT_192	[p11l134t2969r548b3049],
17	genotype	NN	O	genotype	nn	18	SENT_192	[p11l604t2980r908b3049],
18	classes	NNS	O	class	prep_as	14	SENT_192	[p11l966t2969r1208b3042],
19	,	,	O	,	_	0	SENT_192	[p11l966t2969r1208b3042],
20	and	CC	O	and	_	0	SENT_192	[p11l1272t2969r1391b3030],
21	the	DT	O	the	det	22	SENT_192	[p11l1450t2969r1551b3030],
22	details	NNS	O	detail	nsubj	31	SENT_192	[p11l1610t2969r1822b3030],
23	of	IN	O	of	_	0	SENT_192	[p11l1881t2969r1945b3030],
24	their	PRP$	O	they	poss	26	SENT_192	[p11l1998t2969r2149b3030],
25	expected	JJ	O	expected	amod	26	SENT_192	[p11l7t3063r305b3143],
26	effects	NNS	O	effect	prep_of	22	SENT_192	[p11l350t3062r559b3123],
27	are	VBP	O	be	cop	31	SENT_192	[p11l603t3083r703b3123],
28	not	RB	O	not	neg	31	SENT_192	[p11l750t3074r852b3123],
29	clear	JJ	O	clear	amod	30	SENT_192	[p11l894t3063r1056b3123],
30	enough	JJ	O	enough	amod	31	SENT_192	[p11l1099t3051r1409b3143],
31	”	NN	O	”	conj_and	8	SENT_192	[p11l1099t3051r1409b3143],
32	to	TO	O	to	aux	33	SENT_192	[p11l1452t3074r1514b3123],
33	warrant	VB	O	warrant	infmod	31	SENT_192	[p11l1557t3074r1812b3123],
34	grouping	VBG	O	group	xcomp	33	SENT_192	[p11l1853t3067r2149b3143],
35	them	PRP	O	they	dobj	34	SENT_192	[p11l6t3156r169b3217],
36	with	IN	O	with	_	0	SENT_192	[p11l209t3156r350b3217],
37	other	JJ	O	other	amod	38	SENT_192	[p11l391t3156r561b3217],
38	genotypes	NNS	O	genotype	prep_with	34	SENT_192	[p11l597t3168r948b3237],
39	.	.	O	.	_	0	SENT_192	[p11l597t3168r948b3237],

1	In	IN	O	in	_	0	SENT_193	[p11l995t3161r1048b3216],
2	addition	NN	O	addition	_	0	SENT_193	[p11l1089t3156r1359b3217],
3	to	TO	O	to	_	0	SENT_193	[p11l1398t3167r1460b3217],
4	(	CD	NUMBER	(	prep_in_addition_to	20	SENT_193	[p11l1500t3160r1936b3229],
5	A	DT	O	a	det	6	SENT_193	[p11l1500t3160r1936b3229],
6	(	NN	O	(	nsubjpass	20	SENT_193	[p11l1500t3160r1936b3229],
7	TA	NNP	O	TA	dep	6	SENT_193	[p11l1500t3160r1936b3229],
8	)	CD	NUMBER	)	num	10	SENT_193	[p11l1500t3160r1936b3229],
9	nTAA	NN	O	ntaa	nn	10	SENT_193	[p11l1500t3160r1936b3229],
10	)	NN	O	)	dep	6	SENT_193	[p11l1500t3160r1936b3229],
11	,	,	O	,	_	0	SENT_193	[p11l1500t3160r1936b3229],
12	other	JJ	O	other	amod	14	SENT_193	[p11l1979t3156r2149b3217],
13	UGT1A1	NN	O	ugt1a1	nn	14	SENT_193	[p11l12t3253r292b3310],
14	polymorphisms17	NN	O	polymorphisms17	dep	6	SENT_193	[p11l373t3237r1028b3329],
15	’18	CD	NUMBER	’18	dep	14	SENT_193	[p11l373t3237r1028b3329],
16	and	CC	O	and	_	0	SENT_193	[p11l1093t3249r1212b3310],
17	haplotypeslg	NN	O	haplotypeslg	dep	6	SENT_193	[p11l1282t3237r1702b3329],
18	have	VBP	O	have	aux	20	SENT_193	[p11l1771t3249r1924b3310],
19	been	VBN	O	be	auxpass	20	SENT_193	[p11l1989t3249r2144b3310],
20	associated	VBN	O	associate	_	0	SENT_193	[p11l8t3341r348b3402],
21	with	IN	O	with	_	0	SENT_193	[p11l384t3341r525b3402],
22	bilirubin	NN	O	bilirubin	nn	23	SENT_193	[p11l565t3341r842b3402],
23	levels	NNS	O	level	prep_with	20	SENT_193	[p11l885t3341r1067b3402],
24	and	CC	O	and	_	0	SENT_193	[p11l1103t3341r1222b3402],
25	Gilbert	NNP	PERSON	Gilbert	poss	27	SENT_193	[p11l1260t3341r1540b3402],
26	's	POS	O	's	_	0	SENT_193	[p11l1260t3341r1540b3402],
27	syndrome	NN	O	syndrome	prep_with	20	SENT_193	[p11l1577t3341r1918b3422],
28	.	.	O	.	_	0	SENT_193	[p11l1577t3341r1918b3422],

1	These	DT	O	these	nsubj	3	SENT_194	[p11l1956t3341r2148b3402],
2	may	MD	O	may	aux	3	SENT_194	[p11l10t3455r146b3515],
3	prove	VB	O	prove	_	0	SENT_194	[p11l180t3455r365b3515],
4	to	TO	O	to	aux	8	SENT_194	[p11l396t3446r458b3495],
5	be	VB	O	be	cop	8	SENT_194	[p11l493t3434r569b3495],
6	more	RBR	O	more	advmod	7	SENT_194	[p11l604t3455r771b3495],
7	effective	JJ	O	effective	amod	8	SENT_194	[p11l804t3434r1082b3495],
8	biomarkers	NNS	O	biomarker	xcomp	3	SENT_194	[p11l1117t3434r1483b3495],
9	of	IN	O	of	_	0	SENT_194	[p11l1516t3434r1581b3495],
10	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	11	SENT_194	[p11l1613t3434r2147b3515, p11l10t3532r129b3589],
11	risk	NN	O	risk	prep_of	8	SENT_194	[p11l163t3528r273b3589],
12	than	IN	O	than	_	0	SENT_194	[p11l301t3528r442b3589],
13	the	DT	O	the	det	15	SENT_194	[p11l475t3528r576b3589],
14	promoter	NN	O	promoter	nn	15	SENT_194	[p11l608t3539r911b3608],
15	polymorphism	NN	O	polymorphism	prep_than	3	SENT_194	[p11l942t3528r1419b3608],
16	alone	RB	O	alone	advmod	3	SENT_194	[p11l1453t3528r1652b3589],
17	.	.	O	.	_	0	SENT_194	[p11l1453t3528r1652b3589],

1	At	IN	O	at	_	0	SENT_195	[p11l84t3625r157b3681],
2	this	DT	O	this	det	3	SENT_195	[p11l192t3621r306b3681],
3	time	NN	O	time	prep_at	15	SENT_195	[p11l343t3625r505b3694],
4	,	,	O	,	_	0	SENT_195	[p11l343t3625r505b3694],
5	the	DT	O	the	det	7	SENT_195	[p11l547t3621r649b3681],
6	practical	JJ	O	practical	amod	7	SENT_195	[p11l689t3621r969b3701],
7	implications	NNS	O	implication	nsubj	15	SENT_195	[p11l1017t3621r1420b3701],
8	of	IN	O	of	_	0	SENT_195	[p11l1459t3620r1524b3681],
9	this	DT	O	this	det	11	SENT_195	[p11l1557t3621r1671b3681],
10	pharmacoge	NN	O	pharmacoge	nn	11	SENT_195	[p11l1711t3621r2147b3701],
11	—	NN	O	—	prep_of	7	SENT_195	[p11l1711t3621r2147b3701],
12	netic	JJ	O	netic	amod	13	SENT_195	[p11l10t3718r167b3775],
13	effect	NN	O	effect	dep	11	SENT_195	[p11l215t3714r396b3775],
14	are	VBP	O	be	cop	15	SENT_195	[p11l441t3735r540b3775],
15	unclear	JJ	O	unclear	_	0	SENT_195	[p11l590t3714r851b3775],
16	.	.	O	.	_	0	SENT_195	[p11l590t3714r851b3775],

1	The	DT	O	the	det	3	SENT_196	[p11l902t3714r1024b3775],
2	observed	VBN	O	observe	amod	3	SENT_196	[p11l1070t3714r1367b3775],
3	hyperbilirubinemia	NN	O	hyperbilirubinemia	nsubj	6	SENT_196	[p11l1418t3714r2053b3794],
4	is	VBZ	O	be	cop	6	SENT_196	[p11l2105t3718r2148b3775],
5	clinically	RB	O	clinically	advmod	6	SENT_196	[p12l8t13r313b93],
6	manageable	JJ	O	manageable	_	0	SENT_196	[p12l337t13r756b94],
7	,	,	O	,	_	0	SENT_196	[p12l337t13r756b94],
8	as	IN	O	as	_	0	SENT_196	[p12l784t34r848b74],
9	no	DT	O	no	det	19	SENT_196	[p12l874t34r953b74],
10	events	NNS	O	event	npadvmod	15	SENT_196	[p12l976t25r1183b74],
11	of	IN	O	of	_	0	SENT_196	[p12l1206t13r1270b74],
12	grade	NN	O	grade	prep_of	10	SENT_196	[p12l1289t13r1472b94],
13	4	CD	NUMBER	4	number	14	SENT_196	[p12l1494t20r1532b73],
14	(	CD	NUMBER	(	num	10	SENT_196	[p12l1558t17r1738b83],
15	>	JJR	O	>	amod	19	SENT_196	[p12l1558t17r1738b83],
16	10	CD	NUMBER	10	num	17	SENT_196	[p12l1558t17r1738b83],
17	times	NNS	O	time	dep	15	SENT_196	[p12l1760t17r1935b74],
18	upper	JJ	O	upper	amod	19	SENT_196	[p12l1961t34r2149b93],
19	limit	NN	O	limit	nsubjpass	24	SENT_196	[p12l12t105r158b166],
20	of	IN	O	of	_	0	SENT_196	[p12l180t105r244b166],
21	normal	JJ	O	normal	amod	22	SENT_196	[p12l268t105r518b175],
22	)	NN	O	)	prep_of	19	SENT_196	[p12l268t105r518b175],
23	were	VBD	O	be	auxpass	24	SENT_196	[p12l544t126r706b166],
24	observed	VBN	O	observe	prepc_as	6	SENT_196	[p12l730t105r1027b166],
25	and	CC	O	and	_	0	SENT_196	[p12l1054t105r1172b166],
26	the	DT	O	the	det	28	SENT_196	[p12l1197t105r1298b166],
27	bilirubin	NN	O	bilirubin	nn	28	SENT_196	[p12l1324t105r1601b166],
28	elevations	NNS	O	elevation	nsubj	30	SENT_196	[p12l1628t105r1962b166],
29	were	VBD	O	be	cop	30	SENT_196	[p12l1986t126r2148b166],
30	reversible	JJ	O	reversible	conj_and	24	SENT_196	[p12l10t199r346b272],
31	,	,	O	,	_	0	SENT_196	[p12l10t199r346b272],
32	leading	VBG	O	lead	xcomp	30	SENT_196	[p12l381t199r620b280],
33	to	TO	O	to	_	0	SENT_196	[p12l644t211r706b260],
34	permanent	JJ	O	permanent	amod	35	SENT_196	[p12l733t211r1089b280],
35	discontinuation	NN	O	discontinuation	prep_to	32	SENT_196	[p12l1113t199r1625b260],
36	in	IN	O	in	_	0	SENT_196	[p12l1659t203r1712b259],
37	only	RB	O	only	quantmod	38	SENT_196	[p12l1741t199r1884b280],
38	two	CD	NUMBER	two	num	40	SENT_196	[p12l1908t211r2031b260],
39	CP	NN	O	cp	nn	40	SENT_196	[p12l2058t203r2149b260],
40	patients	NNS	O	patient	prep_in	35	SENT_196	[p12l9t296r263b372],
41	(	CD	NUMBER	(	dobj	32	SENT_196	[p12l310t291r395b361],
42	of	IN	O	of	_	0	SENT_196	[p12l310t291r395b361],
43	316	CD	NUMBER	316	num	45	SENT_196	[p12l437t297r560b352],
44	total	JJ	O	total	amod	45	SENT_196	[p12l605t292r769b361],
45	)	NN	O	)	prep_of	41	SENT_196	[p12l605t292r769b361],
46	and	CC	O	and	_	0	SENT_196	[p12l817t292r936b352],
47	no	DT	O	no	det	49	SENT_196	[p12l986t312r1065b352],
48	AP	NN	O	ap	nn	49	SENT_196	[p12l1109t296r1201b352],
49	patients	NNS	O	patient	dep	50	SENT_196	[p12l1247t296r1501b372],
50	(	CD	NUMBER	(	conj_and	24	SENT_196	[p12l1549t291r1633b361],
51	of	IN	O	of	_	0	SENT_196	[p12l1549t291r1633b361],
52	64	CD	NUMBER	64	num	55	SENT_196	[p12l1677t298r1755b352],
53	tota	NN	O	tota	nn	55	SENT_196	[p12l1800t280r2144b361],
54	|	NN	O	|	nn	55	SENT_196	[p12l1800t280r2144b361],
55	)	NN	O	)	prep_of	50	SENT_196	[p12l1800t280r2144b361],
56	.	.	O	.	_	0	SENT_196	[p12l1800t280r2144b361],

1	ll	NN	O	ll	nn	3	SENT_197	[p12l1800t280r2144b361],
2	‘	CD	NUMBER	‘	num	3	SENT_197	[p12l1800t280r2144b361],
3	l3	NN	O	l3	nsubj	26	SENT_197	[p12l1800t280r2144b361],
4	Given	VBN	O	give	prep	3	SENT_197	[p12l9t389r204b446],
5	the	DT	O	the	det	6	SENT_197	[p12l231t385r332b445],
6	severity	NN	O	severity	dep	4	SENT_197	[p12l359t389r610b465],
7	of	IN	O	of	_	0	SENT_197	[p12l636t384r701b445],
8	the	DT	O	the	det	10	SENT_197	[p12l721t385r822b445],
9	CML	NN	ORGANIZATION	cml	nn	10	SENT_197	[p12l849t389r1003b446],
10	indications	NNS	O	indication	prep_of	6	SENT_197	[p12l1034t385r1394b445],
11	being	VBG	O	be	auxpass	12	SENT_197	[p12l1422t385r1603b465],
12	treated	VBN	O	treat	partmod	10	SENT_197	[p12l1626t385r1871b458],
13	,	,	O	,	_	0	SENT_197	[p12l1626t385r1871b458],
14	and	CC	O	and	_	0	SENT_197	[p12l1902t385r2021b445],
15	the	DT	O	the	det	18	SENT_197	[p12l2047t385r2148b445],
16	benign	JJ	O	benign	amod	18	SENT_197	[p12l9t478r229b559],
17	clinical	JJ	O	clinical	amod	18	SENT_197	[p12l264t478r502b539],
18	course	NN	O	course	nsubj	26	SENT_197	[p12l540t499r756b539],
19	of	IN	O	of	_	0	SENT_197	[p12l787t478r851b539],
20	nilotinib-induced	JJ	O	nilotinib-induced	amod	21	SENT_197	[p12l882t478r1454b539],
21	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	18	SENT_197	[p12l1491t478r2142b558],
22	,	,	O	,	_	0	SENT_197	[p12l1491t478r2142b558],
23	it	PRP	O	it	nsubj	26	SENT_197	[p12l11t575r49b632],
24	is	VBZ	O	be	cop	26	SENT_197	[p12l109t575r152b632],
25	not	RB	O	not	neg	26	SENT_197	[p12l215t583r317b632],
26	desirable	JJ	O	desirable	_	0	SENT_197	[p12l374t571r673b632],
27	to	TO	O	to	aux	28	SENT_197	[p12l730t583r792b632],
28	exclude	VB	O	exclude	xcomp	26	SENT_197	[p12l851t571r1111b632],
29	any	DT	O	any	det	30	SENT_197	[p12l1170t592r1286b651],
30	patients	NNS	O	patient	dobj	28	SENT_197	[p12l1346t575r1600b651],
31	from	IN	O	from	_	0	SENT_197	[p12l1658t571r1808b632],
32	nilotinib	JJ	O	nilotinib	amod	33	SENT_197	[p12l1873t571r2147b632],
33	treatment	NN	O	treatment	prep_from	28	SENT_197	[p12l6t675r323b724],
34	on	IN	O	on	_	0	SENT_197	[p12l352t684r430b724],
35	the	DT	O	the	det	36	SENT_197	[p12l464t663r565b724],
36	basis	NN	O	basis	prep_on	33	SENT_197	[p12l598t663r756b724],
37	of	IN	O	of	_	0	SENT_197	[p12l788t663r852b724],
38	their	PRP$	O	they	poss	40	SENT_197	[p12l878t663r1029b724],
39	UGT1A1	NN	O	ugt1a1	nn	40	SENT_197	[p12l1064t667r1343b724],
40	genotype	NN	O	genotype	prep_of	36	SENT_197	[p12l1390t675r1711b744],
41	.	.	O	.	_	0	SENT_197	[p12l1390t675r1711b744],

1	At	IN	O	at	_	0	SENT_198	[p12l1746t667r1818b724],
2	the	DT	O	the	det	4	SENT_198	[p12l1846t663r1947b724],
3	same	JJ	O	same	amod	4	SENT_198	[p12l1979t684r2148b724],
4	time	NN	O	time	prep_at	29	SENT_198	[p12l6t761r168b830],
5	,	,	O	,	_	0	SENT_198	[p12l6t761r168b830],
6	the	DT	O	the	det	7	SENT_198	[p12l216t757r317b818],
7	possibility	NN	O	possibility	nsubjpass	29	SENT_198	[p12l362t757r695b838],
8	of	IN	O	of	_	0	SENT_198	[p12l740t757r804b818],
9	drug	NN	O	drug	nn	12	SENT_198	[p12l845t757r1530b838],
10	—	CD	NUMBER	—	num	12	SENT_198	[p12l845t757r1530b838],
11	drug	NN	O	drug	nn	12	SENT_198	[p12l845t757r1530b838],
12	—	NN	O	—	prep_of	7	SENT_198	[p12l845t757r1530b838],
13	genotype	NN	O	genotype	nn	14	SENT_198	[p12l845t757r1530b838],
14	interactions	NNS	O	interaction	dep	12	SENT_198	[p12l1578t761r1959b818],
15	with	IN	O	with	_	0	SENT_198	[p12l2003t757r2145b818],
16	other	JJ	O	other	amod	17	SENT_198	[p12l7t850r177b910],
17	substances	NNS	O	substance	prep_with	14	SENT_198	[p12l235t850r589b910],
18	that	WDT	O	that	nsubj	23	SENT_198	[p12l646t850r772b910],
19	are	VBP	O	be	auxpass	20	SENT_198	[p12l828t871r928b910],
20	metabolized	VBN	O	metabolize	rcmod	14	SENT_198	[p12l989t850r1397b910],
21	by	IN	O	by	prep	20	SENT_198	[p12l1459t850r1535b930],
22	or	CC	O	or	_	0	SENT_198	[p12l1593t871r1659b910],
23	compete	VB	O	compete	rcmod	14	SENT_198	[p12l1717t861r2003b930],
24	for	IN	O	for	_	0	SENT_198	[p12l2060t849r2149b910],
25	UGT1A1	NN	O	ugt1a1	nn	26	SENT_198	[p12l12t947r292b1004],
26	activity	NN	O	activity	prep_for	23	SENT_198	[p12l337t947r577b1023],
27	should	MD	O	should	aux	29	SENT_198	[p12l607t943r825b1004],
28	be	VB	O	be	auxpass	29	SENT_198	[p12l859t943r935b1004],
29	considered	VBN	O	consider	_	0	SENT_198	[p12l966t943r1346b1004],
30	.	.	O	.	_	0	SENT_198	[p12l966t943r1346b1004],

1	A	DT	O	a	det	3	SENT_199	[p12l1380t947r1430b1003],
2	better	JJR	O	better	amod	3	SENT_199	[p12l1460t943r1647b1004],
3	understanding	NN	O	understanding	nsubj	13	SENT_199	[p12l1679t943r2149b1024],
4	of	IN	O	of	_	0	SENT_199	[p12l7t1036r72b1097],
5	the	DT	O	the	det	6	SENT_199	[p12l106t1036r208b1097],
6	mechanism	NN	O	mechanism	prep_of	3	SENT_199	[p12l250t1036r626b1097],
7	underlying	VBG	O	underlie	partmod	6	SENT_199	[p12l673t1036r1026b1117],
8	nilotinib	JJ	O	nilotinib	amod	9	SENT_199	[p12l1069t1036r1715b1097],
9	—	NN	O	—	dobj	7	SENT_199	[p12l1069t1036r1715b1097],
10	associated	VBN	O	associate	partmod	9	SENT_199	[p12l1069t1036r1715b1097],
11	hyperbilirubinemia	NN	O	hyperbilirubinemia	dobj	10	SENT_199	[p12l1761t1036r2147b1116, p12l9t1128r276b1189],
12	is	VBZ	O	be	cop	13	SENT_199	[p12l324t1132r367b1189],
13	important	JJ	O	important	_	0	SENT_199	[p12l414t1132r734b1209],
14	to	TO	O	to	aux	15	SENT_199	[p12l773t1140r835b1189],
15	predict	VB	O	predict	xcomp	13	SENT_199	[p12l880t1128r1111b1209],
16	better	JJR	O	better	advmod	15	SENT_199	[p12l1154t1128r1340b1189],
17	any	DT	O	any	det	20	SENT_199	[p12l1382t1149r1499b1209],
18	such	JJ	O	such	amod	20	SENT_199	[p12l1542t1128r1690b1189],
19	higher-order	JJ	O	higher-order	amod	20	SENT_199	[p12l1739t1128r2149b1209],
20	interactions	NNS	O	interaction	dobj	15	SENT_199	[p12l11t1225r411b1281],
21	.	.	O	.	_	0	SENT_199	[p12l11t1225r411b1281],

1	These	DT	O	these	det	2	SENT_200	[p12l84t1315r275b1376],
2	findings	NNS	O	finding	nsubj	3	SENT_200	[p12l311t1315r570b1395],
3	underscore	VBP	O	underscore	_	0	SENT_200	[p12l609t1315r973b1376],
4	the	DT	O	the	det	5	SENT_200	[p12l1007t1315r1109b1376],
5	value	NN	O	value	dobj	3	SENT_200	[p12l1143t1315r1322b1376],
6	of	IN	O	of	_	0	SENT_200	[p12l1357t1315r1421b1376],
7	including	VBG	O	include	prepc_of	5	SENT_200	[p12l1457t1315r1766b1395],
8	a	DT	O	a	det	10	SENT_200	[p12l1802t1336r1835b1376],
9	pharmacogenetic	JJ	O	pharmacogenetic	amod	10	SENT_200	[p12l1872t1315r2147b1395, p12l8t1412r328b1488],
10	component	NN	O	component	dobj	7	SENT_200	[p12l370t1419r748b1488],
11	in	IN	O	in	_	0	SENT_200	[p12l791t1412r845b1468],
12	clinical	JJ	O	clinical	amod	14	SENT_200	[p12l889t1408r1127b1468],
13	development	NN	O	development	nn	14	SENT_200	[p12l1174t1408r1609b1488],
14	programs	NNS	O	program	prep_in	7	SENT_200	[p12l1650t1428r1973b1488],
15	.	.	O	.	_	0	SENT_200	[p12l1650t1428r1973b1488],

1	Preclinical	JJ	O	preclinical	amod	3	SENT_201	[p12l2022t1413r2147b1468, p12l8t1501r246b1562],
2	safety	NN	O	safety	nn	3	SENT_201	[p12l289t1501r475b1581],
3	findings	NNS	O	finding	nsubj	4	SENT_201	[p12l512t1501r771b1582],
4	indicated	VBD	O	indicate	_	0	SENT_201	[p12l812t1501r1115b1562],
5	the	DT	O	the	det	6	SENT_201	[p12l1152t1501r1254b1562],
6	phenomenon	NN	O	phenomenon	dobj	4	SENT_201	[p12l1292t1501r1729b1581],
7	of	IN	O	of	_	0	SENT_201	[p12l1769t1501r1833b1562],
8	sporadic	JJ	O	sporadic	amod	9	SENT_201	[p12l1867t1501r2147b1581],
9	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_of	6	SENT_201	[p12l10t1594r645b1674],
10	during	IN	O	during	_	0	SENT_201	[p12l669t1594r881b1675],
11	nilotinib	JJ	O	nilotinib	amod	12	SENT_201	[p12l907t1594r1181b1655],
12	treatment	NN	O	treatment	prep_during	4	SENT_201	[p12l1203t1605r1535b1667],
13	,	,	O	,	_	0	SENT_201	[p12l1203t1605r1535b1667],
14	but	CC	O	but	_	0	SENT_201	[p12l1565t1594r1670b1655],
15	the	DT	O	the	det	16	SENT_201	[p12l1689t1594r1790b1655],
16	cause	NN	O	cause	nsubj	18	SENT_201	[p12l1814t1615r1999b1655],
17	was	VBD	O	be	cop	18	SENT_201	[p12l2021t1615r2148b1655],
18	unclear	JJ	O	unclear	conj_but	4	SENT_201	[p12l10t1686r272b1747],
19	.	.	O	.	_	0	SENT_201	[p12l10t1686r272b1747],

1	As	IN	O	as	prep	18	SENT_202	[p12l305t1690r383b1747],
2	with	IN	O	with	pcomp	1	SENT_202	[p12l412t1686r554b1747],
3	tranilast	NN	O	tranilast	pobj	2	SENT_202	[p12l585t1686r865b1759],
4	,	,	O	,	_	0	SENT_202	[p12l585t1686r865b1759],
5	the	DT	O	the	det	6	SENT_202	[p12l898t1686r999b1747],
6	linkage	NN	O	linkage	nsubj	18	SENT_202	[p12l1033t1686r1267b1767],
7	of	IN	O	of	_	0	SENT_202	[p12l1297t1686r1362b1747],
8	a	DT	O	a	det	10	SENT_202	[p12l1388t1707r1422b1747],
9	significant	JJ	O	significant	amod	10	SENT_202	[p12l1452t1686r1792b1767],
10	portion	NN	O	portion	prep_of	6	SENT_202	[p12l1821t1690r2055b1767],
11	of	IN	O	of	_	0	SENT_202	[p12l2087t1686r2152b1747],
12	the	DT	O	the	det	14	SENT_202	[p12l6t1779r107b1840],
13	hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	14	SENT_202	[p12l139t1779r773b1860],
14	risk	NN	O	risk	prep_of	10	SENT_202	[p12l806t1779r916b1840],
15	to	TO	O	to	_	0	SENT_202	[p12l943t1791r1005b1840],
16	UGT1A1	NN	O	ugt1a1	nn	17	SENT_202	[p12l1038t1783r1318b1840],
17	polymorphism	NN	O	polymorphism	prep_to	14	SENT_202	[p12l1363t1779r1839b1860],
18	supports	VBZ	O	support	_	0	SENT_202	[p12l1872t1791r2148b1860],
19	the	DT	O	the	det	21	SENT_202	[p12l6t1873r107b1934],
20	larger	JJR	O	larger	amod	21	SENT_202	[p12l148t1873r332b1953],
21	finding	NN	O	finding	dobj	18	SENT_202	[p12l367t1873r597b1953],
22	that	IN	O	that	complm	28	SENT_202	[p12l632t1873r758b1934],
23	the	DT	O	the	det	25	SENT_202	[p12l791t1873r892b1934],
24	bilirubin	NN	O	bilirubin	nn	25	SENT_202	[p12l931t1873r1208b1934],
25	elevation	NN	O	elevation	nsubjpass	28	SENT_202	[p12l1248t1873r1549b1934],
26	is	VBZ	O	be	auxpass	28	SENT_202	[p12l1594t1877r1637b1934],
27	biochemically	RB	O	biochemically	advmod	28	SENT_202	[p12l1676t1873r2148b1953],
28	driven	VBN	O	drive	ccomp	18	SENT_202	[p12l8t1967r212b2027],
29	and	CC	O	and	_	0	SENT_202	[p12l255t1967r374b2027],
30	is	VBZ	O	be	cop	33	SENT_202	[p12l419t1971r462b2027],
31	not	RB	O	not	neg	33	SENT_202	[p12l504t1978r607b2027],
32	a	DT	O	a	det	33	SENT_202	[p12l644t1988r678b2027],
33	consequence	NN	O	consequence	conj_and	28	SENT_202	[p12l719t1988r1155b2047],
34	of	IN	O	of	_	0	SENT_202	[p12l1194t1966r1258b2027],
35	some	DT	O	some	det	39	SENT_202	[p12l1295t1988r1467b2027],
36	more	RBR	O	more	advmod	37	SENT_202	[p12l1509t1988r1675b2027],
37	severe	JJ	O	severe	amod	39	SENT_202	[p12l1715t1988r1923b2027],
38	organ	NN	O	organ	nn	39	SENT_202	[p12l1961t1988r2144b2047],
39	complication	NN	O	complication	prep_of	33	SENT_202	[p12l8t2060r464b2140],
40	.	.	O	.	_	0	SENT_202	[p12l8t2060r464b2140],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_203	[p12l6t2302r686b2385],

1	In	IN	O	in	_	0	SENT_204	[p12l11t2489r63b2542],
2	addition	NN	O	addition	_	0	SENT_204	[p12l106t2484r368b2543],
3	to	TO	O	to	_	0	SENT_204	[p12l409t2495r469b2543],
4	those	DT	O	those	det	5	SENT_204	[p12l507t2484r677b2543],
5	investigators	NNS	O	investigator	prep_in_addition_to	12	SENT_204	[p12l720t2488r1116b2562],
6	listed	VBN	O	list	partmod	5	SENT_204	[p12l1160t2484r1323b2543],
7	as	IN	O	as	_	0	SENT_204	[p12l1365t2504r1426b2543],
8	authors	NNS	O	author	prep_as	6	SENT_204	[p12l1467t2484r1718b2555],
9	,	,	O	,	_	0	SENT_204	[p12l1467t2484r1718b2555],
10	Kapil	NNP	PERSON	Kapil	nn	11	SENT_204	[p12l1766t2484r1922b2562],
11	Bhala	NNP	PERSON	Bhala	nsubj	12	SENT_204	[p12l1970t2484r2147b2543],
12	participated	VBD	O	participate	_	0	SENT_204	[p12l9t2577r390b2656],
13	as	IN	O	as	_	0	SENT_204	[p12l414t2598r476b2637],
14	an	DT	O	a	det	15	SENT_204	[p12l500t2598r571b2637],
15	investigator	NN	O	investigator	prep_as	12	SENT_204	[p12l601t2581r970b2656],
16	in	IN	O	in	_	0	SENT_204	[p12l995t2581r1047b2636],
17	this	DT	O	this	det	18	SENT_204	[p12l1072t2577r1182b2637],
18	trial	NN	O	trial	prep_in	12	SENT_204	[p12l1204t2577r1345b2637],
19	.	.	O	.	_	0	SENT_204	[p12l1204t2577r1345b2637],

1	We	PRP	O	we	nsubj	2	SENT_205	[p12l1370t2582r1481b2637],
2	thank	VBP	O	thank	_	0	SENT_205	[p12l1503t2577r1682b2637],
3	Wade	NNP	PERSON	Wade	nn	4	SENT_205	[p12l1702t2577r1893b2637],
4	Brown	NNP	PERSON	Brown	dobj	2	SENT_205	[p12l1920t2582r2143b2649],
5	,	,	O	,	_	0	SENT_205	[p12l1920t2582r2143b2649],
6	Elisabeth	NNP	PERSON	Elisabeth	nn	7	SENT_205	[p12l11t2670r291b2730],
7	Leroy	NNP	PERSON	Leroy	conj_and	4	SENT_205	[p12l347t2675r520b2749],
8	and	CC	O	and	_	0	SENT_205	[p12l569t2670r685b2730],
9	Michele	NNP	PERSON	Michele	nn	10	SENT_205	[p12l736t2670r997b2730],
10	Gysen	NNP	PERSON	Gysen	conj_and	4	SENT_205	[p12l1047t2674r1244b2749],
11	for	IN	O	for	_	0	SENT_205	[p12l1296t2670r1382b2730],
12	their	PRP$	O	they	poss	13	SENT_205	[p12l1428t2670r1575b2730],
13	management	NN	O	management	prep_for	2	SENT_205	[p12l1625t2682r2042b2749],
14	of	IN	O	of	_	0	SENT_205	[p12l2089t2670r2152b2730],
15	sample	NN	O	sample	nn	16	SENT_205	[p12l8t2764r235b2842],
16	collection	NN	O	collection	prep_of	13	SENT_205	[p12l270t2764r588b2823],
17	and	CC	O	and	_	0	SENT_205	[p12l626t2764r741b2823],
18	genotyping	NN	O	genotyping	prep_of	13	SENT_205	[p12l778t2768r1153b2842],
19	.	.	O	.	_	0	SENT_205	[p12l778t2768r1153b2842],

1	This	DT	O	this	det	2	SENT_206	[p12l1191t2764r1322b2823],
2	study	NN	O	study	nsubjpass	4	SENT_206	[p12l1358t2764r1526b2842],
3	was	VBD	O	be	auxpass	4	SENT_206	[p12l1560t2784r1683b2823],
4	supported	VBN	O	support	_	0	SENT_206	[p12l1719t2764r2036b2842],
5	by	IN	O	by	_	0	SENT_206	[p12l2074t2764r2148b2842],
6	research	NN	O	research	nn	7	SENT_206	[p12l10t2857r273b2916],
7	funding	NN	O	funding	agent	4	SENT_206	[p12l334t2857r581b2935],
8	from	IN	O	from	_	0	SENT_206	[p12l639t2857r785b2916],
9	Novartis	NNP	ORGANIZATION	Novartis	nn	10	SENT_206	[p12l851t2861r1117b2916],
10	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_from	4	SENT_206	[p12l1181t2857r1725b2916],
11	.	.	O	.	_	0	SENT_206	[p12l1181t2857r1725b2916],

1	Work	NN	O	work	nsubjpass	3	SENT_207	[p12l1788t2857r1967b2916],
2	was	VBD	O	be	auxpass	3	SENT_207	[p12l2025t2877r2148b2916],
3	performed	VBN	O	perform	_	0	SENT_207	[p12l9t2949r338b3027],
4	at	IN	O	at	_	0	SENT_207	[p12l389t2961r445b3008],
5	Novartis	NNP	ORGANIZATION	Novartis	nn	6	SENT_207	[p12l496t2953r762b3009],
6	Institutes	NNPS	ORGANIZATION	Institutes	prep_at	3	SENT_207	[p12l815t2953r1093b3008],
7	for	IN	ORGANIZATION	for	_	0	SENT_207	[p12l1141t2949r1227b3008],
8	Biomedical	NNP	ORGANIZATION	Biomedical	nn	9	SENT_207	[p12l1279t2949r1637b3008],
9	Research	NNP	ORGANIZATION	Research	prep_for	6	SENT_207	[p12l1695t2949r1979b3008],
10	and	CC	O	and	_	0	SENT_207	[p12l2031t2949r2146b3008],
11	Novartis	NNP	ORGANIZATION	Novartis	nn	12	SENT_207	[p12l11t3045r277b3099],
12	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_for	6	SENT_207	[p12l311t3041r856b3099],
13	.	.	O	.	_	0	SENT_207	[p12l311t3041r856b3099],

1	References	NNS	O	reference	_	0	SENT_208	[p12l11t3241r385b3303],

1	1	CD	NUMBER	1	num	3	SENT_209	[p13l47t77r64b127],
2	Bosma	NNP	ORGANIZATION	Bosma	nn	3	SENT_209	[p13l121t77r319b128],
3	PJ	NNP	ORGANIZATION	PJ	_	0	SENT_209	[p13l357t77r425b139],
4	,	,	O	,	_	0	SENT_209	[p13l357t77r425b139],
5	Seppen	NNP	PERSON	Seppen	nn	6	SENT_209	[p13l464t76r681b146],
6	J	NNP	PERSON	J	appos	3	SENT_209	[p13l713t77r749b139],
7	,	,	O	,	_	0	SENT_209	[p13l713t77r749b139],
8	Goldhoorn	NNP	O	Goldhoorn	nn	9	SENT_209	[p13l790t72r1116b128],
9	B	NNP	O	B	appos	3	SENT_209	[p13l1158t77r1209b139],
10	,	,	O	,	_	0	SENT_209	[p13l1158t77r1209b139],
11	Bakker	NNP	PERSON	Bakker	nn	12	SENT_209	[p13l1251t72r1455b128],
12	C	NNP	O	C	appos	3	SENT_209	[p13l1488t76r1547b139],
13	,	,	O	,	_	0	SENT_209	[p13l1488t76r1547b139],
14	Oude	NNP	PERSON	Oude	nn	16	SENT_209	[p13l1585t73r1755b128],
15	Elferink	NNP	PERSON	Elferink	nn	16	SENT_209	[p13l1793t72r2017b128],
16	RP	NNP	O	RP	appos	3	SENT_209	[p13l2053t77r2144b139],
17	,	,	O	,	_	0	SENT_209	[p13l2053t77r2144b139],
18	ChowdhuryJR	NNP	O	ChowdhuryJR	appos	3	SENT_209	[p13l118t152r554b225],
19	et	FW	O	et	nn	20	SENT_209	[p13l578t163r634b207],
20	al.	FW	O	al.	dep	18	SENT_209	[p13l651t152r717b207],
21	.	.	O	.	_	0	SENT_209	[p13l651t152r717b207],

1	Bilirubin	NNP	O	Bilirubin	nn	2	SENT_210	[p13l745t152r1001b207],
2	UDP	NNP	O	UDP	nsubj	12	SENT_210	[p13l1029t152r1915b225],
3	—	CD	NUMBER	—	num	2	SENT_210	[p13l1029t152r1915b225],
4	glucuronosyltransferase	NN	O	glucuronosyltransferase	dep	2	SENT_210	[p13l1029t152r1915b225],
5	1	CD	NUMBER	1	num	4	SENT_210	[p13l1940t157r1957b207],
6	is	VBZ	O	be	cop	12	SENT_210	[p13l1996t156r2036b207],
7	the	DT	O	the	det	12	SENT_210	[p13l2056t152r2148b207],
8	only	RB	O	only	advmod	9	SENT_210	[p13l118t231r248b304],
9	relevant	JJ	O	relevant	amod	12	SENT_210	[p13l295t231r537b286],
10	bilirubin	NN	O	bilirubin	nn	12	SENT_210	[p13l581t231r834b286],
11	glucuronidating	VBG	O	glucuronidate	amod	12	SENT_210	[p13l880t231r1360b305],
12	isoform	NN	O	isoform	_	0	SENT_210	[p13l1408t231r1627b286],
13	in	IN	O	in	_	0	SENT_210	[p13l1677t235r1726b286],
14	man	NN	O	man	prep_in	12	SENT_210	[p13l1776t250r1920b286],
15	.	.	O	.	_	0	SENT_210	[p13l1776t250r1920b286],

1	1	CD	NUMBER	1	num	3	SENT_211	[p13l1962t236r1989b295],
2	Biol	NNP	ORGANIZATION	Biol	nn	3	SENT_211	[p13l2033t231r2154b286],
3	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_211	[p13l122t312r298b367],
4	1994	CD	DATE	1994	num	3	SENT_211	[p13l328t317r493b379],
5	;	:	O	;	_	0	SENT_211	[p13l328t317r493b379],
6	269	CD	NUMBER	269	num	8	SENT_211	[p13l525t317r655b367],
7	:	:	O	:	_	0	SENT_211	[p13l525t317r655b367],
8	17960-17964	CD	NUMBER	17960-17964	dep	3	SENT_211	[p13l691t316r1128b367],
9	.	.	O	.	_	0	SENT_211	[p13l691t316r1128b367],

1	Bosma	NNP	PERSON	Bosma	nn	2	SENT_212	[p13l121t396r319b447],
2	PJ	NNP	PERSON	PJ	_	0	SENT_212	[p13l352t396r419b458],
3	,	,	O	,	_	0	SENT_212	[p13l352t396r419b458],
4	Chowdhury	NNP	PERSON	Chowdhury	nn	5	SENT_212	[p13l453t391r809b464],
5	JR	NNP	O	JR	appos	2	SENT_212	[p13l833t396r913b458],
6	,	,	O	,	_	0	SENT_212	[p13l833t396r913b458],
7	Bakker	NNP	PERSON	Bakker	nn	8	SENT_212	[p13l950t391r1154b447],
8	C	NNP	O	C	appos	2	SENT_212	[p13l1182t395r1241b458],
9	,	,	O	,	_	0	SENT_212	[p13l1182t395r1241b458],
10	Gantla	NNP	LOCATION	Gantla	nn	11	SENT_212	[p13l1276t392r1477b447],
11	S	NNP	LOCATION	S	appos	2	SENT_212	[p13l1507t395r1553b458],
12	,	,	O	,	_	0	SENT_212	[p13l1507t395r1553b458],
13	de	FW	O	de	nn	15	SENT_212	[p13l1586t392r1657b447],
14	Boer	FW	O	boer	nn	15	SENT_212	[p13l1690t396r1826b447],
15	A	NN	O	a	appos	2	SENT_212	[p13l1853t395r1913b458],
16	,	,	O	,	_	0	SENT_212	[p13l1853t395r1913b458],
17	Oostra	NNP	O	Oostra	nn	18	SENT_212	[p13l1947t395r2148b447],
18	BA	NN	O	ba	appos	2	SENT_212	[p13l121t475r205b526],
19	et	FW	O	et	nn	20	SENT_212	[p13l236t482r293b526],
20	al.	FW	O	al.	dep	18	SENT_212	[p13l317t471r383b526],
21	.	.	O	.	_	0	SENT_212	[p13l317t471r383b526],

1	The	DT	O	the	det	3	SENT_213	[p13l415t471r527b526],
2	genetic	JJ	O	genetic	amod	3	SENT_213	[p13l555t475r773b544],
3	basis	NN	O	basis	_	0	SENT_213	[p13l804t471r948b526],
4	of	IN	O	of	_	0	SENT_213	[p13l978t471r1037b526],
5	the	DT	O	the	det	7	SENT_213	[p13l1061t471r1154b526],
6	reduced	VBN	O	reduce	amod	7	SENT_213	[p13l1186t471r1427b526],
7	expression	NN	O	expression	prep_of	3	SENT_213	[p13l1457t475r1774b544],
8	of	IN	O	of	_	0	SENT_213	[p13l1806t471r1865b526],
9	bilirubin	NN	O	bilirubin	nn	10	SENT_213	[p13l1892t471r2146b526],
10	UDP	NN	O	udp	prep_of	7	SENT_213	[p13l122t552r1008b625],
11	—	CD	NUMBER	—	num	12	SENT_213	[p13l122t552r1008b625],
12	glucuronosyltransferase	NN	O	glucuronosyltransferase	tmod	7	SENT_213	[p13l122t552r1008b625],
13	1	CD	NUMBER	1	advmod	12	SENT_213	[p13l1052t557r1070b606],
14	in	IN	O	in	_	0	SENT_213	[p13l1128t556r1176b606],
15	Gilbert	NNP	PERSON	Gilbert	poss	17	SENT_213	[p13l1220t552r1477b607],
16	’s	POS	O	’s	_	0	SENT_213	[p13l1220t552r1477b607],
17	syndrome	NN	O	syndrome	prep_in	13	SENT_213	[p13l1518t552r1830b625],
18	.	.	O	.	_	0	SENT_213	[p13l1518t552r1830b625],

1	N	NN	O	n	nn	3	SENT_214	[p13l1877t556r1930b607],
2	Englj	NNP	O	Englj	nn	3	SENT_214	[p13l1970t552r2153b625],
3	Med	NNP	O	Med	_	0	SENT_214	[p13l118t631r260b687],
4	1995	CD	DATE	1995	num	3	SENT_214	[p13l284t636r450b698],
5	;	:	O	;	_	0	SENT_214	[p13l284t636r450b698],
6	333	CD	NUMBER	333	num	8	SENT_214	[p13l481t637r611b687],
7	:	:	O	:	_	0	SENT_214	[p13l481t637r611b687],
8	1171-1175	CD	DATE	1171-1175	dep	3	SENT_214	[p13l647t636r1005b687],
9	.	.	O	.	_	0	SENT_214	[p13l647t636r1005b687],

1	Monaghan	NNP	PERSON	Monaghan	nn	2	SENT_215	[p13l118t712r439b785],
2	G	NNP	PERSON	G	_	0	SENT_215	[p13l475t715r541b778],
3	,	,	O	,	_	0	SENT_215	[p13l475t715r541b778],
4	Ryan	NNP	PERSON	Ryan	nn	5	SENT_215	[p13l581t716r725b785],
5	M	NNP	PERSON	M	appos	2	SENT_215	[p13l762t715r835b778],
6	,	,	O	,	_	0	SENT_215	[p13l762t715r835b778],
7	Seddon	NNP	PERSON	Seddon	nn	8	SENT_215	[p13l873t712r1094b767],
8	R	NNP	PERSON	R	appos	2	SENT_215	[p13l1132t716r1184b778],
9	,	,	O	,	_	0	SENT_215	[p13l1132t716r1184b778],
10	Hume	NNP	PERSON	Hume	nn	11	SENT_215	[p13l1225t716r1408b767],
11	R	NNP	PERSON	R	appos	2	SENT_215	[p13l1443t716r1495b778],
12	,	,	O	,	_	0	SENT_215	[p13l1443t716r1495b778],
13	Burchell	NNP	PERSON	Burchell	nn	15	SENT_215	[p13l1536t712r1781b767],
14	B.	NNP	O	B.	nn	15	SENT_215	[p13l1822t716r1874b767],
15	Genetic	NNP	O	Genetic	appos	11	SENT_215	[p13l1912t715r2148b767],
16	variation	NN	O	variation	dep	2	SENT_215	[p13l117t794r381b845],
17	in	IN	O	in	_	0	SENT_215	[p13l416t794r465b845],
18	bilirubin	NN	O	bilirubin	nn	19	SENT_215	[p13l498t790r751b845],
19	UPD	NN	O	upd	prep_in	16	SENT_215	[p13l786t790r1672b864],
20	—	CD	NUMBER	—	num	23	SENT_215	[p13l786t790r1672b864],
21	glucuronosyltransferase	NN	O	glucuronosyltransferase	nn	23	SENT_215	[p13l786t790r1672b864],
22	gene	NN	O	gene	nn	23	SENT_215	[p13l1700t809r1843b864],
23	promoter	NN	O	promoter	dep	2	SENT_215	[p13l1873t801r2150b863],
24	and	CC	O	and	_	0	SENT_215	[p13l118t871r227b926],
25	Gilbert	NNP	PERSON	Gilbert	poss	27	SENT_215	[p13l258t871r514b926],
26	’s	POS	O	’s	_	0	SENT_215	[p13l258t871r514b926],
27	syndrome	NN	O	syndrome	dep	2	SENT_215	[p13l542t871r855b944],
28	.	.	O	.	_	0	SENT_215	[p13l542t871r855b944],

1	Lancet	NNP	O	Lancet	_	0	SENT_216	[p13l890t875r1091b926],
2	1996	CD	DATE	1996	num	1	SENT_216	[p13l1116t876r1281b937],
3	;	:	O	;	_	0	SENT_216	[p13l1116t876r1281b937],
4	347	CD	NUMBER	347	num	6	SENT_216	[p13l1314t876r1443b926],
5	:	:	O	:	_	0	SENT_216	[p13l1314t876r1443b926],
6	578-581	CD	NUMBER	578-581	dep	1	SENT_216	[p13l1477t876r1760b926],
7	.	.	O	.	_	0	SENT_216	[p13l1477t876r1760b926],

1	UGT1A1	NN	O	ugt1a1	nn	2	SENT_217	[p13l10t1091r186b1135],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_217	[p13l211t1091r593b1145],
3	and	CC	O	and	_	0	SENT_217	[p13l612t1091r687b1134],
4	nilotinib	JJ	O	nilotinib	amod	7	SENT_217	[p13l709t1091r878b1135],
5	safety	NN	O	safety	nn	7	SENT_217	[p13l897t1091r1021b1145],
6	JB	NN	MISC	jb	nn	7	SENT_217	[p13l7t1157r53b1200],
7	Singer	NNP	MISC	Singer	conj_and	2	SENT_217	[p13l72t1156r190b1210],
8	et	FW	MISC	et	nn	9	SENT_217	[p13l205t1159r242b1200],
9	al	FW	MISC	al	dep	2	SENT_217	[p13l257t1157r292b1200],

1	Beutler	NNP	PERSON	Beutler	nn	2	SENT_218	[p13l107t1335r290b1382],
2	E	NNP	O	E	_	0	SENT_218	[p13l323t1339r361b1392],
3	,	,	O	,	_	0	SENT_218	[p13l323t1339r361b1392],
4	Gelbart	NNP	PERSON	Gelbart	nn	5	SENT_218	[p13l398t1335r594b1382],
5	T	NN	O	t	appos	2	SENT_218	[p13l623t1339r667b1392],
6	,	,	O	,	_	0	SENT_218	[p13l623t1339r667b1392],
7	Demina	NNP	PERSON	Demina	nn	10	SENT_218	[p13l706t1338r911b1382],
8	A.	NNP	O	A.	nn	10	SENT_218	[p13l942t1338r994b1382],
9	Racial	JJ	O	racial	amod	10	SENT_218	[p13l1033t1335r1187b1382],
10	variability	NN	O	variability	appos	2	SENT_218	[p13l1222t1335r1482b1398],
11	in	IN	O	in	_	0	SENT_218	[p13l1518t1338r1560b1382],
12	the	DT	O	the	det	15	SENT_218	[p13l1593t1335r1673b1382],
13	UDP	NNP	O	UDP	nn	15	SENT_218	[p13l1708t1339r1851b1382],
14	—	NN	O	—	nn	15	SENT_218	[p13l1708t1339r1851b1382],
15	glucuronosyltransferase	NN	O	glucuronosyltransferase	prep_in	10	SENT_218	[p13l104t1403r721b1467],
16	1	CD	NUMBER	1	number	17	SENT_218	[p13l753t1408r768b1450],
17	(	CD	NUMBER	(	dep	2	SENT_218	[p13l811t1407r1077b1458],
18	UGT1A1	NN	O	ugt1a1	nn	20	SENT_218	[p13l811t1407r1077b1458],
19	)	NN	O	)	nn	20	SENT_218	[p13l811t1407r1077b1458],
20	promoter	NN	O	promoter	dep	17	SENT_218	[p13l1110t1412r1362b1467],
21	:	:	O	:	_	0	SENT_218	[p13l1110t1412r1362b1467],
22	a	DT	O	a	det	24	SENT_218	[p13l1394t1420r1421b1451],
23	balanced	JJ	O	balanced	amod	24	SENT_218	[p13l1452t1403r1688b1451],
24	polymorphism	NN	O	polymorphism	dep	17	SENT_218	[p13l1720t1403r1851b1467, p13l106t1471r364b1534],
25	for	IN	O	for	_	0	SENT_218	[p13l390t1471r460b1519],
26	regulation	NN	O	regulation	prep_for	24	SENT_218	[p13l487t1471r745b1534],
27	of	IN	O	of	_	0	SENT_218	[p13l772t1471r823b1519],
28	bilirubin	NN	O	bilirubin	nn	29	SENT_218	[p13l846t1471r1064b1519],
29	metabolism	NN	O	metabolism	prep_of	26	SENT_218	[p13l1093t1471r1417b1519],
30	?	.	O	?	_	0	SENT_218	[p13l1093t1471r1417b1519],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_219	[p13l1447t1475r1563b1519],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_219	[p13l1588t1471r1699b1519],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_219	[p13l1718t1471r1859b1519],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_219	[p13l105t1543r183b1588],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_219	[p13l209t1543r320b1588],
6	1998	CD	DATE	1998	num	5	SENT_219	[p13l347t1544r489b1597],
7	;	:	O	;	_	0	SENT_219	[p13l347t1544r489b1597],
8	95	CD	NUMBER	95	num	10	SENT_219	[p13l516t1545r595b1588],
9	:	:	O	:	_	0	SENT_219	[p13l516t1545r595b1588],
10	8170-8174	CD	DURATION	8170-8174	dep	5	SENT_219	[p13l623t1544r935b1588],
11	.	.	O	.	_	0	SENT_219	[p13l623t1544r935b1588],

1	Premawardhena	NNP	O	Premawardhena	nn	2	SENT_220	[p13l107t1608r529b1655],
2	A	NNP	O	A	_	0	SENT_220	[p13l567t1611r619b1665],
3	,	,	O	,	_	0	SENT_220	[p13l567t1611r619b1665],
4	Fisher	NNP	PERSON	Fisher	nn	5	SENT_220	[p13l664t1608r815b1655],
5	CA	NNP	O	CA	appos	2	SENT_220	[p13l853t1611r944b1665],
6	,	,	O	,	_	0	SENT_220	[p13l853t1611r944b1665],
7	Liu	NNP	PERSON	Liu	nn	8	SENT_220	[p13l990t1612r1062b1655],
8	YT	NNP	PERSON	YT	appos	2	SENT_220	[p13l1103t1612r1185b1665],
9	,	,	O	,	_	0	SENT_220	[p13l1103t1612r1185b1665],
10	Verma	NNP	PERSON	Verma	nn	11	SENT_220	[p13l1226t1612r1397b1655],
11	IC	NN	PERSON	ic	appos	2	SENT_220	[p13l1439t1611r1504b1665],
12	,	,	O	,	_	0	SENT_220	[p13l1439t1611r1504b1665],
13	de	FW	PERSON	de	appos	2	SENT_220	[p13l1546t1608r1607b1655],
14	Silva	NNP	PERSON	Silva	nn	15	SENT_220	[p13l1646t1608r1769b1656],
15	S	NNP	O	S	dep	13	SENT_220	[p13l1807t1611r1847b1665],
16	,	,	O	,	_	0	SENT_220	[p13l1807t1611r1847b1665],
17	Arambepola	NNP	O	Arambepola	nn	18	SENT_220	[p13l103t1677r423b1740],
18	M	NNP	O	M	appos	2	SENT_220	[p13l448t1680r496b1724],
19	et	FW	O	et	nn	20	SENT_220	[p13l523t1686r571b1724],
20	al.	FW	O	al.	dep	18	SENT_220	[p13l589t1677r647b1724],
21	.	.	O	.	_	0	SENT_220	[p13l589t1677r647b1724],

1	The	DT	O	the	det	3	SENT_221	[p13l671t1677r767b1724],
2	global	JJ	O	global	amod	3	SENT_221	[p13l790t1677r946b1740],
3	distribution	NN	O	distribution	dep	16	SENT_221	[p13l973t1677r1267b1724],
4	of	IN	O	of	_	0	SENT_221	[p13l1292t1677r1343b1724],
5	length	NN	O	length	nn	6	SENT_221	[p13l1366t1677r1520b1740],
6	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_221	[p13l1547t1677r1851b1740, p13l107t1747r216b1792],
7	of	IN	O	of	_	0	SENT_221	[p13l260t1744r311b1792],
8	the	DT	O	the	det	9	SENT_221	[p13l351t1744r431b1792],
9	promoters	NNS	O	promoter	prep_of	6	SENT_221	[p13l476t1753r736b1807],
10	of	IN	O	of	_	0	SENT_221	[p13l780t1744r831b1792],
11	the	DT	O	the	det	12	SENT_221	[p13l871t1744r951b1792],
12	glucuronosyltransferase	NN	O	glucuronosyltransferase	prep_of	9	SENT_221	[p13l994t1744r1611b1807],
13	1	CD	NUMBER	1	num	14	SENT_221	[p13l1658t1748r1673b1791],
14	gene	NN	O	gene	dep	16	SENT_221	[p13l1729t1761r1852b1807],
15	(	NN	O	(	nn	16	SENT_221	[p13l105t1816r388b1868],
16	UGT1A1	NN	O	ugt1a1	dep	22	SENT_221	[p13l105t1816r388b1868],
17	)	CD	NUMBER	)	dep	16	SENT_221	[p13l105t1816r388b1868],
18	:	:	O	:	_	0	SENT_221	[p13l105t1816r388b1868],
19	hematologic	JJ	O	hematologic	amod	22	SENT_221	[p13l438t1813r759b1876],
20	and	CC	O	and	_	0	SENT_221	[p13l804t1813r898b1860],
21	evolutionary	JJ	O	evolutionary	conj_and	19	SENT_221	[p13l944t1813r1271b1876],
22	implications	NNS	O	implication	_	0	SENT_221	[p13l1319t1813r1650b1876],
23	.	.	O	.	_	0	SENT_221	[p13l1319t1813r1650b1876],

1	Blood	NN	O	blood	nn	2	SENT_222	[p13l1702t1813r1859b1860],
2	Cells	NNS	O	cell	_	0	SENT_222	[p13l108t1880r233b1928],
3	Mol	NNP	O	Mol	nn	4	SENT_222	[p13l255t1880r361b1928],
4	Dis	NNP	O	Dis	dep	2	SENT_222	[p13l383t1884r469b1928],
5	2003	CD	DATE	2003	num	4	SENT_222	[p13l489t1885r636b1937],
6	;	:	O	;	_	0	SENT_222	[p13l489t1885r636b1937],
7	31	CD	NUMBER	31	num	9	SENT_222	[p13l663t1885r741b1928],
8	:	:	O	:	_	0	SENT_222	[p13l663t1885r741b1928],
9	98-101	CD	NUMBER	98-101	dep	2	SENT_222	[p13l769t1885r979b1928],
10	.	.	O	.	_	0	SENT_222	[p13l769t1885r979b1928],

1	Iyer	NNP	O	Iyer	nn	2	SENT_223	[p13l107t1952r201b2011],
2	L	NNP	O	L	_	0	SENT_223	[p13l231t1952r269b2006],
3	,	,	O	,	_	0	SENT_223	[p13l231t1952r269b2006],
4	King	NNP	O	King	nn	5	SENT_223	[p13l305t1951r418b2011],
5	CD	NNP	O	CD	appos	2	SENT_223	[p13l446t1951r545b2006],
6	,	,	O	,	_	0	SENT_223	[p13l446t1951r545b2006],
7	Whitington	NNP	ORGANIZATION	Whitington	nn	8	SENT_223	[p13l576t1948r868b2011],
8	PF	NNP	ORGANIZATION	PF	appos	2	SENT_223	[p13l902t1952r974b2006],
9	,	,	O	,	_	0	SENT_223	[p13l902t1952r974b2006],
10	Green	NNP	ORGANIZATION	Green	nn	11	SENT_223	[p13l1008t1951r1164b1996],
11	MD	NNP	ORGANIZATION	MD	appos	2	SENT_223	[p13l1196t1951r1307b2005],
12	,	,	O	,	_	0	SENT_223	[p13l1196t1951r1307b2005],
13	Roy	NNP	PERSON	Roy	nn	14	SENT_223	[p13l1343t1952r1439b2011],
14	SK	NNP	PERSON	SK	appos	2	SENT_223	[p13l1468t1951r1545b2005],
15	,	,	O	,	_	0	SENT_223	[p13l1468t1951r1545b2005],
16	Tephly	NNP	O	Tephly	nn	17	SENT_223	[p13l1577t1948r1755b2011],
17	TR	NN	O	tr	appos	2	SENT_223	[p13l1782t1952r1852b1995],
18	et	FW	O	et	nn	19	SENT_223	[p13l106t2027r155b2065],
19	al.	FW	O	al.	dep	17	SENT_223	[p13l191t2018r249b2065],
20	.	.	O	.	_	0	SENT_223	[p13l191t2018r249b2065],

1	Genetic	JJ	O	genetic	amod	2	SENT_224	[p13l294t2021r497b2065],
2	predisposition	NN	O	predisposition	_	0	SENT_224	[p13l540t2018r903b2081],
3	to	TO	O	to	_	0	SENT_224	[p13l946t2027r995b2065],
4	the	DT	O	the	det	5	SENT_224	[p13l1035t2018r1114b2065],
5	metabolism	NN	O	metabolism	prep_to	2	SENT_224	[p13l1157t2018r1457b2065],
6	of	IN	O	of	_	0	SENT_224	[p13l1500t2017r1551b2065],
7	irinotecan	NN	O	irinotecan	nn	10	SENT_224	[p13l1592t2021r1849b2065],
8	(	CD	NUMBER	(	num	10	SENT_224	[p13l105t2090r346b2141],
9	CPT-11	NN	O	cpt-11	nn	10	SENT_224	[p13l105t2090r346b2141],
10	)	NN	O	)	prep_of	2	SENT_224	[p13l105t2090r346b2141],
11	.	.	O	.	_	0	SENT_224	[p13l105t2090r346b2141],

1	Role	NN	O	role	_	0	SENT_225	[p13l396t2086r509b2134],
2	of	IN	O	of	_	0	SENT_225	[p13l553t2086r604b2134],
3	uridine	NN	O	uridine	nn	7	SENT_225	[p13l647t2086r829b2134],
4	diphosphate	NN	O	diphosphate	nn	7	SENT_225	[p13l872t2086r1192b2149],
5	glucuronosyltransferase	NN	O	glucuronosyltransferase	nn	7	SENT_225	[p13l1235t2086r1852b2150],
6	isoform	NN	O	isoform	nn	7	SENT_225	[p13l107t2155r296b2203],
7	1A1	NN	O	1a1	prep_of	1	SENT_225	[p13l348t2159r438b2202],
8	in	IN	O	in	_	0	SENT_225	[p13l500t2159r542b2203],
9	the	DT	O	the	det	10	SENT_225	[p13l590t2155r670b2203],
10	glucuronidation	NN	O	glucuronidation	prep_in	7	SENT_225	[p13l716t2155r1129b2219],
11	of	IN	O	of	_	0	SENT_225	[p13l1178t2155r1229b2203],
12	its	PRP$	O	its	poss	16	SENT_225	[p13l1276t2159r1327b2203],
13	active	JJ	O	active	amod	16	SENT_225	[p13l1374t2159r1529b2203],
14	metabolite	NN	O	metabolite	nn	16	SENT_225	[p13l1577t2155r1852b2203],
15	(	CD	NUMBER	(	num	16	SENT_225	[p13l105t2226r300b2277],
16	SN	NN	O	sn	prep_of	10	SENT_225	[p13l105t2226r300b2277],
17	—	CD	NUMBER	—	number	18	SENT_225	[p13l105t2226r300b2277],
18	38	CD	NUMBER	38	num	19	SENT_225	[p13l105t2226r300b2277],
19	)	NN	O	)	dep	1	SENT_225	[p13l105t2226r300b2277],
20	in	IN	O	in	_	0	SENT_225	[p13l343t2226r385b2270],
21	human	JJ	O	human	amod	23	SENT_225	[p13l428t2223r604b2270],
22	liver	NN	O	liver	nn	23	SENT_225	[p13l648t2223r759b2270],
23	microsomes	NNS	O	microsome	prep_in	19	SENT_225	[p13l798t2226r1123b2270],
24	.	.	O	.	_	0	SENT_225	[p13l798t2226r1123b2270],

1	/	:	O	/	punct	3	SENT_226	[p13l1159t2227r1182b2278],
2	Clin	NNP	O	Clin	nn	3	SENT_226	[p13l1220t2223r1324b2270],
3	Invest	NNP	O	Invest	_	0	SENT_226	[p13l1364t2227r1517b2270],
4	1998	CD	DATE	1998	dep	3	SENT_226	[p13l1552t2227r1695b2280],
5	;	:	O	;	_	0	SENT_226	[p13l1552t2227r1695b2280],
6	101	CD	NUMBER	101	dep	3	SENT_226	[p13l1737t2227r1848b2270],
7	:	:	O	:	_	0	SENT_226	[p13l1737t2227r1848b2270],
8	847-854	CD	NUMBER	847-854	dep	6	SENT_226	[p13l105t2297r349b2340],
9	.	.	O	.	_	0	SENT_226	[p13l105t2297r349b2340],

1	Ando	NNP	PERSON	Ando	_	0	SENT_227	[p13l103t2360r243b2408],
2	Y	NN	PERSON	y	nn	1	SENT_227	[p13l279t2364r327b2417],
3	,	,	O	,	_	0	SENT_227	[p13l279t2364r327b2417],
4	Saka	FW	PERSON	saka	dep	1	SENT_227	[p13l368t2360r487b2408],
5	H	NN	PERSON	h	dep	1	SENT_227	[p13l526t2364r581b2417],
6	,	,	O	,	_	0	SENT_227	[p13l526t2364r581b2417],
7	Ando	NNP	PERSON	Ando	nn	8	SENT_227	[p13l620t2360r760b2408],
8	M	NNP	O	M	appos	5	SENT_227	[p13l797t2364r861b2417],
9	,	,	O	,	_	0	SENT_227	[p13l797t2364r861b2417],
10	Sawa	NNP	ORGANIZATION	Sawa	nn	11	SENT_227	[p13l902t2364r1038b2408],
11	T	NN	ORGANIZATION	t	appos	5	SENT_227	[p13l1073t2364r1118b2417],
12	,	,	O	,	_	0	SENT_227	[p13l1073t2364r1118b2417],
13	Muro	NNP	PERSON	Muro	nn	14	SENT_227	[p13l1159t2364r1297b2408],
14	K	NNP	PERSON	K	appos	5	SENT_227	[p13l1336t2364r1381b2417],
15	,	,	O	,	_	0	SENT_227	[p13l1336t2364r1381b2417],
16	Ueoka	NNP	LOCATION	Ueoka	nn	17	SENT_227	[p13l1425t2360r1592b2408],
17	H	NNP	O	H	appos	5	SENT_227	[p13l1631t2364r1669b2407],
18	et	FW	O	et	nn	19	SENT_227	[p13l1711t2369r1760b2408],
19	al.	FW	O	al.	dep	17	SENT_227	[p13l1791t2360r1849b2408],
20	.	.	O	.	_	0	SENT_227	[p13l1791t2360r1849b2408],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_228	[p13l107t2428r505b2491],
2	of	IN	O	of	_	0	SENT_228	[p13l531t2428r581b2476],
3	UDP	NNP	O	UDP	prep_of	1	SENT_228	[p13l607t2428r1370b2491],
4	—	CD	NUMBER	—	num	3	SENT_228	[p13l607t2428r1370b2491],
5	glucuronosyltransferase	NN	O	glucuronosyltransferase	nn	6	SENT_228	[p13l607t2428r1370b2491],
6	gene	NN	O	gene	dep	1	SENT_228	[p13l1395t2445r1518b2491],
7	and	CC	O	and	_	0	SENT_228	[p13l1544t2428r1637b2476],
8	irinotecan	NN	O	irinotecan	nn	9	SENT_228	[p13l1667t2431r1851b2476, p13l104t2513r193b2544],
9	toxicity	NN	O	toxicity	dep	1	SENT_228	[p13l225t2500r432b2560],
10	:	:	O	:	_	0	SENT_228	[p13l225t2500r432b2560],
11	a	DT	O	a	det	13	SENT_228	[p13l465t2513r492b2544],
12	pharmacogenetic	JJ	O	pharmacogenetic	amod	13	SENT_228	[p13l524t2497r975b2560],
13	analysis	NN	O	analysis	dep	1	SENT_228	[p13l1006t2497r1224b2560],
14	.	.	O	.	_	0	SENT_228	[p13l1006t2497r1224b2560],

1	Cancer	NNP	O	Cancer	nn	2	SENT_229	[p13l1261t2500r1448b2544],
2	Res	NNP	O	Res	_	0	SENT_229	[p13l1475t2501r1563b2544],
3	2000	CD	DATE	2000	num	2	SENT_229	[p13l1590t2501r1737b2554],
4	;	:	O	;	_	0	SENT_229	[p13l1590t2501r1737b2554],
5	60	CD	NUMBER	60	num	7	SENT_229	[p13l1771t2501r1848b2544],
6	:	:	O	:	_	0	SENT_229	[p13l1771t2501r1848b2544],
7	6921-6926	CD	DURATION	6921-6926	dep	2	SENT_229	[p13l106t2569r416b2613],
8	.	.	O	.	_	0	SENT_229	[p13l106t2569r416b2613],

1	lnnocenti	NN	O	lnnocentus	nn	2	SENT_230	[p13l107t2638r346b2682],
2	F	NN	O	f	_	0	SENT_230	[p13l374t2638r411b2692],
3	,	,	O	,	_	0	SENT_230	[p13l374t2638r411b2692],
4	Undevia	NNP	O	Undevia	nn	5	SENT_230	[p13l440t2634r658b2682],
5	SD	NN	O	sd	appos	2	SENT_230	[p13l681t2638r769b2692],
6	,	,	O	,	_	0	SENT_230	[p13l681t2638r769b2692],
7	Iyer	NNP	PERSON	Iyer	nn	8	SENT_230	[p13l797t2638r890b2697],
8	L	NNP	PERSON	L	appos	2	SENT_230	[p13l914t2638r952b2692],
9	,	,	O	,	_	0	SENT_230	[p13l914t2638r952b2692],
10	Chen	NNP	LOCATION	Chen	nn	11	SENT_230	[p13l978t2634r1111b2682],
11	PX	NNP	LOCATION	PX	appos	2	SENT_230	[p13l1138t2638r1216b2692],
12	,	,	O	,	_	0	SENT_230	[p13l1138t2638r1216b2692],
13	Das	NNP	O	Das	nn	14	SENT_230	[p13l1245t2638r1340b2682],
14	S	NNP	O	S	appos	2	SENT_230	[p13l1363t2638r1403b2692],
15	,	,	O	,	_	0	SENT_230	[p13l1363t2638r1403b2692],
16	Kocherginsky	NNP	O	Kocherginsky	nn	17	SENT_230	[p13l1431t2634r1779b2698],
17	M	NNP	O	M	appos	2	SENT_230	[p13l1802t2638r1851b2681],
18	et	FW	O	et	nn	19	SENT_230	[p13l106t2711r155b2750],
19	al.	FW	O	al.	dep	17	SENT_230	[p13l184t2702r241b2750],
20	.	.	O	.	_	0	SENT_230	[p13l184t2702r241b2750],

1	Genetic	JJ	O	genetic	amod	2	SENT_231	[p13l280t2705r483b2750],
2	variants	NNS	O	variant	nsubj	10	SENT_231	[p13l516t2705r718b2750],
3	in	IN	O	in	_	0	SENT_231	[p13l755t2705r797b2749],
4	the	DT	O	the	det	9	SENT_231	[p13l832t2702r912b2750],
5	UDP	NNP	O	UDP	nn	9	SENT_231	[p13l950t2702r1712b2765],
6	—	NN	O	—	nn	9	SENT_231	[p13l950t2702r1712b2765],
7	glucuronosyltransferase	NN	O	glucuronosyltransferase	nn	9	SENT_231	[p13l950t2702r1712b2765],
8	1A1	NN	O	1a1	nn	9	SENT_231	[p13l1750t2705r1840b2749],
9	gene	NN	O	gene	prep_in	2	SENT_231	[p13l104t2788r227b2835],
10	predict	VBP	O	predict	_	0	SENT_231	[p13l258t2772r440b2835],
11	the	DT	O	the	det	12	SENT_231	[p13l467t2772r547b2819],
12	risk	NN	O	risk	dobj	10	SENT_231	[p13l579t2772r667b2819],
13	of	IN	O	of	_	0	SENT_231	[p13l696t2771r747b2819],
14	severe	JJ	O	severe	amod	15	SENT_231	[p13l776t2788r939b2819],
15	neutropenia	NN	O	neutropenia	prep_of	12	SENT_231	[p13l971t2775r1281b2835],
16	of	IN	O	of	_	0	SENT_231	[p13l1312t2771r1363b2819],
17	irinotecan	NN	O	irinotecan	prep_of	15	SENT_231	[p13l1394t2775r1667b2819],
18	.	.	O	.	_	0	SENT_231	[p13l1394t2775r1667b2819],

1	/	:	O	/	punct	3	SENT_232	[p13l1696t2776r1719b2827],
2	Clin	NNP	O	Clin	nn	3	SENT_232	[p13l1750t2772r1853b2819],
3	Oncol	NNP	O	Oncol	_	0	SENT_232	[p13l108t2839r272b2887],
4	2004	CD	DATE	2004	dep	3	SENT_232	[p13l290t2844r438b2896],
5	;	:	O	;	_	0	SENT_232	[p13l290t2844r438b2896],
6	22	CD	NUMBER	22	dep	3	SENT_232	[p13l465t2844r543b2886],
7	:	:	O	:	_	0	SENT_232	[p13l465t2844r543b2886],
8	1382-1388	CD	DATE	1382-1388	dep	6	SENT_232	[p13l574t2843r882b2887],
9	.	.	O	.	_	0	SENT_232	[p13l574t2843r882b2887],

1	Danoff	NNP	PERSON	Danoff	nn	2	SENT_233	[p13l107t2907r285b2955],
2	TM	NNP	O	TM	_	0	SENT_233	[p13l304t2910r403b2964],
3	,	,	O	,	_	0	SENT_233	[p13l304t2910r403b2964],
4	Campbell	NNP	ORGANIZATION	Campbell	nn	5	SENT_233	[p13l430t2907r678b2970],
5	DA	NNP	ORGANIZATION	DA	appos	2	SENT_233	[p13l709t2910r804b2964],
6	,	,	O	,	_	0	SENT_233	[p13l709t2910r804b2964],
7	McCarthy	NNP	PERSON	McCarthy	nn	8	SENT_233	[p13l832t2907r1088b2970],
8	LC	NNP	O	LC	appos	2	SENT_233	[p13l1113t2910r1192b2964],
9	,	,	O	,	_	0	SENT_233	[p13l1113t2910r1192b2964],
10	Lewis	NNP	PERSON	Lewis	nn	11	SENT_233	[p13l1222t2910r1366b2955],
11	KF	NNP	O	KF	appos	2	SENT_233	[p13l1392t2911r1467b2964],
12	,	,	O	,	_	0	SENT_233	[p13l1392t2911r1467b2964],
13	Repasch	NNP	O	Repasch	nn	14	SENT_233	[p13l1498t2907r1710b2970],
14	MH	NNP	O	MH	appos	2	SENT_233	[p13l1736t2910r1848b2965],
15	,	,	O	,	_	0	SENT_233	[p13l1736t2910r1848b2965],
16	Saunders	NNP	ORGANIZATION	Saunders	nn	17	SENT_233	[p13l105t2977r338b3024],
17	AM	NNP	ORGANIZATION	AM	appos	2	SENT_233	[p13l360t2980r451b3024],
18	et	FW	O	et	nn	19	SENT_233	[p13l477t2986r525b3024],
19	al.	FW	O	al.	dep	17	SENT_233	[p13l543t2977r601b3024],
20	.	.	O	.	_	0	SENT_233	[p13l543t2977r601b3024],

1	A	DT	O	a	det	2	SENT_234	[p13l625t2980r664b3024],
2	Gilbert	NNP	PERSON	Gilbert	poss	6	SENT_234	[p13l687t2977r908b3024],
3	’s	POS	O	’s	_	0	SENT_234	[p13l687t2977r908b3024],
4	syndrome	NN	O	syndrome	nn	6	SENT_234	[p13l930t2977r1185b3040],
5	UGT1	NN	O	ugt1	nn	6	SENT_234	[p13l1211t2980r1356b3024],
6	A1	NN	O	a1	nsubj	8	SENT_234	[p13l1371t2980r1431b3024],
7	variant	JJ	O	variant	amod	6	SENT_234	[p13l1464t2980r1644b3024],
8	confers	VBZ	O	confer	_	0	SENT_234	[p13l1665t2976r1851b3024],
9	susceptibility	NN	O	susceptibility	dobj	8	SENT_234	[p13l104t3045r445b3108],
10	to	TO	O	to	aux	11	SENT_234	[p13l474t3054r522b3092],
11	tranilast	VB	O	tranilast	xcomp	8	SENT_234	[p13l551t3045r990b3092],
12	—	NN	O	—	dobj	11	SENT_234	[p13l551t3045r990b3092],
13	induced	VBN	O	induce	partmod	12	SENT_234	[p13l551t3045r990b3092],
14	hyperbilirubinemia	NN	O	hyperbilirubinemia	dobj	13	SENT_234	[p13l1024t3045r1536b3108],
15	.	.	O	.	_	0	SENT_234	[p13l1024t3045r1536b3108],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_235	[p13l1573t3045r1854b3092, p13l102t3116r356b3176],
2	/	:	O	/	punct	3	SENT_235	[p13l371t3117r394b3168],
3	2004	CD	DATE	2004	dep	1	SENT_235	[p13l413t3118r560b3170],
4	;	:	O	;	_	0	SENT_235	[p13l413t3118r560b3170],
5	4	CD	NUMBER	4	num	7	SENT_235	[p13l587t3118r632b3160],
6	:	:	O	:	_	0	SENT_235	[p13l587t3118r632b3160],
7	49-53	CD	NUMBER	49-53	dep	3	SENT_235	[p13l658t3118r836b3160],
8	.	.	O	.	_	0	SENT_235	[p13l658t3118r836b3160],

1	Zucker	NNP	O	Zucker	nn	2	SENT_236	[p13l106t3180r289b3227],
2	SD	NN	O	sd	_	0	SENT_236	[p13l310t3183r397b3237],
3	,	,	O	,	_	0	SENT_236	[p13l310t3183r397b3237],
4	Qin	NN	O	qin	nn	5	SENT_236	[p13l422t3183r518b3240],
5	X	NN	O	x	appos	2	SENT_236	[p13l542t3184r589b3237],
6	,	,	O	,	_	0	SENT_236	[p13l542t3184r589b3237],
7	Rouster	NNP	O	Rouster	nn	8	SENT_236	[p13l617t3184r809b3227],
8	SD	NN	O	sd	appos	5	SENT_236	[p13l830t3183r918b3237],
9	,	,	O	,	_	0	SENT_236	[p13l830t3183r918b3237],
10	Yu	NN	O	yu	nn	11	SENT_236	[p13l941t3184r1007b3227],
11	F	NN	O	f	appos	5	SENT_236	[p13l1034t3184r1072b3237],
12	,	,	O	,	_	0	SENT_236	[p13l1034t3184r1072b3237],
13	Green	NNP	O	Green	nn	14	SENT_236	[p13l1098t3183r1254b3228],
14	RM	NN	O	rm	appos	5	SENT_236	[p13l1280t3183r1379b3237],
15	,	,	O	,	_	0	SENT_236	[p13l1280t3183r1379b3237],
16	Keshavan	NNP	O	Keshavan	nn	18	SENT_236	[p13l1407t3180r1650b3227],
17	P	NN	O	p	nn	18	SENT_236	[p13l1677t3184r1704b3227],
18	etal	NN	O	etal	appos	5	SENT_236	[p13l1727t3180r1849b3227],
19	.	.	O	.	_	0	SENT_236	[p13l1727t3180r1849b3227],

1	Mechanism	NN	O	mechanism	nsubj	5	SENT_237	[p13l108t3250r408b3297],
2	of	IN	O	of	_	0	SENT_237	[p13l447t3249r497b3297],
3	indinavir	NN	O	indinavir	nn	4	SENT_237	[p13l534t3250r996b3297],
4	—	NN	O	—	prep_of	1	SENT_237	[p13l534t3250r996b3297],
5	induced	VBD	O	induce	_	0	SENT_237	[p13l534t3250r996b3297],
6	hyperbilirubinemia	NN	O	hyperbilirubinemia	dobj	5	SENT_237	[p13l1037t3250r1550b3313],
7	.	.	O	.	_	0	SENT_237	[p13l1037t3250r1550b3313],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_238	[p13l1593t3254r1709b3297],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_238	[p13l1745t3250r1857b3297],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_238	[p13l106t3317r247b3365],
4	SCI	NNP	ORGANIZATION	SCI	nn	5	SENT_238	[p13l265t3321r343b3365],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_238	[p13l369t3321r480b3365],
6	2001	CD	DATE	2001	num	5	SENT_238	[p13l502t3321r649b3374],
7	;	:	O	;	_	0	SENT_238	[p13l502t3321r649b3374],
8	98	CD	NUMBER	98	num	10	SENT_238	[p13l676t3322r754b3365],
9	:	:	O	:	_	0	SENT_238	[p13l676t3322r754b3365],
10	12671-12676	CD	NUMBER	12671-12676	dep	5	SENT_238	[p13l785t3322r1161b3365],
11	.	.	O	.	_	0	SENT_238	[p13l785t3322r1161b3365],

1	Kantarjian	JJ	MISC	kantarjian	amod	2	SENT_239	[p13l110t3388r371b3448],
2	H	NN	O	h	_	0	SENT_239	[p13l429t3389r483b3443],
3	,	,	O	,	_	0	SENT_239	[p13l429t3389r483b3443],
4	Giles	NNP	PERSON	Giles	nn	5	SENT_239	[p13l541t3385r673b3433],
5	F	NN	O	f	appos	2	SENT_239	[p13l728t3389r766b3442],
6	,	,	O	,	_	0	SENT_239	[p13l728t3389r766b3442],
7	Wunderle	NNP	PERSON	Wunderle	nn	8	SENT_239	[p13l820t3385r1081b3433],
8	L	NNP	PERSON	L	appos	2	SENT_239	[p13l1136t3389r1174b3442],
9	,	,	O	,	_	0	SENT_239	[p13l1136t3389r1174b3442],
10	Bhalla	NNP	PERSON	Bhalla	nn	11	SENT_239	[p13l1233t3385r1394b3433],
11	K	NNP	PERSON	K	appos	2	SENT_239	[p13l1449t3389r1494b3443],
12	,	,	O	,	_	0	SENT_239	[p13l1449t3389r1494b3443],
13	O'Brien	NNP	PERSON	O'Brien	nn	14	SENT_239	[p13l1550t3388r1753b3433],
14	S	NNP	O	S	appos	2	SENT_239	[p13l1807t3388r1847b3442],
15	,	,	O	,	_	0	SENT_239	[p13l1807t3388r1847b3442],
16	Wassmann	NNP	PERSON	Wassmann	nn	17	SENT_239	[p13l106t3458r391b3501],
17	B	NNP	O	B	appos	2	SENT_239	[p13l442t3458r470b3500],
18	et	FW	O	et	nn	19	SENT_239	[p13l522t3463r570b3501],
19	al.	FW	O	al.	dep	17	SENT_239	[p13l612t3454r670b3501],
20	.	.	O	.	_	0	SENT_239	[p13l612t3454r670b3501],

1	Nilotinib	NNP	O	Nilotinib	_	0	SENT_240	[p13l721t3454r950b3501],
2	in	IN	O	in	_	0	SENT_240	[p13l1000t3457r1042b3500],
3	imatinib-resistant	JJ	O	imatinib-resistant	amod	4	SENT_240	[p13l1094t3454r1543b3501],
4	CML	NN	ORGANIZATION	cml	prep_in	1	SENT_240	[p13l1588t3457r1709b3501],
5	and	CC	O	and	cc	4	SENT_240	[p13l1757t3454r1850b3501],

1	Philadelphia	NNP	LOCATION	Philadelphia	nn	3	SENT_241	[p14l110t17r434b80],
2	chromosome	NN	O	chromosome	nn	3	SENT_241	[p14l478t17r1043b80],
3	—	NN	O	—	_	0	SENT_241	[p14l478t17r1043b80],
4	positive	JJ	O	positive	amod	5	SENT_241	[p14l478t17r1043b80],
5	ALL	NN	O	all	dep	3	SENT_241	[p14l1085t20r1199b64],
6	.	.	O	.	_	0	SENT_241	[p14l1085t20r1199b64],

1	N	NN	O	n	nn	3	SENT_242	[p14l1249t20r1294b65],
2	Engl	NNP	O	Engl	nn	3	SENT_242	[p14l1337t17r1504b80],
3	]	NNP	O	]	nsubj	4	SENT_242	[p14l1337t17r1504b80],
4	Med	VBD	O	med	_	0	SENT_242	[p14l1544t17r1667b64],
5	2006	CD	DATE	2006	dobj	4	SENT_242	[p14l1701t22r1848b74],
6	;	:	O	;	_	0	SENT_242	[p14l1701t22r1848b74],
7	354:2542	CD	NUMBER	354:2542	number	8	SENT_242	[p14l108t89r558b133],
8	—	CD	NUMBER	—	dep	5	SENT_242	[p14l108t89r558b133],
9	2551	CD	DATE	2551	dep	8	SENT_242	[p14l108t89r558b133],
10	.	.	O	.	_	0	SENT_242	[p14l108t89r558b133],

1	Kantarjian	JJ	O	kantarjian	amod	2	SENT_243	[p14l110t156r371b216],
2	HM	NNS	O	hm	_	0	SENT_243	[p14l399t156r508b210],
3	,	,	O	,	_	0	SENT_243	[p14l399t156r508b210],
4	Gattermann	NNP	PERSON	Gattermann	nn	5	SENT_243	[p14l536t156r842b201],
5	N	NNP	PERSON	N	appos	2	SENT_243	[p14l871t156r925b210],
6	,	,	O	,	_	0	SENT_243	[p14l871t156r925b210],
7	Hochhaus	NNP	O	Hochhaus	nn	8	SENT_243	[p14l955t153r1216b201],
8	A	NNP	O	A	appos	2	SENT_243	[p14l1238t156r1290b211],
9	,	,	O	,	_	0	SENT_243	[p14l1238t156r1290b211],
10	Larson	NNP	PERSON	Larson	nn	11	SENT_243	[p14l1320t157r1484b201],
11	R	NNP	PERSON	R	appos	2	SENT_243	[p14l1512t157r1556b211],
12	,	,	O	,	_	0	SENT_243	[p14l1512t157r1556b211],
13	Rafferty	NNP	ORGANIZATION	Rafferty	nn	14	SENT_243	[p14l1586t153r1782b216],
14	T	NN	ORGANIZATION	t	appos	2	SENT_243	[p14l1803t157r1847b211],
15	,	,	O	,	_	0	SENT_243	[p14l1803t157r1847b211],
16	Weitzman	NNP	PERSON	Weitzman	nn	17	SENT_243	[p14l106t226r375b270],
17	A	NNP	O	A	appos	2	SENT_243	[p14l402t226r441b270],
18	et	FW	O	et	nn	19	SENT_243	[p14l469t232r518b270],
19	al.	FW	O	al.	dep	17	SENT_243	[p14l540t223r598b270],
20	.	.	O	.	_	0	SENT_243	[p14l540t223r598b270],

1	A	DT	O	a	det	4	SENT_244	[p14l626t226r665b270],
2	Phase	NN	O	phase	nn	4	SENT_244	[p14l694t223r841b270],
3	II	CD	NUMBER	ii	num	4	SENT_244	[p14l870t227r894b270],
4	study	NN	O	study	nsubj	13	SENT_244	[p14l925t223r1061b286],
5	of	IN	O	of	_	0	SENT_244	[p14l1087t222r1138b270],
6	nilotinib	NN	O	nilotinib	prep_of	4	SENT_244	[p14l1164t223r1394b280],
7	,	,	O	,	_	0	SENT_244	[p14l1164t223r1394b280],
8	a	DT	O	a	det	12	SENT_244	[p14l1424t239r1451b270],
9	novel	JJ	O	novel	amod	12	SENT_244	[p14l1480t223r1617b270],
10	tyrosine	NN	O	tyrosine	nn	12	SENT_244	[p14l1646t226r1852b286],
11	kinase	NN	O	kinase	nn	12	SENT_244	[p14l109t290r271b338],
12	inhibitor	NN	O	inhibitor	appos	6	SENT_244	[p14l300t290r520b338],
13	administered	VBN	O	administer	conj_and	13	SENT_244	[p14l546t290r882b338],
14	to	TO	O	to	_	0	SENT_244	[p14l908t299r957b338],
15	imatinib-resistant	JJ	O	imatinib-resistant	prep_to	13	SENT_244	[p14l986t290r1436b338],
16	and	CC	O	and	_	0	SENT_244	[p14l1461t290r1554b338],
17	-	:	O	-	_	0	SENT_244	[p14l1582t290r1854b338],
18	intolerant	JJ	O	intolerant	amod	19	SENT_244	[p14l1582t290r1854b338],
19	patients	NNS	O	patient	dep	26	SENT_244	[p14l108t361r308b421],
20	with	IN	O	with	_	0	SENT_244	[p14l327t358r439b406],
21	chronic	JJ	O	chronic	amod	23	SENT_244	[p14l462t358r659b406],
22	myelogenous	JJ	O	myelogenous	amod	23	SENT_244	[p14l682t358r1026b421],
23	leukemia	NN	O	leukemia	prep_with	19	SENT_244	[p14l1050t358r1286b406],
24	(	CD	NUMBER	(	num	26	SENT_244	[p14l1308t361r1461b413],
25	CML	NN	ORGANIZATION	cml	nn	26	SENT_244	[p14l1308t361r1461b413],
26	)	NN	O	)	dep	13	SENT_244	[p14l1308t361r1461b413],
27	in	IN	O	in	_	0	SENT_244	[p14l1487t361r1529b405],
28	accelerated	VBN	O	accelerate	amod	29	SENT_244	[p14l1551t358r1850b406],
29	phase	NN	O	phase	prep_in	13	SENT_244	[p14l108t426r257b489],
30	(	CD	NUMBER	(	num	32	SENT_244	[p14l313t429r431b481],
31	AP	NN	O	ap	nn	32	SENT_244	[p14l313t429r431b481],
32	)	NN	O	)	dep	29	SENT_244	[p14l313t429r431b481],
33	.	.	O	.	_	0	SENT_244	[p14l313t429r431b481],

1	Blood	NN	O	blood	nn	3	SENT_245	[p14l493t426r650b474],
2	(	CD	NUMBER	(	num	3	SENT_245	[p14l702t429r836b481],
3	ASH	NNP	O	ASH	_	0	SENT_245	[p14l702t429r836b481],
4	Annual	JJ	SET	annual	dep	3	SENT_245	[p14l885t426r1078b474],
5	Meeting	VBG	O	meet	partmod	3	SENT_245	[p14l1129t429r1346b489],
6	Abstracts	NNS	O	abstract	dobj	5	SENT_245	[p14l1394t426r1649b481],
7	)	CD	NUMBER	)	num	8	SENT_245	[p14l1394t426r1649b481],
8	2006	CD	DATE	2006	dep	6	SENT_245	[p14l1701t431r1848b483],
9	;	:	O	;	_	0	SENT_245	[p14l1701t431r1848b483],
10	108:2169	CD	NUMBER	108:2169	dep	6	SENT_245	[p14l109t499r393b543],
11	.	.	O	.	_	0	SENT_245	[p14l109t499r393b543],

1	le	DT	O	le	det	3	SENT_246	[p14l110t564r152b612],
2	Coutre	NNP	O	Coutre	nn	3	SENT_246	[p14l183t568r356b612],
3	P	NN	O	p	_	0	SENT_246	[p14l390t568r431b622],
4	,	,	O	,	_	0	SENT_246	[p14l390t568r431b622],
5	Bhalla	NNP	PERSON	Bhalla	nn	6	SENT_246	[p14l469t564r630b612],
6	K	NNP	O	K	appos	3	SENT_246	[p14l664t568r708b622],
7	,	,	O	,	_	0	SENT_246	[p14l664t568r708b622],
8	Giles	NNP	PERSON	Giles	nn	9	SENT_246	[p14l744t564r876b612],
9	F	NN	O	f	appos	3	SENT_246	[p14l910t568r947b622],
10	,	,	O	,	_	0	SENT_246	[p14l910t568r947b622],
11	Baccarani	NNP	O	Baccarani	nn	12	SENT_246	[p14l985t568r1238b612],
12	M	NNP	O	M	appos	3	SENT_246	[p14l1273t568r1337b622],
13	,	,	O	,	_	0	SENT_246	[p14l1273t568r1337b622],
14	Ossenkoppele	NNP	O	Ossenkoppele	nn	15	SENT_246	[p14l1372t564r1742b628],
15	GJ	NNP	O	GJ	appos	3	SENT_246	[p14l1774t568r1848b622],
16	,	,	O	,	_	0	SENT_246	[p14l1774t568r1848b622],
17	Hochhaus	NNP	O	Hochhaus	nn	18	SENT_246	[p14l110t632r372b680],
18	A	NNP	O	A	appos	3	SENT_246	[p14l398t635r437b679],
19	et	FW	O	et	nn	20	SENT_246	[p14l466t641r514b680],
20	al.	FW	O	al.	dep	18	SENT_246	[p14l537t632r594b680],
21	.	.	O	.	_	0	SENT_246	[p14l537t632r594b680],

1	A	DT	O	a	det	4	SENT_247	[p14l623t635r662b679],
2	Phase	NN	O	phase	nn	4	SENT_247	[p14l692t632r838b680],
3	II	CD	NUMBER	ii	num	4	SENT_247	[p14l868t636r892b679],
4	study	NN	O	study	_	0	SENT_247	[p14l923t632r1059b695],
5	of	IN	O	of	_	0	SENT_247	[p14l1086t632r1136b680],
6	nilotinib	NN	O	nilotinib	prep_of	4	SENT_247	[p14l1162t632r1392b689],
7	,	,	O	,	_	0	SENT_247	[p14l1162t632r1392b689],
8	a	DT	O	a	det	12	SENT_247	[p14l1423t649r1450b680],
9	novel	JJ	O	novel	amod	12	SENT_247	[p14l1480t632r1616b680],
10	tyrosine	NN	O	tyrosine	nn	12	SENT_247	[p14l1646t635r1852b695],
11	kinase	NN	O	kinase	nn	12	SENT_247	[p14l109t701r271b748],
12	inhibitor	NN	O	inhibitor	appos	4	SENT_247	[p14l300t701r520b748],
13	administered	VBN	O	administer	partmod	12	SENT_247	[p14l546t701r882b748],
14	to	TO	O	to	_	0	SENT_247	[p14l908t710r957b748],
15	imatinib-resistant	JJ	O	imatinib-resistant	prep_to	13	SENT_247	[p14l986t701r1436b748],
16	and	CC	O	and	_	0	SENT_247	[p14l1461t701r1554b748],
17	-	:	O	-	_	0	SENT_247	[p14l1582t701r1854b748],
18	intolerant	JJ	O	intolerant	amod	19	SENT_247	[p14l1582t701r1854b748],
19	patients	NNS	O	patient	dep	26	SENT_247	[p14l108t773r308b832],
20	with	IN	O	with	_	0	SENT_247	[p14l342t769r454b817],
21	chronic	JJ	O	chronic	amod	23	SENT_247	[p14l492t769r688b817],
22	myelogenous	JJ	O	myelogenous	amod	23	SENT_247	[p14l726t770r1070b833],
23	leukemia	NN	O	leukemia	prep_with	19	SENT_247	[p14l1109t769r1344b817],
24	(	CD	NUMBER	(	num	26	SENT_247	[p14l1381t773r1535b824],
25	CML	NN	ORGANIZATION	cml	nn	26	SENT_247	[p14l1381t773r1535b824],
26	)	NN	O	)	dep	13	SENT_247	[p14l1381t773r1535b824],
27	in	IN	O	in	_	0	SENT_247	[p14l1575t773r1617b817],
28	chronic	JJ	O	chronic	amod	29	SENT_247	[p14l1654t769r1851b817],
29	phase	NN	O	phase	prep_in	13	SENT_247	[p14l108t837r257b900],
30	(	CD	NUMBER	(	num	35	SENT_247	[p14l313t840r431b892],
31	CPL	NNP	O	CPL	nn	35	SENT_247	[p14l313t840r431b892],
32	Bkxxl	NNP	O	Bkxxl	nn	35	SENT_247	[p14l493t837r651b885],
33	04SFl	NNP	O	04SFl	nn	35	SENT_247	[p14l702t840r836b892],
34	Annual	JJ	SET	annual	amod	35	SENT_247	[p14l885t837r1078b885],
35	AAeeﬁng	NN	O	aaeeﬁng	dobj	13	SENT_247	[p14l1129t837r1649b900],
36	'	''	O	'	_	0	SENT_247	[p14l1129t837r1649b900],
37	,	,	O	,	_	0	SENT_247	[p14l1129t837r1649b900],
38	AbsUacB	NN	O	absuacb	appos	12	SENT_247	[p14l1129t837r1649b900],
39	)	CD	NUMBER	)	num	38	SENT_247	[p14l1129t837r1649b900],
40	2006	CD	DATE	2006	num	42	SENT_247	[p14l1701t842r1848b894],
41	;	:	O	;	_	0	SENT_247	[p14l1701t842r1848b894],
42	108:165	CD	NUMBER	108:165	dep	38	SENT_247	[p14l109t910r359b953],
43	.	.	O	.	_	0	SENT_247	[p14l109t910r359b953],

1	Cancer	NN	O	cancer	nn	4	SENT_248	[p14l107t978r292b1023],
2	Therapy	NN	O	therapy	nn	4	SENT_248	[p14l325t975r538b1038],
3	Evaluation	NN	O	evaluation	nn	4	SENT_248	[p14l575t975r842b1022],
4	Program	NN	O	program	_	0	SENT_248	[p14l883t979r1111b1038],
5	,	,	O	,	_	0	SENT_248	[p14l883t979r1111b1038],
6	National	NNP	ORGANIZATION	National	nn	8	SENT_248	[p14l1153t975r1371b1023],
7	Cancer	NNP	ORGANIZATION	Cancer	nn	8	SENT_248	[p14l1411t978r1595b1023],
8	Institute	NNP	ORGANIZATION	Institute	appos	4	SENT_248	[p14l1633t978r1848b1022],
9	.	.	O	.	_	0	SENT_248	[p14l1633t978r1848b1022],

1	Connnon	NNP	PERSON	Connnon	nn	6	SENT_249	[p14l107t1047r346b1091],
2	Tennhuﬂogy	NNP	PERSON	Tennhuﬂogy	nn	6	SENT_249	[p14l385t1043r717b1107],
3	Ckﬁena	NNP	PERSON	Ckﬁena	nn	6	SENT_249	[p14l754t1047r946b1091],
4	kw	NN	O	kw	nn	6	SENT_249	[p14l982t1043r1052b1091],
5	Adveme	NNP	O	Adveme	nn	6	SENT_249	[p14l1088t1043r1297b1091],
6	Evenm	NNP	O	Evenm	_	0	SENT_249	[p14l1337t1047r1497b1091],
7	v31l	NN	O	v31l	dep	6	SENT_249	[p14l1534t1048r1661b1091],
8	2006	CD	DATE	2006	num	7	SENT_249	[p14l1701t1048r1848b1091],
9	.	.	O	.	_	0	SENT_249	[p14l1701t1048r1848b1091],

1	Available	JJ	O	available	_	0	SENT_250	[p14l106t1111r354b1159],
2	from	IN	O	from	_	0	SENT_250	[p14l376t1111r494b1159],
3	http://ctep.cancer.gov/reporting/ctc_v30.html	NN	O	http://ctep.cancer.gov/reporting/ctc_v30.html	prep_from	1	SENT_250	[p14l523t1111r1721b1174],
4	.	.	O	.	_	0	SENT_250	[p14l523t1111r1721b1174],

1	Maitland	NNP	PERSON	Maitland	nn	2	SENT_251	[p14l108t1180r338b1228],
2	ML	NNP	O	ML	_	0	SENT_251	[p14l367t1183r462b1237],
3	,	,	O	,	_	0	SENT_251	[p14l367t1183r462b1237],
4	Vasisht	NNP	PERSON	Vasisht	nn	5	SENT_251	[p14l492t1180r679b1228],
5	K	NNP	PERSON	K	appos	2	SENT_251	[p14l707t1184r752b1237],
6	,	,	O	,	_	0	SENT_251	[p14l707t1184r752b1237],
7	Ratain	NNP	O	Ratain	nn	8	SENT_251	[p14l787t1183r945b1228],
8	MJ	NNP	O	MJ	appos	5	SENT_251	[p14l976t1183r1057b1236],
9	.	.	O	.	_	0	SENT_251	[p14l976t1183r1057b1236],

1	TPMT	NNP	O	TPMT	_	0	SENT_252	[p14l1087t1183r1254b1237],
2	,	,	O	,	_	0	SENT_252	[p14l1087t1183r1254b1237],
3	UGT1A1	NN	O	ugt1a1	nsubj	7	SENT_252	[p14l1288t1183r1508b1228],
4	and	CC	O	and	_	0	SENT_252	[p14l1548t1180r1642b1228],
5	DPYD	NN	O	dpyd	conj_and	3	SENT_252	[p14l1674t1184r1848b1228],
6	:	:	O	:	_	0	SENT_252	[p14l1674t1184r1848b1228],
7	genotyping	VBG	O	genotype	dep	1	SENT_252	[p14l107t1253r397b1313],
8	to	TO	O	to	aux	9	SENT_252	[p14l420t1258r469b1297],
9	ensure	VB	O	ensure	xcomp	7	SENT_252	[p14l494t1266r664b1297],
10	safer	JJR	O	safer	amod	12	SENT_252	[p14l689t1249r809b1297],
11	cancer	NN	O	cancer	nn	12	SENT_252	[p14l833t1266r1008b1297],
12	therapy	NN	O	therapy	dobj	9	SENT_252	[p14l1030t1249r1248b1313],
13	?	.	O	?	_	0	SENT_252	[p14l1030t1249r1248b1313],

1	Trends	NNS	O	trend	_	0	SENT_253	[p14l1281t1249r1451b1297],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_253	[p14l1476t1249r1756b1297],
3	Sci	NNP	O	Sci	dep	1	SENT_253	[p14l1777t1253r1856b1297],
4	2006	CD	DATE	2006	num	3	SENT_253	[p14l106t1323r631b1375],
5	;	:	O	;	_	0	SENT_253	[p14l106t1323r631b1375],
6	27:432	CD	NUMBER	27:432	num	7	SENT_253	[p14l106t1323r631b1375],
7	-437	CD	NUMBER	-437	dep	1	SENT_253	[p14l106t1323r631b1375],
8	.	.	O	.	_	0	SENT_253	[p14l106t1323r631b1375],

1	Monaghan	NNP	PERSON	Monaghan	nn	2	SENT_254	[p14l108t1386r383b1449],
2	G	NNP	O	G	dep	18	SENT_254	[p14l418t1389r474b1443],
3	,	,	O	,	_	0	SENT_254	[p14l418t1389r474b1443],
4	McLellan	NNP	PERSON	McLellan	nn	5	SENT_254	[p14l510t1386r749b1434],
5	A	NNP	O	A	appos	2	SENT_254	[p14l781t1389r833b1443],
6	,	,	O	,	_	0	SENT_254	[p14l781t1389r833b1443],
7	McGeehan	NNP	PERSON	McGeehan	nn	8	SENT_254	[p14l869t1386r1154b1434],
8	A	NNP	O	A	appos	2	SENT_254	[p14l1187t1389r1239b1443],
9	,	,	O	,	_	0	SENT_254	[p14l1187t1389r1239b1443],
10	Li	NNP	PERSON	Li	nn	12	SENT_254	[p14l1277t1389r1314b1433],
11	Volti	NNP	PERSON	Volti	nn	12	SENT_254	[p14l1348t1386r1468b1434],
12	S	NN	O	s	appos	2	SENT_254	[p14l1504t1389r1543b1444],
13	,	,	O	,	_	0	SENT_254	[p14l1504t1389r1543b1444],
14	Mollica	NNP	PERSON	Mollica	nn	15	SENT_254	[p14l1579t1386r1776b1434],
15	F	NN	O	f	appos	2	SENT_254	[p14l1810t1390r1847b1443],
16	,	,	O	,	_	0	SENT_254	[p14l1810t1390r1847b1443],
17	Salemi	NNS	PERSON	salemus	appos	2	SENT_254	[p14l108t1455r278b1503],
18	I	PRP	O	I	_	0	SENT_254	[p14l324t1459r330b1502],
19	et	FW	O	et	nn	20	SENT_254	[p14l376t1464r425b1502],
20	al.	FW	O	al.	dep	18	SENT_254	[p14l460t1455r517b1502],
21	.	.	O	.	_	0	SENT_254	[p14l460t1455r517b1502],

1	Gilbert	NNP	PERSON	Gilbert	poss	3	SENT_255	[p14l561t1455r782b1503],
2	's	POS	O	's	_	0	SENT_255	[p14l561t1455r782b1503],
3	syndrome	NN	O	syndrome	nsubj	7	SENT_255	[p14l821t1455r1076b1518],
4	is	VBZ	O	be	cop	7	SENT_255	[p14l1118t1458r1152b1502],
5	a	DT	O	a	det	7	SENT_255	[p14l1192t1471r1219b1502],
6	contributory	JJ	O	contributory	amod	7	SENT_255	[p14l1259t1455r1579b1518],
7	factor	NN	O	factor	_	0	SENT_255	[p14l1616t1455r1766b1502],
8	in	IN	O	in	_	0	SENT_255	[p14l1807t1458r1849b1502],
9	prolonged	JJ	O	prolonged	amod	11	SENT_255	[p14l108t1523r371b1587],
10	unconjugated	JJ	O	unconjugated	amod	11	SENT_255	[p14l424t1523r777b1587],
11	hyperbilirubinemia	NN	O	hyperbilirubinemia	prep_in	7	SENT_255	[p14l830t1523r1329b1586],
12	of	IN	O	of	_	0	SENT_255	[p14l1378t1523r1429b1571],
13	the	DT	O	the	det	14	SENT_255	[p14l1474t1523r1554b1571],
14	newborn	JJ	O	newborn	prep_of	11	SENT_255	[p14l1606t1523r1848b1571],
15	.	.	O	.	_	0	SENT_255	[p14l1606t1523r1848b1571],

1	,	,	O	,	_	0	SENT_256	[p14l101t1591r907b1648],
2	IPbdkUr1999	NN	O	ipbdkur1999	_	0	SENT_256	[p14l101t1591r907b1648],
3	;	:	O	;	_	0	SENT_256	[p14l101t1591r907b1648],
4	134:441	CD	NUMBER	134:441	num	5	SENT_256	[p14l101t1591r907b1648],
5	—	NN	O	—	dep	2	SENT_256	[p14l101t1591r907b1648],
6	446	CD	NUMBER	446	dep	5	SENT_256	[p14l101t1591r907b1648],
7	.	.	O	.	_	0	SENT_256	[p14l101t1591r907b1648],

1	Ferraris	NNP	O	Ferraris	nn	2	SENT_257	[p14l110t1663r298b1708],
2	A	NNP	O	A	nsubj	35	SENT_257	[p14l345t1663r397b1717],
3	,	,	O	,	_	0	SENT_257	[p14l345t1663r397b1717],
4	D’Amato	NNP	O	D’Amato	nn	5	SENT_257	[p14l453t1663r686b1708],
5	G	NNP	O	G	conj_and	2	SENT_257	[p14l735t1663r792b1717],
6	,	,	O	,	_	0	SENT_257	[p14l735t1663r792b1717],
7	Nobili	NNP	PERSON	Nobili	nn	8	SENT_257	[p14l847t1660r1005b1708],
8	V	NNP	O	V	conj_and	2	SENT_257	[p14l1056t1664r1108b1717],
9	,	,	O	,	_	0	SENT_257	[p14l1056t1664r1108b1717],
10	Torres	NNP	PERSON	Torres	nn	11	SENT_257	[p14l1159t1664r1320b1708],
11	B	NNP	PERSON	B	conj_and	2	SENT_257	[p14l1371t1664r1416b1717],
12	,	,	O	,	_	0	SENT_257	[p14l1371t1664r1416b1717],
13	Marcellini	NNP	O	Marcellini	nn	14	SENT_257	[p14l1469t1660r1732b1708],
14	M	NNP	O	M	conj_and	2	SENT_257	[p14l1784t1663r1847b1717],
15	,	,	O	,	_	0	SENT_257	[p14l1784t1663r1847b1717],
16	Dallapiccola	NNP	PERSON	Dallapiccola	nn	19	SENT_257	[p14l110t1729r442b1792],
17	B.	NNP	O	B.	nn	19	SENT_257	[p14l485t1733r530b1776],
18	Combined	NNP	O	Combined	nn	19	SENT_257	[p14l573t1729r844b1777],
19	test	NN	O	test	nsubj	35	SENT_257	[p14l882t1738r971b1776],
20	for	IN	O	for	_	0	SENT_257	[p14l1008t1729r1078b1776],
21	UGT1A1	NN	O	ugt1a1	nn	23	SENT_257	[p14l1120t1732r1340b1777],
22	—	CD	NUMBER	—	num	23	SENT_257	[p14l1391t1732r1714b1777],
23	3279T	NN	O	3279t	prep_for	19	SENT_257	[p14l1391t1732r1714b1777],
24	—	CD	NUMBER	—	num	23	SENT_257	[p14l1391t1732r1714b1777],
25	>	JJR	O	>	amod	26	SENT_257	[p14l1391t1732r1714b1777],
26	G	NN	O	g	dep	19	SENT_257	[p14l1391t1732r1714b1777],
27	and	CC	O	and	_	0	SENT_257	[p14l1757t1729r1850b1776],
28	A	DT	O	a	det	33	SENT_257	[p14l106t1801r405b1852],
29	(	CD	NUMBER	(	num	33	SENT_257	[p14l106t1801r405b1852],
30	TA	NNP	O	TA	nn	33	SENT_257	[p14l106t1801r405b1852],
31	)	CD	NUMBER	)	num	33	SENT_257	[p14l106t1801r405b1852],
32	nTAA	NN	O	ntaa	nn	33	SENT_257	[p14l106t1801r405b1852],
33	polymorphisms	NNS	O	polymorphism	nsubj	35	SENT_257	[p14l440t1797r841b1861],
34	best	JJS	O	best	dep	2	SENT_257	[p14l878t1797r980b1845],
35	predicts	VBZ	O	predict	_	0	SENT_257	[p14l1016t1797r1219b1861],
36	Gilbert	NNP	PERSON	Gilbert	poss	38	SENT_257	[p14l1256t1797r1477b1845],
37	's	POS	O	's	_	0	SENT_257	[p14l1256t1797r1477b1845],
38	syndrome	NN	O	syndrome	dobj	35	SENT_257	[p14l1513t1797r1769b1860],
39	in	IN	O	in	_	0	SENT_257	[p14l1807t1801r1849b1844],
40	Hahan	NNP	LOCATION	Hahan	nn	42	SENT_257	[p14l110t1865r1618b1928],
41	[	CD	NUMBER	[	num	42	SENT_257	[p14l110t1865r1618b1928],
42	xxhauk	NN	O	xxhauk	prep_in	38	SENT_257	[p14l110t1865r1618b1928],
43	:	:	O	:	_	0	SENT_257	[p14l110t1865r1618b1928],
44	paﬁenm	NN	O	paﬁenm	dep	38	SENT_257	[p14l110t1865r1618b1928],
45	.	.	O	.	_	0	SENT_257	[p14l110t1865r1618b1928],

1	(	NN	O	(	nn	2	SENT_258	[p14l110t1865r1618b1928],
2	3enetTest2006	NN	O	3enettest2006	_	0	SENT_258	[p14l110t1865r1618b1928],
3	;	:	O	;	_	0	SENT_258	[p14l110t1865r1618b1928],
4	10:121	CD	NUMBER	10:121	number	5	SENT_258	[p14l110t1865r1618b1928],
5	-125	CD	NUMBER	-125	dep	2	SENT_258	[p14l110t1865r1618b1928],
6	.	.	O	.	_	0	SENT_258	[p14l110t1865r1618b1928],

1	Rouits	JJ	O	rouits	amod	2	SENT_259	[p14l110t1937r267b1981],
2	E	NN	O	e	_	0	SENT_259	[p14l311t1938r348b1991],
3	,	,	O	,	_	0	SENT_259	[p14l311t1938r348b1991],
4	Boisdron	NNP	PERSON	Boisdron	appos	2	SENT_259	[p14l395t1934r780b1981],
5	.	.	O	.	_	0	SENT_259	[p14l395t1934r780b1981],

1	—	NN	O	—	_	0	SENT_260	[p14l395t1934r780b1981],
2	.	.	O	.	_	0	SENT_260	[p14l395t1934r780b1981],

1	Ce	NN	O	ce	_	0	SENT_261	[p14l395t1934r780b1981],
2	|	CD	NUMBER	|	num	1	SENT_261	[p14l395t1934r780b1981],
3	le	DT	O	le	det	4	SENT_261	[p14l395t1934r780b1981],
4	M	NN	O	m	nsubj	25	SENT_261	[p14l821t1937r885b1991],
5	,	,	O	,	_	0	SENT_261	[p14l821t1937r885b1991],
6	Dumont	NNP	O	Dumont	nn	7	SENT_261	[p14l932t1938r1145b1981],
7	A	NNP	O	A	appos	4	SENT_261	[p14l1182t1937r1234b1991],
8	,	,	O	,	_	0	SENT_261	[p14l1182t1937r1234b1991],
9	Guerin	NNP	PERSON	Guerin	nn	10	SENT_261	[p14l1279t1937r1456b1981],
10	O	NNP	PERSON	O	appos	4	SENT_261	[p14l1499t1937r1560b1991],
11	,	,	O	,	_	0	SENT_261	[p14l1499t1937r1560b1991],
12	Morel	NNP	PERSON	Morel	nn	13	SENT_261	[p14l1604t1934r1753b1981],
13	A	NNP	O	A	appos	4	SENT_261	[p14l1796t1937r1847b1991],
14	,	,	O	,	_	0	SENT_261	[p14l1796t1937r1847b1991],
15	Gamelin	NNP	O	Gamelin	nn	17	SENT_261	[p14l108t2002r330b2050],
16	E.	NNP	O	E.	nn	17	SENT_261	[p14l373t2006r410b2050],
17	Relevance	NNP	O	Relevance	appos	4	SENT_261	[p14l454t2002r721b2050],
18	of	IN	O	of	_	0	SENT_261	[p14l757t2002r808b2050],
19	different	JJ	O	different	amod	21	SENT_261	[p14l842t2002r1059b2050],
20	UGT1A1	NN	O	ugt1a1	nn	21	SENT_261	[p14l1097t2006r1317b2050],
21	polymorphisms	NNS	O	polymorphism	prep_of	17	SENT_261	[p14l1367t2002r1767b2066],
22	in	IN	O	in	_	0	SENT_261	[p14l1807t2006r1849b2049],
23	irinotecan	JJ	O	irinotecan	amod	24	SENT_261	[p14l110t2070r603b2118],
24	—	NN	O	—	prep_in	21	SENT_261	[p14l110t2070r603b2118],
25	induced	VBD	O	induce	rcmod	1	SENT_261	[p14l110t2070r603b2118],
26	toxicity	NN	O	toxicity	dobj	25	SENT_261	[p14l630t2073r837b2133],
27	:	:	O	:	_	0	SENT_261	[p14l630t2073r837b2133],
28	a	DT	O	a	det	32	SENT_261	[p14l867t2086r893b2118],
29	molecular	JJ	O	molecular	amod	32	SENT_261	[p14l923t2070r1184b2118],
30	and	CC	O	and	_	0	SENT_261	[p14l1210t2070r1303b2118],
31	clinical	JJ	O	clinical	conj_and	29	SENT_261	[p14l1332t2070r1520b2118],
32	study	NN	O	study	dep	1	SENT_261	[p14l1550t2070r1686b2133],
33	of	IN	O	of	_	0	SENT_261	[p14l1713t2070r1763b2118],
34	75	CD	NUMBER	75	num	35	SENT_261	[p14l1790t2075r1848b2118],
35	paﬁenm	NN	O	paﬁenm	prep_of	32	SENT_261	[p14l108t2139r1390b2202],
36	.	.	O	.	_	0	SENT_261	[p14l108t2139r1390b2202],

1	C	NN	O	c	nn	3	SENT_262	[p14l108t2139r1390b2202],
2	]	CD	NUMBER	]	num	3	SENT_262	[p14l108t2139r1390b2202],
3	H7ChncerRes2004	NN	O	h7chncerres2004	_	0	SENT_262	[p14l108t2139r1390b2202],
4	;	:	O	;	_	0	SENT_262	[p14l108t2139r1390b2202],
5	10:5151	CD	DURATION	10:5151	number	6	SENT_262	[p14l108t2139r1390b2202],
6	-5159	CD	DURATION	-5159	dep	3	SENT_262	[p14l108t2139r1390b2202],
7	.	.	O	.	_	0	SENT_262	[p14l108t2139r1390b2202],

1	Mercke	NNP	PERSON	Mercke	nn	2	SENT_263	[p14l108t2207r302b2254],
2	Odebergj	NNP	PERSON	Odebergj	nsubj	36	SENT_263	[p14l321t2207r595b2270],
3	,	,	O	,	_	0	SENT_263	[p14l321t2207r595b2270],
4	Andrade	NNP	PERSON	Andrade	nn	5	SENT_263	[p14l618t2207r840b2254],
5	J	NNP	PERSON	J	nsubj	36	SENT_263	[p14l856t2211r887b2264],
6	,	,	O	,	_	0	SENT_263	[p14l856t2211r887b2264],
7	Holmberg	NNP	PERSON	Holmberg	nn	8	SENT_263	[p14l914t2207r1174b2270],
8	K	NNP	PERSON	K	conj_and	2	SENT_263	[p14l1196t2211r1240b2264],
9	,	,	O	,	_	0	SENT_263	[p14l1196t2211r1240b2264],
10	Hoglund	NNP	PERSON	Hoglund	nn	11	SENT_263	[p14l1267t2207r1491b2270],
11	P	NN	PERSON	p	conj_and	2	SENT_263	[p14l1515t2211r1555b2264],
12	,	,	O	,	_	0	SENT_263	[p14l1515t2211r1555b2264],
13	Malmqvist	NNP	PERSON	Malmqvist	nn	14	SENT_263	[p14l1579t2207r1854b2270],
14	U	NNP	PERSON	U	conj_and	2	SENT_263	[p14l111t2279r165b2333],
15	,	,	O	,	_	0	SENT_263	[p14l111t2279r165b2333],
16	Odeberg	NNP	O	Odeberg	nn	19	SENT_263	[p14l215t2275r444b2339],
17	J.	NNP	O	J.	nn	19	SENT_263	[p14l484t2279r516b2331],
18	UGT1A	NNP	O	UGT1A	nn	19	SENT_263	[p14l568t2279r767b2323],
19	polymorphisms	NNS	O	polymorphism	conj_and	2	SENT_263	[p14l813t2275r1213b2339],
20	in	IN	O	in	_	0	SENT_263	[p14l1261t2279r1303b2322],
21	a	DT	O	a	det	23	SENT_263	[p14l1352t2292r1379b2323],
22	Swedish	JJ	MISC	swedish	amod	23	SENT_263	[p14l1425t2275r1637b2323],
23	cohort	NN	O	cohort	prep_in	19	SENT_263	[p14l1685t2276r1853b2323],
24	and	CC	O	and	_	0	SENT_263	[p14l107t2343r201b2391],
25	a	DT	O	a	det	28	SENT_263	[p14l250t2360r276b2391],
26	lunnan	JJ	O	lunnan	amod	28	SENT_263	[p14l326t2343r501b2391],
27	chvemhy	NN	O	chvemhy	nn	28	SENT_263	[p14l551t2343r769b2406],
28	paneL	NN	O	panel	conj_and	2	SENT_263	[p14l817t2343r972b2406],
29	and	CC	O	and	_	0	SENT_263	[p14l1023t2343r1116b2391],
30	the	DT	O	the	det	31	SENT_263	[p14l1164t2343r1244b2391],
31	rebﬂon	NN	O	rebﬂon	conj_and	2	SENT_263	[p14l1293t2343r1486b2391],
32	to	TO	O	to	aux	33	SENT_263	[p14l1534t2352r1583b2391],
33	bﬂuubhw	VB	O	bﬂuubhw	infmod	31	SENT_263	[p14l1631t2343r1849b2391],
34	rﬁaynalevebin	NN	O	rﬁaynalevebin	nn	35	SENT_263	[p14l108t2412r538b2475],
35	nuﬂesandlenuﬂes	NNS	O	nuﬂesandlenuﬂes	dobj	33	SENT_263	[p14l570t2412r1081b2459],
36	Eurj	VBP	O	eurj	_	0	SENT_263	[p14l1115t2412r1848b2469],
37	(	CD	NUMBER	(	number	38	SENT_263	[p14l1115t2412r1848b2469],
38	]	CD	NUMBER	]	num	39	SENT_263	[p14l1115t2412r1848b2469],
39	HiPhannacol2006	NN	O	hiphannacol2006	dobj	36	SENT_263	[p14l1115t2412r1848b2469],
40	;	:	O	;	_	0	SENT_263	[p14l1115t2412r1848b2469],
41	62:829	CD	NUMBER	62:829	num	42	SENT_263	[p14l108t2485r457b2528],
42	-837	CD	NUMBER	-837	dep	39	SENT_263	[p14l108t2485r457b2528],
43	.	.	O	.	_	0	SENT_263	[p14l108t2485r457b2528],

1	Leukemia	NN	O	leukemia	_	0	SENT_264	[p14l1904t2722r2149b2764],

